Dietary advice for people with diabetes: the role of carbohydrate in dietary treatment and an assessment of video education by Dyson, P
WWW.BROOKES.AC.UK/GO/RADAR
RADAR 
Research Archive and Digital Asset Repository
Dietary advice for people with diabetes: the role of carbohydrate in dietary treatment and an assessment of video 
education 
Pamela A. Dyson (2010) 
https://radar.brookes.ac.uk/radar/items/c0e6a243-1e36-4820-806d-d3a1c1724266/1/ 
Copyright © and Moral Rights for this thesis are retained by the author and/or other copyright owners. A copy can 
be downloaded for personal non-commercial research or study, without prior permission or charge. This thesis 
cannot be reproduced or quoted extensively from without first obtaining permission in writing from the copyright 
holder(s). The content must not be changed in any way or sold commercially in any format or medium without the 
formal permission of the copyright holders. 
When referring to this work, the full bibliographic details must be given as follows: 
Dyson, P A (2010) Dietary advice for people with diabetes: the role of carbohydrate in dietary treatment and an 
assessment of video education PhD, Oxford Brookes University 
Dietary advice for people with diabetes: the role of 
carbohydrate in dietary treatment and an assessment of 
video education 
Pamela Ann Dyson 
A thesis submitted in partial fulfilment of the requirements 
of Oxford Brookes University for the degree of 
Doctor of Philosophy 
Volume I 
July 2010 
Abstract 
This thesis investigated novel approaches to the delivery of lifestyle education for 
people with diabetes. The principles of dietary advice for diabetes recommend a high 
carbohydrate intake, yet carbohydrate foods raise blood glucose levels significantly. 
Study 1 was designed as a randomised controlled trial to evaluate the effect of a low 
carbohydrate (LC) and low fat (LF) diet on glycaemic control and body weight in 26 
subjects. Weight loss was greater in the LC group (-6.9kg v -2.1kg, p=0.003). 
Glycaemic control improved in both groups with a reduction in Alc in both LC and 
LF groups (-0.3% v -0.2%, p=0.582). There were no significant changes in 
cardiovascular risk assessed by lipid levels and blood pressure. 
Study 2 was designed as a randomised controlled trial to assess a novel education 
programme delivered by video for 42 people newly diagnosed with Type 2 diabetes. 
At six months follow-up, there was a significant increase in knowledge in the video 
intervention group (p=<O.OOOI). There were reductions in A1c (-0.7% v -0.6%, 
p=0.843), total cholesterol (-0.5mmo1l1 v -0.2mmolll, p=0.347) and LDL cholesterol 
(-0.5mmo/1 v 0.2mmolll, p=O.l), and physical activity increased in the intervention 
group. There were no changes in the control group, but these differences failed to 
reach between group significance. 
Study 3 was an intervention study examining structured education in 51 people with 
Type 1 diabetes. At one year's follow-up, there was a significant improvement in Ale 
levels (-0.3%, p=0.03) with no increase in body weight or hypoglycaemia. Diabetes 
related distress improved significantly at six months follow-up and this was 
maintained at one year (p=O.O 19). 
11 
These studies indicate that both education and modification of carbohydrate intake 
have a positive effect on outcomes in people with diabetes. People with Type 2 
diabetes show increased knowledge after video education, and can achieve significant 
weight loss by adopting a low carbohydrate diet. People with long-standing Type 1 
diabetes can significantly improve glycaemic control and quality of life by adopting a 
strategy of carbohydrate counting and insulin adjustment. 
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Dietary advice for people with diabetes: the role of carbohydrate 
in dietary treatment and an assessment of video education 
Chapter 1 
Introduction and background 
1.0. Background 
Diabetes Mellitus (DM) is a chronic condition characterised by high circulating blood glucose 
levels. It is caused by complete or relative lack of the hormone insulin. Insulin is normally 
produced by the pancreas; complete failure to produce insulin leads to Type 1 diabetes and 
insufficient insulin production leads to Type 2 diabetes. Type 1 diabetes usually presents in 
children and young adults, although it can be diagnosed ay any age. Type 1 diabetes is an 
autoimmune condition and accounts for approximately 10-20% of diabetes in the developed 
world. It is treated by a combination of insulin replacement by insulin injection, diet and 
exercise. 
Type 2 diabetes is most frequently diagnosed in middle-aged or elderly people and is due to a 
combination of impaired insulin secretion and resistance to the action of insulin. Type 2 
diabetes is associated with lifestyle factors and is more common in societies with high levels 
of obesity and low levels of physical activity. Approximately 80% of people with Type 2 
diabetes are overweight or obese. Type 2 diabetes affects approximately 80 - 90% of those 
diagnosed with diabetes in the developed world and is treated by a combination of diet, 
exercise, oral medications and, increasingly, insulin. 
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1.1. Physiology of diabetes 
Diabetes is a condition in which the body is unable to utilise the glucose (sugar) in the blood 
for energy due to complete or relative lack of insulin, insulin resistance (a condition where the 
body does not respond adequately to insulin) or a combination of the two. Insulin is produced 
and secreted in the ~-cells of the pancreas and Type 1 diabetes is characterised by complete ~­
cell failure leading to absolute insulin deficiency. Type 2 diabetes is characterised by 
progressIve ~-cell failure and is usually associated with peripheral insulin resistance. 
Complete or relative lack of insulin results in raised blood glucose levels and the diagnosis of 
diabetes is made when the fasting blood glucose exceeds 7.0 mmolll on two occasions (World 
Health Organisation 2000) 
Glucose is the body's pnmary energy source and is provided by foods containing 
carbohydrate. Carbohydrate is found in starchy foods such as bread, potatoes, rice and pasta, 
sugary foods such as sweets, chocolate and cakes and occurs as natural sugars in milk and 
fruit. Excess glucose is stored in the liver and muscle as glycogen and is released into the 
blood stream as blood glucose levels fall. 
Insulin is the hormone responsible for regulating blood glucose levels and is secreted by the 
fl-cells of the pancreas. It is automatically released as blood glucose levels rise following 
carbohydrate intake. Insulin facilitates entry of glucose into muscle and adipose tissue cells to 
be utilised as energy. Lack of insulin leads directly to increased blood glucose levels and the 
symptoms of diabetes - polyuria, polydipsia, fatigue, weight loss and increased susceptibility 
to infections. 
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1.2. Long-term complications of diabetes 
Exposure to high blood glucose levels in the short-tenn will result in the above symptoms, but 
one of the most important features diabetes is the association of sustained hyperglycaemia 
with long-tenn tissue damage. Diabetes is a disease with high rates of morbidity and mortality 
(Zimmet, Alberti et al. 2001). Diabetes is associated with macrovascular complications 
(cardiovascular disease, stroke, peripheral vascular disease) leading to heart attacks, 
haemiplegia and amputations, and with microvascular complications (neuropathy, 
retinopathy, nephropathy) causing foot ulcers, blindness and kidney failure (EURODIAB 
IDDM Complications Study Group 1994; Turner and Holman 1995). There is evidence that 
the risk of complications for people with Type 2 diabetes has been significantly reduced over 
the past thirty years and this reflects improvements in care (Nathan, Zinman et al. 2009). 
However, even those receiving intensive treatment still show relatively high levels of 
complications, with over one fifth developing proliferative retinopathy and 9% developing 
nephropathy and cardiovascular disease. Traditionally, Type 2 diabetes has been regarded as a 
disease of the elderly and of the affluent, but although diabetes remains the most common 
cause for adult blindness in the developed world, the morbidity of diabetes is no longer 
concentrated in the elderly and it affects those aged from 40 upwards. The age of diagnosis of 
Type 2 diabetes is now falling, and 8 to 45% of all diabetes reported among children and 
adolescents in the United States is now Type 2. The few data on follow-up of children suggest 
a high prevalence of microvascular and macrovascular complications among young adults 
who developed Type 2 diabetes during childhood (Fagot-Campagna, Pettitt et al. 2000). 
Diabetes-related mortality and morbidity now affects the working-age population and there 
are economic repercussions in tenns of productivity and health-care costs, with a recent report 
3 
estimating that between 7-12% ofNHS funding is spent on the treatment of diabetes and its 
complications and this amounted to £2.8 billion in 2007 (NICE 2008). 
1.3. Global prevalence of diabetes 
The global prevalence of diabetes has been estimated by the International Diabetes Federation 
(IDF) at 285 million in 2010 (6.4% of world population) and is projected to increase to 439 
million (7.7%) by 2030, of whom over 75% will live in the developing world. This increase in 
prevalence is largely due to Type 2 diabetes and is associated with lifestyle factors. The 
predicted global increase in diabetes is shown below in Table 1.1. 
Table 1.1. Predicted increase in diabetes prevalence 2010-2030 
All diabetes 
Total world population (billions) 
Adult population (billions) 
Number of people (20-79 years) with diabetes (millions) 
W orId diabetes prevalence (%) 
2010 
7.0 
4.3 
285 
6.4 
2030 
8.4 
5.6 
439 
7.7 
Source: Diabetes Atlas 4th edition. ©Intemational Diabetes Federation, 2009 
The rising incidence of diabetes is not confined to developing countries, and the IDF reports a 
wide geographic spread. Table 1.2 below shows the rising pandemic, split by world region. It 
illustrates that the diabetes epidemic, although well established in the developed world, will 
be much more prominent as an increasing problem in the developing world. For example, it is 
predicted that the number of people with diabetes will double in Africa and the Middle East 
and North Africa between 2010 and 2030. 
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Table 1.2. Regional estimates for diabetes (20-79 age group), 2010 and 2030 
2010 2030 
Region Population No of Diabetes Population Noof Diabetes 
(20-79) people prevalence (20-79) people prevalence 
withDM withDM 
(millions) _(millions) (%) (millions) (millions) (%) 
NAC 320 37.4 10.2 390 53.2 12.1 
MENA 344 26.6 9.3 533 51.7 10.8 
SEA 838 58.7 7.6 1200 101.0 9.1 
EUR 646 55.2 6.9 659 66.2 8.1 
SACA 287 18.0 6.6 382 29.6 7.8 
WP 1531 76.7 4.7 1772 112.8 5.7 
AFR 379 12.1 3.8 653 23.9 4.7 
Total 4345 284.6 6.4 5589 438.4 7.7 
Source: Diabetes Atlas 4th edition. ©Intemational Diabetes Federation, 2009 
Key: NAC North America and Caribbean, MENA Middle East and North Africa, SEA South 
East Asia, EUR Europe, SACA South and Central America, WP Western Pacific, AFR Africa 
There is a positive association between the developing diabetes epidemic and obesity as 
shown below (Figure 1.1). However it must be recognised that not all those who are obese 
become diabetic, nor is diabetes solely related to weight gain. Some individuals may be 
grossly obese for years without developing hyperglycaemia. There is also a large genetic 
component in type 2 diabetes, with strong familial traits and high concordance in twins. 
Nevertheless the diabetes epidemic has been strongly associated with the obesity epidemic, 
and there are specific racial groups (especially the Pima Indians) where the combination of 
inherited characteristics and obesity has been associated with diabetes in up to 50% of the 
population (Knowler, Pettitt et al. 1981). 
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Figure 1.1. Proportion of Type 2 diabetes (%) attributable to weight gain by region 
(30+ years) 
1 
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Source: Diabetes Atlas second edition. © Jntemational Diabetes Federation, 2003 
1.4. Prevalence of type 2 diabetes in the United Kingdom 
In the UK, the number of people diagnosed with diabetes is estimated to have increased from 
1.4 million in 1996 to 1.8 million in 2004, equivalent to 3% of the population (DOH 2005). 
Diabetes registers have been introduced in General Practice over the past few years, and a 
random sample of practices reported a diabetes prevalence of 3.3% in 2006 (Millett, Car et al. 
2007). This study also reported higher diabetes prevalence in smaller, more deprived practices 
(3.8%) compared with larger, more affluent areas (2.8%). More recent statistics from Diabetes 
UK, based upon the Quality and Outcomes Framework (QOF) introduced into general 
practice in the UK in 2004, suggest that the overall prevalence of diabetes in 2008 was 3.86% 
(Table 1.3). 
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These statistics do not differentiate between Type 1 and Type 2 diabetes, but as it is generally 
assumed that approximately 80-90% of diabetes in the developed world is accounted for by 
Type 2 diabetes, then it can be estimated that the prevalence of Type 2 diabetes in the UK is 
3% (1.9 million people). An epidemiological approach applying prevalence rates for different 
populations to the 2001 census data has calculated that the prevalence of total diabetes in the 
UK is 4.41%, equating to 2,168,000 people, of which 2,002,000 (92.3%) have Type 2 
diabetes (Forouhi, Merrick et a1. 2006). These reported increases in diabetes are largely 
explained by an increase in the incidence of Type 2 diabetes. 
Table 1.3. Prevalence of diagnosed diabetes in the UK in 2008 
Country 
England 
Northern Ireland 
Scotland 
Wales 
Total 
Number of people with 
diagnosed diabetes 
2,088,335 
60,822 
200,669 
138,988 
2,488,814 
Diabetes prevalence 
(%) 
3.9 
3.3 
3.7 
4.4 
3.86 
Source: Department of Health. Quality and Outcomes Framework (QOF) 2008 
The numbers of people with Type 2 diabetes in the UK are increasing rapidly due to several 
factors. Firstly, Type 2 diabetes is more common in elderly populations as shown by a mean 
age of diagnosis of 53 in the United Kingdom Prospective Diabetes Study (UKPDS 1998), 
and the British population is an ageing population. Although Type 2 diabetes is traditionally 
diagnosed in people over the age of 40, there is a worrying trend in increasing diagnosis in 
young children and adolescents. Type 2 diabetes has been diagnosed in over 100 children in 
the UK and is usually associated with obesity, although some authorities believe that this may 
be an under-diagnosis and as many as 1,400 children may have Type 2 diabetes in the UK 
(Lobstein and Leach 2004). Secondly, obesity is a strong risk factor for the development of 
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Type 2 diabetes and obesity is increasing rapidly in the UK, which has the fastest growing 
rate of obesity in the developed world (Rennie and Jebb 2005). In 2004, 22% of the adu lt 
population in the UK were obese (BMI >30) and 65% overweight or obese (BMI>25) (DOH 
2005). Obesity prevalence in the UK is shown in Figure 1.2. 
Figure 1.2. Prevalence of obesity in the UK (2004) 
Prevalence of obesity (%) 
30 
25 • Men 
o Women 
20 
15 
10 
5 
0 
1980 1999 2002 2004 
Year 
Source: Department of Health. Health Survey for England, 2004 
The risk of developing Type 2 diabetes increases tenfold in people with a BMI of more than 
30. There is also a strong independent risk of Type 2 diabetes associated with reduced 
physical activity (Bassuk and Manson 2005; Hu, Jousilahti et al. 2005). 
Ethnicity is a strong predictor of diabetes; in the UK, people from ethnic minority groups 
have a higher crude prevalence of diabetes than White Europeans. The prevalence of diabetes 
in ethnic minority groups in the UK is shown in Table 1.4. 
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Table 1.4. Prevalence of diabetes amongst ethnic groups in the UK 
Ethnic Group 
White European 
Black African/Caribbean 
South Asian 
Other - Chinese, Japanese, Middle Eastern 
Prevalence (%) 
4.29 
5.69 
6.63 
2.13 
Source: (Forouhi, Merrick et a1. 2006) 
A small study in primary care in London suggests that the higher prevalence of diabetes in 
UK South Asians is accompanied by poorer glycaemic control and this may be related to 
inequality in care, although biological and cultural factors may also contribute (SoIjak, 
Majeed et a1. 2007) 
1.5. Treatment of diabetes 
Treatment for diabetes is a combination of lifestyle factors and medication. Type 1 diabetes is 
treated by insulin therapy, diet and physical activity. Treatment of Type 2 diabetes 
traditionally begins with diet and exercise advice and progresses to medication, usually oral 
agents, and may eventually require insulin injections. Type 2 diabetes is characterised by 
progressive beta-cell failure and requires intensity of treatment over time. Although diet and 
lifestyle changes remain the first-line treatment for Type 2 diabetes, most people (80-90%) 
will require some fonn of medication to achieve long-tenn glycaemic control and reduce the 
chance of complications (Turner, Cull et a1. 1999). For both Type 1 and Type 2 diabetes 
medication is most effective used in conjunction with dietary control and regular physical 
activity. 
1.6. Lifestyle factors 
Nutritional therapy is an integral part of effective management of diabetes and has a vital role 
in helping people with diabetes achieve and maintain optimal glycaemic control and reduce 
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the risk oflong-tenn tissue damage (Bantle, Wylie-Rosett et al. 2008). There is evidence that 
intensive treatment of Type 1 diabetes, especially diet, improves outcomes (Delahanty and 
Halford 1993) and that dietary change, weight loss and increased physical activity are of 
benefit to people with Type 2 diabetes, although there are few well-designed studies 
investigating the most effective approach (Nield, Moore et al. 2007). The aims of dietary 
treatment are complementary to the aims of medical treatment and are summarised below. 
1. 7. Goals of dietary treatment 
• To maintain or improve health through the use of appropriate and healthy food choices 
• To achieve and maintain optimal metabolic and physiological outcomes, including 
reduction of risk for microvascular disease by achieving near nonnal 
glycaemia without undue risk of hypo glycaemia 
reduction of risk for macrovascular disease, including management of body 
weight, dyslipidaemia and hypertension 
• To optimise outcomes in diabetic nephropathy and in any concominant disorder such 
as coeliac disease or cystic fibrosis 
Source: Manual of Dietetic Practice, 2001 
Many countries have published nutritional recommendations for diabetes (Ha and Lean 1998; 
Nutrition sub-committee of the Diabetes Care Advisory Committee of Diabetes UK 2003; 
Bantle, Wylie-Rosett et a1. 2008). Nutritional recommendations have been subject to change 
over the years as evidence emerged for effective dietary treatment of diabetes, and the main 
changes over the years are shown in Fig 1.3 
lO 
Fig 1.3. Timeline of changes in nutritional recommendations for diabetes 
1910 
1925 
Lawrence line diet: 
10% carbohydrate 
70-75% fat 
no added sugar 
1950 
1960 
Restricted dietary 
prescriptions: 
40% carbohydrate 
40-50% fat 
no added sugar 
1983 1993 
BDA dietary 
recommendations: 
50-55% 
carbohydrate 
<35% fat 
:s 1 0% sat fat 
~l 0% poly fat 
10-15% mono fat 
~1O% sugar 
2000 
2003 
Diabetes UK: 
45-60% 
carbohydrate 
<35% fat 
:s10% sat fat 
:s10% poly fat 
10-20% mono 
fat 
~10% sugar 
In the UK it is common practice that the most recently published recommendations from 
Diabetes UK should form the basis for lifestyle advice offered to people with diabetes. The 
main nutritional recommendations are summarised in Table 1.5 
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Table 1.5. Nutritional recommendations for people with diabetes 
Nutrient 
Protein 
Total fat 
Saturated fat 
n-6 polyunsaturated fat 
n-3 polyunsaturated fat 
Monounsaturated fat 
Carbohydrate 
Added sugar 
Salt 
Vitamins and anti-oxidants 
Fructose and sorbitol 
Artificial sweeteners 
Herbal supplements 
Diabetic foods 
Recommendation 
Not <lg per kg body weight 
<35% total energy intake 
<10% total energy intake 
< 1 0% total energy intake 
Eat oily fish 1-2 times/week 
10-20% total energy intake ) 60-70% total 
40-50-% total energy intake ) energy intake 
Up to 10% total energy intake 
<6g NaCI daily 
Encourage natural sources 
No advantage over sucrose 
Useful for the overweight 
No evidence of benefit 
None 
Source: Diabetes UK, 2003 
These recommendations from Diabetes UK show a change in emphasis from the last 
published nutritional recommendations (Nutrition sub-committee of the British Diabetic 
Association's Professional Advisory Committee 1992) and the main changes are summarised 
below: 
I. A greater emphasis on the benefits of regular physical activity and weight management 
2. More flexibility in the proportion of monounsaturated fat and carbohydrate in dietary 
intake 
3. Sucrose no longer restricted to a specific amount 
4. A recommendation to choose foods that have a low glycaemic index 
1.8. Components of effective dietary interventions for diabetes 
There is general agreement amongst the published dietary recommendations about the 
components of an effective diet for treating diabetes, although only the American Diabetes 
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Association attempts to grade the evidence-base for dietary recommendations (Bantle, Wylie-
Rosett et al. 2008). There is also recognition that the majority of recommendations included in 
the latest review by Diabetes UK are concensus-based, rather than evidence-based (Lean 
2003) and that as more evidence emerges, there may well be changes to current advice. At 
present dietary advice conforms to conventional healthy eating advice and includes the 
following recommendations: 
Carbohydrate: 
• Select foods of low glycaemic index 
• Include at least five portions of fruit and vegetables daily 
• Include moderate amounts of sucrose 
Protein: 
• Adopt a moderate protein intake 
Fat: 
• Reduce total and saturated fat 
1.9. Recommendations for carbohydrate intake 
1.9.1. Glycaemic index 
There is still much controversy over the role of glycaemic index (GI) in the dietary 
management of diabetes. The evidence to date investigating the effect of low GI diets in 
people with diabetes remains controversial, with some authorities recommending this strategy 
as first-line treatment (Brand-Miller, Hayne et al. 2003), others recommending that low GI 
diets may have useful role (Nutrition sub-committee of the Diabetes Care Advisory 
Committee of Diabetes UK 2003) and yet others who state that there is insufficient evidence 
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at present and that the amount rather than the type of carbohydrate is a better predictor of 
blood glucose levels (Sheard, Clark et al. 2004). 
The benefits of low GI diets include improved glycaemia control, reduced cardiovascular risk 
and reductions in body weight (Brand-Miller, Hayne et al. 2003). Epidemiological evidence 
from the EUORDIAB study in 2810 people with Type 1 diabetes has shown that there is a 
significant association between the GI of habitual diets and Alc, with significantly lower Alc 
reported in those with low GI diets (Buyken, Toeller et al. 2001). There have been few 
randomised intervention studies investigating the effects of low GI diets in people with both 
Type 1 and Type 2 diabetes, but a meta-analysis of 14 trials published in 2003 has shown that 
low GI interventions lowered Alc by 0.43% compared with subjects adopting a high GI diet 
(Brand-Miller, Hayne et al. 2003). However, the authors point out that these studies were 
generally of short duration (only two lasted more than twelve weeks) and included small 
numbers. A more recent Cochrane review supports this meta-analysis and states that low GI 
or low glycaemic load (GL) diets reduce Alc by a weighted mean of 0.5%. However, the 
relevance of low GI diets in routine clinical practice has been questioned in two more recent, 
larger, randomised trials, both of which were conducted over longer periods of time in people 
with Type 2 diabetes (Ma, Olendzki et al. 2008; Wolever, Gibbs et al. 2008) and which failed 
to show any benefit in glycaemia when compared with other dietary strategies. One study 
compared low GI with high GI and low carbohydrate diets in 162 people over one year and 
reported no change between the three groups in glycaemic control (Wolever, Gibbs et al. 
2008). The second study compared a low GI approach with standard American Diabetes 
Association (ADA) medical nutrition therapy and reported significant reductions in Ale and 
lipid levels in both groups, but no differences between the two groups (Ma, Olendzki et al. 
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2008). There was, however, a reduction in the use of glucose-lowering medication in the low 
GI group compared with the ADA group. 
Studies of the effects of low GI diets in people with diabetes have tended to concentrate on 
glycaemic control, although the benefits of low GI diets in people without diabetes include 
increased weight loss, improvements in cardiovascular risk (Thomas, Elliott et al. 2007) and 
improved physical endurance (Wu and Williams 2006). This evidence that low GI diets are 
more effective for weight loss in people without diabetes has not been replicated for people 
with diabetes and there is no evidence that low GI diets are more effective for weight loss 
than other dietary interventions in people with diabetes. The two more (Ma, Olendzki et al. 
2008; Wolever, Gibbs et al. 2008) recent studies conducted in people with Type 2 diabetes 
reported no significant weight change, despite the fact that obese subjects were recruited to 
both studies. 
There is some evidence that low GI diets reduces cardiovascular risk in people with diabetes 
with evidence for reductions in both total and LDL cholesterol (RizkaIla, Taghrid et al. 2004), 
reductions in C-reactive protein (W olever, Gibbs et at. 2008), and epidemiological evidence 
that low GI diets are associated with higher HDL cholesterol levels in people with Type 1 
diabetes (Buyken, Toeller et at. 2001). 
One of the main criticisms for low GI diets as a strategy for blood glucose control is that there 
are other dietary approaches that are more effective for glycaemic control. The amount of 
carbohydrate, rather than the type, is the best predictor of postprandial glycaemic response 
(Sheard, Clark et al. 2004). There is evidence that dietary approaches addressing the amount 
of carbohydrate (carbohydrate counting) and insulin adjustment can significantly reduce A I c 
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in people with Type 1 diabetes (DAFNE study group 2002). In addition, total energy intake 
has a significant effect on glycaemia. The United Kingdom Prospective Diabetes Study 
(UKPDS) showed that a decrease in energy intake significantly reduced A1c in people with 
Type 2 diabetes (UKPDS 1990). 
It has also been suggested that low GI diets are difficult to understand and implement and that 
this may be counter-productive for those adopting this dietary strategy. It is challenging for 
those well-versed in healthy eating to discover that wholemeal bread and baked potatoes are 
high GI foods and should be reduced if adopting a low GI diet. However, a recent study 
suggests that these criticisms are not substantiated in practice and that implementing a low GI 
diet is no more challenging than adopting a more conventional approach (Ma, Olendzki et al. 
2008) 
In conclusion, there is evidence that reductions in glycaemic load, which may be achieved by 
adopting a low GI diet, improve blood glucose control and cardiovascular risk in people with 
diabetes and this strategy is included as a recommendation in most published guidelines. 
1.9.2. Fruit and vegetables 
Dietary recommendations about fruit and vegetable intake refer to the general health effects of 
eating fruit and vegetables and are not directly related to glycaemic control. Intakes of fruit 
and vegetables show positive associations with a reduction in chronic disease including 
cardiovascular disease and some cancers in people with diabetes (Nothlings, Schulze et al. 
2008). In people without diabetes, epidemiological studies have shown that fruit and 
vegetable intakes are inversely associated with some cancers (Lunet, Valbuena et al. 2007), 
coronary heart disease (He, Nowson et al. 2007) and stroke (He, Nowson et al. 2006). The 
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role of fruit and vegetables in the prevention and treatment of diabetes is unclear. Studies 
have shown that there is no evidence that fruit and vegetables intake have a protective role in 
the development of diabetes (Liu, Serdula et al. 2004; Hamer and Chida 2007), although there 
is some evidence for green leafy vegetables (Bazzano, Li et al. 2008). Fruit contains a natural 
sugar, fructose, and this raises blood glucose levels after eating and although there is no 
evidence that fruit intake has any effect upon diabetes, there is limited evidence for fruit juice 
consumption (Bazzano, Li et al. 2008). 
1.9.3. Sucrose 
There is less importance attached to the role of sucrose (table sugar) in the diet of people with 
diabetes as it has long been known that sugar does not increase blood glucose levels more 
than starchy foods containing the same amount of carbohydrate. There is still widespread 
belief amongst people with diabetes that 'simple sugars' like sucrose are digested and 
absorbed quickly and should be avoided and that 'complex carbohydrates' like bread and 
potatoes are digested more slowly and should form the basis of the diet. There is now robust 
research supporting the evidence that the total amount of carbohydrate eaten will determine 
post-prandial blood glucose levels regardless of whether it is derived from sucrose or starch 
(Sheard, Clark et at. 2004). 
Traditionally table sugar (sucrose) has been restricted for people with diabetes and the 
original nutritional recommendations from the British Diabetic Association (now known as 
Diabetes UK) in 1992 stated that no more than 25g sucrose should be consumed daily. 
Research supports the recommendation that sucrose can provide up to 10% total energy intake 
(Slama, Haardt et al. 1984) without compromising glycaemic control. For the average adult 
consuming 2000 kcal/day this would translate as approximately 50g of sucrose each day. 
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There has been some recent research questioning sucrose intake for people with diabetes, 
particularly concerning the role of the high fructose corn syrup used in the manufacture of 
soft drinks in the development of obesity and diabetes, with some authorities identifying a 
causal link from epidemiological evidence and recommending a reduction in the intake of soft 
drinks (Schulze, Manson et al. 2004; Malik, Schulze et al. 2006). A recent review and meta-
analysis supports reduction in soft drink intake (Vartanian, Schwartz et al. 2007) although in 
the absence of any randomised controlled trials in people with diabetes, it is difficult to draw 
firm conclusions. 
1.10. Recommendations for protein intake 
The role of protein in the management of diabetes remains uncertain, and the effect of protein 
on blood glucose levels, renal function and body weight remain unclear. A study in people 
with Type 2 diabetes has demonstrated that dietary protein appears to promote insulin 
secretion and reduces post-prandial blood glucose levels (Gannon, Nuttall et al. 2003) 
There are further questions about protein's effects on renal function and the development of 
nephropathy in people with diabetes. There is little evidence of a causal relationship between 
protein intake and the development of renal disease and the majority of nutritional 
recommendations state that usual protein intakes (15-20% of total energy intake) are advised 
for people with diabetes (Bantle, Wylie-Rosett et al. 2008). For those with established renal 
disease, a Cochrane review has shown that limiting protein intake reduces the rate of 
progression of renal disease, but that this is not statistically significant (Robertson, Waugh et 
al. 2007). 
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The effects of adopting a high protein (providing >20% total energy intake), weight reducing 
diet for people with Type 2 diabetes have been investigated in some small studies. These 
short-term studies suggest that high protein diets can improve blood glucose levels and 
promote weight loss (Gannon, Nuttall et al. 2003; Gannon and Nuttall 2004), but as these 
diets are also low in carbohydrate it is difficult to evaluate the different effects of altering the 
macronutrient content of the diet. The American Diabetes Association continues to 
recommend that high protein diets should not be promoted for weight loss as the long-term 
effects of high protein intakes on renal function are unknown. 
1.11. Recommendations for fat intake 
All authorities recommend a reduction in both total and saturated fat for people with diabetes, 
and this advice is associated with the risk of cardiovascular disease. The risk of 
cardiovascular events in people with diabetes is 2-4 times that of the non-diabetic population 
and the majority of dietary recommendations for people with diabetes are the same as those 
with pre-existing cardiovascular disease as they appear to have similar risk (Nutrition sub-
committee of the Diabetes Care Advisory Committee of Diabetes UK 2003; Bantle, Wylie-
Rosett et al. 2008). 
1.12. The effectiveness of lifestyle modifications in treating Type 2 diabetes 
1.12.1. Dietary modification 
Dietary modification has been shown to be effective in both Type 1 and Type 2 diabetes, 
although the emphasis varies between the two. People with Type 1 diabetes are encouraged to 
assess carbohydrate intake at each meal and snack, and to inject insulin to match the amount 
of carbohydrate eaten. This strategy has been shown to improve gJycaemic control in two 
large randomised controlled trials (DCCT study group 1993; DAFNE study group 2002). 
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Dietary intervention, including weight loss, at diagnosis of Type 2 diabetes has been shown to 
be effective in the short-tenn. The UKPDS reported that in 5,000 people newly diagnosed 
with Type 2 diabetes, dietary modification reduced fasting plasma glucose from 11.5 to 8.3 
mmol/l over three months and this corresponded to a drop in A1c (a longer tenn measure of 
levels of glycaemia) from 9.1 to 7.0% (Manley, Stratton et al. 2000) This reduction in blood 
glucose level was associated with a reduction in weight of 3kg. However, the UKPDS went 
on to show that after 10 years of treatment in the group randomised to conventional treatment 
(diet alone unless clinical indication that more intensive treatment was required) only 8% 
were able to achieve the target value of fasting plasma glucose <7.8 mmol/l (Turner, Cull et 
al. 1999). This result reflects the nature of Type 2 diabetes, characterised by beta cell failure 
over time, as well as the failure of dietary strategies alone to control plasma glucose levels 
effectively. There remains some uncertainty about the effectiveness of dietary modification 
over the long-tenn and a recent Cochrane review (Nield, Moore et al. 2007) concluded that 
there are no high quality data in the efficacy of the dietary treatment of Type 2 diabetes. This 
review states that these conclusions reflect a lack of high quality studies that examine a range 
of interventions rather than that dietary interventions are ineffective in the treatment of Type 2 
diabetes. At present, it is still not clear which dietary strategies are most effective in the 
treatment of Type 2 diabetes, but the lack of effectiveness of therapy underpins the idea that 
there may well be a more effective way of delivering lifestyle advice which can have positive 
outcomes. 
A recently published study from the United States, the Look-AHEAD (Action for HEAlth in 
Diabetes) study (Pi-Sunyer, Blackburn et al. 2007) set out to test the efficacy of lifestyle 
interventions in people with established Type 2 diabetes and showed that a structured 
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education programme can improve biomedical outcomes significantly over one year. This was 
a large, multi-centred randomised controlled trial with over 5,000 patients taking part. The 
patients were randomised to either intensive diabetes education and support or usual care. All 
medical diabetes care remained the responsibility of the patients' diabetes physician, 
regardless of study allocation. At the end of I year, those who received the lifestyle 
intervention showed a significant reduction in HbAlc of 0.8% (from 7.2% to 6.6%) compared 
with no change in the control group receiving usual care. This improvement in glycaemic 
control was associated with a reduction in weight of 8kg, with no change in weight in the 
control group. There were also significant improvements in cardiovascular risk factors with 
lower blood pressure, increases in physical fitness and improvements in lipid profile in the 
intervention group. The Look-AHEAD study utilised experience from the Diabetes 
Intervention Programme (Knowler, Barrett-Connor et al. 2002) that had identified lifestyle 
strategies that resulted in a 60% reduction in progression to type 2 diabetes in individuals with 
impaired glucose tolerance (IGT) and who were at high risk of diabetes. The strategies 
employed in look-AHEAD study included dietary and physical activity strategies, and a key 
component was tailoring the lifestyle programme to the individual. 
1.12.2. Components of effective dietary intervention 
Evidence suggests that the most effective component of dietary intervention for people with 
Type 1 diabetes is strategies to address carbohydrate assessment and insulin adjustment. 
There is little evidence for the relative importance of other macronutrients (protein and fat) in 
the diet of people with Type 1 diabetes. 
For people with Type 2 diabetes, the limited evidence available suggests that strategies 
employed to maximise the effectiveness of dietary treatment include energy restriction 
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resulting in weight loss and increased physical activity. The relative importance of and their 
role in glycaemic control and weight loss has yet to be fully investigated. There has been very 
little work done on assessing the relative importance of the separate contributions of diet and 
physical activity to blood glucose control and management of Type 2 diabetes. 
Effective dietary strategies employed in Look-AHEAD emphasised energy restriction and this 
was achieved by utilising three approaches comprising individual portion-controlled meal 
plans, provision of liquid replacement meals and frozen prepared meals and a reduction in fat 
intake aiming to provide <30% energy as total fat and <10% as saturated fat. In addition, 
recent evidence has supported the role of moderate protein intakes in weight loss (Westerterp-
Plantenga, Nieuwenhuizen et al. 2009) and it was recommended that a minimum of 15% of 
total energy intake was derived from protein. 
1.12.3. Physical activity 
Epidemiological studies have demonstrated that physically active individuals are less likely to 
develop Type 2 diabetes (Manson, Rimm et al. 1991; Manson, Nathan et al. 1992) and that 
sedentary behaviour is positively associated with Type 2 diabetes (Hu, Leitzmann et al. 2001; 
Hu, Li et al. 2003). It has also been established that physical activity can help prevent the 
development of Type 2 diabetes when used in combination with diet and weight loss 
(Tuomilehto, Lindstrom et at. 2001; Knowler, Barrett-Connor et al. 2002). The role of 
physical activity in the treatment of diabetes is less certain, with contradictory evidence 
suggesting that there may be little benefit in terms of glycaemic control for those with Type 1 
diabetes, although there is a reduction in cardiovascular risk (Kavookjian, Elswick et al. 
2007). Evidence of benefit for those with Type 2 diabetes suggests that glycaemic control 
improves in the physically active with a weighted mean reduction of 0.66% in Ale (Boule, 
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Haddad et al. 2001). In addition, cardiovascular risks are reduced, although there is no 
evidence of weight loss with increased physical activity (Boule, Kenny et a1. 2003). 
Physical activity strategies employed in the successful Look-AHEAD study included home-
based exercise programme and a gradual progression to 175 minutes of moderate activity 
each week 
1.13. Medical Treatment of Diabetes 
People diagnosed with Type 1 diabetes are treated by a combination of insulin replacement 
via injection or pump therapy and diet. Diet and lifestyle are traditionally seen as the first-line 
treatment for Type 2 diabetes, but the majority of people (80-90%) will require some form of 
medication to minimise the risk of long-term tissue damage or complications. 
1.13.1. Oral medications 
There are five different types of oral medication available to treat Type 2 diabetes and their 
generic name, brand names, action, dosage and side effects are summarised in Table 1.6. 
Metformin (the only available biguanide) is usually given as the first-line agent and is the 
most commonly prescribed drug for diabetes. It has been used in the UK since the 1970s. It is 
derived from guanidine, an active ingredient found in French lilac and its main effect is to 
increase insulin sensitivity, it does not cause weight gain and there is limited evidence that it 
may be associated with a reduced risk of cardiovascular events (NICE 2008). Around 10% of 
patients do not respond to metformin and approximately 5-10% patients a year on metformin 
will need another agent in addition. If maximum tolerated doses of metformin fail to achieve 
target glucose levels, a second agent is commonly added to metformin and this is either a 
sulphoylurea agent, a thiazolidinedione or a metiglinide. 
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Table 1.6. Oral bypoglycaemic agents for treatment of diabetes 
Drug - generic name Brand name Action Dosage Side-effects 
Biguanides: Glucophage Increases insulin sensitivity SOO-2S00mg daily with Nausea, indigestion, 
• Metfonnin Decreases liver glucose food diarrhoea 
• Extended release Glucophage SR production SOO-2S00mg once daily 
metfonnin 
Sulphonylureas: 
• Gliclazide Diamicron Stimulate insulin production 40-160mg twice daily Hypoglycaemia, 
• Extended release Diamicron MR by the pancreas 30-120mg once daily weight gain 
gliclazide 
• Glibenclamide Daonil, Euglcon S-lSmg twice daily 
• Glipizide Glibenese, Minodiab 2.S-20mg twice daily 
• Glimeperide Amaryl 1-4mg once daily 
Thiazolidinediones: 
• Rosiglitazone Avandia Enhance the action of insulin 4-Smg once daily Weight gain, fluid 
• Pioglitazone Actos 15-45mg once daily retention 
Metiglinides: 
• Repaglanide Prandin Stimulate insulin secretion 2-4mg with meals Hypoglycaemia, 
• Nateglinide Starlix post -prandially 60-1S0mg with meals weight gain 
Alpha-glucosidase inhibitor 
• Acarbose Glucobay Reduces speed of absorption SO-200mg with meals Wind, diarrhoea, 
of carbohydrate from the gut bloating 
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Sulphonylureas were discovered by chance during the Second World War when it was 
observed that soldiers treated with sulphonamide antibiotics experienced a reduction in blood 
glucose levels. These drugs act directly on the pancreas and stimulate insulin production. 
Thiazoladinediones (also known as glitazones) have been used only relatively recently since 
1997. They are taken once daily, starting with a low dose, and take up to three months to have 
their maximum effect. Their action is to reduce insulin resistance and they produce a 
lowering of blood glucose levels comparable to metformin or sulphonylurea. Glitazones tend 
to be given as second or third-line therapy, partly because of the 10-12 weeks it takes for them 
to have effect. Generally a person is offered a combination of metformin and a sulphonylurea 
before a glitazone is added in. Glitazones are also often prescribed if a person cannot tolerate 
metformin. 
Meglitinides are short-acting agents that are used to control post-prandial rises in glucose. 
They are taken before main meals and stimulate insulin production for that meal. Essentially, 
they may be viewed as a short-acting sulphonylurea. The fifth class of oral agent is acarbose, 
an alpha-glucosidase inhibitor, which relies upon reducing the rate of carbohydrate digestion 
and controlling post-prandial blood glucose rises. This agent has unpleasant side-effects of 
wind, abdominal pain, bloating and diarrhoea. As its effect is moderate compared to the other 
agents available, it is rarely prescribed. 
1.13.2. Insulin 
Insulin therapy is essential for those with Type 1 diabetes and is a necessary adjunct to 
therapy in people with Type 2 diabetes who are failing to achieve target blood glucose levels 
although they are taking maximum doses of oral hypoglycaemic agents. There are many 
different insulins available and selection of the appropriate type, dose and regimen depends 
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upon the lifestyle of each individual. There are many different forms of insulin available in 
the UK but until the 1980s insulin was only available by extraction and purification from the 
pancreas of cattle and pigs. This animal insulin is still in use but has been largely replaced by 
human insulin that is engineered genetically in laboratories. Newer analogue insulin has been 
introduced over the past five years in an attempt to replicate the action of naturally produced 
insulin in the body. Table 1.7 shows the main types of insulin in use in the UK today. 
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Table 1.7. Insulin treatment for diabetes 
Type of insulin Examples of insulin Onset of action Peak action Length of action 
Rapid-acting analogue NovoRapid (Aspart), Humalog (Lispro), 5-10 minutes 90 minutes 3 hours 
Apidra (Glulisine) 
Short-acting Actrapid, Humulin S, Insuman Rapid, 30 minutes 2 hours 4-8 hours 
Hypurin Bovine Neutral, Hypurin Porcine 
Neutral 
Medium and long-acting Insulatard, Humulin I, Insuman Basal, 90 minutes 4 - 12 hours 12-24 hours 
Hypurin Bovine Isophane, Hypurin Porcine 
Isophane 
Long-acting analogue Lantus (Glargine), Levemir (Detemir) 18 -24 hours 
Mixed insulin Mixtard 10, 20, 30 and 40, Humulin M3, 30 minutes 2 -8 hours 16-20 hours 
Insuman Comb 15,25 and 50, Hypurin 
Porcine 30/70 Mix 
Analogue mixed insulin Humalog Mix 25 and 50, NovoMix 30 5-10 minutes 90 minutes 16-20 hours 
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1.13.3. Incretin agonists and inhibitors 
Two new agents for treatment of type 2 diabetes have recently been introduced and they are 
known as incretin agonists and DPP-4 inhibitors. Incretins are gut hormones that are secreted 
in response to ingestion of nutrients and the most widely researched are human glucagon-like 
peptide (GLP-I) and glucose-dependent insulinotropic peptide (GIP). Incretins have four 
main physiological actions including: 
1. Stimulation of glucose-dependant insulin secretion from the pancreas 
2. Reduction in glucagon secretion 
3. Inhibition of gastric emptying, thus promoting satiety 
4. Weight reduction 
Two incretin agents are available for treatment of type 2 diabetes (exenatide and liraglutide) 
and these are both synthetic hormones that act like GLP-I. They are injected therapies and are 
often introduced as an alternative to insulin therapy when people with Type 2 diabetes are 
unable to achieve glycaemic control on oral agents alone. One advantage of these therapies is 
that they do not induce hypoglycaemia as their action is glucose-dependent. There are two 
documented side-effects; nausea associated with their effects upon gastric emptying and 
pancreatitis. 
Incretins are rapidly degraded in the body by the action of an enzyme known as dipeptidyl 
peptidase 4 (DPP-4). The introduction of DPP-4 inhibitors, which act to increase 
concentrations of endogonous, naturally occurring incretin hormones by preventing rapid 
degredation by DPP-4, is another strategy that has been developed to help control blood 
glucose levels in people with diabetes. Two oral DPP-4 inhibitors have been developed to 
date (sitagliptin and vildagliptin) and are used as an add-on therapy to metformin or 
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glitazones when there is inadequate glycaemic control. DPP-4 inhibitors have a weaker action 
than the injected incretin agonists and do not promote weight loss. The most frequently 
documented side-effect is that of nausea. 
Table 1.8 shows the relative effectiveness of all the medical treatments available for Type 2 
diabetes and their effects upon A1c and body weight. 
Table l.8. Effects of medication for diabetes on Alc and weight 
Medication 
Oral medication: 
Metformin 
Sulphonylureas 
Thiazolodinediones: 
Rosiglitazone 
Pioglitazone 
Metiglinides: 
Repaglinide 
Nateglinide 
Alpha-glucosidase inhibitors 
Insulin 
Incretins: 
GLP-1 agonists 
DPP-4 inhibitors 
1 (Bolen, Feldman et al. 2007) 
2 (Holman, Thome et a1. 2007) 
3 (Amori, Lau et al. 2007) 
NR: not reported 
Change in Ale (%) 
-1.141 
-1.521 
-1.161 
-0.971 
-1.321 
-0.541 
-0.771 
-0.8 to _1.42 
-0.973 
-0.743 
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Change in body 
weight (kg) 
0.31 
3.81 
3.1 1 
3.01 
NRI 
NRI 
_0.1 1 
1.9 to 5.72 
-2.373 
0.53 
1.14. Effectiveness of medical treatment of diabetes 
1.14.1. Oral agents 
The most robust evidence for the relative effectiveness of the two most commonly used oral 
agents was supplied by the UKPDS in 1998 (UKPDS 1998). This study evaluated long-tenn 
follow-up of people with Type 2 diabetes who were randomly allocated to sulphoylureas or 
metfonnin and showed a significant reduction in Ale over ten years. There were no 
differences between the two groups for any outcomes, with the exception of body weight (a 
mean gain of 3 kg in the sulphonylurea group vs no change in the metformin group), 
hypoglyacaemia and a reduction in cardiovascular events in the metformin group (UKPDS 
1998). 
1.14.2. Insulin therapy 
Insulin is essential treatment for Type I diabetes, and evidence suggests that good glycaemic 
control is associated with a reduction in long-term tissue damage (DCCT study group 1993). 
In the DCCT study, those in the intervention group achieved better glycaemic control than 
those in the control group by increasing the number of injections to at least four each day (one 
injection of long-acting insulin and three injections of short-acting insulin with meals; the 
basal prandial regimen) or by using an insulin pump. 
There is very little evidence for the most effective method of insulin therapy in treating Type 
2 diabetes. Insulin was included as a treatment option in the UKPDS and showed no greater 
benefit in terms of glycaemic control compared with groups allocated oral therapy (UKPDS 
1998). Three insulin regimens are commonly used when initiating therapy in people with 
Type 2 diabetes. Most commonly, one injection of long-acting insulin (usually at night)is 
introduced together with maintenance of oral therapy. Alternatively, two injections (usually 
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before breakfast and before the evening meal) of biphasic (mixed) insulin may be initiated. 
Any sulphonylurea agent would usually be discontinued although metformin therapy is 
usually maintained. The third and most complex regimen is the introduction of a basal bolus 
(prandial) regimen of one injection of medium or long-acting insulin at night, and three 
injections before main meals of rapid or short-acting insulin. Any sulphonylurea agent would 
usually be discontinued. A recent trial, the 4-T (Treating To Target in Type 2 diabetes) 
compared three insulin regimens; one injection of long-acting insulin, two injections of 
biphasic insulin and three injections of rapid-acting insulin before meals and showed that all 
three regimens significantly reduced Ale from baseline over one year. The regimen of one 
injection per day showed less of a reduction in Al c compared to the other groups, but there 
was also less hypoglycaemia and weight gain in this group (Holman, Thorne et al. 2007). 
1.15. Treating Type 2 diabetes in Primary Care 
Traditionally, diabetes education has been largely provided by secondary care with the 
majority of diabetes specialist dietitians and nurses based within diabetes centres in hospitals, 
but the increasing prevalence of Type 2 diabetes and the recent introduction in 2003 of the 
General Medical Services (GMS) contracts in primary care have resulted in the growing 
responsibility for first-line treatment of Type 2 diabetes being assumed by primary care 
(Fitzsimons, Wilton et al. 2002). This movement from secondary to primary care has been 
supported by the introduction of the Quality and Outcomes Framework (QOF) as part of the 
new GMS contracts in 2004. 
1.16. The Quality and Outcomes Framework 
The QOF is the annual reward and incentive programme detailing General Practice (GP) 
results. It was introduced in 2004 and participation is purely voluntary, although in 2006 over 
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90% of general practices within the UK took part in the scheme (Khunti, Gadsby et al. 2007). 
QOF awards GP surgeries achievement points, which translate into financial incentives, for 
managing many chronic disease e.g. cardiovascular disease, asthma and diabetes, for how 
well the practice is organised, for the patient's experience and for the amount of additional 
services offered such as child and maternity services. In April 2006, a revised QOF was 
introduced and was divided into four domains including clinical, organisational, patient 
experience and additional services. 
The total allocation of points is 1,000, and the majority of points (655) is allocated to the 
clinical domain. The clinical domain consists of 80 indicators across 19 clinical areas and 
diabetes is allocated the highest number of indicators (18) compared to the next highest 
(cardiovascular disease with 10 indicators). Importantly, the indicators for diabetes include 
outcomes together with maintaining current records. For example, practices are awarded 
points for recording Al c over the past 15 months, and more points are allocated if a certain 
percentage of the population have Alc results below the two cut-off points of 10% and 7.4%. 
1.17. Provision of dietetic support in primary care 
'Practical dietary assessment and education play an essential part in the management of the 
diabetic condition.' So begins a report published by the British Diabetic Association (BDA), 
now known as Diabetes UK, in 1987 (Nutrition sub-committee of the British Diabetic 
Association 1987). This report, which investigated the provision of dietetic advice for people 
with diabetes and took place during 1984, first highlighted the inequality in the service 
provision in the UK. It reported that 20% of all hospital diabetes clinics were being run 
without the presence of a dietitian. In nearly 30% of all health districts, general practitioners 
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had no access to dietitians and freely admitted that they rarely discussed their patient's diet, 
whether a dietitian was available or not. 
This report showed that there was great variability in provision of dietitians involved in 
diabetes education in different parts of the UK, ranging from over 3 dietetic whole-time 
equivalents (WTE) per one hundred thousand catchment population in North West Thames to 
just over 1 WTE in the West Midlands. Furthermore, four districts (South West Herts, 
Hereford, Bath and Oxford) agreed to log the actual amount of time spent conducting one-to-
one interviews with people with diabetes over a 2-week period in February 1985. This 
showed that there were further inequalities in time spent with people with diabetes, ranging 
from 20.2 hours per one hundred thousand catchment population in South West Herts to 5.2 
hours in Oxford. This is the first documented evidence of the under-provision of dietetic time 
to diabetes in Oxford. This report went on to recommend the minimum service that should be 
offered in diabetes care and stated that there should be a minimum of 15 hours of direct 
dietietic time per 100 000 population per week. Only 17% of the areas surveyed in this study 
met this standard. A further recommendation was made that there should be 1.5 WTE 
dietitians for every 250 000 population. It also recommended that with the increasing trend to 
treat people with diabetes in the community that there should be 'early action' to address the 
lack of care in the community. 
Publication of this report was followed by a second survey in 1996 and which was published 
in 2000 (Nelson, Lean et al. 2000). The marked difference in regional provision of services 
was still noted, with ranges of 2.0 to 27.6 hours per 100000 thousand population per week, 
and a median of 10.7 h/100000/week and only 37% of the health areas (compared with 17% 
in 1987) reported providing the minimum levels of care recommended in the 1987 report. 
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Publication of this report was followed by a document recommending core staffing levels for 
an average district specialist diabetes care team and included recommendations for dietetic 
services (Diabetes UK 2000). The main recommendations for dietetic services included the 
following: 
• 1.5 state-registered dietitians with a special interest in diabetes per 250 000 population 
• 15 hours direct contact time per 100000 population per week 
• dietetic consultation within 4 weeks of diagnosis 
• non-crisis review annually 
Again, provision of services in Oxford did not compare well to the rest of the country and it 
was decided to audit the dietetic service to people with diabetes during 1999-2000 within 
Oxfordshire and compare this to the published recommendations. Over 2,500 people with 
diabetes were seen by dietitians in Oxfordshire during this period, the majority being seen in 
primary care. The population of Oxfordshire at this time was approximately 600 000 and the 
Table 1.9 shows the comparison between service provision with the recommendations. The 
service in Oxfordshire is fragmented and divided between primary and secondary care. 
Secondary care is provided to out-patients by a specialist diabetes dietitian at the Oxford 
Centre for Diabetes, Metabolism and Endocrinology (OCDEM) at the Churchill Hospital and 
by general dietitians at the Horton Hospital in Banbury. All diabetic in-patients at all hospitals 
within Oxfordshire are seen by general dietitians or by those with specialities other than 
diabetes e.g. renal, gastroenterology. In addition children with diabetes are seen by a part-time 
paediatric dietitian who is based at the John Radcliffe hospital. Provision in primary care is 
provided by a team of community dietitians who run clinics in various parts of the county. 
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Table 1.9. Comparison between care recommendations from Diabetes UK and service 
provision in Oxfordshire 
Recommendation Oxfordshire 
1.5 WTE per 250 000 population 1.5 WTE per 600 000 population 
90 hours direct contact time per week 40 hours direct contact time per week 
Consultation within 4 weeks of diagnosis Only applicable to newly diagnosed type 
1 patients and paediatric services 
Annual review Available at Horton hospital, Banbury 
and to paediatric patients 
A further report published in 2002 (Winocour, Mearing et al. 2002) confirmed that little had 
changed to improve dietetic services to people with diabetes, with only 3% able to provide the 
recommended 22 hours per week and annual reviews available in only 15%. 
The conclusion from this body of evidence is that provision of dietetic advice to people with 
diabetes within Oxfordshire has been under-resourced and fails to meet national targets. 
Issues around the funding of dietetic services mean that it is unlikely that there will be any 
increase in diabetes dietitians over the next few years and it may be more efficient to utilise 
the skills of the specialist secondary care team to provide support to primary care in the 
delivery of lifestyle education to people with diabetes. 
1.IS. Delivering diabetes education in primary care 
The emphasis of most published reports is on the provision of dietetic care from hospital 
based diabetes centres, whereas the majority of care for those with Type 2 diabetes now takes 
place in primary care. General practitioners (GPs) are increasingly responsible for provision 
of care for 75% of their patients with diabetes (Pierce, Agarwal et at. 2000) and both the 
increasing incidence and prevalence of diabetes and the new OMS contracts for primary care 
35 
suggest that the burden of care will fall increasingly on the primary care team. A recent report 
highlighted the inadequate provision of dietetic services in primary care and made the 
statement that 'there is an urgent need to develop effective techniques for lifestyle alterations 
that can be used in the primary care setting' (Winocour, Mearing et al. 2002). Diabetes care 
can be complex and demanding for both patients and primary healthcare workers alike 
(Agarwal, Pierce et al. 2002). However, GPs are keen to provide diabetes care and their 
patients prefer the primary health care setting. A King's Fund report examining patients' 
perspectives on the way ahead for self-management for long-term conditions identified that 
patients feel that an on-going relationship with their primary health-care team is fundamental 
to enhancing self-management (Corben and Rosen 2005). There is little evidence assessing 
the relative effectiveness of diabetes education delivered in primary rather than secondary 
care, although two large studies demonstrating positive outcomes of education have taken 
place in community settings (Davis, Heller et al 2008, Deakin, Cade et al 2006) and a recent 
review reports that group education is especially effective in community gathering places 
(Loveman, Frampton et al 2008). 
The challenge is to provide education to patients that can be delivered by the primary health 
care team, that is cost-effective and that is shown to have a positive effect upon the health of 
people with diabetes. GPs are aware of their duty of care to provide nutrition information to 
people with diabetes, a recent study in Australia showing that 86% agreed that nutrition 
advice was necessary for people with diabetes and 79% provided some nutrition counselling 
(Nicholas, Pond et al. 2005). A recently published survey of primary care in the Trent region 
showed that just under one third (31.3%) of patients with Type 2 diabetes in primary care are 
being managed by diet alone and it is important that these patients receive the best possible 
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lifestyle advice (Hippisley-Cox and Pringle 2004). There does seem to be a relationship 
between doctors' nutrition counselling skills and the percentage of patients receiving dietary 
advice and this will exert an effect upon patients (Agarwal, Pierce et a1. 2002). Overall, there 
seems to be some recognition amongst GPs that nutrition counselling is important for people 
with diabetes, but that GPs do not generally have the necessary resources or skills to effect 
this. Family physicians are keen to implement lifestyle interventions for Type 2 diabetes, but 
are hampered by barriers and use of ineffective strategies. It is likely, under present economic 
restraints within the health service in the UK that there will never be a sufficient number of 
dietitians to deliver dietary advice to people with Type 2 diabetes in the primary care setting 
and that other methods of delivering this information should be designed and evaluated. 
1.19. Delivering diabetes education in secondary care 
As GPs have assumed more responsibility for care of people with Type 2 diabetes, there has 
been recognition that the delivery of education for those with Type 1 diabetes is more 
specialist and should include a structured approach (Diabetes UK 2005). In the UK, many 
centres have adopted structured group education for people with Type 1 diabetes and run 
education programmes that address carbohydrate counting and insulin adjustment. A 
randomised controlled trial has demonstrated that this approach improves glycaemic control 
and quality of life, but this has not been shown clearly in clinical practice, despite many 
centres adopting structured group education for people with Type 1 diabetes. 
1.20. Summary 
Although there is some evidence for the effectiveness of lifestyle advice in people with 
diabetes, there remains some uncertainty about both the content and the delivery of education 
programmes. One of the most contentious issues concerns the type and amount of 
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carbohydrate that should be recommended to people with diabetes. Recent recommendations 
state that there should be more flexibility in the amount of carbohydrate in the diet of people 
with diabetes, and that this may improve glycaemic control and weight loss. In addition, new 
approaches to delivering lifestyle education may improve outcomes for people with diabetes. 
Traditionally, consultations take place on an individual basis, but the combination of a 
shortage of dietitians and the increasing prevalence of Type 2 diabetes has meant that many 
people receive little, if any, advice at diagnosis. People with Type 1 diabetes have long been 
subject to rigid dietary prescriptions and may benefit from more flexibility. Novel, innovative 
methods to deliver lifestyle advice are urgently needed and should be subject to rigorous 
evaluation before application to clinical practice. 
1.21. Hypothesis 
The over-arching hypothesis for this thesis is that the introduction of a more flexible approach 
to carbohydrate intake and utilising more innovative methods of delivering lifestyle education 
to people with diabetes will improve knowledge, glycaemic control and cardiovascular risk. 
Study 1 is designed to investigate the role of carbohydrate in weight loss and glycaemic 
control in people with Type 2 diabetes. If reducing carbohydrate intake is related to weight 
loss, then overweight people with Type 2 diabetes who adopt a low carbohydrate diet will 
show significant weight reduction compared to those who adopt a relatively high 
carbohydrate diet. 
Study 2 is designed to examine the effects of a novel method if delivering education by means 
of video for people newly diagnosed with Type 2 diabetes. If video education is effective for 
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the treatment of Type 2 diabetes, then exposing people to video education will increase 
knowledge of diabetes and may improve glycaemic control and cardiovascular risk. 
Study 3 is designed to explore an innovative approach to education in people with Type 1 
diabetes; that of carbohydrate counting and insulin adjustment taught in a group setting. If 
matching insulin to the amount of carbohydrate eaten is effective in improving gJycaemic 
control and quality of life in people with Type 2 diabetes, then introducing this system will 
show improvements in these parameters. 
1.22. Aims 
The aims of these three studies are: 
• To design and assess the impact of a low carbohydrate diet on body weight, Ale, 
ketone and lipid levels in people with and without Type 2 diabetes 
• To develop a novel video-based lifestyle education programme for people newly 
diagnosed with Type 2 diabetes and to evaluate changes in knowledge, glycaemic 
control and quality of life 
• To evaluate the effect of an education programme for carbohydrate counting and 
insulin adjustment on glycaemic control and quality of life in people with Type 1 
diabetes. 
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Chapter 2 
Materials and methods 
2.0. Introduction 
This chapter is divided into five main sections exploring the methodology and materials for 
assessment of the following: 
1. Study protocol and designs for: 
- Study 1: an investigation of low carbohydrate diets in the treatment of Type 2 
diabetes 
- Study 2: an assessment of video lifestyle education for people newly diagnosed with 
Type 2 diabetes 
- Study 3: an assessment of carbohydrate counting and insulin adjustment for people 
with Type 1 diabetes 
2. Statistical analyses 
3. Dietary intake, quality oflife and diabetes knowledge 
4. Anthropometric measurements 
5. Blood chemistry 
2.1. Study protocols and design 
2.1.1. Ethical approval and compliance with Good Clinical Practice (GCP) 
A study protocol was written and submitted to the Oxford Clinical Research Ethics 
Committee (OxREC) for Study 1 (low carbohydrate diet study) and Study 2 (video 
education). Both studies were approved by the ethical committee, the low carbohydrate study 
was allocated the reference OxREC 04/Q1606/39, and the video education study reference 
OxREC C03.097. All subjects taking part in Studies 1 and 2 received subject information 
sheets and provided informed consent before undertaking the trial. Copies of the letters 
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confirming ethical approval can be found in Appendix 1 of Volume 2. Copies of the subject 
information sheets and consent forms can be found in Appendices 2 and 3 respectively. Study 
3, which was designed to investigate the effect of carbohydrate counting and insulin 
adjustment in people with Type 1 diabetes was submitted to the Oxford Clinical Research 
Ethics Committee and received verbal Chairman's approval. The Chairman stated that this 
study was assessed to be part of clinical audit and, as such, was not considered to be subject to 
formal submission to the ethics committee. 
In compliance with recommended data collection and storage, Case Report Forms (CRF) and 
Source Data Notes (SDN) were established for all three studies. These forms were completed 
by members of the research team. Data were stored on computer using Data Protection Act 
1999 guidelines and using pre-assigned randomisation numbers. Patients were asked, on the 
consent form, for permission to access their medical records. 
Safety monitoring included recording adverse events (AE). An adverse event (AE) is any 
unintended or unfavourable sign, symptom or disease occurring during the course of the 
study, whether or not believed to be related to the intervention. This includes any worsening 
of a medical condition that was present at time of entry into the study and any clinically 
significant change in laboratory values. A serious adverse event (SAE) is an adverse event 
that falls in any ofthe following categories: 
Results in death 
Is life-threatening 
Requires admission to hospital as an inpatient 
Is an important medical event which requires intervention to prevent one of the above. 
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All adverse events were reported in subject's clinical and trial files and were reported to the 
study co-ordinator who was responsible for reporting serious adverse events to the ethics 
committee. During the low carbohydrate study, the video education study and the assessment 
of carbohydrate counting and insulin adjustment study there were no serious adverse events. 
2.1.2. Low carbohydrate diet study (Study 1) 
2.1.2.1. Study design 
This study was designed as a randomised, parallel group study to assess the safety and 
efficacy of a low carbohydrate diet for people with established Type 2 diabetes. 
Randomisation was undertaken by means of sealed envelopes equivalent to the number of 
subjects and filled fifty-fifty with an indicator of either a low carbohydrate diet or healthy 
eating advice. Two separate sets of envelopes were prepared for both diabetic and non-
diabetic subjects. An independent observer witnessed randomisation. 24 subjects were 
invited to take part in the study. They were randomly allocated as follows: 
12 subjects with Type 2 diabetes randomly allocated to: 
6 subjects followed a low carbohydrate diet for 12 weeks 
6 subjects followed a standard healthy eating weight reduction programme 
12 subjects without diabetes randomly allocated to: 
6 subjects followed a low carbohydrate diet for 12 weeks 
6 subjects followed a standard healthy eating weight reduction programme 
2.1.2.2. Intervention 
Groups were randomised by allocation. Both groups followed the same protocol. The 
intervention group was asked to adhere to a low carbohydrate diet (less than 40g/carbohydrate 
per day) for 12 weeks. The control group was asked to adopt a standard low fat weight 
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reduction regime for 12 weeks. All subjects received an individual dietetic consultation and 
full written information together with formal dietary guidelines. The diets were explained to 
all subjects by a qualified dietitian at an individual randomisation visit and written 
information was provided. 
2.1.2.3. Low carbohydrate diet 
The low carbohydrate diet used in this study was formulated to provide <50g/carbohydrate 
per day. This quantity of carbohydrate was selected as there is evidence that ketosis readily 
occurs below this level (Vanltallie and Nufert 2003). The most well-known low carbohydrate 
diet, the Atkins diet, recommends that intakes of carbohydrate should be :s20g/day for the first 
two weeks of the regimen and then should be gradually increased. This severe carbohydrate 
restriction involves avoiding all foods containing sugar and starch, all fruit, all milk and most 
vegetables and many people find they have side-effects of headache, fatigue, constipation and 
halitosis on this regimen. Fruit and vegetables are considered essential for health, and the 
exclusion of milk products may lead to low calcium intakes over the long-term. As a result, it 
was decided that the diet used in this study should be designed to provide 40g/carbohydrate 
per day and that all carbohydrate should be supplied from milk, fruit and vegetables as shown 
in Table 2.1. 
Food portion lists of fruit and vegetables were provided to all subjects and they were advised 
to select from these lists the following amounts; all subjects were advised to consume either 
200ml (YJpt) skimmed or semi-skimmed milk or 125g pot natural or diet yogurt and this 
provided calcium and 109 carbohydrate. In addition, subjects were advised to select either 2 
portions of fruit (20g carbohydrate) and 2 portions of vegetables (lOg carbohydrate), or I 
portion of fruit (lOg carbohydrate) and 4 portions of vegetables (20g carbohydrate). 
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Table 2.1. Carbohydrate content of foods for low carbohydrate diet 
Food Amount Amount of carbohydrate 
per portion (g) 
Total carbohydrate (g) 
Milk (skimmed or 
semi-skimmed) 
Natural or diet 
yogurt 
Fruit 
Vegetables 
200ml 
125g pot 
1 portion 
1 portion 
10 10 
10 10 
10 10 
5 5 
In addition subjects were provided with a list of all starchy and sugary foods and advised to 
avoid these foods completely. Information was supplied about foods containing protein and 
carbohydrate and all subjects were advised that they could choose freely from these lists but 
that they may lose weight more quickly if they reduced energy intake by selecting lower fat 
alternatives. Concerns have been expressed about saturated fat intakes on low carbohydrate 
diets, and as a result subjects were advised to include lean meats, poultry, fish and game, low-
fat dairy products, avoid large amounts of saturated fat and use mono-unsaturated fat. A copy 
of the dietary information given to the subjects can be found in Appendix 4 of Volume 2. 
2.1.2.4. Low fat diet 
The subjects in the healthy eating group were given information in accordance with the 
dietary guidelines of Diabetes UK and were issued with a leaflet produced by Diabetes UK 
which incorporates a ten-step approach to eating well. The ten steps are: 
1. Eating three meals daily and avoiding missing meals 
2. Including starchy carbohydrate at each meal 
3. Reducing total and saturated fat intake 
4. Increasing fruit and vegetable intake 
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5. Including more legumes (beans and lentils) 
6. Including oily fish at least twice weekly 
7. Limiting sugar and sugary foods 
8. Reducing salt and salty foods 
9. Drinking alcohol in moderation 
1 O. Avoiding diabetic foods and drinks 
Subjects were given specific advice about reducing energy intake to 500kcaVday less than 
their calculated energy requirements and counselled to aim for slow weight loss at the rate of 
1-21b (0.5-1.0kg) per week rather than reducing intake to achieve rapid weight loss. 
2.1.2.5. Physical activity 
All subjects, regardless of dietary allocation, were encouraged to increase physical activity 
and advised to exercise at moderate intensity for 30 minutes at least 5 and preferably 7 days 
per week. 
2.1.2.6. Monitoring 
Subjects were required to monitor blood glucose and ketone concentrations four times per day 
(before breakfast, before lunch, before the evening meal and before bed) during the twelve 
weeks of the intervention. The subjects used a hand-held combined glucose and ketone meter 
(Optium, Medisense) which relied upon a simple finger-prick test and which has shown to be 
an accurate reflection of both blood glucose and ketone levels (Wallace, Meston et at. 2001). 
During the study, all subjects were asked to complete a three-day food diary, glucose and 
ketone concentration diary and quality of life and hunger questionnaires. This information 
was collected at baseline and at monthly intervals throughout the study. Intervention for both 
groups included a weekly telephone call to monitor blood ketone and blood glucose 
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concentrations and to offer any support required by the patient. There were clinic visits at 
four weekly intervals for monitoring and data collection. 
2.1.2.7. Outcomes 
The primary outcome was change in body weight and body mass index (BMI). Secondary 
biomedical outcomes included Ale, blood ketone concentrations, lipid concentrations and 
blood pressure. In addition, measures were made of dietary intake, quality of life and hunger. 
Routine safety measurements included urea and electrolytes (U&E), liver function tests 
(LFT), full blood count (FBC) and recording adverse events. 
2.1.2.S. Trial Procedures 
Subjects were eligible for the study if they fulfilled the following inclusion criteria; aged over 
18 years of age, BMI >25 kg/m2, without Type 2 diabetes or with Type 2 diabetes treated by 
diet alone or metformin monotherapy. Exclusion criteria included individuals with Type 1 or 
Type 2 diabetes treated by insulin, sulphonylurea or thiazolidinedione therapy, pregnancy or 
women of childbearing age without adequate contraception, breastfeeding women, major 
psychiatric disease including eating disorders, history of alcohol or drug abuse, creatinine 
level> 150mmoVI, abnormal liver function tests (> 1.5 x upper limit of reference interval) or 
any known malignancy. All subjects attended a screening visit prior to the start of the study, a 
randomisation visit and then 2 monthly visits with a final visit at the end of week 12. In 
addition, all subjects were offered weekly telephone calls for support and to monitor blood 
glucose and blood ketone concentrations. All visits required the subject to be fasting, and to 
ensure this, all subjects were advised to have nothing to eat or drink from midnight the night 
before attending clinic visits. Subjects were seen a total of five occasions during the study. 
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At the screening visit, signed consent was taken from each subject and baseline data were 
collected; these included each subject's age, gender, duration of diabetes, prescribed 
antidiabetic therapy and other medication. A physical examination recorded height, weight, 
waist and hip measurement, bioimpedance to asses total body fat and blood pressure. In 
addition an ECG was performed as a safety measure. Blood samples were collected to assess 
fasting blood glucose and ketone concentrations, Alc and lipid levels. Quality of life and 
hunger were assessed using validated questionnaires and each subject was requested to 
complete a three day food diary. 
Once the screening visit had assessed the subject's eligibility for the study and prior to the 
randomisation, subjects were asked to self-monitor ketone and glucose concentrations for one 
week while maintaining their usual diet. Readings were taken at staggered times, including 
before breakfast, mid-morning, before the mid-day meal, mid-afternoon, before the evening 
meal and at bedtime to provide a picture of usual ketone concentrations for each subject. 
Once the subjects had been randomised to either a low carbohydrate or a low fat diet, they 
were asked to self-monitor and record glucose and ketone concentrations four times a day 
during the first week of the diet. If ketone concentrations above 2.9mmolll were recorded, the 
subjects were advised to contact the research team was. After the first week of the diet, ketone 
and glucose concentrations were measured 4 times daily for 1 day each week. 
On completion of the study at week 12, data were collected for comparison with baseline and 
included weight, waist and hip measurement, bioimpedance to asses total body fat and blood 
pressure. Blood samples were collected to assess fasting blood glucose and ketone 
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concentrations, Ale and lipid levels. Quality of life and hunger were assessed using validated 
questionnaires and each subject was requested to complete a three day food diary. 
Professor David Matthews (DRM) acted as Principal Investigator (PI), Sue Beatty (SB) as 
research nurse and Pamela Dyson (PAD) as dietitian and lead investigator for this study. All 
three researchers contributed to the concept and design of the study. PAD wrote the protocol, 
prepared the paperwork, including the diet booklets, and gained ethical approval for the study. 
SB and PAD recruited subjects to the study and conducted the clinical visits, with SB taking 
blood samples, and both researchers collecting and recording anthropometric data. PAD 
explained and reinforced dietary advice at each clinic visit. SB and PAD collected and entered 
all clinical data and PAD undertook analysis of the results and drafted a paper for publication. 
All authors critically reviewed the manuscript and approved the final version submitted for 
publication in a peer-reviewed journal; Diabetic Medicine. 
2.1.3. Video education study (Study 2) 
2.1.3.1. Study design 
The aims of this study were to design and produce video-based lifestyle education for people 
newly diagnosed with Type 2 diabetes and to evaluate the effect of video education on 
diabetes knowledge, biochemical and anthropometric outcomes and quality of life. This study 
was designed as a randomised parallel group study. Randomisation took place using sealed 
envelopes filled 50:50 with either immediate or delayed randomisation. Randomisation was 
observed by an independent monitor. One group was offered the intervention programme 
immediately, and the other group acted as a delayed intervention control group. All control 
subjects were offered the programme at the end of the six month study. 
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2.1.3.2. Intervention - design and production 
The video-based education intervention consisted of three 20-minute videos covering three 
topics; diet and Type 2 diabetes, weight management and physical activity. Subjects 
randomised to the intervention group were encouraged to watch all three videos in their own 
time and given evaluation forms to assess each video. These evaluation forms included both 
visual Lickert scales and free-text boxes. Subjects were given stamped addressed envelopes to 
return the videos after watching, if this did not occur within three months of randomisation, 
subjects were telephoned and asked to return the videos. 
There is still much discussion about the components of dietary education that should be 
delivered to people newly diagnosed with Type 2 diabetes. The content of lifestyle education 
programmes for Type 2 diabetes usually include information about the effect of different 
foods upon blood glucose levels, on risk factors for cardiovascular disease, weight 
management and physical activity (Deakin, Cade et at. 2006). It was decided to elicit the 
views and opinions of people with diabetes and to incorporate these concepts into the videos 
for the healthy eating programme. A simple questionnaire was designed based upon the topics 
that are usually included in lifestyle education programmes. A random sample of patients with 
Type 2 diabetes who attended the Oxford Centre for Diabetes, Endocrinology and 
Metabolism (OCDEM) during the months January - March 2005 was asked to complete the 
questionnaire in order to formulate the topics to be included in the video. A sample of the 
questionnaire is shown in Appendix 5 of Volume 2. The results from these questionnaires 
were analysed and these data were used as the basis for the videos. A proposal was developed 
from the questionnaires to generate three 15-20 minute programmes available on video and 
DVD covering the following modules: 
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Food choices 
Physical activity 
Weight management 
A full curriculum for each topic was written and is shown below: 
2.1.3.2.1 Food choices 
Section Topic Action plan 
1 Introduction Provide an overview of the effects of food on blood glucose 
and the principles of a healthy diet - reduced fat, reduced 
sugar and increased dietary fibre. 
Discuss the effects of changing eating habits on quality of life. 
Emphasise the practical application of the theory of nutritional 
recommendations. 
2 Carbohydrates and Provide infonnation about the carbohydrate foods which affect 
blood glucose blood glucose levels. Divide the carbohydrate foods into four 
main groups - starchy foods, sugary foods, fruit and fruit 
juices and milk and yogurt. 
Summarise the foods which most affect blood glucose levels. 
3 Cardiovascular Advise reduction in animal (saturated) fat. 
risk and fat Recommend substitution offish (omega-3 oils) for meat and 
poultry. 
Recommend substitution of monounsaturated and 
polyunsaturated fats for saturated fat. 
4 Healthy eating Introduce the concept of a healthy diet. 
Recommend at least 5 portions of fruit and vegetables every 
day. 
Advise moderate intake of starchy carbohydrate foods and 
issue reminder of effect on blood glucose levels. 
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Advocate low fat protein foods. 
Suggest small amounts of sugary and fatty foods. 
Address issues of culture and different eating patterns. 
5 Case studies Provide case studies of people with diabetes who have 
successfully adapted their eating patterns. 
6 Summary Provide a summary of a healthy diet for diabetes. 
2.1.2.3.2. Physical activity 
Section Topic Action plan 
1 Introduction Offer an overview of the importance of physical activity in 
terms of the balance between food, activity and medication. 
Mention positive effects on blood glucose levels, reducing 
cardiovascular risk, weight management and well-being. 
2 Type of activity Discuss suitable activity. 
Explore different factors including enjoyment, any physical 
limitations, compatibility with current lifestyle and starting 
with gentle exercise. 
3 How to increase Discuss gradual increase of exercise, starting with increased 
exerCIse daily physical activity. 
4 Safety issues Provide guidelines for exercising safely including checking 
with a doctor before starting moderate or strenuous exercise, 
wearing suitable footwear and never exercising when unwell. 
Offer suggestions for suitable treatment for hypoglycaemia. 
5 Case study Provide case study illustrating how to overcome barriers to 
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exercise, fitting it into daily life and the benefits of increasing 
physical activity. 
2.1.3.2.3. Weight management 
Section Topic Action plan 
1 Introduction Provide overview of the relationship between diabetes and 
weight gain. 
Discuss cause and effect. 
2 Case study Provide illustration of successful weight management for 
people with diabetes. 
3 Weight Offer suggestions for different strategies for weight loss 
management including: 
strategies • Healthy eating and reduction in quantity eaten 
• Calorie controlled diet 
• Slimming clubs 
4 Setting targets Discuss optimum and realistic weight loss. 
5 Contact details Provide contact details for slimming clubs 
2.1.3.2.4. Video production 
The videos were filmed, edited and produced by Joose TV, a web-casting company with 
experience in the field of diabetes and health education. The written curriculum was used as 
the basis for each video and it was recommended that the best approach for health education 
was to use a mix of comments and advice from experts and a case study approach to illustrate 
the practical application. For each video, a diabetes dietitian and GPs who have a specialist 
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interest in diabetes were interviewed and encouraged to discuss food choices, weight 
management and physical activity. Relevant quotes were then taken from each of these 
interviews and used for each specific topic. Some gaps were identified, where the expert had 
not fully explained a subject and a script was then written to be used as a voice-over. An 
example of this can be found in the 'Food choices' video where a voice-over explaining the 
effects of carbohydrate foods on blood glucose was inserted. A copy of the voice-over script 
can be found in Appendix 6 of Volume 2. 
The opinion and advice from experts was supported by the use of case studies. Relevant case 
studies were identified for each topic and interviewed at home, in a non-threatening 
environment, to elicit their experiences of living with diabetes. Personal experiences from 
each case study were intercut with quotes from the health professional who had advised each 
subject and this formed a story line to illustrate the practical application of the theory already 
outlined by the health expert. 
Joose advised that filming each interview with the health professionals and people with 
diabetes would last between 2-3 hours. It was also necessary to produce some background 
shots of different foods groups, people exercising and people eating. A filming schedule was 
drawn up over a 4-week period to complete the filming. All footage was then encoded in the 
studio at Joose TV and produced approximately 30 hours of footage. The film editor at Joose 
made the first cut based upon the agreed curriculum for each video and the final cuts were 
made in conjunction with the specialist dietitian to produce the final 3 videos. The editing 
process took 2 weeks to complete. 
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There were some tensions between the production team and the dietitian involved in the 
filming process. The main area of difference was the focus for the videos. The loose team, 
and especially the director, were interested in entertainment, drama and engaging the 
emotions of the audience, and often encouraged the case studies to put more expression and 
drama into their stories. The dietitian felt that the main objective should be on supplying 
accurate and practical advice for people with diabetes and that the individuals in the case 
studies should be allowed to tell their own stories in their own way. For example, the weight 
management case study features Muriel who has lost a significant amount of weight, but in 
the video makes the simple statement 'So, I lost the seven stone.' The director felt that this 
statement did not betray enough delight in her achievement and attempted to encourage her to 
say the sentence in various ways to increase the drama. Muriel found this process quite 
uncomfortable and was unable to make the statement sound natural and eventually the 
dietitian asked the director to stop and move on. The original statement remains in the final 
cut. 
Once the three videos had been designed and produced, a pilot study was undertaken to 
evaluate the content and presentation. A random sample of 10 people with type 2 diabetes was 
selected from routine diabetes clinic, and these subjects were asked to watch each of the three 
videos and complete a pre-designed form for feedback. A copy of the form is shown in 
Appendix 7. Once evaluation was complete, the videos received their final edit, taking into 
account the comments received, and were then copied for use in the video education study. 
2.1.3.3. Outcomes 
Primary outcomes included changes in levels of diabetes knowledge and understanding, 
changes in dietary intake and biomedical outcomes including Ale and lipid levels. Secondary 
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outcomes consisted of weight loss, bioimpedence to assess levels of body fat, quality of life 
and changes in physical activity, assessed by use of a pedometer. 
2.1.3.4. Trial procedures 
Subjects were referred to this study from Primary Care through either their General 
Practitioner (ap) or Practice Nurse once their eligibility had been assessed and confirmed. 
The inclusion criteria were for subjects aged over 18 years of age, who had had Type 2 
diabetes diagnosed within the previous six months. Exclusion criteria included individuals 
with Type 1 diabetes, pregnancy or women of childbearing age without adequate 
contraception, breastfeeding women, major psychiatric disease including eating disorders, 
history of alcohol or drug abuse, creatinine level> 150mmoVI, abnormal liver function tests 
(> 1.5 x upper limit of reference interval) or any known malignancy. None of the subjects had 
received formal education from a State Registered Dietitian at entry to the study. All eligible 
subjects received information about the study by post and were invited to join the study. They 
then attended for a baseline clinic visit and a six month follow-up visit. At the baseline visit, 
signed consent was taken and baseline data were collected. These data included each subject's 
age, gender, duration of diabetes, prescribed antidiabetic therapy and other medication. A 
physical examination included collection of data on height, weight, waist and hip 
measurement, bioimpedance to asses total body fat and blood pressure. Blood samples were 
collected to measure Ale and lipid levels. Quality of life and diabetes knowledge were 
assessed using a validated questionnaire. After the baseline visit, all subjects were given a 
stamped addressed envelope to return a 3-day food diary and record of physical activity using 
a pedometer at baseline. Once collection of baseline data was complete, they were randomised 
to either the intervention or the control group. Those subjects allocated the video intervention 
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were sent either a DVD or video set of the three education programmes. All subjects were 
sent a 3-day food diary and record of pedometer readings two weeks before the end of the 
study and asked to complete these and return them at their six-month follow-up visit. 
The final visit took place at 6 months post-intervention and data were collected for 
comparison to baseline including weight, waist and hip measurement, bioimpedance to asses 
total body fat and blood pressure. Blood samples were collected to Ale and lipid levels. 
Quality of life and diabetes knowledge were assessed using validated questionnaires and the 
completed three day food diary and record of physical activity were collected. 
Pamela Dyson (PAD) acted as lead investigator and assumed overall responsibility for the day 
to day running of this study with Professor David Matthews (DRM) acting as Principal 
Investigator (PI) and Sue Beatty (SB) employed as research nurse. All three researchers 
contributed to the concept and design of the study. PAD wrote the protocol, prepared the 
paperwork, organised and supervised the production of the videos and gained ethical approval 
for the study. SB conducted the clinical visits, taking blood samples and collecting and 
recording anthropometric data. SB and PAD collected and entered all clinical data and PAD 
undertook analysis of the results and drafted a paper for publication. All authors critically 
reviewed the manuscript and approved the final version submitted for publication in a peer-
reviewed journal; Journal of Human Nutrition and Dietetics. 
2.1.4. Carbohydrate counting and insulin adjustment (Study 3) 
2.1.4.1. Study design 
This study was designed as an intervention trial investigating the effects of structured 
education on glycaemic control and quality oflife in people with Type I diabetes. 
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2.1.4.2. Intervention 
A structured education programme known as InSight was designed and written by a diabetes 
specialist nurse and a diabetes specialist dietitian. The Insight programme was designed to 
facilitate skills for matching insulin to carbohydrate intake based upon reflection from self-
monitoring diaries and to support self-management of hypoglycaemia, hyperglycaemia, 
illness and exercise. InSight utilised the adult learning model comprising of experiment and 
enquiry and relates to empowerment principles (Funnell and Anderson 2004; Meetoo and 
Gopaul 2004) . It is based upon the theory of experiential learning, interaction of participants, 
partnership and focuses on developing new skills for self care. There is recognition of the 
shift from the clinician's traditional approaches, recommending treatments from the medical 
model and perspective, to an approach of integration of individualised goals (Rollnick, Mason 
et at. 1999). Skills are developed through feedback and reflection. Participants are taught to 
match insulin to carbohydrate over a four week period relating the new information gained to 
actual life situations, in every day life. The role of the health care professional is to provide 
support to people on the programme to enable them to develop realistic short and long term 
management goals and to help them acquire the knowledge and skills necessary to achieve 
those goals. 
Carbohydrate counting was facilitated by different techniques, aiming to present the 
information using different strategies to maximise the acquisition of skills in the course 
participants. The strategies taught included weighing and calculation from food tables, 
reading and interpreting nutritional labels and visual estimation. Foods that are commonly 
eaten in different portion sizes and that are difficult to quantify included breakfast cereals, 
rice, pasta and mashed potato. The participants were provided with scales for the duration of 
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the course and pocket-sized copies of food tables and encouraged to weigh their individual 
portions of food and calculate the carbohydrate content. Nutritional infonnation from food 
tables was also used and participants were taught to interpret the data provided on the packet. 
In addition, participants were provided with small booklets, compiled by the consultant 
dietitian and which included the carbohydrate content of commonly eaten foods, for example 
sliced bread, biscuits and pots of yogurt. Photographs of foods with calculated carbohydrate 
content were also utilised to support carbohydrate calculations. 
Mealtime insulin doses were calculated from the total daily dose of insulin taken by each 
individual using the fonnula: 
Total daily dose of insulin = amount of insulin (in units) for every 109 
50 carbohydrate eaten 
For example, someone with a total daily dose of 100 units of insulin, would inject 2 units of 
insulin for every 109 carbohydrate eaten. A large pasta meal containing 100g carbohydrate 
would require 20 units insulin and a lower carbohydrate meal, for example, steak and salad 
with a small baked potato would contain approximately 50g carbohydrate and would require 
10 units of insulin. 
The programme took place over four weeks, including 15 hours education in total. Weeks 1,3 
and 4 comprised three hours each of education and week 2 consisted of one six-hour session 
.The full programme is shown in Table 2.2. In addition to carbohydrate counting and insulin 
adjustment, the course included diabetes physiology, managing hypoglycaemia and 
hyperglycaemia and addressed specific lifestyle issues such as alcohol, exercise and stress. 
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Table 2.2. InSight course programme 
Week 1 
(3 hours) 
Week 2 
(6 hours) 
Week 3 
(3 hours) 
Week 4 
(3 hours) 
Introductions -
getting to know one 
another 
Reflection of past week utilising self-monitoring diaries 
Sharing ideas and Carbohydrate Hypoglycaemia 
understanding counting - theory 
about diabetes and practice 
Exploring the Insulin ratios and Managing physical 
physiology of correction doses activity 
diabetes 
Effects of alcohol 
Self-monitoring using daily diaries and data collection 
Diabetic 
ketoacidosis 
Managing illness 
Any other topics 
identified by course 
participants 
Using all the 
information 
together 
The programme was co-facilitated by two diabetes professionals from nursing and dietetic 
disciplines, with a physician providing clinical support when patients identified specific 
medical issues. Professional input to the study included delivery of the programme, follow-up 
at six months and one year and audit and evaluation of the results. In total, each course was 
calculated to require 44 hours of professional time. 
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2.1.4.3. Outcomes 
The primary outcome was change in glycaemic control measured by Al c, and secondary 
outcomes included changes in body weight, lipid levels, quality of life and hypoglycaemia 
measured by validated questionnaires. 
2.1.4.4. Study procedure 
People with Type 1 diabetes were recruited from the Oxford Centre for Diabetes, 
Endocrinology and Metabolism (OCDEM) by direct referral from a physician, nurse or 
dietitian during attendance at a routine clinic visit. All subjects expressing an interest in 
taking part in the inSight sessions were sent details of the course and invited to contact the 
facilitators to confinn attendance. Inclusion criteria were subjects aged over 18 years of age 
with Type 1 diabetes treated by a basal prandial insulin regimen using analogue insulin. 
Exclusion criteria included individuals with Type 2 diabetes, pregnancy or women of 
childbearing age without adequate contraception, breastfeeding women, major psychiatric 
disease including eating disorders and any history of alcohol or drug abuse. All subjects who 
volunteered to take part in the study were included in the education sessions. 
Subjects were invited to the next available group and attended the four-week course. Before 
each course began, baseline data were collected from all subjects using computerised medical 
records available in OCDEM. Data collected included age, gender, duration of diabetes, 
prescribed antidiabetic therapy and other medication, height, weight, Ale and lipid levels. 
Quality of life and frequency and awareness of hypoglycaemia were assessed by validated 
questionnaires. 
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Six months after the education course, subjects were invited to return for a follow-up visit and 
data were collected for comparison with baseline including weight, Al c and lipid levels, 
quality of life and frequency and awareness of hypo glycaemia. 
Pamela Dyson (PAD) and Janet Sumner (JS, Lead Diabetes Specialist Nurse) acted as co-
investigators and assumed overall responsibility for the day to day running of this study with 
the support of the Clinical Director of OCDEM, Dr Jonathan Levy. PAD and JS contributed 
to the concept and design of the education programme and PAD wrote the curriculum, 
prepared the paperwork, and gained Chair's approval for the audit from the local ethics board. 
PAD and JS jointly facilitated the education programme. Clinic nurses performed routine 
blood sample collection and recorded anthropometric data. PAD collected and entered all 
clinical data and undertook analysis of the results. 
2.2. Statistical analysis and power calculations 
2.2.1. Power calculations for the low carbohydrate study 
The power calculation for the low carbohydrate study (Study 1) was based upon weight 
change from baseline using a two group paired t-test of equal means at a 5% statistical 
significance. Weight changes from previous studies showed a treatment effect of 3.0 SD. 
Power calculations indicated that group sizes of 9 would give >90% power at the 0.05 level. 
The sample size was calculated as 10 in each group and we aimed to recruit 12 to each ann to 
allow for possible drop out. 
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2.2.2. Power calculations for the video education study 
The power calculation for the video education study (Study 2) was based upon changes in 
Alc from baseline to follow-up at 6 months. Based on a paired two group t-test of equal 
means at a 5% statistical significance, the trial had a statistical power of 95% to detect a mean 
change of 0.5% Al c in the intervention group with an approximate standard deviation of 0.1. 
Power calculations indicated that group sizes of 27 would give >90% power at the 0.05 level. 
The sample size was calculated as 30 in each group and we aimed to recruit 40 to each arm to 
allow for possible drop out, as attrition rates are traditionally high in dietary intervention 
studies (Dansinger, Tatsioni et a1. 2007). 
2.2.3. Power calculations for the carbohydrate counting study 
The number of subjects taking part in this study was decided on a pragmatic basis taking into 
account achievable numbers of groups and the optimal number of participants per group. It 
was calculated that 50 participants could be recruited within the study period. 
2.2.4. Data analysis 
Date were analysed as absolute change from baseline in subjects who completed the final 
assessment at three months for the low carbohydrate study (Study 1), six months for the video 
education study (Study 2) and one year for the carbohydrate counting study (Study 3). 
Statistical analysis was carried out on an intention to treat basis. In the low carbohydrate 
study, analysis was performed by means of last observation carried forward at one or two 
months and this applies to one subject allocated to the low carbohydrate group and one 
subject allocated healthy eating advice. There were no drop-outs after randomisation in the 
low carbohydrate group, and this contrasts with four subjects in the low fat group who refused 
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follow-up after randomisation. In the case of the four drop-outs, missing outcomes were not 
replaced. In the video education study, there were no drop-outs in the video intervention 
group and three in the control group; missing outcomes were not replaced for these three 
subjects who failed to attend the six-month visit. In the carbohydrate counting study, three 
subjects were lost to follow-up and missing outcomes were not replaced. 
All data were analysed usmg parametric statistics where appropriate and in the low 
carbohydrate study, triglyceride values were log-transformed before analysis. Normally 
distributed continuous data variables were compared between groups using independent 
sample I-tests. 
The ADKnowl questionnaire used to assess diabetes knowledge in the healthy living video 
intervention study was analysed as recommended by Clare Bradley (ADKnowl guidelines, 
Appendix 3). Briefly, the items are scored on a true/false/don't know basis and entered onto 
an Excel spreadsheet, with a further column to record no response. The percentage of correct 
answers to each question in both the intervention and the control group was calculated and the 
absolute changes from baseline could then be analysed and comparisons made between the 
two groups. As these are non-parametric data, analysis was performed using the Mann-
Whitney statistical test. 
Data from the PAID and hypoglycaemia questionnaires were analysed using the Mann-
Whitney statistical test. 
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2.3. Dietary intake, physical activity, quality of life and diabetes knowledge 
2.3.1. Dietary intake 
An objective measure of the impact of dietary education is change in dietary intake. There has 
been much discussion about the efficacy of measuring dietary intake by self-reported food 
diaries, with the overwhelming evidence supporting the supposition that most people under-
report dietary intake (Kipnis, Midthune et a1. 2002; Day, Wong et a1. 2004) and that there is a 
strong inverse correlation between self-reported energy intake and obesity (Prentice, Black et 
a1. 1996). The 7 -day food diary has long been regarded as the gold standard for measuring 
dietary intake (James, Bingham et a1. 1981) and is widely used in large epidemiological 
studies (Bingham 1997). A. recent survey of the dietary intake of people with diabetes has 
shown that 3-day food records are as accurate as 7 -day records (Toeller, Buyken et a1. 1997) 
and for this reason have been utiltised in both the low carbohydrate ketogenic diet study 
(Study I) and the video education study (Study 2). A copy of the 3-day dietary record booklet 
can be found in Appendix 8. Nutritional data from the food diaries were analysed by a 
computer programme, Dietplan5 for Windows (Forestfield Software Ltd 2002). 
2.3.2. Physical activity 
Changes in physical activity can be determined using objective and subjective measures. 
Objective measures investigate changes in physical fitness either by measuring the amount of 
oxygen used or by monitoring heart rate during an exercise test. Indirect measures of changes 
in physical activity may include self-reported activity diaries or use of a pedometer. Changes 
in physical activity in the video education study (Study 2) were assessed by means of 
pedometer as this method is cheap, non-invasive and has been well validated (Freedson and 
Miller 2000). In addition, the use of pedometers has been shown to be effective in increasing 
physical activity and improving health (Bravata, Smith-Spangler et al 2007). 
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2.3.3. Hunger and appetite 
One hypothesis for the efficacy of low carbohydrate, ketogenic diets is that ketone production 
is associated with a reduction in hunger. This hypothesis was tested in Study I by measuring 
hunger and appetite using a validated scale (Roth 1993). This is based upon a Lickert visual 
analog item and was completed by the participants in the low carbohydrate study before a 
main meal to indicate the level of hunger. The item was scored from I-lOusing a ten-point 
scale ranging from 'starving hungry, feeling irritable and dizzy' to 'stuffed to the point of 
feeling ill'. Lower scores denoted higher levels of hunger and higher scores satiety. The scale 
is shown in Table 2.3. 
Table 2.3. Roth hunger scale 
Response 
Stuffed to the point of feeling ill 
Very uncomfortably full, need to loosen belt 
Uncomfortably full, feel stuffed 
Very full, have overeaten 
Comfortably full, feel satisfied 
Comfortable, neither hungry nor full 
Beginning to feel peckish 
Hungry, feel ready to eat 
Very hungry, unable to concentrate 
Starving hungry, feel irritable and dizzy 
2.3.4. Quality of life: the WHO-5 Well-Being Index 
Score 
10 
9 
8 
7 
6 
5 
4 
3 
2 
I 
General quality of life in both the low carbohydrate (Study I) and video education studies 
(Study 2) was measured by the widely-used and well-validated questionnaire, the WHO-5 
Well-being index (World Health Organisation 1998). The WHO-5 Well-being index is not 
diabetes-specific and consists of five simple statements relating to general quality of life over 
the previous two weeks. Each statement offers a choice of six responses ranging from 'all of 
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the time' to 'none of the time'. Each answer is allocated a number from 0-5 as shown in Table 
2.4. 
Table 2.4. WHO-S Well-Being index: scoring system 
Response 
All of the time 
Most of the time 
More than half of the time 
Less that half of the time 
Some of the time 
At no time 
Score 
5 
4 
3 
2 
I 
o 
Higher numbers denote better well-being. Raw scores are calculated by summing the figures 
of each response with 0 representing the worst possible and 25 the best possible quality of 
life. WHO-5 Well-being scores are commonly reported as a percentage and this is derived by 
multiplying the raw score by 4. A raw score of <13 (52%), or any answers that score either 1 
or 0 indicate poor well-being and may be a symptom of depression. A change of 10% in the 
percentage scores is indicative of a significant change in quality of life. A copy of the WHO-5 
Well-being form can be found in Appendix 9. 
2.3.5. General Health: the EQ-SD 
General health was measured in the video education study (Study 2) by means of the EQ-50 
(Brookes, Rabin et a1. 2003) which assesses overall health status by means of five dimensions 
related to mobility, self-care, pain, depression and anxiety and ability to perform usual 
activities. Each item has three responses these are scored according to the problems that the 
item presents to the individual, ranging from 'no problem' through 'some problem' to 
'extreme problem'. In addition, the EQ-5D VAS was completed by the participants. The EQ-
50 VAS is a standard vertical 20 cm visual analogue scale (similar to a thermometer) for 
scoring a participant's rating for their current health-related quality of life state. The scale is 
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numbered 0-100 and a score for an individual's health state can be read off the scale and 
recorded. Value sets for evaluation of the EQ-5D are available, or the data can be reported as 
a percentage of the population under study reporting any problem (whether slight or extreme) 
for each of the dimensions. A copy of the EQ-5D form can be found in Appendix 10. 
2.3.6. Diabetes related distress: the PAID and hypogJycaemia 
The PAID questionnaire (Polonsky, Anderson et a1. 1995) was used to assess diabetes related 
distress in the study investigating the effect of carbohydrate counting and insulin adjustment 
(Study 3). PAID consists of twenty questions addressing potential problem areas relating to 
diabetes and each question is scored from 0-4. PAID scores are totalled and expressed as a 
percentage, with 100% representing maximum diabetes-related distress and 0% minimum 
distress. Scores over 40% indicate a significant problem. Hypoglycaemia is a major concern 
for people with Type 1 diabetes and incidence and severity was measured by a validated 
questionnaire (Clarke, Cox et a1. 1995). Copies of the PAID questionnaire and the 
hypoglycaemia questionnaire can be found in Appendix 11. 
2.3.7. Diabetes Knowledge: the ADKnowl questionnaire 
Study 2 was designed as an education programme and it was therefore necessary to measure 
any change in diabetes knowledge. Changes in diabetes knowledge were assessed by a 
questionnaire (the ADKnowl questionnaire) provided by agreement with Professor Clare 
Bradley (© Bradley, 1993 latest revision 2001). The ADKnowl is a validated questionnaire 
for measuring diabetes knowledge (Speight and Bradley 2001; Bradley and Speight 2002). 
The full ADKnowl questionnaire includes 25 items questions sub-divided into 2-9 sections 
with a total of 123 questions covering the topics which include general knowledge about 
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diabetes, medication (tablets and insulin) for treating diabetes, hypoglycaemia, food, alcohol 
and physical activity, tissue damage and complications of diabetes, foot care and Alc levels. 
As the ADKnowl is designed to be analysed item-by-item, users can remove items from the 
ADKnowl that may not be relevant to the study in question without affecting the overall 
validity of the questionnaire. Items that are retained cannot be edited, reworded or changed in 
any way without affecting validity and opportunities to compare with other datasets. Many of 
the original items of the ADKnowl were not necessary for measuring changes in knowledge 
of lifestyle factors in the healthy living study and some question were deleted leaving only the 
relevant questions. The sections covering insulin and tablets are designed to be used only by 
those taking insulin or sulphonylurea tablets and these were deleted. In addition, the sections 
covering foot care, hypoglycaemia and A I c were also deleted. The final questionnaire 
included the following sections: 
Section I: General knowledge of diabetes (5 questions) 
Section 2: Effects of physical activity (4 questions) 
Section 3: Food and blood glucose levels (7 questions) 
Section 4: Food knowledge (9 questions) 
Section 5: Alcohol (3 questions) 
Section 6: Tissue damage and complications of diabetes (3 questions) 
Section 7: Regular examinations (5 questions) 
The edited ADKnowl questionnaire used in the healthy living study included seven sections 
with a total of 36 questions. The questionnaire is designed to be analysed item by item, and it 
is not recommended that the responses are summed into a composite score, or that a 
composite knowledge score is related to biomedical indices e.g. Al c. Data from the 
ADKnowl were analysed item-by-item by presenting the data as percentage of correct 
reponses to each item by at baseline and at six months in each group. The changes within each 
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group were compared over the six months of the study and non-parametric analysis was 
applied to assess significance. A copy of the edited ADknowl questionnaire can be found in 
Appendix 12. 
2.4. Anthropometric measurements 
2.4.1. Body weight 
A change in total body weight was the primary outcome for measuring the efficacy of 
interventions that were designed to reduce energy intake or increase physical activity in 
overweight individuals in both the low carbohydrate and video education studies. Body 
weight was measured in kilograms by SECA electronic, quality assured scales. 
2.4.2. Body Mass Index 
A recorded change in total body weight reflects absolute change without allowance for height 
differences and for this reason a measure of relative weight change was utilised. The most 
commonly used measurement is that of body mass index (BMI) (World Health Organisation 
1995). BMI was calculated using the specified formula wt(kg)lht(m2). This calculation 
requires a measurement of height and this was assessed by means of a wall-mounted 
appliance (Holtain Ltd, Crymych, Devon). 
2.4.3. Waist/hip circumference 
Waist and hip circumference were measured a using standard operating procedure (SOP) in 
the clinical research unit at OCDEM (World Health Organisation 1995). There is growing 
evidence that the risk of chronic disease is correlated more significantly with abdominal 
adipose tissue than with peripheral adipose fat and that this is reflected by the waist:hip ratio 
(Janssen, Katzmarzyk et a1. 2002). Waist:hip ratio was calculated by measuring the 
circumference of the waist and the hips and using the formula waist(cm)lhips(cm). 
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2.4.4. Body fat 
Percentage body fat was measured by body composition analysis. This measurement utilises 
bioelectrical impedance analysis (BIA) using the Bodystat R 1500 which had been shown to 
have an accuracy of within 5% compared to the gold standard of densitometry using 
underwater weighing (Fuller, Fowler et a1. 1994). Body fat was assessed to determine the 
components of weight lost during the studies and to explore the assumption that the weight 
loss associated with low carbohydrate diets is associated with fluid and lean tissue loss 
(Kennedy, Chokkalingam et a1. 2005). 
2.4.5. Blood pressure 
Blood pressure was measured by Omron HEM 757 electronic blood pressure meter. Blood 
pressure is a surrogate marker for cardiovascular risk and has been shown to fall m 
individuals who lose weight and increase physical activity (Williams, Poulter et a1. 2004). 
2.5. Blood chemistry 
All blood chemistry was performed by the central biochemistry laboratory at the John 
Radcliffe Hospital, Oxford and all analysers undergo rigorous quality assurance. 
2.5.1. Ale 
Glycated haemoglobin (Alc) is the internationally agreed standard for the measurement of 
longer-term glycaemic control (Barth, Marshall et a1. 2008) and was used to asesss glycaemic 
control in two land-mark studies of diabetes, the Diabetes Control and Complications Trial 
(DCCT study group 1993) and the United Kingdom Prospective Diabetes Study (UKPDS 
1998). Levels of Alc in people without diabetes range from 4.9-6.1%. Alc analysis in these 
studies was performed using a HA 8160 (A Menarini Diagnostics, Wokingham, Berkshire) 
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utilising dedicated high pressure liquid chromatography (HPLC) involving reverse phase 
partition and ion exchange chromatography. Quality assurance performed during the period of 
the three studies showed the following values of Ale: low 5.6% @ CV of 15.1 %; high 9.0% 
@CVof9.4% 
2.5.2. Lipid levels 
Many people with Type 2 diabetes show symptoms of the metabolic syndrome including 
dyslipidaemia, characterised by high total cholesterol, high levels of low density lipoprotein 
cholesterol (LDL), reduced levels of high density lipoprotein cholesterol (HDL) and elevated 
triglyceride levels (Zimmet, Magliano et a1. 2005). Total cholesterol, HOL cholesterol and 
triglycerides were analysed by multi-stage enzymatic assay by the Seimens Advia 2400 
analyser. Quality assurance performed during the period of the three studies showed the 
following values: total cholesterol; low 2.9 mM @ 3.62%; high 5.8mM @ 6.7%, HOL 
cholesterol; low 0.89mM @ 3.7%; high 2.6mM @ 7.6%, triglycerides; low 1.06mM @ 7.9%; 
high 2.92mM @ 7.7%. LDL cholesterol was calculated from levels of total cholesterol, HDL 
cholesterol and triglycerides levels using the Friedewald equation (Tremblay, Drouin et a1. 
2004). 
2.5.3. Blood ketone levels 
Low carbohydrate diets have been shown to increase blood ketone levels {Vanlta11ie and 
Nufert 2003)and these levels were assessed in the low carbohydrate diet study. Blood ketone 
levels were measured by a hand-held combined glucose and ketone meter (Optium TM, 
Medisense) using a finger-prick test which has shown to be an accurate reflection of both 
blood glucose and ketone levels (Wallace, Meston et at. 2001). 
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2.6. Funding and conflict of interest 
There was no conflict of interest in any of the three studies contributing to this thesis. Study 1, 
the low carbohydrate diet study was funded by a grant from Medisense UK, Abbott 
Laboratories. Study 2, the video education study, was partly funded by an unrestricted 
educational grant from the Sugar Bureau. Study 3, the carbohydrate counting and insulin 
adjustment study was partly funded by a research grant from Diabetes UK. 
2.7. Summary 
This chapter describes the materials and methods required for all three studies described, 
namely the low carbohydrate diet study for people with Type 2 diabetes (Study 1), the video 
education study for people newly diagnosed with type 2 diabetes (Study 2) and the 
carbohydrate counting and insulin adjustment study for people with Type 1 diabetes (Study 
3). Details of the full protocol, ethical approval and all anthropometric, biochemical and 
psychosocial data collection and analyses are reported. In addition, a full description of the 
formulation of all interventions used in the studies is provided and the results of these studies 
are reported in Chapters 3, 5 and 6. 
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Chapter 3 
Low carbohydrate diets and diabetes 
3.0. Introduction 
Historically, diabetes has been seen as a disorder of carbohydrate metabolism and the first 
recommendations for dietary treatment included reduction of carbohydrate as the mainstay for 
dietary treatment. This concept was first introduced in the UK by RD Lawrence in 1925 and 
he proposed that dietary intake, especially carbohydrates, should be restricted to help maintain 
blood glucose levels within the normal range, following the teaching of Frederick Allen in the 
US (Allen 1925). This type of prescriptive diet, concentrating on carbohydrate restriction was 
given to patients over the next 50 years and formed the foundation of dietary advice for 
people with diabetes (Moran 2004). 
The first move towards more liberal diets came in 1982 with the publication by the British 
Diabetic Association (now Diabetes UK) of the first nutritional recommendations for people 
with diabetes (Nutrition sub-committee of the British Diabetic Association 1982). These 
recommendations promoted the 'healthy eating' approach for treating diabetes and suggested 
that the nutritional advice to those with diabetes should not differ greatly from the approach 
proposed for the general population. The biggest change in these recommendations was that 
of fat reduction and of an increase in so-called complex carbohydrate intake. Starchy foods 
were actively encouraged and people with diabetes were commonly advised to fill half their 
plate with bread, cereals, grains, potatoes, rice and pasta. 
Some critics argued against this approach as it is well established that the main type of 
nutrient in food that affects blood glucose levels is carbohydrate (Sheard, Clark et a1. 2004). 
Most foods contain a mixture of fat, protein and carbohydrate, but foods containing mainly 
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protein and fat have a minimal effect on blood glucose levels compared to carbohydrate-
containing foods. Carbohydrates are found mainly in starchy and sugary foods. All 
carbohydrates are digested into glucose and appear in the bloodstream between 10 minutes 
and 2 hours or more after eating, and there has been increasing opposition to the idea that a 
high-carbohydrate diet is the most effective method of controlling blood glucose levels in 
people with diabetes. There is still uncertainty about the relative effects of the type and the 
amount of carbohydrate on postprandial blood glucose levels. There remains some 
disagreement amongst experts about the importance of the type of carbohydrate rather than 
the total amount and this has become polarised with some experts arguing for the type of 
carbohydrate, especially in terms of glycaemic index (Brand-Miller, Hayne et al. 2003) and 
some recommending approaches incorporating assessment of the amount of carbohydrate 
(Wheeler and Pi-Sunyer 2008). 
3.1. Quality of carbohydrate 
Much interest has been expressed in the concept of effects of different types of carbohydrate 
on blood glucose levels, body weight control and cardiovascular risk in people with diabetes 
and most research has investigated the effects of two main components of the diet, that of 
glycaemic index and whole grain foods and dietary fibre. 
3.1.1. Glycaemic index and glycaemic load 
The term glycaemic index (GI) was first coined in 1981 by researchers at the University of 
Toronto (Jenkins, Wolever et al. 1981) and was used to give an indication of the effect of 
different carbohydrate foods on blood glucose levels. The glycaemic index is a scale that 
ranks carbohydrate foods by how much they raise blood glucose levels compared to a 
reference food containing an equivalent amount of carbohydrate, usually glucose or white 
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bread. These first studies by Jenkins showed that high GI foods cause large fluctuations in 
glucose and insulin levels; conversely low GI foods cause smaller fluctuations and as a result 
should be of benefit to people with diabetes. 
GI is measured practically in the laboratory using a standard procedure. Foods containing 50g 
of carbohydrate are fed to fasting volunteers and samples for measurement of blood glucose 
levels are taken every 15 minutes for 2-3 hours. The results of the blood glucose levels are 
plotted on a graph over time and compared to a reference food, usually pure glucose. The GI 
of each food is expressed as a number and the lower the number, the lower the GI of the food. 
Both the amount (quantity) and type (quality) of carbohydrate will affect blood glucose levels 
and the concept of the glycaemic load (GL) was introduced in an attempt to rationalise these 
two components (Salmeron, Manson et al. 1997). The glycaemic load reflects the amount and 
the type of carbohydrate eaten. The GL can be calculated from the following equation: 
Glycaemic load = glycaemic index of a food x net carbs· 
100 
• net carbs = total carbohydrate - dietary fibre 
Low GI diets have been proposed for people with diabetes and claims have been made for 
beneficial effects on glycaemic control, body weight and cardiovascular risk (Thomas and 
Elliott 2009). There is also evidence for the effects of low G I diets in the prevention of Type 2 
diabetes, with a recent systematic review showing that lower GI diets were associated with 
reduced fasting blood glucose and Alc (Livesey, Taylor et al. 2008) and another meta-
analysis reporting that low GI or low GL diets are independently associated with a reduction 
in the risk of Type 2 diabetes and heart disease (Barclay, Petocz et at. 2008). 
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3.1.2. Whole grain foods and dietary fibre 
Whole grain foods are rich in dietary fibre and have been associated with both prevention and 
treatment of diabetes. Evidence for the protective effect of whole grain foods is based upon 
epidemiology and a recent systematic review of this epidemiological evidence has shown that 
whole grain intake is inversely associated with risk of Type 2 diabetes (de Munter, Hu et a1. 
2007). However, a recent Cochrane review of evidence from prospective trails has concluded 
that the evidence is too weak for finn conclusions of whole grain foods in the prevention of 
diabetes (Priebe, van Binsbergen et a1. 2008). There is more evidence for the role of dietary 
fibre in the treatment of diabetes, and high fibre intakes have been advocated for over twenty 
five years (Mann, Kinmonth et a1. 1981) and the American Diabetes Association make the 
recommendation of at least 14g/dietary fibre for each 1000 kcal consumed (Wheeler and Pi-
Sunyer 2008). 
3.2. Quantity of carbohydrate 
The effect of a known quantity of carbohydrate on blood glucose levels has been little studied, 
although it is well-recognised that carbohydrates raise blood glucose after eating. Studies 
done in people with Type 1 diabetes have shown that 109 of dietary glucose raises blood 
glucose by 2 mmoIll, and 20g glucose raises blood glucose by 5mmoIlI within 30 minutes of 
ingestion (Wiethop and Cryer 1993). If this is extrapolated to an average meal containing SOg 
carbohydrate, this suggests that a theoretical rise in blood glucose of 10 -12.5 mmoIlI would 
follow ingestion of this amount of carbohydrate. People with Type 2 diabetes who exhibit 
insulin insufficiency may show a postprandial rise in glucose above target levels following a 
high carbohydrate meal. Traditionally, dietary advice for people with diabetes first 
recommended carbohydrate restriction in an attempt to control glucose levels after eating. 
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More recent recommendations have relaxed this approach and recommended higher levels of 
carbohydrate, up to 55% of total energy intake, accompanied by a reduction in fat intake 
(Nutrition sub-committee of the British Diabetic Association's Professional Advisory 
Committee 1992), although there is now recognition by most authorities that for some 
individuals less carbohydrate may be beneficial, especially for the obese individual (Nutrition 
sub-committee of the Diabetes Care Advisory Committee of Diabetes UK 2003; Bantle, 
Wylie-Rosett et a1. 2008; Wheeler and Pi-Sunyer 2008). 
Average carbohydrate intakes in the UK are between 200-300g/day. The National Diet and 
Nutrition Survey reports mean carbohydrate intakes of 203g/day for women and 275g/day for 
men (Henderson, Gregory et a1. 2003) and dietary survey data from the INTERMAP study 
have reported means intakes of 307g/day of available carbohydrate for adults in the UK 
(Zhou, Stamler et a1. 2003). There are no recommendations for a maximum amount of dietary 
carbohydrate for health, and only one authority, the American Diabetes Association, 
recommends a minimum amount of carbohydrate for health of l30g/day, based upon 
calculated average demand for glucose by the brain (Wheeler and Pi-Sunyer 2008). This 
suggests that there is a theoretical range of recommended daily carbohydrate intake of 130 -
300glday, and there is no evidence for the optimum amount within this range for people with 
diabetes. There has been increasing interest in the positive effect of low carbohydrate diets on 
glycaemic control, weight loss and cardiovascular risk factors in people with Type 2 diabetes 
(Kennedy, Chokkalingam et a1. 2005) and this has led to re-evaluation of their role in 
treatment and an acknowledgement by the American Diabetes Association that they may have 
a role in weight loss (Bantle, Wylie-Rosett et a1. 2008). There remains much discussion 
between experts about the optimum amount of carbohydrate in the diet, and this is especially 
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true of people with type 2 diabetes who are overweight or obese (Mann and McAuley 2007). 
As a result of this uncertainty about the role of carbohydrate in the diet of people with type 2 
diabetes, this chapter includes: 
• A review of the evidence of the effects of low carbohydrate diet in people with type 2 
diabetes 
• The results of a low carbohydrate dietary intervention over three months in people 
with and without type 2 diabetes 
3.3. A review of the safety and efficacy of low carbohydrate diets for people with Type 2 
diabetes 
3.3.1. Background 
The health benefits of weight loss for overweight and obese people with Type 2 diabetes are 
now well established (Aucott, Poobalan et al. 2004) but controversies remain over the most 
effective dietary intervention to promote successful weight loss (Moore, Summerbell et at. 
2004). The majority of people with diabetes who successfully lose weight will regain the lost 
weight over subsequent months or years (Wadden, Butryn et al. 2004). All national and 
international diabetes organisations promote weight loss by a combined strategy of increased 
physical activity and a reduction in energy intake achieved by reducing total fat, saturated fat 
and processed carbohydrate, but they continue to recommend relatively high total 
carbohydrate intakes of between 45-60% energy intake (W olever, Barbeau et at. 1999; EASD 
2000; Nutrition sub-committee of the Diabetes Care Advisory Committee of Diabetes UK 
2003; Bantle, Wylie-Rosett et at. 2008). There is limited evidence that high carbohydrate diets 
may stimulate appetite and increase energy intake in people with the metabolic syndrome and 
Type 2 diabetes (Boden, Sargrad et al. 2005) and claims have been made that low fat, high 
carbohydrate diets may exacerbate obesity and hyperglycaemia (Arora and McFarlane 2005). 
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This has led to some discussion about the optimal amount of carbohydrate in the diets of 
people with diabetes to induce weight loss and improve glycaemic control (Mann and 
McAuley 2007) and an investigation of the safety and efficacy of low carbohydrate diets in 
the treatment of Type 2 diabetes (Kennedy, Chokkalingam et al. 2005). 
Low carbohydrate diets, of which Atkins is probably best known, have been popular for 
weight reduction since the 1960s. Reduction in carbohydrate intake and thus availability of 
glucose stimulates fat oxidation to supply energy and this process results in loss of body fat 
stores and ultimately weight loss. There is now substantial evidence from randomised 
controlled trials for the positive effect of low carbohydrate diets for weight loss in people 
without diabetes over the short-term (Foster, Wyatt et al. 2003; Samaha, Iqbal et al. 2003; 
Stern, Iqbal et al. 2004; Volek, Sharman et al. 2004; Yancy, Olsen et al. 2004), but there is 
limited evidence for the use of these diets over the longer term and in people with Type 2 
diabetes. It has been proposed that the mechanism of action of low carbohydrate diets would 
benefit people with Type 2 diabetes but whether there would be any added effect over and 
above reduction in energy intake with associated weight loss is open to question. 
The benefits of improvement in glycaemic control for people with Type 2 diabetes were 
established by the results of the United Kingdom Prospective Diabetes Study in 1998 
(UKPDS 1998). Weight loss improves insulin sensitivity and lowers Alc in people with 
diabetes, but glycaemia per se is not the full picture for risk reduction in type 2 diabetes 
(Aucott, Poobalan et al. 2004). Other risk factors include high blood pressure, alterations in 
lipid levels and central obesity and are associated with insulin resistance. This cluster of risk 
factors is found in overweight and obese people with type 2 diabetes and is referred to as the 
metabolic syndrome (Alberti, Zimmet et at. 2006). The presence of metabolic syndrome 
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increases cardiovascular risk, which remains the leading cause of death for people with Type 
2 diabetes. The evaluation of weight reducing diets, including low carbohydrate diets, should 
investigate effects on glycaemic control, measures of insulin resistance and cardiovascular 
risk reduction in people with Type 2 diabetes. 
3.3.2. Definition of low and reduced carbohydrate diets 
Low carbohydrate diets have been called a variety of names including ketogenic diets, high 
protein diets and high fat diets. Some high fat and high protein diets are not particularly low 
in carbohydrate and it has been proposed that the term low carbohydrate should include any 
diet providing ~50g carbohydrate/day (Volek and Westman 2002; Adam-Perrot, Clifton et al. 
2006) . Although there are differences between individuals in blood ketone levels with 
various amounts of dietary carbohydrate, it has been shown that ketosis readily occurs at 
carbohydrate intakes below this level of 50g/day (VanItallie and Nufert 2003). 
For the purposes of this review, low carbohydrate refers to a diet providing ~50g of 
carbohydrate per day, and reduced carbohydrate refers to any dietary intervention designed to 
lower usual carbohydrate intake. 
3.3.3. Mechanism of action of reduced carbohydrate diets 
Carbohydrate metabolism begins with digestion in the small intestine to monosaccharides, 
including glucose, which are then absorbed into the blood stream. Glucose is the preferred 
metabolic fuel in all tissues of the body, and levels in the bloodstream are regulated by the 
hormones insulin, glucagon and adrenaline. Consumption of excess energy by the individual 
(whether as protein, fat or carbohydrate) will result in fat deposition within adipose tissue by 
the process of lipogenesis. Reduced carbohydrate diets, which are designed to limit both 
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energy intake and available glucose, result in increased fat oxidation generating free fatty 
acids (FF A) to supply energy needs and lead ultimately to weight loss (Adam-Perrot, Clifton 
et a1. 2006). 
Fatty acids can be oxidised by the liver and muscles for energy production. In the liver, FF A 
are partially oxidised to form ketone bodies as the liver attempts to limit the rise in plasma 
FF A levels. Unlike muscle tissue, the liver has no need to completely oxidise FF A for its own 
energy needs and ketone bodies are produced as an overflow mechanism of FF A metabolism. 
These ketone bodies can be used as a fuel by tissues including the brain and muscles. 
Ketone levels are raised in most fasting subjects where fat oxidation is providing energy, 
although levels do not rise to those seen in diabetic ketoacidosis, as the presence of insulin 
inhibits acceleration of ketone production. There has been much discussion over the role of 
ketones in the mechanism of weight loss in low carbohydrate diets; animal models suggest 
that circulating ketones have a direct effect on appetite by increasing satiety (Volek and 
Westman 2002). There is some contradictory evidence for the effects of mi ld dietary-induced 
ketosis, one study reported ketogenic low carbohydrate diets have a more favourable effect on 
glycaemia (Gumbiner, Wendel et a1. 1996) and a more recent report stated that ketogenic diets 
have no metabolic advantage over non-ketogenic low carbohydrate diets (Johnston, Tjonn et 
a1. 2006). 
Restriction of carbohydrate intake is usually accompanied by a reduction in total energy 
intake leading to weight loss; there is now evidence from trials of low carbohydrate diets in 
people without diabetes that energy restriction accounts fully for all weight loss in individuals 
adopting these diets (Bravata, Sanders et a1. 2003). 
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3.3.4. Characteristics of studies 
Metabolic studies in people with Type 2 diabetes on reduced carbohydrate diets have shown 
that low carbohydrate diets have direct effects on glucose metabolism by reducing plasma 
glucose levels (Gannon and NuttaI12004), increasing insulin sensitivity (Boden, Sargrad et a1. 
2005), and reducing postabsorptive glycogenolysis (AIlick, Bisschop et al. 2004). At present, 
there are no published studies of randomised controlled trials including an intervention diet 
which provides ~50g carbohydrate/day in people with Type 2 diabetes. An electronic search 
was performed using MEDLlNE (1966 - March 2007), EMBASE (1988 - March 2007) and 
the Cochrane Central Register of Controlled Trials (1991 - March 2007) using the search 
terms low carbohydrate, Type 2 diabetes and weight loss. All studies relating to intervention 
trials of low carbohydrate diets in people with Type 2 diabetes were included. Six trials were 
identified and included in this review, see Fig 3.1 Of these six trials, only one was a 
randomised controlled trial, two were designed as cross-over trials and the remaining three 
trials were single-arm intervention studies. The follow-up period of these trials tended to be of 
short duration and ranged from 14 days to 22 months, and only two studies reported data 
beyond six months. There was little consistency in the amount of carbohydrate included in the 
intervention arms of these studies, the lowest intake is reported as <20glday and the highest as 
95g/day. In addition, the number of subjects in each study ranged from 10 -102 and, where 
age was reported, was confined to a population in late middle-age (average age 51 - 66 
years). Table 3.1 summarises details of the clinical trials of hypo caloric, reduced carbohydrate 
diets in people with Type 2 diabetes that have been published to date. 
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Fig 3.1. Quorum flowchart of reviewing process for articles investigating low 
carbohydrate diets and Type 2 diabetes 
298 articles identified though 
database searching 
15 potentially appropriate 
articles to be included in review 
6 published articles identified 
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283 articles excluded: 
268 did not include low 
carbohydrate diets 
15 non-English language 
articles 
9 articles excluded: 
Included people without 
Type 2 diabetes 
Table 3.1. Details of clinical trials of hypocaloric, low carbohydrate diets in people with Type 2 diabetes 
Author No of subjects Age Male/Female Type of study Carbohydrate intake Duration of 
(years) (glday) study 
Gutierrez, 1998 28 66.4 8/20 Cross-over 25% total energy* 8 weeks 
Robertson, 2002 88 N 42/46 Single arm intervention :s40 12 months 
Boden, 2005 10 51 317 Cross-over 21 14 days 
Yancy, 2005 28 56 20/8 Single ann pilot :s20 4 months 
intervention 
Nielsen, 2005 31 N N Non-randomised 75-95 6 months 
(16 intervention/15 intervention with 
control) comparison control group 
Neilsen, 2006 28 N N Retrospective follow-up of * 22 months 
(16 interventionl7 above study 
cross-over/5controI) 
Daly, 2006 102 58.7 49/53 Randomised controlled trial 70 3 months 
(51 intervention/51 
controls) 
Daly, 2006 6 month follow-up data 
206 N N from above study 
* 6 months 
* No details of absolute carbohydrate intake given 
N No data reported 
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3.3.5. Positive effects of low carbohydrate diets 
Low carbohydrate diets are postulated to have positive effects on body weight, glycaemic 
control, body composition, medication use and attrition rates in people with Type 2 diabetes. 
These factors are discussed more fully below. 
3.3.6. Weight and glycaemic control 
Table 3.2 shows changes in weight, BMI and Ale from baseline for each of the six studies in 
people with Type 2 diabetes. A short-term, 8-week cross-over study in 28 individuals of a diet 
providing 25% energy as carbohydrate showed significant reductions in weight and Ale, 
compared with a diet providing 55% energy from carbohydrate after cross-over for 12 weeks 
(Gutierrez, Akhavan et a1. 1998). An intervention study of a low carbohydrate diet «4 0 glday) 
in 88 subjects reported significant reductions in both Ale and body weight at one year 
(Robertson and Broom 2002). A short-term in-patient study (21 g carbohydrate/day) over 14 
days in 10 obese subjects reported greater weight loss and significant improvements in 
glycaemic control and insulin sensitivity (Boden, Sargrad et a1. 2005). A more recently 
published intervention study reported improvements in Ale and body weight over 16 weeks 
with a 20glday carbohydrate intake in 28 subjects (yancy, Foy et a1. 2005). A non-
randomised study in 31 diabetic subjects compared a 20% carbohydrate diet (equivalent to 
85-96g1day for men and 75-85g1day for women) to a low fat diet (25% energy as fat) over six 
months and reported significant reductions in weight and Ale (Nielsen, Jonsson et at. 2005). 
This benefit remained at 22 months retrospective follow-up. Interestingly, 7 of the original 15 
controls had crossed over to the reduced carbohydrate diet after the six months intervention 
and these data are included in the follow-up report at 22 months (Nielsen, Westerlund et a1. 
2006). A recent and larger scale randomised trial of 102 patients with Type 2 diabetes 
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compared a prescribed 70g/day carbohydrate intake (actual reported intake 109.5g/day) with a 
low fat diet «35% energy as fat) and showed a significant reduction in body weight and 
improvement in lipid profile, but no significant change in A I cover 3 months compared with a 
control (Daly, Paisey et al. 2006). Data for 206 subjects at 6 months showed maintenance of 
significant weight loss, but no change in differences in Alc between the two groups (Daly, 
Piper et al. 2006). 
Other studies that have been published show that a reduction in carbohydrate intake does have 
positive effects in people with diabetes, but as these studies either included a small diabetic 
sub-group (54 of 132 subjects) and did not fully report changes in the sub-group (Stem, Iqbal 
et al. 2004) or used a relatively high carbohydrate intake (138g/day) (Sargrad, Homko et al. 
2005), they have not been included in this review. Two studies also excluded from this review 
investigated the effect of a eucaloric low carbohydrate diet on glycaemic control in people 
with Type 2 diabetes and have shown positive metabolic effects of low carbohydrate diets in 
the absence of weight loss, including reductions in glucose and insul in levels, Al c and 
triglyceride levels (Allick, Bisschop et al. 2004; Gannon and Nuttall 2004). 
It can be seen from Table 3.1 that only three of these studies reduced carbohydrate intakes to 
< SOg/day, and that two of these three studies were of short duration (less than six months). 
The lack of randomised controlled trails in this area and the varying amounts of carbohydrate 
prescribed in the trials to date make it difficult to reach significant conclusions about the role 
of carbohydrate in weight loss and glycaemic control for people with Type 2 diabetes. 
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Table 3.2. Changes from baseline in body weight, BMI, and Ale in studies of hypocaloric, low carbohydrate diets in people with 
type 2 diabetes 
Author Weight (kg) BMI (kg/m2) Ale (%) 
Baseline Weight Pvalue Baseline Change P value Baseline Change P value 
loss 
Gutierrez, 76.2 1.2 N 28.5 -0.4 N 9.7 -1.7 <0.05 
1998 
Robertson, 109.6 7.2 N 38.6 -2.5 N 9.6 -0.8 N 
2002 
Boden, 2005 114.8 2.0 0.042 40.3 -0.8 N 7.3 -0.5 0.006 
Yancy, 2005 131.4 8.7 <0.001 42.2 -2.8 <0.001 7.5 -1.2 <0.001 
Nielsen, 100.6 11.4 <0.001 36.1 -4.1 <0.001 8.0 -1.4 <0.001 
2005 
Nielsen, N 8.6 <0.001 N -3.2 <0.001 N -1.1 <0.001 
2006 
Daly, 2006 102.0 3.6 0.001* 36.1 -1.3 N 9.1 -0.55 0.132* 
Daly, 2006 N 3.8 <0.0005* N N N N -0.48 NS 
N No data reported 
NS Not significant 
* Significance assessed by comparison with changes from baseline in the control group 
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3.3.7. Body composition 
All these published studies report significant weight loss with hypocaloric, reduced 
carbohydrate diets in people with Type 2 diabetes. A theoretical view is that the majority of 
weight loss seen with low carbohydrate diets is due to water losses associated with glycogen 
depletion and increased urinary ketone secretion (Denke 2001). However, this is not 
supported by evidence from two of the studies in diabetic subjects that investigated body 
composition and which showed that the majority of weight loss is explained by a reduction of 
body fat rather than fluid loss (Boden, Sargrad et at. 2005; Yancy, Foy et at. 2005) 
Fat distribution, and specifically high levels of visceral fat, is a known risk factor for heart 
disease and diabetes and changes in intra-abdominal fat were investigated by two studies. 
Both report a positive effect of a reduction in carbohydrate intake; one reports a 5% decrease 
in waist circumference from 130 to 123 cm (p=<O.OOI) (Yancy, Foy et at. 2005) and another 
reports a loss of 4.4cm over 6 months (p=<O.OOl) (Daly, Piper et at. 2006). 
3.3.8. Medication 
The majority of studies in people with type 2 diabetes have included subjects taking a variety 
of glucose-lowering therapies, including metfonnin, thiazo]odinediones, sulphonylurea and 
insulin. The studies that report changes in medication as a result of adopting a reduced 
carbohydrate diet have recorded either reduction or discontinuation of this medication 
(Gutierrez, Akhavan et at. 1998; Boden, Sargrad et at. 2005; Yancy, Foy et at. 2005; Daly, 
Paisey et at. 2006; Nielsen and Joensson 2006). For example, Daly (Daly, Paisey et at. 2006) 
reported that insulin doses were reduced in 85% of those adopting a low carbohydrate diet 
compared with 22% of the low fat group. Robertson (Robertson and Broom 2002) stated that 
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before adoption of a reduced carbohydrate diet, all sulphonylurea therapy was stopped and 
insulin doses reduced by 50%. 
3.3.9. Attrition rates 
Attrition rates in dietary intervention studies are traditionally high, commonly between 30-
60% (Dansinger, Gleason et a1. 2005). In these low carbohydrate studies in people with 
diabetes, attrition rates ranged from no drop-outs for the short-term studies over 2 and 8 
weeks, to 10-25% attrition for those conducted over three months to two years. These rates 
are relatively low, but little is known about attrition rates for most reduced carbohydrate 
intervention studies over the longer term. 
3.3.10. Potential adverse effects of reduced carbohydrate diets 
Intuitively, it has been assumed that reduced carbohydrate diets, by definition, provide higher 
amounts of both fat (especially saturated fat) and protein in the diet. Potential adverse effects 
associated with this dietary change include dyslipidaemia as a result of a high fat intake, 
decline in renal function and increased calcium loss from bones as a result of increased 
protein intake, compromised nutritional intake as a result of low intakes of dietary fibre, fruit, 
vegetables and milk products and finally, adverse effects of ketosis on cognitive function. At 
present, there is little evidence for the safety of reduced carbohydrate diets in people with 
Type 2 diabetes over the long-term and this is discussed more fully below. 
3.3.11. Cardiovascular risk 
Concern has been expressed about the effect of high fat intakes on blood lipid levels and risk 
of cardiovascular disease. This view is largely refuted for people without diabetes by a meta-
analysis of the effect of low carbohydrate diets that shows favourable changes in triglyceride 
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and HOL cholesterol, but higher LDL cholesterol (Nordmann, Nordmann et a1. 2006). A 
recent review of aspects of low carbohydrate diets in people without diabetes reports 
significant reductions in both postprandial lipaemia and fasting triglyceride levels (Adam-
Perrot, Clifton et a1. 2006). Evidence from long-term studies in people with diabetes is 
lacking; from the studies reported in Table 3.2, only 4 authors report changes in lipid levels 
and these are summarised in Table 3.3. Two studies have reported a significant reduction in 
triglyceride levels, with no significant changes in total cholesterol, HOL cholesterol or LDL 
cholesterol (Yancy, Foy et a1. 2005). Neilson (Nielsen and Joensson 2006; Nielsen and 
Joensson 2008) did not report levels of LDL cholesterol at either 6 or 22 months follow-up, 
but stated there was a significant rise in HOL cholesterol from baseline and no significant 
change in triglyceride and total cholesterol levels. Daly (Daly, Paisey et a1. 2006) does not 
report absolute values for total, HOL and LDL cholesterol at 3 months, but states that there 
was significant reduction in the ratio oftotal:HOL cholesterol in the group allocated a reduced 
carbohydrate intake. Lipid levels have not yet been reported for this study at 6 months follow-
up. 
The main trend from these studies appears to be a reduction in triglyceride levels with no 
significant change in other lipid levels and little evidence for any increased cardiovascular 
risk in people with type 2 diabetes. However, these results must be interpreted with caution 
as these studies are short-term and most lack a control group. 
3.3.12. Renal function 
Nutritional recommendations for people with diabetes promote a moderate protein intake to 
reduce the risk of renal disease. Reduced carbohydrate diets are assumed to include larger 
quantities of dietary protein and this may have an impact on renal function. However, only 
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two of the studies in people with Type 2 diabetes have investigated renal function. One study 
over two weeks reported a small but significant rise in mean blood urea nitrogen, but no 
changes in serum creatinine and uric acid levels and no changes in urinary creatinine and 
albumin excretion (Boden, Sargrad et a1. 2005). Yancy (Yancy, Foy et at. 2005) reported a 
reduction in serum creatinine and an increase in urea nitrogen over 16 weeks. Neither of these 
changes reached statistical significance. Counter-intuitively, a recent case-study reported that 
a low carbohydrate diet was successful in preventing end-stage renal failure in one individual 
(Nielsen, Westerlund et a1. 2006). There are no data from long-term studies in people with or 
without diabetes to either support or refute claims that reduced carbohydrate diets impair 
renal function and further research is needed in this area (Bantle, Wylie-Rosett et a1. 2008). 
3.3.13. Calcium balance 
There have been suggestions that reduced carbohydrate diets may have a negative impact in 
bone health and calcium metabolism as the acidosis associated with the presence of ketones, 
coupled with high protein intakes, promotes urinary calcium loss (Adam-Perrot, Clifton et at. 
2006). There is very little evidence for the effects of reduced carbohydrate diets on calcium 
metabolism. One study in people without diabetes showed no effect of increased dietary 
protein over the short-term (Kerstetter, O'Brien et a1. 2005) and only one study in people with 
diabetes investigated effects on serum calcium levels (Yancy, Foy et a1. 2005). This study 
reported no change in serum calcium levels over 16 weeks in individuals adopting a low 
carbohydrate diet. There is no evidence for the effects of reduced carbohydrate diets on 
calcium balance and risk of osteoporosis in the long-term. 
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Table 3.3. Effect of low carbohydrate diets on lipid levels in people with Type 2 diabetes 
Author Total cholesterol (mmol/l) 
Baseline Change 
Boden, 4.68 -0.44 
2005 
Yancy, 4.61 -0.07 
2005 
Nielsen, 5.6 +0.5 
2005 
Nielsen, N -0.1 
2006 
Daly, 2006 4.89 N 
* Calculated from published data 
N. No data reported 
NS. Not significant 
P value 
<0.02 
NS 
NS 
NS 
N 
HDL cholesterol (mmoVl) LDL cholesterol (mmol/l) 
Baseline Change P value Baseline Change P value 
1.16 -0.02 NS 2.61 -0.05 NS 
0.92 +0.07 NS 2.51 +0.26 NS 
1.1 +0.2 <0.001 3.9* +0.3* N 
N +0.2 <0.001 N -0.2* N 
1.2 N N 2.6* N N 
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Triglycerides (mmoVl) 
Baseline Change P value 
1.84 -0.65 <0.001 
2.69 -1.12 0.001 
1.4 0 NS 
N 0 NS 
2.5 -0.67 0.223 
3.3.14. Dietary intake 
A major criticism of reduced carbohydrate diets is that they may be nutritionally inadequate 
as they restrict consumption of foods generally associated with good health; fruit, vegetables, 
starchy foods and milk products (Adam-Perrot, Clifton et a1. 2006). There is no evidence at 
present to support or refute these claims. Two studies in people with diabetes reported dietary 
intake and found that although there was a highly significant decrease in both energy and 
carbohydrate intake, that absolute intakes of both protein and fat did not change significantly 
(Yancy, Foy et a1. 2005). A third study (Daly, Paisey et a1. 2006) reported that there were 
significant increases in the amount of protein and fat in the diet of a reduced carbohydrate 
group compared with a control group receiving low fat advice, but this study was a 
comparison between groups after the intervention and did not include any data at baseline. 
However, although absolute protein and fat intakes were higher in the reduced carbohydrate 
group, these stilI remain lower than maximum recommended levels. In addition, the reduced 
carbohydrate group ate similar amounts of fruit and vegetables and significantly more oily 
fish than the low fat group. Calcium intakes were similar between the groups, but fibre 
intakes were significantly lower in the reduced carbohydrate group. The long-term nutritional 
effects of reduced carbohydrate diets in people with Type 2 diabetes are unknown. 
3.3.15. Cognitive function and quality of life 
There is very little published evidence for the effects of low carbohydrate ketogenic diets on 
either quality of life or cognitive function in people without diabetes and no published data 
for people with diabetes. Of the two small, randomised, controlled trials studies conducted on 
people without diabetes, one study including 21 obese women allocated to either ketogenic or 
nonketogenic very low energy liquid diets reports that hypocaloric, ketogenic diets have no 
effect on performance on attention tasks, but neurophysical tests requiring high order mental 
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processing and flexibility are adversely affected (Wing, Vazquez et a1. 1995). A six-week 
randomised trial in 20 obese individuals used the Profile of Mood States (POMS) to measure 
six distinct mood states and found that a low carbohydrate ketogenic diet showed no 
difference in five of the six mood states measured, but that vigour-activity scores were 
significantly lower in those allocated a ketogenic diet (Johnston, Tjonn et at. 2006). 
3.3.16. Conclusions 
In summary, the available evidence shows that in all intervention studies of reduced 
carbohydrate diets in people with Type 2 diabetes, there were reductions in both body weight 
and Alc. No study published to date has shown a deleterious effect on glycacmic control or 
cardiovascular risk factors, but these findings should be interpreted with caution as there were 
no control groups in the majority of studies and that these studies are of short-term duration. 
At present, it appears that low carbohydrate diets may be useful over the short term to 
promote weight loss in people with Type 2 diabetes, but there is no evidence that these diets 
are more successful in the long-term than traditional approaches. More research is needed to 
investigate the long-term effects of these diets on weight loss, glycaemic control, lipid levels, 
calcium metabolism and nutritional adequacy in people with diabetes. In an attempt to 
identify the role of low carbohydrate diets in people with and without type 2 diabetes, we 
designed and evaluated a randomised controlled trial of low carbohydrate diets «40g/day) 
over three months. 
3.4. A randomised controlled trial of low carbohydrate and low fat, healthy eating diets 
in people with and without Type 2 diabetes 
3.4.1. Introduction 
There has been a resurgence of interest in the role of low carbohydrate diets and weight loss 
over the past few years. Evidence from randomised, controlled trials have shown low 
94 
carbohydrate diets are effective for weight loss over the short-tenn in people without diabetes 
(Brehm, Seeley et at. 2003; Foster, Wyatt et at. 2003; Yancy, Olsen et al. 2004), but the effect 
appears to be related to reduction in energy rather than carbohydrate intake (Bravata, Sanders 
et at. 2003) and concern has been expressed about the long-tenn effects of these diets (Astrup, 
Meinert Larsen et at. 2004). In addition, little is known about the long-term effects of these 
diets, studies have shown that weight loss is greater with low carbohydrate diets compared 
with low fat diets over six months (Samaha, Iqbal et at. 2003), but the difference disappears 
at twelve months follow-up (Stern, Iqbal et at. 2004). Concerns about the effects of a 
relatively high fat diet on cardiovascular risk factors appear to be unfounded over the short-
tenn (Meckling, O'Sullivan et at. 2004; Volek, Sharman et at. 2004), even in individuals with 
established heart disease (Gann 2004) but little is known about the long-term effects. Low 
carbohydrate diets have been shown to decrease insulin levels and increase ketosis (Volek, 
Sharman et al. 2002; Volek and Westman 2002; Gann 2004) and these effects have been 
noted within 72 hours of starting the diet (Willi, Oexmann et al. 1998). There is no evidence 
that ketone production varies between diabetic and non-diabetic subjects, or for the role of 
ketosis in weight loss. 
Although there is now evidence from randomised controlled trials for the effect of low 
carbohydrate diets in people without diabetes, there is limited evidence for people with Type 
2 diabetes. The review above of previous studies in people with Type 2 diabetes reports that 
most studies have involved small numbers of subjects, lacked a control group, had high 
attrition rates, had short follow-up periods or used a relatively moderate carbohydrate 
restriction and have shown highly variable effects upon weight loss and glycaemic control. In 
response to these somewhat contradictory results, the study reported below was designed to 
evaluate the effect of a low carbohydrate diet (40g/day) on quality of life, appetite and 
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biomedical outcomes including body weight, glycaemic control, ketone production and lipid 
levels in subjects with and without type 2 diabetes and to compare this with subjects allocated 
a low fat diet. 
3.4.2. Aims and Objectives 
This study was designed with a primary aim to investigate the effect of a low carbohydrate 
ketogenic diet on weight loss, biomedical outcomes and quality of life in people with and 
without Type 2 diabetes. In addition, secondary outcomes included the investigation of the 
rate of development and concentration of ketone bodies in both diabetic and non-diabetic 
subjects following a low carbohydrate diet and to investigate the relationship between ketone 
production and weight loss. 
3.4.3. Subject Selection 
The study population was designed to include 24 overweight individuals, 12 with Type 2 
diabetes and 12 non-diabetic individuals, who meet the inclusion/exclusion criteria. 
3.4.7. Methods 
The methodology for this study is explained fully in Chapter 2. Briefly, 26 (13 subjects with 
type 2 diabetes and 13 without) overweight or obese individuals were recruited from a 
volunteer database held in the research unit at OCDEM, from direct referral from a physician 
during attendance at a routine clinic visit or by means of advertisements placed around the 
hospital. All subjects expressing an interest were invited to attend an appointment at the 
research unit where the study was explained in detail and they were invited to participate. 
Subjects were randomly assigned either a low carbohydrate diet (40glday) or a low fat, weight 
reducing diet. All subjects who agreed to take part in the study had not attempted weight loss 
in the previous twelve months and all non-diabetic subjects had never received formal dietary 
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advice. All subjects with diabetes had received dietary advice in line with Diabetes UK 
recommendations at diagnosis, but none had had formal dietary intervention in the preceding 
twelve months. 
3.4.8. Results 
Baseline physical characteristics of the 26 subjects recruited into the study are shown in Table 
3.4 by dietary allocation and Table 3.5 by diagnosis of diabetes. There were no significant 
differences between the two groups for any of the baseline variables. Table 3.5 shows a 
comparison of the characteristics of the diabetic and non-diabetic subjects at baseline. There 
were no differences for any of these variables with the exception of waisthip ratio and Al c, 
and this was, obviously, significantly higher in the diabetic population (7.3 v 6.0%, p=O.OOI). 
Three-month data are presented for 22 (85%) of the 26 patients randomised into the study. Fig 
3.2 shows that 12 subjects were randomised to the low carbohydrate diet and 14 to low fat 
advice. Analysis is by last observation carried forward at one or two months and this applies 
to one subject allocated to the low carbohydrate group and one subject allocated low fat 
advice. There were no drop-outs after randomisation in the low carbohydrate group, and this 
contrasts with four subjects in the low fat group who refused follow-up after randomisation. 
All four of these subjects expressed disappointment at being allocated to the low fat dietary 
arm of the study rather than the low carbohydrate diet, and their decision to withdraw was 
made as they did not receive their preferred diet. 
The differences in the changes between the low carbohydrate and low fat groups at three 
months are shown in Table 3.6 and % changes from baseline are shown in Fig 3.3. There was 
a significant reduction in weight in both groups, but a greater reduction in the low 
carbohydrate group compared with the low fat group (6.9 v 2.lkg, p=O.003). There was also a 
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significant reduction in the amount of body fat in the group allocated the low carbohydrate 
diet (-1.5 v 0.6%, p=0.012). There were no differences between the groups for all other 
measured variables including Ale, lipid profiles, blood pressure, quality of life and hunger 
score. 
Tables 3.7 and 3.8 show the differences in characteristics at baseline and three months and the 
differences from baseline at three months in the diabetic and non-diabetic subjects by dietary 
allocation. 
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Table 3.4. Baseline characteristics of 26 diabetic and non-diabetic subjects 
Variable Low carbohydrate Low fat All subjects 
(n=12) (n=14) (n=26) 
Mean (SD) Mean (SD) Mean (SD) 
% male 17 36 23 
Age (years) 55 (5) 50 (12) 52 (9) 
Weight (kg) 95.6 (16.7) 97.0 (17.2) 96.3 (16.6) 
BMI 35.1 (6.8) 35.0 (7.4) 35.1 (7.0) 
Waisthip ratio 0.90 (0.07) 0.91 (0.07) 0.90 (0.07) 
Body fat (%) 47.3 (8.6) 43.9 (8.7) 43.5 (8.7) 
Alc (%) 6.7 (1.3) 6.6 (1.0) 6.6(1.1) 
Total cholesterol 5.1 (1.3) 5.1 (0.8) 5.1 (1.1) 
(mmo1Jl) 
HDL cholesterol 1.28 (0.44) 1.37 (0.33) 1.32 (0.38) 
(mmo1Jl) 
LDL cholesterol 3.1 (1.1) 3.1 (0.8) 3.1 (0.9) 
(mmo1JI) 
Triglycerides 1.55 (1.01, 2.35)* 1.12 (0.74, 1.72)* 1.48 (0.82, 2.14)* 
(mmo1JI) 
Ketones (mmo1JI) 0.0- 0.2** 0.0 - 0.1 ** 0.0 -0.2** 
Blood pressure: 
Systolic 138 (20.6) 138 (20.4) 138 (11.0) 
Diastolic 79 (13.4) 84 (8.4) (11.0) 
(mmHg) 
Quality of life (%) 60.7 (21.6) 49.4 (21.7) 54.6 (22.0) 
Hunger score 3.8 (0.8) 4.5 (1.2) 4.2 (1.1) 
(Lickert scale) 
SD standard deviation 
* Triglyceride concentrations expressed as geometric means 
** Ketone concentrations expressed as ranges 
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Table 3.S. Baseline comparison of diabetic and non-diabetic subjects 
Variable Diabetic subjects Non-diabetic p-value 
(n=13) subjects 
Mean (SD) (n=13) 
Mean (SD) 
% male 30 23 
Age (years) 54 (9) 51(9) 0.331 
Weight (kg) 99.0 (12.9) 93.5 (19.8) 0.412 
BMI (kglm2) 34.8 (4.8) 35.8 (7.1) 0.874 
Waist:hip ratio 0.93 (0.07) 0.87 (0.05) 0.016 
Body fat (%) 43.6 (9.6) 47.3 (7.5) 0.284 
Ale (%) 7.3 (1.3) 6.0 (0.3) 0.001 
Total cholesterol 4.8 (1.2) 5.4 (0.9) 0.184 
(mmoVI) 
HDL cholesterol 1.34 (0.5) 1.31 (0.2) 0.837 
(mmoVI) 
LDL cholesterol 2.8 (0.9) 3.4 (0.9) 0.090 
(mmoVI) 
Triglycerides 1.51 (0.76,2.27)* 1.47 (0.57, 2.04)* 0.862 
(mmoVI) 
Ketones (mmoVl) 0-0.1** 0-0.2** 
Blood pressure: 
Systolic 142 (20.5) 134(19.5) 0.287 
Diastolic 82 (lOA) 82 (12.2) 0.994 
(mmHg) 
Quality oflife (%) 62.2 (23.0) 47.1 (18.8) 0.734 
Hunger score 4.1 (0.8) 4.2 (1.4) 0.734 
(Liekert scale) 
SD standard deviation 
• Triglyceride concentrations expressed as geometric means 
*. Ketone concentrations expressed as ranges 
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Fig 3.2. Consort Flowchart 
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Table 3.6. Absolute changes from baseline at three months, low carbohydrate v low fat 
diet 
Variable Low carbohydrate Low fat diet p-value 
diet 
Weight (kg) -6.9 -2.1 0.003 
BMI(kg/m2) -2.7 -0.8 0.001 
Waist:hip ratio -0.01 -0.01 0.990 
Body fat (%) -1.5 0.6 0.012 
Alc (%) -0.3 -0.2 0.582 
Total cholesterol 0.1 -0.1 0.282 
(mmol/l) 
HDL cholesterol 0.09 -0.06 0.113 
(mmol/l) 
LDL cholesterol 0.2 0 0.126 
(mmol/l) 
Triglycerides* -0.4 0 0.07 
(mmol/l) 
Ketones 0.1 0 0.055 
(mmolll) 
Blood pressure: 
Systolic -0.9 -4.6 0.386 
Diastolic 2.2 -3.4 0.186 
(mmHg) 
Quality oflife (%) 6 9 0.715 
Hunger score -0.6 0.6 0.106 
(Lickert scale) 
* Triglyceride concentrations reported as changes in geometric means 
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Fig 3.3. % changes from baseline at three months, low carbohydrate v low fat diet 
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Diastolic BP 
Table 3.7. Baseline and 3 months characteristics and absolute changes from baseline by dietary allocation and diagnosis of diabetes 
Diabetes Non-diabetes 
Variable Low carbohydrate Low fat Low carbohydrate Low fat 
(n=6) (n=6) (n=6) (n=4) 
Baseline 3 months Change Baseline 3 months Change Baseline 3 months Change Baseline 3 months Change 
Weight (kg) 99.7 91.7 -8.0 96.9 96.1 -0.8 91.1 85.3 -5.8 95.7 92.9 -2.8 
BMI (kg/m2) 36.5 3304 -3.1 33.3 33.0 -0.1 33.7 31.5 2.2 37.3 36.2 -1.1 
Waist:hip ratio 0.92 0.91 -0.02 0.93 0.93 0.0 0.87 0.87 0.0 0.88 0.87 -0.01 
Bodyfat(%) 46.8 4404 -2.4 41.8 42.2 0.4 47.9 47.4 -0.5 44.6 45.4 0.8 
Alc (%) 7.2 6.8 -0.4 7.5 7.3 -0.2 6.1 5.9 -0.2 6.0 5.8 -0.2 
Total cholesterol 
(mmolll) 4.8 4.8 0 4.7 4.6 -0.1 5.5 5.7 +0.2 5.5 5.4 -0.1 
HDL cholesterol 
(mmolll) 1.24 1.32 +0.08 1.47 1.34 -0.13 1.32 lAO +0.08 1.32 1.38 +0.06 
LDL cholesterol 
(mmomll) 2.70 2.94 +0.24 2.69 2.75 +0.06 3.46 3.60 +0.16 3.57 3.40 -0.17 
Triglycerides 1.8 1.2 -0.6 1.2 1.3 +0.1 1.6 1.5 -0.1 1.4 1.3 -0.1 
(mmolll) 
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Table 3.8. Baseline and 3 months characteristics and absolute changes from baseline by dietary allocation and diagnosis of diabetes 
Diabetes Non-diabetes 
Variable 
Low carbohydrate Low fat Low carbohydrate Low fat 
(n=6) (n=6) (n=6) (n=4) 
Baseline 3 months Change Baseline 3 months Change Baseline 3 months Change Baseline 3 months Change 
Blood pressure: 
Systolic 145 139 -6 138 133 -5 132 136 4 133 129 -4 
Diastolic 76 78 3 86 83 -3 83 85 2 84 81 -4 
(mmHg) 
Quality oflife (%) 70 67 -3 51 56 5 51 66 15 49 65 16 
Hunger 4.0 4.2 -0.2 4.0 4.0 0.0 3.5 4.5 -1.0 5.5 4.0 1.5 
(Lickert Scale) 
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Dietary intake is shown in Table 3.9. There were no significant differences in nutrient intake 
between the two groups at baseline. At the end of the study, dietary analysis showed a 
significant reduction in energy intake in both groups, and a greater reduction in calories in the 
low carbohydrate group (949 v 515 kcal/day, p=0.036). There were no differences in changes 
in absolute protein and fat intakes between the two groups, but there was a highly significant 
reduction in carbohydrate intake in the low carbohydrate group to 56.8g/day. This reduction 
in carbohydrate intake was reflected in significant changes in % energy from macronutrients. 
Table 3.9. Changes in daily dietary intake over three months 
Variable Baseline (n=26) 3 months p-value 
Mean (SD) Low Low 
carbohydrate fat (Changes in LC v LF) 
(n=ll) (n=10) 
Energy (kcal) 2130 (457) 1313 (205) 1593 (277) 0.036 
Protein (g) 95.2 (18.4) 97.2 (18.9) 79.5 (16.6) 0.113 
Fat (g) 92.5 (30.1) 69.3 (25.6) 62.7 (22.4) 0.634 
Carbohydrate (g) 223.2 (62.0) 56.8 (26.5) 167.3 (60.4) 0.001 
Protein (%energy) 18.4 (3.8) 31.1 (6.9) 19.8(3.1) <0.001 
Fat (%energy) 38.6 (7.2) 46.2 (10.6) 34.4 (7.8) 0.033 
Carbohydrate 39.5 (6.8) 17.3 (9.7) 39.3 (12.8) <0.001 
(%energy) 
Alcohol (%energy) 3.5 (5.0) 6.1 (9.3) 6.6 (6.6) 0.611 
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3.4.9. Discussion 
3.4.9.1. Weight change 
In common with other published work, this study shows a greater reduction in weight over 
three months in subjects allocated a low carbohydrate diet compared to a low fat regimen. 
Individual weight changes are shown in Fig 3.4. Weight losses in the low carbohydrate group 
ranged from 1.4 - 13.8kg over the three months of the study, with a mean weight loss of 
6.9kg. The group allocated to the low fat diet showed a mean weight loss of 2.1 kg and a 
narrower range weight loss of 0.4 - 5.4 kg. Only 2 individuals in failed to lose weight, one of 
these showed no change in weight and another gained 2.4kg over the 3 months of the study. 
Both these individuals were allocated low fat advice. Significant weight loss in the low 
carbohydrate group was accompanied by significant loss of fat as measured by electrical 
impedance, the low carbohydrate group reduced body fat levels by 1.5% compared with an 
increase of 0.6% in the low fat group (p=O.O 12). It has been postulated that weight loss is 
more challenging in people with type 2 diabetes and that they lose less weight than people 
without diabetes (Wing, Marcus et al. 1987) but the results of this study do not appear to 
support these claims. Although this study was not powered to show differences between those 
with and without diabetes allocated to the 2 different regimens, Tables 3.7 and 3.8 show that 
there were no clinically significant differences between the diabetic and non-diabetic subjects. 
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Fig 3.4. Individual weight changes over 3 months. Low carbohydrate v low fat 
4 
2 • 
0 • • • 0:0 -2 • • C -4 ! t ., CIIl 
!a -6 • .c '" • .= 
.[f -8 • 
~ * -10 
-12 
• -14 • 
-16 
Low Healthy 
carbohydrate eating 
3.4.9.2. Glycaemic control 
Glycaemic control improved in both groups, with no difference between the two groups. This 
result may reflect the fact that this study included both subjects with and without diabetes. A 
sub-analysis showed that there was a clinical reduction in A I c in all the subjects with diabetes 
(-0.3%, p=0.07) but this failed to reach statistical significance. However, the non-diabetic 
subjects also showed a statistically significant reduction in A Ic (-0.1 %, p=0.038) although 
this is unlikely to be of clinical significance. Further analysis of all subjects, regardless of 
dietary allocation or diagnosis of diabetes showed a significant improvement in glycaemic 
control (-0.3% Al c, p= 0.012) over the three months of the study. 
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3.4.9.3. Lipid levels 
There were no significant differences in the changes in lipid levels between the low 
carbohydrate and low fat groups, although HDL cholesterol significantly increased and 
triglyceride levels decreased in the low carbohydrate group over three months. Lipid levels 
were relatively low in the subjects with Type 2 diabetes and this is partly explained by the use 
of lipid-lowering medication, 5 of the 13 (38%) diabetic subjects were taking prescribed statin 
therapy compared with none of the non-diabetic subjects. There was no evidence of an 
adverse effect of a low carbohydrate diet on lipid profiles in either the diabetic or non-diabetic 
group. 
3.4.9.4. Blood pressure 
There were no significant changes in blood pressure during the 3 months of the study, either 
between the low carbohydrate groups and the healthy eating group, or in the diabetic and non-
diabetic subjects. These data suggest that low carbohydrate diets do not increase 
cardiovascular risk over the short-tenn in people with and without diabetes. 
3.4.9.5. Quality of life 
There was a non-significant improvement in quality of life in both the low carbohydrate and 
the healthy eating group over the three months of the study, with no significant difference 
between the two groups. 
3.4.9.6. Mode of action of low carbohydrate diets 
This study has shown significant weight loss in those allocated a low carbohydrate diet 
compared to those allocated a low fat dietary plan, and the possible modes of action of low 
carbohydrate diets include appetite suppression associated with ketone production, large 
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initial weight losses associated with changes in body composition and diuresis and reduction 
in dietary intake caused by reduction in carbohydrate intake. 
3.4.9.7. Appetite suppression, weight loss and ketones 
The premise of low carbohydrate diets is that they are associated with increased ketone 
production and this supports weight loss by suppressing appetite. This supposition was 
investigated in this study by measuring appetite with a validated hunger-satiety scale (Roth 
1993). This scale is based upon a visual analogue scale (VAS) and utilises a scoring system 
from 1-10, where 1 represents starving hungry and 10 absolutely full. The higher the number, 
the greater the satiety and lower numbers represent greater hunger. There were no significant 
changes in appetite or hunger in either the low carbohydrate or the low fat group over the 
three months of this study and no significant changes between groups. This suggests that 
appetite suppression is not the primary action of low carbohydrate diets. There was no 
association between ketone levels and hunger or appetite in the subjects in this study, further 
suggesting that ketones have little or no effect upon appetite at the levels recorded. Further 
analysis investigated the relationship between ketone levels and weight loss to determine if 
ketones do exert some effect. 
All subjects in this study were required to measure ketone levels using a hand-held meter. 
Ketone measurements were taken four times daily at the following time-points; before 
breakfast (fasting levels), before the mid-day and evening meal and before bed. 
Measurements were taken at baseline while the subjects were on their usual diets and during 
the first week of the intervention, ketones levels were recorded daily. During the remainder of 
the study, ketones levels were measured and recorded four times daily on one day each week. 
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Baseline fasting ketone levels ranged from 0.0 - 0.2 mmolll. A mean blood ketone level for 
each subject was calculated from all the available blood ketone levels measured during the 3-
month study. Pearson's correlation coefficient was derived between mean blood ketone levels 
and weight loss from baseline at 3 months. Data were analysed by categorisation into % 
positive ketone tests and correlation was derived between weight loss and % positive ketone 
tests. 22 of26 (84.6%) subjects completed the study at 3 months and provided a full record of 
ketone measurements. There were no significant differences in blood ketone levels either at 
baseline or over the 3 months of the study between the two dietary groups. Ketone production 
over three months was significantly higher in the low carbohydrate group from baseline 
(p=0.05), but failed to reach statistical significance when compared with the low fat group 
(Fig 3.5), and this can be largely explained by the three outliers in the low carbohydrate group 
who showed large increases in blood ketone levels over the course of the study. 
Although there appeared to be more ketone production in the low carbohydrate group, it is 
interesting to note that 50% of the low fat group recorded positive ketones during the study 
period. As a proportion of the low fat group had also lost a significant amount of weight, the 
relationship between weight loss and ketone production was explored in all subjects, 
regardless of dietary allocation. 
Further analysis of % positive ketone tests showed that the low carbohydrate group showed a 
higher frequency of positive tests than the low fat group (46.4 v 18.2%, p=0.019). An analysis 
including all subjects regardless of dietary allocation showed there was a significant 
correlation between mean blood ketone levels and weight loss over 3 months (r = 0.72, 
p<O.Ol) in all subjects (Fig 3.6). There was also a significant correlation between the 
frequency of positive ketone tests and weight loss (r = 0.61, p<O.O 1). Analysis of tertiles of 
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frequency of positive blood ketone tests and weight loss and showed that those in the lower 
tertile lost least weight [mean (SO)] with weight losses of 3.1 (2.8)kg, those in the middle 
tertile 4.9 (3.5)kg, and those in the upper tertile significantly more weight 11.7 (3.l)kg which 
was greater than either the weight losses of those in the lower (p = 0.02) or middle terti Ie (p = 
0.03) .• 
Fig 3.5. Changes in blood ketone levels over three months. Low carbohydrate v low fat 
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This analysis shows a positive association between self-reported blood ketone levels and 
degree of weight loss in people with and without Type 2 diabetes. Although it is assumed that 
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ketone production is higher in people adopting a low carbohydrate diet, this study fails to 
confinn that finding and suggests that mild ketosis is associated with weight loss regardless of 
carbohydrate intake. The only significant difference in blood ketone levels between those 
allocated a low carbohydrate diet and those adopting a healthy eating, low fat approach is that 
the frequency of positive blood ketone tests was higher in those adopting a low carbohydrate 
diet. This raises the question of a cut-off point for significant weight loss associated with the 
frequency of blood ketone testing. Further analysis revealed that subjects showing positive 
ketone tests 40% of the time had significantly greater weight loss that those who had lower 
frequencies (8.7 v 3.1 kg, p = 0.01). It could be postulated that recording blood ketones levels 
in individuals attempting weight loss may be a useful tool in identifying concordance and 
successful weight loss. 
Fig 3.6. Correlation between blood ketone levels and weight loss in 22 individuals 
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3.4.9.8. \Veight loss and fluid balance 
The dramatic effects of low carbohydrate diets are often explained as fluid losses associated 
with utilisation of glycogen stores. Subjects in this study had body composition measured by 
electrical impedance to assess changes in body water and fat. There were no significant 
changes in body water during the three months of the study, but there were significant 
reductions in body fat in the low carbohydrate group, suggesting that the weight loss during 
the study was loss of fat and not fluid. 
3.4.9.9. Dietary intake 
The significant weight reduction in the low carbohydrate group appeared to be associated 
with a significant reduction in energy intake related to decreased carbohydrate intake and was 
not associated with an absolute increase in either protein or fat intake. Interestingly, subjects 
in both the low fat and the low carbohydrate group reported significant reductions in fat 
intake over the three months of the study, and this suggests that is possible to adopt a low 
carbohydrate diet without an increase in fat intake. This may reflect the fact that much of the 
fat eaten today is associated with carbohydrate for example in savoury snacks, biscuits, cakes 
and chocolate and that eliminating these foods reduces both carbohydrate and fat intake. 
There was no evidence from this study that either the low carbohydrate or the low fat diets 
resulted in any nutritional inadequacy, and there were no significant differences between the 
two diets for any vitamins or minerals. This may reflect the specific dietary advice given to 
the low carbohydrate group recommending 5 portions of low carbohydrate fruit and 
vegetables daily and the inclusion of 200ml milk. 
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3.5. Statistical analysis 
In this set of analyses, there is the possibility of a type 2 error having occurred. A type 2 error 
may have arisen as the null hypothesis (in this case, that low carbohydrate diets have the same 
effect as low fat diets) has been accepted and this is, in fact, incorrect. There may well be 
differences between the groups, for example in Alc and lipid levels, although the data suggest 
that they are the same. A type 2 error may have arisen as the sample size is small and has 
been subject to multiple statistical tests. 
3.6. Summary 
This preliminary study shows that low carbohydrate diets are more effective than traditional 
low fat diets over the short tenn for weight reduction in overweight and obese people with 
and without diabetes. As has been shown in studies of people without diabetes, low 
carbohydrate diets induce weight loss by reduction in energy intake achieved by carbohydrate 
restriction. Although a review of studies has shown that low carbohydrate diets have no 
adverse effects and do no increase cardiovascular risk over the short tenn, litt]e is known 
about the effects of these diets in the long tenn and further research is needed in this field. It 
appears that the primary mode of action for low carbohydrate diets on weight loss is that of 
energy reduction, but there may be an alternative mode of action to account for both weight 
reduction and improvements in glycaemic control. Low carbohydrate diets have a low 
glycaemic load, independent of the type of carbohydrate that is eaten. The diet used in this 
study, providing 40g carbohydrate from fruit, vegetables and milk products has an estimated 
daily glycaemic load of 15 (a low glycaemic load diet is considered to have a daily total 
<79). The effect of low glycaemic load diets, achieved by either adopting a diet of low 
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glycaemic index, or by reducing the total amount of carbohydrate eaten, may prove to be of 
benefit to people with diabetes. 
Diabetes UK, the charity for people with diabetes, does not advocate low carbohydrate diets 
for weight loss and recommends that up to 60% of energy in the diet should be derived from 
carbohydrate. This study, illustrating the relative efficacy of low carbohydrate diets for weight 
loss for people with Type 2 diabetes, suggests that there may be room for more flexibility in 
the dietary interventions promoted for both weight loss and glycaemic control. This approach 
is explored further in Study 3, which investigates a more accomodating approach to 
carbohydrate in the diets of people with Type 1 diabetes. Flexibility in approach is also 
explored in Study 3 and in Study 2 with an investigation of the effects of lifestyle 
interventions delivered by means of video education rather than by traditional individual 
interview. 
3.7. Publications 
Two articles based upon work from Chapter 3 have been published and are included in the 
Appendices at the back of this volume. The first is entitled' A low carbohydrate diet is more 
effective for reducing body weight than healthy eating in both diabetic and non-diabetic 
subjects'. This article was published in Diabetic Medicine in 2007 and can be found in 
Appendix 1. The second is entitled 'A review of low and reduced carbohydrate diets and 
weight loss in Type 2 diabetes' and was published in the Journal of Human Nutrition and 
Dietetics in 2008. A copy of this article can be found in Appendix 2. 
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Chapter 4 
Health education for people with diabetes 
4.0. Introduction 
Webster's dictionary defines education as 'the process of educating or teaching', with a 
further definition of educating as 'developing knowledge, skills or character' (Merriam-
Webster 2006). The Oxford English dictionary includes the following definition of education; 
'The systematic instruction, schooling or training given to the young in preparation for the 
work of life; by extension, similar instruction or training obtained in adult age. Also, the 
whole course of scholastic instruction which a person has received. Often with limiting words 
denoting the nature of the predominant subject of the instruction or kind of life it prepares, as 
classical, legal, medical, technical, commercial or art education' (Oxford English Dictionary 
1989). Both these definitions stress the purpose of education; that the individual should 
acquire some information, knowledge or training that was previously lacking. These 
traditional definitions of education suggest that the pr.mary focus is on knowledge and 
teaching rather than on the leamer, and that people undergoing an education process are 
expected to conform to the programme rather than the programme serving the needs of the 
learners. 
Health education differs from education per se as it includes an implicit expectation that 
acquiring knowledge is not sufficient for improving health, and that some behaviour change is 
necessary to move the individual towards a state of optimal health. Health education has been 
defined as 'any combination of learning experiences designed to facilitate voluntary actions 
conducive to health' (Green and Kansler 1980). The theories and models underpinning health 
education have been summarised by the National Institute for Health in the US (NIH 2005) 
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and include the following models; social cognitive (learning) theory, theory of reasoned 
action and planned behaviour, health belief model, trans theoretical model, relapse prevention 
model, social support and ecological approaches. 
4.1. Social cognitive theory 
Most health education is based upon social cognitive theory with a central principle of self-
efficacy. Self-efficacy reflects the estimate or personal judgement of an individual's ability 
and capacity to succeed in achieving specific goals. In addition, social cognitive theory 
includes the concepts of incentive and value from any health behaviour change. 
4.2. Theory of reasoned action and planned behaviour 
The theory of reasoned action and planned behaviour depcnds upon the individual attitudes 
and the influence of the social environment and includes the conccpt ofpcrceived behavioural 
control. This concept is similar to that of self-efficacy. 
4.3. Health belief model 
The health belief model takes into account perceptions including perceptions of severity of 
any illness, individual susceptibility and the advantages and disadvantages of making a health 
behaviour change. 
4.4. Transtheoretical model 
The transtheoretical model is probably the best known and relates to readiness to change and 
embraces five key stages; precontemplation, contemplation, preparation, action and 
maintenance. The key to utilising this model effectively is matching the intervention to the 
stage of change. 
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4.5. Relapse prevention 
Relapse prevention addresses the concept of adherence and examines the process of 
identifying high-risk situations and formulating solutions. It commonly involves four stages; 
indentifying the specific problem, brainstorming all possible solutions, evaluating each 
solution and committing to action. 
4.6. Social support and ecological approaches 
Social support and ecological approaches rely upon extrinsic models of health education and 
comprise the creation of supportive environments in both physical and emotional tenns to 
support behaviour change. These approaches have been developed to support the individual 
behaviour change process relying upon intrinsic theories such as self-efficacy. 
4.7 Health education for people with diabetes 
There is some evidence that knowledge about diabetes is reflected in glycaemic control, but 
there is an acknowledged difference between knowledge and its relation to behaviour change 
(Panja, Starr et al. 2005). Outcomes from published studies vary greatly, with most education 
programmes for people with diabetes reporting greater effects on knowledge than on skills, 
behaviour change and metabolic effects (NICE 2005). GPs have reported that the biggest 
barrier to diabetes management is getting their patients to alter their lifestyles (Agarwal, 
Pierce et al. 2002) and this may well reflect that education is delivered within the parameters 
of the medical model (the health professional as the expert and in charge) rather than 
acknowledging the patients agenda and that lifestyle changes are completely under the 
patient's control (Meetoo and Gopaul 2004) . There is general agreement that it is necessary 
to provide lifestyle education as a package for people with diabetes, and a growing awareness 
that education should be combined with behavioural approaches in order to increase 
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knowledge and induce beneficial change in lifestyle. There has been very little work done on 
evaluating the effectiveness of lifestyle advice for people with diabetes. This is for two 
reasons, firstly that the provision of lifestyle advice is widely perceived as central to the 
diagnosis of diabetes and it is considered unethical to withhold this advice, making 
randomised, controlled trails impossible to conduct. Secondly, there is much confusion about 
whether to assess knowledge, behaviour change or metabolic outcomes from the delivery of 
diabetes education. Full evaluation of education should includes an assessment of cost 
effectiveness and there is evidence that people with diabetes who participate in diabetes 
education sessions have lower average costs than those who have little or no education 
(Duncan, Birkmeyer et al 2009). In addition, evidence shows that diabetes education is 
associated with cost saving and positive return on investment (Boren, Fitzner et al 2008). The 
total amount expended on diabetes education in the UK is unknown, but there is an imbalance 
between the amount spent on health education generally and the amount allocated by the food 
industry to promote processed foods. Globally, for every US dollar spent by the World Health 
Organisation (WHO) trying to improve nutrition of the world's population, $500 is spent by 
the food industry promoting processed food (Consumers International 2008). A recent health 
programme promoting fruit and vegetables in the US cost $9.55 million, compared with 
$11.26 billion promoting processed foods (CPEHN 2005). 
Traditional, medically-centred models of health care delivery tend to concentrate upon the 
problem of 'non-compliance' and emphasise and evaluate the delivery of knowledge (Wolpert 
and Anderson 2001). It is becoming more widely accepted that this model should not be 
applied to chronic conditions like diabetes that depend upon self-management and that 
lifestyle advice for diabetes should be delivered using a more patient-centred approach 
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(Anderson and Funnell 2000). The rationale for a more patient-centred approach states that 
patients are constantly making decisions in their everyday life about food and physical 
activity that have a greater impact on their overall health than the decisions made by health 
professionals caring for them. If advice is framed from the patient's rather than the health 
professional's perspective, the patient may be more likely to regard that information as 
appropriate and should be more likely to incorporate it into their life. There is evidence that 
this more patient-centred approach can lead to significant improvements in self-management 
(Funnell and Anderson 2004). 
The importance of structured education for people with diabetes has long been recognised, but 
until recently data have been lacking for the effectiveness of this education. Traditionally, 
diabetes education is delivered using a didactic, one-to-one model, but this is time consuming 
and requires a well-trained, motivated educator. This model is neither effective nor efficient 
and has led to frustration for educators and people with diabetes alike which resulted in an 
evaluation of and changes to the delivery of education during the 1990s. Amid growing 
recognition that the most effective approach was not an expert simply dispensing advice 
piece-meal to people with diabetes, there was a movement towards group education and 
utilisation of the expert experience of people with diabetes. At the same time, the Department 
of Health was developing the National Services Framework (NSF) (Department of Health 
2001) for diabetes and recognised that self-management is the cornerstone for diabetes care 
(Department of Health 2003). In addition, Standard 3 of the NSF identifies structured 
education as a key intervention in encouraging partnership in decision-making, supporting 
self-management and helping people adopt and sustain a healthy life. 
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A review by the National Institute of Clinical Excellence (NICE 2003) supported the role of 
self-management as a fundamental part of diabetes care and went on to address the principles 
of education interventions. The Department of Health and Diabetes UK published a joint 
report in 2005 identifying the key components of structured education and stated that, from 
April 2006, structured education should be available to all people with diabetes in the UK 
(Diabetes UK 2005). 
4.8. The development of education for people with diabetes in the UK 
Recognition that education for people with diabetes should not consist solely of the medical 
professional dispensing advice, but should rely and build upon the existing knowledge and 
experience of the person with diabetes has led to a revolution in education for people with 
diabetes. This revolution has been supported by the Department of Health (DOH), the 
National Institute of Clinical Excellence (NICE) and Diabetes UK. The St Vincent 
Declaration, which was ratified by the World Health Organisation in 1991, first set goals for 
reducing the impact of diabetes and over twenty years later, the delivery strategy for the UK 
was published in 2003 in the NSF (Department of Health 2003). The NSF was established to 
improve services to people with diabetes by setting national standards, identifying the 
interventions and actions that will help meet each standard and proposing milestones by 
which service delivery will be measured. The NSF comprises twelve standards, ranging from 
preventing diabetes to managing complications, but the standard which underpins the 
education of people with diabetes is standard 3 which states: • All children, young people and 
adults with diabetes will receive a service which encourages partnership in decision-making, 
supports them in managing their diabetes and helps them adopt and maintain a healthy 
lifestyle. This will be reflected in an agreed and shared care plan in an appropriate format and 
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language. Where appropriate, parents and carers should be fully engaged in this process.' It 
goes on to identify structured education as a key intervention to improve knowledge, blood 
glucose levels, body weight, dietary management, physical activity and psychological well-
being in people with diabetes. 
The National Institute for Clinical Excellence (NICE) published guidance on the use of 
patient education models for diabetes in 2003 (NICE 2003) and included a review of the 
education offered to people with diabetes in the UK. The review concluded that self-
management is a fundamental part of diabetes care and that most people in England and 
Wales are offered some form of education at the time of diagnosis, but that this education 
varies greatly in content and length. However, this report also stated that very few individuals 
delivering education to people with diabetes had been formally trained for the purpose, and 
that there was a lack of evaluation of education. The conclusion was that there was 
insufficient evidence available to recommend a specific type of education or to provide 
guidance on the setting, delivery and frequency of educational interventions. The report did 
examine best practice and made some recommendations for interventions and recommended 
that they reflect established principles of adult learning, be provided by multi-disciplinary 
teams to groups of people with diabetes, ensure that the sessions are accessible to the 
broadest range of people by addressing differences in age, gender, culture, ethnicity and 
geography, that they are delivered in community or diabetes centres, use a variety of 
techniques to promote adult learning, specifically to engage with people by relating to their 
personal experience and are integrated into care in the long-term. 
This report was followed by a publication recommending clinical guidelines for the 
management of both Type 1 (NICE 2004; NICE 2008) and Type 2 diabetes (NICE 2005), 
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specifically investigating effects of various interventions on glycaemic control. In tenns of 
diabetes education, the report for people with Type 2 diabetes recommended that they receive 
a programme of structured education and that this should include modules designed to 
empower adults to participate in self-care. The report for people with Type 2 diabetes was the 
first to suggest the use of technology in delivering education and suggested that a variety of 
techniques could be utilised including picture charts, video techniques, computer packages, 
text messaging and e-mail tailored to the group or individual. 
By 2005, when the Department of Health and Diabetes UK published a report from the patient 
education working group entitled 'Structured education in diabetes' (Diabetes UK 2005) it 
was well-established that education was fundamental to supporting self-management for 
people with diabetes. The DOH identified four key components to structured education 
programmes and they are as follows: 
1. A structured, written curriculum including philosophy and theoretical principles 
2. Trained educators 
3. Quality assurance 
4. Audit and evaluation of both biomedical and quality of life outcomes 
More detailed criteria for education programmes were identified and included the 
recommendations that all programmes should be patient-centred and incorporate individual 
assessment, they should be reliable, valid, relevant and comprehensive, theory-driven and 
evidence-based, flexible and able to cope with diversity, able to utilise different teaching 
techniques, resource effective with supporting materials, written down (this included 
philosophy, aims and objective, timetables and detailed content) and finally that they should 
be subject to robust audit and evaluation. 
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These criteria apply more to structured education delivered in groups than to education 
delivered by leaflets or video, but the principles can be applied to all education. There are 
only three programmes in the UK which meet these standards, two designed for Type 2 
diabetes (Diabetes Education and Self-Management for Ongoing and Newly Diagnosed -
DESMOND and the X-PERT programme), and one for Type 1 diabetes (Dose Adjustment for 
Normal Eating - DAFNE). All three programmes have both shown a positive effect upon 
outcomes in terms of glycaemic control, weight, lipid levels and quality of Ii fe (DAFNE study 
group 2002; Deakin, Cade et a1. 2006; Davies, Heller et a1. 2008). The DAFNE programme 
for Type I diabetes is delivered to groups by specialist diabetes staff, predominately in 
secondary care. Both programmes for people with Type 2 diabetes offer education to groups 
and are delivered in primary care by trained health professionals, usually nurses and 
dietitians. Although these programmes have shown that they are effective, they do require 
resources and trained educators and may be beyond the reach of many primary health care 
trusts. 
4.9. Innovation and delivery of education 
The traditional model of delivering education is that of the one-to-one interview between the 
health care professional and the person with diabetes and is often based upon dietary histories 
and prescriptive advice. These didactic based approaches have been shown to produce modest 
improvements in outcomes, but patient education has been shown to be more effective if it 
has a behavioural element rather than being didactic (Brown, Lieberman et al. 1997). Both 
NICE and Diabetes UK suggest that innovative approaches may be needed to deliver 
education to people with diabetes (NICE 2003; Diabetes UK 2005). Patients with chronic 
disease including diabetes state that they would like information in as many formats as 
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possible and as early as possible after diagnosis (Corben and Rosen 2005). The challenges of 
instigating different approaches to education include the concept and design of suitable 
education programmes and evaluating the efficacy of education programmes. Two main 
studies were designed to address these issues; firstly Study 2 investigated the role of video 
education for people newly diagnosed with Type 2 diabetes, and Study 3 evaluated a 
structured, self-management education programme incorporating carbohydrate counting and 
insulin adjustment for people with Type 1 diabetes. Both Study 2 and 3 utilised novel, 
innovative methods to deliver education and both were subject to rigorous audit and 
evaluation to ensure that they both complied with the criteria set by NICE and Diabetes UK, 
and that they were shown to be effective in practice. 
4.10. Rationale for innovative diabetes education 
4.10.1. Video education and Type 2 diabetes 
A variety of techniques have been suggested for providing health education for people with 
diabetes, including picture charts, video techniques, computer packages, text messaging and 
e-mail tailored to the group or individual (NICE 2005). These techniques are useful to 
support diabetes education provided by health professionals, and are not necessarily designed 
as stand-alone programmes. The published evidence for these innovative approaches is scarce. 
A recent systematic review of the contribution of teleconsultation and videoconferencing to 
diabetes care concluded that these are practical, cost-effective and reliable ways of delivering 
education to people with diabetes, but there is little evidence for benefit beyond that offered 
by more traditional approaches (Verhoeven, van Gemert-Pijnen et a1. 2007) . Computer-
assisted learning has been shown to have a positive effect on diabetes knowledge, but there is 
no evidence for weight reduction or glycaemic control (NICE 2005). 
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There are few studies examining the effects of video on knowledge or biomedical parameters 
in Type 2 diabetes, and most of these studies do not report metabolic outcomes. An electronic 
MEDLINE search in Pubmed, the Cochrane Library and EMBASE was undertaken from 
1980 until December 2008 using the search terms diabetes mellitus and video education, see 
Fig 4.1. 
Fig 4.1. Quorum flowchart of reviewing process for articles investigating video 
education and diabetes 
79 articles identified though 
database searching 
4 published studies identified 
75 articles excluded: 
50 did not assess the usc of video 
21 did not include people with diabetes 
4 non-English language articles 
Only four studies utilising video education for the treatment of people with diabetes were 
found (Wheeler, Wheeler et a1. 1985; Brown, Liebennan et a1. 1997; Day, Rayman et a1. 
1997; Gerber, Brodsky et a1. 2005), and of these only two studies used video education for 
people with type 2 diabetes (Wheeler, Wheeler et a1. 1985; Gerber, Brodsky et a1. 2005). 
These two programmes consisted of a dietary education programme and general diabetes 
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education. The first, an evaluation of a computer-based diet education programme that 
provided meal-planning information by an individualised computer programme which was 
combined with an interactive videodisc system showed that knowledge increased significantly 
in the intervention group, but effects upon biomedical outcomes where not measured 
(Wheeler, Wheeler et a1. 1985). A more recent randomised controlled trial investigating the 
effect of a computer multimedia system and which included audio/video sequences reported 
an increase in perceived susceptibility to diabetes complications but no significant change in 
either biomedical outcomes, self-efficacy or knowledge (Gerber, Brodsky et al. 2005). In 
addition, Fleming (Fleming, Simmons et al. 1995) reported a study in New Zealand 
examining the effects of a video on diabetes awareness, among local Maori and Pacific Island 
communities and reported that the video was highly rated and improved knowledge, but 
metabolic effects were not measured. 
A search in both the American Diabetes Association (ADA) web-site and the National 
Institute of Health (NIH) web-site has shown that neither of these bodies produce videos 
designed for people with diabetes. Diabetes UK has recently introduced a 4S-minute DVD 
intended for people with Type 2 diabetes and this is designed to answer many of the questions 
that surround the diagnosis of the condition. It uses an approach of advice from experts in the 
field intercut with case-studies and stories from people diagnosed with Type 2 diabetes. This 
DVD is available for sale, but the effectiveness of this approach to education has not been 
subject to audit or evaluation. 
4.10.2. Evidence for video education and other chronic conditions 
There is some evidence for the effects of video education on other chronic diseases, apart 
from diabetes. A further electronic search using MEDLINE in Pubmed, the Cochrane Library 
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and EMBASE was undertaken from 1980 until December 2008 using the search terms 
chronic disease, illness and video education, see Fig 4.2. 
Fig 4.2. Quorum flowchart of reviewing process for articles investigating video 
education and chronic disease (excluding diabetes) 
91 articles identified though 
database searching 
15 potentially appropriate 
articles to be included in review 
9 published articles identified 
76 articles excluded: 
73 did not utilise videos 
3 non-English language 
articles 
6 articles excluded: 
all used video for purposes 
other than education 
Nine studies were found reporting the effects of video education in the management of 
chronic diseases other that diabetes, but only four of these studies were designed as 
randomised controlled trials. The majority of studies do not report clinical outcomes, but use 
as an endpoint either changes in knowledge or behaviour. These nine studies show variable 
outcomes. Video teaching has been shown to improve: 
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• Patient satisfaction and reduce hospital expenditure in a preanaesthetic evaluation 
clinic (Yang, Wang et a1. 2007) 
• Knowledge of general health in native American people (Dick, Manson et a1. 2007) 
• Satisfaction in men with erectile dysfunction (Brock, Carrier et a1. 2007) 
• Knowledge in patients undergoing percutaneous cardiac interventions (Steffenino, 
Viada et a1. 2007) 
• Self-care behaviour leading to a reduction in signs and symptoms in people with heart 
failure (Albert, Buchsbaum et a1. 2007) 
• Reduction in pain rating and narcotic use in people with whiplash injury (Oliveira, 
Gevirtz et a1. 2006) 
A further study has reported that although video education can improve knowledge, it has 
little or no effect on adaptive behaviours in people with low vision (Goldstein, Dugan et al. 
2007) and a report on managing asthma in South Asians in the UK (Hussein and Partridge 
2002) also reported that video education was judged useful to both asthma sufferers and their 
families, but did not measure clinical outcomes. 
4.10.3. Rationale for a trial of video education 
Many recent reports have emphasised the importance of education for self-management of 
chronic conditions including Type 2 diabetes. There is evidence that patient education and 
knowledge can affect outcomes and that a patient-centred approach is beneficial. Didactic 
one-to-one teaching has been shown to be ineffective and demands huge resources. The 
increasing incidence of Type 2 diabetes and changes in health care structures have resulted in 
primary care taking responsibility for lifestyle education for people newly diagnoses with 
Type 2 diabetes. In the UK, there are now approximately 2 million people with Type 2 
diabetes, and each of these should receive structured education at diagnosis and as an on-
going procedure. Although the gold standard remains an individual appointment with a 
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diabetes specialist dietitian, lack of resources prevent this in Oxfordshire and other, more 
innovative, methods of supplying education should be investigated. Using new technologies 
to provide education for people with diabetes has not been fully explored or evaluated and 
this new approach involved investigating a video-based lifestyle education programme for 
people with Type 2 diabetes. This novel idea should increase access to education for people 
newly diagnosed with diabetes and offer equitable standards of care, including education 
about self-management, for all. Any new educational initiatives should be supported by sound 
evidence of efficacy and acceptability for people with diabetes and this was the rationale for 
the design and execution of this study. 
4.10.4. Structured education and Type 1 diabetes 
4.10.5. Evidence for structured education 
There is wide recognition that education plays a central role in the management of Type 1 
diabetes and has played a major part in the success of landmark studies designed to improve 
glycaemic control and reduce the risk of tissue damage (DCCT study group 1993; DAFNE 
study group 2002). Although education is regarded as a cornerstone in self-management of 
diabetes and is considered an integral part of treatment, there are few studies evaluating the 
overall effect of education and no systematic reviews specifically aimed at investigating self-
management (NICE 2008). 
The effects of education programmes for Type I diabetes was reviewed by a health 
tcchnology assessment which reviewed four controllcd trials and reported positive outcomes 
compared to normal care. End points differed between studies and included improvements in 
diabetes knowledge, glycaemic control, blood pressure, rates of diabetic ketoacidosis and 
hypo glycaemia (NICE 2002). However, most of these studies included small numbers of 
131 
subjects and had methodological limitations in design. Other randomised controlled trials 
have shown contradictory results, with one reporting improvements in glycaemic control 
(Lennon, Taylor et al. 1990) and another showing no effects of self-management education on 
either glycaemic control or quality oflife (de Weerdt, Visser et al. 1991). 
4.10.6. Rationale for trial of structured education 
The day to day responsibility of diabetes control lies with the person with Type 1 diabetes; 
they are in charge of making the decisions about what and when to eat, how much insulin they 
inject and how much physical activity and blood glucose monitoring they undertake. In order 
to make appropriate choices about these various aspects of self-management, education is 
fundamental to enable the individual to acquire the relevant knowledge and skills to be 
successful in managing independently. Despite the recognition that education is the 
cornerstone in the treatment of diabetes, there is little evidence investigating the role of 
education in self-management. This study was designed to address this lack of evidence and 
investigated the effects of a structured education programme incorporating the concepts of 
carbohydrate counting and insulin adjustment for people with Type 1 diabetes. 
4.11. Meeting the criteria for structured education 
Both Study 2 and 3 were designed to meet the four key components for structured education 
(Diabetes UK 2005). These criteria are more relevant for teaching either individuals or groups 
as was the case for Study 3, but the basic principles can be applied to video education 
programmes. The four components including a structured curriculum with stated philosophy, 
trained educators, quality assurance and full audit were addressed. 
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4.11.1 Philosophy 
The Thames Valley core philosophy for structured education states: 
'Patients with diabetes have the right to take control of their care. All programmes delivered 
will enable patients with diabetes to develop skills, knowledge and the confidence to ensure 
that they can take responsibility for decisions they make regarding the daily management of 
their diabetes.' 
In conjunction with the Diabetes Education Network, a national body operating under the 
umbrella of Diabetes UK, the core philosophy from the Thames Valley was further developed 
specifically for the healthy living programme and states: 
'Diabetes is a complex condition, which is affected by, and can affect almost all daily activity. 
Most day to day decisions about lifestyle factors, including food choices and activity levels, 
which affect blood glucose levels are made by the person with diabetes. As such, people with 
diabetes are responsible for managing their condition (unless due to mental disability they are 
unable to make informed decisions). People with diabetes require knowledge and skills to 
enable them to understand the effects of lifestyle on their diabetes and vice versa, and how 
they can manipulate their diet and levels of physical activity to enable them to lead the 
lifestyle of their choice while maintaining stable blood glucose control and managing the 
associated risk factors of diabetes. The role of the health care professional is to provide a 
foundation to people with diabetes to enable them to develop realistic short term and long-
term management goals, and to help them acquire the knowledge and skills necessary to 
achieve those goals.' 
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4.11.2. Core principles 
The above philosophy was adopted for Studies 2 and 3 and was developed into core 
principles. These principles underpin the approach to health education adopted in the video 
education package and reflected the underlying philosophy. These core principles were 
developed over a series of workshops organised by the Diabetes Education Network. The core 
principles state that: 
The person with diabetes has the right to expect the following from the education programme: 
• Provision of non-judgemental, up-to-date, evidence-based information 
• The development of practical skills to identify and address individual issues 
The programme will achieve this by: 
• Engaging with each individual by providing case-studies of people with diabetes 
• Providing appropriate information to support decision-making 
• Providing access to knowledge and skills needed to achieve self-care behaviour 
appropriate to that decision 
On completion of the education programme, individuals will be able to: 
• Utilise the information gained to formulate a self-management plan 
• Identify and move towards personal targets and goals, whether biomedical or 
behavioural 
4.11.3. Adult learning principles 
The education programmes utilise a variety of learning theories including social learning 
theory (Bandura 1977), adult learning styles (Honey and Mumford 1982) and Lewin's cycle 
for adult learning (Kolb 1984). 
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4.11.3.1. Social learning theory 
Social learning theory underpins the healthy living programme by utilising the concept that 
interaction between personal factors, behaviour and the environment dictate behaviour. Social 
learning theory focuses on the learning that occurs within a social context. It considers that 
people learn from one another and the environment and includes such concepts as 
observational learning, imitation and modelling. 
General principles of social learning utilised in the education programmes: 
• Observational learning. Participants can learn by observing and imitating the 
behaviour of others and the outcomes of this behaviour. This is the theoretical 
foundation for the use of case-studies as an educational tool 
• Intrinsic reinforcement. Cognition plays a role in learning and mental states are 
important for learning to occur. A form of internal reward such a pride, satisfaction 
and a sense of accomplishment can provide positive reinforcement for behaviour 
change. 
• Learning does not necessarily lead to behaviour change. Successful application of the 
modelling process to produce behaviour change includes addressing the concepts of 
attention, retention, reproduction and motivation. This theory supports the use of case 
studies. 
4.11.3.2. Adult learning styles 
Four main categories of adult learning styles have been identified: 
• Activist. Relies on concrete experience, prefers doing and experimenting 
• Reflector. Uses observation and reflection 
• Theorist. Relies on abstract conceptualisation, wants to understand underlying 
concepts, reasons and relationships 
• Pragmatist. Uses active experimentation, likes to try things out to see if they work 
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The education programmes address different learning styles by delivering information in 
various ways to match these different styles. This ensures that all individuals have the 
opportunity to learn in their preferred style. 
4.11.3.3. Lewin's cycle of adult learning 
This theory suggests that there are four stages of learning which follow on from each other: 
• Concrete Experience - direct practical experience is followed by 
• Reflection on that experience on a personal basis - what the experience means to 
person undergoing it. This reflection on personal experience may then be followed by 
• Abstract Conceptualisation - the derivation of general rules describing the experience 
(comprehension), or the application of known theories to the experience and then to 
• Active Experimentation - the construction of ways of modifying the next occurrence 
of the experience based upon the transformation of theory into practice and this leads 
in turn to the next Concrete Experience. 
The education programme utilised this cycle by encouraging participants to reflect and learn 
from personal experience during the education. 
4.11.4. Curriculum 
4.11.4.1. Video education programme 
Development of the curriculum of the video education programme involved identification of 
the knowledge and information required by people with diabetes. A small focus group of 
professionals (2 diabetes specialist nurses, 1 diabetes specialist dietitian, 1 specialist registrar 
and 2 volunteers with diabetes from the Oxford Patient Involvement Group) met and agreed 
the design and content of a form designed to elicit information from people with diabetes. 
This formed the basis of a pilot study aiming to identify the most important lifestyle issues for 
people with diabetes. 
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A small pilot study was conducted to investigate the preferences of people newly diagnosed 
with diabetes. Ten patients attending diabetes out-patient clinics at the Oxford Centre for 
Diabetes, Endocrinology and Metabolism were selected at random and asked to complete a 
fonn (Appendix 1) including specific questions and a box for free-text. Section 1 was 
designed to identify the areas of lifestyle that the patients considered the most important. All 
participants were encouraged to select as many categories as they liked from a selection. The 
number of patients, expressed as n (%), selecting each category is shown below. 
Category n(%) 
Foods that affect blood glucose levels 10 (100%) 
Foods that are related to heart disease 8 (80%) 
Sugar 7 (70%) 
Fruit and vegetables 8 (80%) 
Fatty foods 7 (70%) 
Salty foods 2 (20%) 
Glycaemic index 1 (10%) 
Alcohol 2 (20%) 
Losing weight 10 (100%) 
Physical activity (exercise) 9 (90%) 
Section 2 asked the participants to record the three most important topics from the above list 
and from this most participants selected weight loss (90%), foods that affect blood glucose 
levels (100%) and physical activity (80%). Other topics selected once by 3 different patients 
were fatty foods, sugar and glycaemic index. 
Section 3 asked participants for any other comments. Only 4 of the participants entered free 
text in the box provided and these comments are reproduced below: 
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'I'm not sure about all the pills I'm taking - it would be nice to know a bit more about these' 
'You should talk much more about physical activity. My blood pressure is right down now 
since I started going to the gym' 
'I think this is a very good idea - please could 1 have a copy of the videos?' 
'If you can help me lose weight, that would be great!' 
From the above feedback, a curriculum was developed based upon a mixture of expert 
opinion and a case-study approach. The feedback suggested that weight management, 
physical activity and the effect of foods on blood glucose levels were considered the most 
important topics, although the majority of patients were also interested in fatty foods and 
heart disease, sugar and fruit and vegetables. Most patients expressed little interest in the 
concept of glycaemic index and in salty foods and alcohol. The free-text comments suggested 
that there was patient support for the idea of video education. The patient who was unsure 
about his medication was given an individual appointment to discuss this as it was not seen a 
relevant part of this lifestyle programme. As a result of this survey, it was decided that three 
10-15 minute videos would be produced and that they would be entitled 'Food choices', 
'Physical Activity' and 'Weight Management' reflecting the participant's feedback. The video 
entitled 'Food choices' would include sections on carbohydrate foods that affect blood 
glucose levels, fruit and vegetables, low fat options, reducing sugar intake and would not 
address glycaemic index, salt and alcohol. The company employed to produce the videos, 
Joose TV, were involved in the design of the videos as they had extensive expertise in the 
field and they recommended a case-study approach. 
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Curriculum of 'Food choices' section 
• The dietitian educator will introduce the concept of food and diabetes and explain the 
importance of diet. A specialist General Practitioner (GP) will offer a summary of 
basic principles of nutrition for people with diabetes. 
• The role of sugar in the diet of people with diabetes will be explored and the concept 
ofthe ideal diet and quality oflife will be introduced and discussed. 
• The effect of different foods on blood glucose levels will be explained and a list of 
carbohydrate-containing foods will be provided 
• The educator will explore the issue of a healthy diet and clarify the ingredients of a 
healthy diet for diabetes including recommendations for 5 portions of fruit and 
vegetables daily, moderate intake of starchy carbohydrate foods, moderate intake of 
low fat protein foods, low total and saturated fat intakes and inclusion of small 
amounts of sugary foods. 
• All participants will be actively engaged throughout the programme by being 
encouraged to reflect on their experiences through the use of case studies of people 
with Type 2 diabetes who will share their experiences of dietary change. 
Curriculum of 'Weight management' section 
• The dietitian educator will introduce the concept of body weight and diabetes and 
explain the importance of weight management. 
• A case study will be utilised to offer personal experience of weight loss. The case 
study will review the lifestyle changes necessary to induce weight loss. 
• A review of the different methods to achieve weight loss will be described including 
adopting a healthy, low fat diet, calorie counting, joining a commercial weight loss 
programme 
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• All participants will be actively engaged throughout the programme by being 
encouraged to reflect on their experiences through the use of a case study of a person 
with type 2 diabetes who will share their experiences of weight loss. 
Curriculum of 'Physical activity' section 
• The dietitian educator will introduce the concept of physical activity and diabetes and 
two specialist GPs will explain the importance of increased physical activity and 
describe the benefits for blood glucose control, cardiovascular function, weight 
maintenance and quality of life. 
• The type of activity will be discussed and the factors affecting choice of activity will 
be explored, including practical tips for increasing general daily activity. 
• The recommended procedure for increasing physical activity will be explained and 
safety factors for people with diabetes will be clarified, including recommendations to 
check with a physician before starting exercise, wearing supportive footwear, never 
exercising when unwell and specific advice about preventing potential hypoglycaemia. 
• All participants will be actively engaged throughout the programme by being 
encouraged to reflect on their experiences through the use of a case study of a person 
with type 2 diabetes who will share their personal experiences of increased physical 
activity. 
4.11.4.2. Structured education for Type 1 diabetes 
The curriculum for the structured education programme for Type 1 diabetes was developed in 
accordance with the recommendations of the Diabetes Education Network and is reproduced 
in full in Appendix 13. 
4.12. Trained educators 
It was considered of importance that the educator designing this programme should have 
recognised qualifications in both diabetes and education. In Oxford, all educators are required 
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to fulfil the following criteria: 
• A professional, recognised medical qualification in the field of medicine, nursing or 
dietetics 
• At least 2 years experience of the management and education of people with diabetes 
• Currently employed at a specialist level, whether in primary or secondary care 
The dietitian organising and delivering the programme holds State Registration and has 25 
years experience of diabetes education. She also holds a recognised education qualification. 
All experts (hospital consultants, general practitioners and diabetes nurses) who appear in the 
video are experienced in diabetes and diabetes education. 
4.13. Quality assurance 
4.13.1. Video education programme 
It is challenging to apply quality assurance to a one-off education session. Quality assurance 
commonly relates to the maintenance of the programme over time, and it was decided in this 
case to measure quality assurance by assessing the videos by the stated aims and objectives, 
the philosophy and the principles. This was a subjective process completed by all experts 
involved in the video production. Verbal feedback indicated that those involved in the process 
felt that the videos complied with the agreed principles. 
4.13.2. Structured education programme for Type 1 diabetes 
A quality assurance (QA) programme was developed for the structured education programme 
in conjunction with the Diabetes Education Network. As very little work has been done in this 
area, the QA process was designed to be trialled and re-assessed after an initial period of six 
months. The aim of the QA process was to ensure our local education programme for people 
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with Type 1 diabetes met the key criteria and matched the written philosophy, alms, 
objectives and curriculum. The objectives of the QA process were to demonstrate that 
programme educators met the documented philosophy and curriculum, to show that the 
programme provided the education it was designed to deliver and to ensure that the 
facilitation was of an appropriate standard. 
The QA process was conducted by a trained educator from another site who attended the third 
week of the four-week programme. Week three was chosen for pragmatic reasons, firstly 
because all group participants were familiar with carbohydrate counting and insulin 
adjustment and secondly because it included a session exploring hypoglycaemia and most 
people with Type 1 diabetes were fully engaged during this session. The outside educator 
observed the complete session and completed a QA form for each of the topics covered. At 
the end of the session, the two educators delivering the course completed self and peer 
reflection forms and the outside educator then facilitated a reflection based upon all 
completed forms and any recommendations for action were agreed and recorded. The 
completed forms were then filed. 
In addition, a dot test was undertaken during the hypoglycaemia session, which lasted 45 
minutes. The aim of the session was to explore hypo glycaemia, and the dot test was devised 
to test the philosophy of the programme that patients are supported and encouraged to develop 
their own strategies to treat hypo glycaemia. The dot test was designed to assess the amount of 
time the subject or educator spends talking. The observer notes whether a participant or 
educator is talking at ten-second intervals throughout the 45 minutes session with the aim that 
the educators talk no more than 50% of the time. 
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4.14. Audit and evaluation 
There were three areas subject to audit and evaluation including biomedical outcomes, well-
being and diabetes knowledge. In addition, subjective evaluation of the videos and structured 
education programmes were collected from the participants. 
Biomedical outcomes included glycaemic control measured by glycated haemoglobin (Ale), 
body weight and body mass index (BMI) and blood lipid levels. The video education study 
also included % body fat, blood pressure and insulin resistance measured by homeostatis 
model assessment (HOMA) (Levy, Matthews et al. 1998). In addition, the video education 
study also included measurement of dietary intake by validated 3-day food diary (Toeller, 
Buyken et al. 1997) and levels of physical activity by pedometer (Bravata, Smith-Spangler et 
al. 2007) were used to assess lifestyle changes. Well-being measurements included a general 
measurement of quality of life using a World Health Organisation questionnaire (WHO-5) 
(World Health Organisation 1998) and the EQ-5D health related quality of life questionnaire 
(Brazier 1993) in the case of the video education study and the Problem Areas in Diabetes 
(PAID) scale for the structured education programme (Polonsky, Anderson et al. 1995). 
Changes in diabetes knowledge in the video education study were assessed using a validated 
knowledge questionnaire, the ADKnowl (Speight and Bradley 2001). 
Subjective feedback from the video education study was collected in two stages. Firstly, the 
videos were filmed, produced and edited into a rough cut and these were assessed by a panel 
of people with Type 2 diabetes for further refinement. A panel of 10 people with Type 2 
diabetes were recruited from the OCDEM database and were given the videos to watch in 
their own time. They were asked to complete an assessment form (Appendix 7) and the videos 
were modified according to this feedback. The acceptance of the videos were marked using a 
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Lickert scale with 0 indicating lower acceptance and 10 higher acceptance. The scores were 
converted to % and are reported below: 
Question Score 
(%) 
How useful were these videos? 82 
What do you think of the idea of using videos? 93 
What do you think of the presentation? 81 
What do you think of the ease of use? 95 
What do you think of the amount of information? 92 
The majority of patients expressed an overwhelmingly positive response to the videos and felt 
that the amount of information contained in the videos was about right (although 2 patients 
felt that there was not sufficient detail about weight loss) and that this was an excellent 
method of presentation about the lifestyle issues of managing diabetes. 
All patients expressed the opinion that the video entitled 'Food choices' was very clear and 
needed no amendment. 
The case study in the video entitled 'Weight Management' produced a positive response, but 
some patients asked for further details of methods of weight management. In response to this, 
information about the web-sites of commercial slimming groups was added to the end of the 
video. 
The video entitled 'Physical activity' was found to be the least acceptable. The majority of the 
panel felt that as the case-study was French, his experience may not be applicable to English 
people, and that the accent of the dubbed voice was difficult to understand. As it was 
impossible to film another case study, due to lack of resources, the French case study was 
retained, but the dubbed translation was changed to another voice which was easier to 
understand. 
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In addition, all subjects who took part in the study were invited to complete the assessment 
form and the results of this evaluation are presented in Chapter 5. 
Subjective feedback from the structured education study for Type 1 diabetes was collected by 
means of a form based upon a visual analogue scale. The results are presented in Chapter 6. 
4.15. Summary 
Health education based upon established theories and models is recognised as fundamental for 
people with diabetes and this is supported by the Department of Health, who have 
recommended that structured education should be available to all people with diabetes. The 
traditional model of patient education with the expert dispensing advice is ineffective in 
inducing behaviour change, but there are few studies exploring the role of different 
approaches in delivering patient education. Most diabetes centres in the UK offer structured 
education either to individuals or in small groups, but these programmes do not always fulfil 
the key criteria for structured education and are not subject to rigorous evaluation as they are 
seen as part of routine care. Study 3 is designed to evaluate a structured self-management 
education programme for people with Type 1 diabetes incorporating carbohydrate counting 
and insulin adjustment and the results are described in Chapter 6. 
Most education programmes rely on personal interaction and teaching and ignore innovative 
new technologies such as video and DVD education. The challenge is to produce an effective, 
resource-efficient education programme for people with diabetes that complies with 
Department of Health recommendations and which is subject to audit and evaluation. In 
response to this challenge, OCDEM designed and implemented a video-based education 
intervention for people with newly diagnosed Type 2 diabetes which was fully evaluated over 
145 
a 6 month period. Evaluation investigated both objective and subjective measures, including 
changes in metabolic outcomes, diabetes knowledge and quality of life. The results of this 
study are presented in Chapter 5. 
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Chapter 5 
Video education for people newly diagnosed with Type 2 diabetes 
5.0. Introduction 
It is recognised that education plays a key role in development of self-management 
skills, but gaps in service delivery have meant that few people with diabetes have 
access to education programmes. One of the gaps in service has been identified as a 
lack of innovative, effective education programmes that are subject to robust 
evaluation and this led to the development of a video-based lifestyle education 
programme for people newly diagnosed with Type 2 diabetes. 
5.1. Aims and Objectives 
The aim of this study is to investigate the effect of a video-based lifestyle education 
programme on biomedical outcomes, diabetes knowledge and quality of life in people 
newly diagnosed with Type 2 diabetes 
5.2. Methods 
See Chapter 2 for full details. 
5.3. Results 
Results were collected for both objective and subjective outcomes. Objective 
outcomes included diabetes knowledge, quality of life and biomedical indices and are 
presented in the first section of the results and subjective outcomes included feedback 
on the videos by the subjects themselves using the evaluation sheet devised and 
applied in the pilot study. 
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5.3.1. Objective results 
46 subjects were referred to the study and 42 agreed to take part. Figure 5.1 shows the 
consort flowchart for the subjects in the healthy living study. Of the 42 subjects 
randomised into the study, 21 were allocated to the video intervention group and 21 
allocated to the control group. All 21 of the intervention group completed the study 
and 18 (86%) of the control group completed the study. The overall drop-out rate was 
7%, meaning that 93% of the subjects recruited into the study completed it. This drop-
put rate compares well with many other dietary or lifestyle studies where the attrition 
rate is typically much higher (Dans inger, Gleason et al. 2005). 
Baseline characteristics of the subjects are shown in Tables 5.1 - 5.6 and include 
demographic details, physical characteristics, biochemical indices, dietary intake, 
quality of life and knowledge scores for lifestyle from the ADKnowl questionnaire. 
There were no significant differences between the groups for any baseline variables. 
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Fig 5.1. Consort Flowchart 
Assessed for eligibility 
n=46 
Excluded n = 4 
Not meeting inclusion criteria n = 0 
Refused to participate n = 4 
Other reasons n = 0 
Randomised n = 42 
/ '\ 
Allocated to and received Allocated to control group 
intervention n = 21 n=21 
Lost to follow up n = 0 Lost to follow up n = 3 
Analysed n = 21 Analysed n = 18 
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Table 5.1. Baseline demographic details of 42 people with newly diagnosed type 2 
diabetes 
Variable All subjects Intevention Control p-value 
Mean (SD) Mean (SD) Mean (SO) 
Number 42 21 21 
Male/female 18/24 8/13 10/11 
Age (years) 60.8 (9.6) 58.6 (9.2) 62.9 (9.5) 0.141 
Duration of diabetes 3.6 (2.5) 3.8 (2.7) 3.3 (2.3) 0.539 
(months) 
Table 5.2. Physical characteristics at baseline 
Variable All subjects Intervention Control p-value 
Mean (SO) Mean (SO) Mean (SD) 
(n=42) (n=21) (n=21) 
Weight (kg) 89.5 (15.5) 90.7 (16.0) 88.3 (15.1) 0.616 
BMI (kg/m2) 31.3 (5.1) 31.9 (504) 30.6 (4.9) 00410 
Waistlhip ratio 0.94 (0.06) 0.93 (0.05) 0.95 (0.06) 0.314 
% body fat 41.2 (9.2) 41.5 (9.0) 40.9 (9.5) 0.837 
Blood pressure: 
Systolic 143 (21.1) 139 (21.2) 147 (20.7) 0.234 
Diastolic 80 (12.3) 81 (13.1) 79 (11.7) 0.730 
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Table 5.3. Biochemical indices at baseline 
Variable All subjects Intervention Control p-value 
Mean (SD) Mean (SD) Mean (SD) 
(n=42) (n=21) (n=21) 
Ale (%) 7.4 (1.7) 7.6 (1.3) 7.2 (2.0) 0.555 
Total cholesterol (mmo1JI) 4.7 (1.2) 4.7 (1.2) 4.8 (1.2) 0.811 
HDL cholesterol (mmo1JI) 1.15 (0.34) 1.13 (0.28) 1.17 (0.39) 0.669 
Triglycerides (mmol/l) 1.8 (1.0) 1.9 (1.1) 1.7 (0.9) 0.697 
LDL cholesterol (mmol/l) 2.8 (1.0) 2.7 (1.1) 2.8 (0.9) 0.733 
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Table 5.4. Dietary intake and physical activity at baseline 
Variable All subjects Intervention Control p-value 
Mean (SD) Mean (SD) Mean (SD) 
(n=42) (n=21) (n=21) 
Energy (ke al) 1861 (439) 1825 (427) 1896 (458) 0.608 
Protein (g) 82.0 (19.2) 81.0 (12.2) 82.9 (24.8) 0.748 
Fat (g) 72.9 (25.3) 69.9 (22.0) 75.9 (27.4) 0.448 
Carbohydrate (g) 219.0 (58.9) 213.8 (57.3) 224.1 (61.5) 0.576 
Total sugars (g) 82.0 (33.0) 74.6 (29.8) 89.3 (35.1) 0.151 
Saturated fat (g) 24.3 (10.2) 23.1 (10.7) 25.6 (9.8) 0.427 
Monounsaturated fat 23.8 (9.2) 22.1 (6.8) 25.6 (10.9) 0.223 
(g) 
Polyunsaturated fat (g) 15.8 (7.2) 15.1 (6.5) 16.5 (8.0) 0.539 
Dietary fibre (g) 16.2 (4.7) 15.5 (3.5) 17.0 (5.6) 0.314 
% energy from: 
Protein 17.9 (3.3) 18.1 (2.7) 17.7 (3.8) 0.632 
Fat 34.8 (6.3) 34.1 (6.7) 35.5 (5.9) 0.469 
Carbohydrate 44.2 (7.8) 44.0 (7.7) 44.5 (8.0) 0.833 
Alcohol 3.1 (4.6) 3.8 (4.9) 2.3 (4.3) 0.313 
Pedometer reading 5721 (3446) 6097 (3457) 5346 (3483) 0.498 
(steps/day) 
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Table 5.5. Quality of life at baseline 
Variable All subjects Intervention Control p-
Mean (SD) Mean (SD) Mean (SD) value 
(n=42) (n=21) (n=21) 
QOL: 
WHO-5 (%) 65.8 (18.3) 64.6 (18.5) 67.0 (18.4) 0.666 
EQ-5DVAS 75.6 (14.0) 76.6 (13.2) 74.6 (15.0) 0.657 
EQ-5D Dimensions % reporting any problems 
Dimension 1 (Mobility) 30.0 33.3 26.3 0.681 
Dimension 2 (Self-care) 2.5 0.0 5.3 0.753 
Dimension 3 (Usual activity) 17.5 9.5 26.3 0.419 
Dimension 4 (Pain/discomfort) 38.4 40.0 39.8 0.862 
Dimension 5 30.7 23.8 38.8 0.232 
(Anxiety/depression) 
Table 5.6. Diabetes knowledge at baseline 
Variable All subjects Intervention Control p-value 
(n=42) (n=21) (n=21) 
% of subjects identifying correct answer 
Item 1 (General diabetes) 70.4 75.0 65.8 0.548 
Item 2 (Physical activity) 51.1 55.0 47.3 0.686 
Item 3 (Food and 41.9 44.3 39.4 0.901 
blood glucose) 
Item 4 (Food) 68.4 71.7 65.2 0.666 
Item 5 (Alcohol) 51.7 58.3 45.0 0.700 
Item 6 (Tissue damage) 83.8 81.7 86.0 0.400 
Item 7 84.5 87.0 82.0 0.222 
(Regular examination) 
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The baseline characteristics of the 42 subjects entered into the healthy living study 
show that 43% were male, they were aged over 60 years and had been diagnosed with 
diabetes just over three months prior to recruitment. They were overweight with body 
weight of 89.5 kg and BMI 31.3 kg/m2, had Ale levels of 7.4% and had both blood 
pressure and lipid levels within the normal range. Mean quality of life scores 
suggested no major problems, although depression or anxiety was reported by over 
30% of subjects at baseline and this reflects the reported increased prevalence of 
depression in people with diabetes (Anderson, Freedland et al. 2001; Li, Ford et al. 
2008). Diabetes knowledge was measured at baseline and Table 5.6 shows that 
although general diabetes knowledge including the effects of complications of 
diabetes and the need for regular examinations was good, the majority of subjects 
were unable to identify correctly the effects of different foods on blood glucose levels. 
Six-month data are presented for 39 (93%) of the 42 patients randomised into the 
study. Fig 5.1 shows that 21 subjects were randomised to immediate video education 
and 21 to a control group. Data analysis was performed on all subjects completing the 
study and this applies to all subjects randomised to the lifestyle intervention and 18 
(86%) of subjects in the control group. There were no drop-outs after randomisation 
in the video education group and this contrasts with three subjects allocated to the 
control group who failed to attend six-month follow-up after randomisation. 
5.3.1.1. Biomedical indices 
Changes at six months from baseline for both the video intervention and control 
groups are shown in Table 5.7. There were significant reductions in Alc, total 
cholesterol and LDL cholesterol at six months in the video intervention group and a 
significant increase in the amount of physical activity measured by pedometer, but no 
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significant change in the control group. Fig 5.2 shows % changes from baseline at sic 
months for the intervention and control groups. A comparison of absolute changes 
from baseline showed no significant differences in changes over six months between 
the groups (Table 5.8), despite the significant changes in the intervention group from 
baseline. 
5.3.1.2. Dietary intake 
Changes from baseline to six months in dietary intake in both the video intervention 
and the control groups are shown in Tables 5.9 and 5.10. There were no significant 
differences between intakes of any nutrients in either groups and no differences 
between the groups. 
5.3.1.3. Quality of life 
Changes in quality of life measured by WHO 5 Well-Being Index and the EQ-5D are 
shown in Table 5.11 and 5.12. There were no significant changes in general quality of 
life or in any specific areas of mobility, self-care, usual activity, pain or discomfort or 
anxiety or depression from baseline to six months follow-up and no significant 
differences between the two groups. 
5.3.1.4. Diabetes Knowledge 
Changes in knowledge of diabetes are shown in Tables 5.13 and 5.14. Knowledge was 
measured by the ADKnowl questionnaire, a validated questionnaire developed by 
Professor Clare Bradley and which can be adapted to match the specific areas of 
knowledge changed anticipated in a particular study. For the purposes of this study, 
general questions about diabetes were included together with specific questions about 
diet, physical activity and alcohol. Although there were no significant changes in 
overall diabetes knowledge in either the intervention or the control group from 
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baseline to six months, there was a trend for increased knowledge in the video 
intervention group and decreased knowledge in the control group (Table 5.15). Table 
5.16 shows that when the changes in knowledge from baseline to six months were 
compared between the groups, there was a highly significant increase in overall 
diabetes knowledge in the intervention group (p=<O.OOOI). 
Analysis of individual items shows that there were no significant changes in the two 
groups from baseline to six months for any of the seven different items, but when 
comparing changes from baseline between the two groups, there were significant 
differences between the groups for knowledge about food (p=<O.OI) and the need for 
regular examinations (p=<O.05). 
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Table 5.7. Mean changes from baseline at six months: video intervention v control 
Video intervention group (n=21) Control group (n=18) 
Variable Mean (SD) Mean (SD) 
Baseline 6 months Change p-value Baseline 6 months Change p-value 
Alc (%) 7.6 (1.3) 6.8 (1.0) -0.7 (1.4) 0.024* 7.2 (2.1) 6.5 (0.6) -0.6 (1.8) 0.177 
Weight (kg) 89.8 (16.0) 88.4 (16.5) -1.4 (4.4) 0.165 87.8 (15.7) 88.0 (17.9) 0.2 (3.7) 0.801 
BMI (kg/m2) 31.7 (5.4) 31.3 (5.2) -0.4 (1.7) 0.264 30.4 (5.0) 30.4 (5.6) 0.0 (1.3) 0.927 
Waist/hip ratio 0.93 (0.05) 0.93 (0.06) 0.0 (0.03) 0.899 0.94 (0.06) 0.93 (0.07) -0.01 (0.03) 0.195 
% body fat 41.0 (9.0) 40.3 (9.2) -0.8 (3.8) 0.381 40.8 (9.2) 40.3 (9.5) -0.5 (4.6) 0.676 
Blood pressure: 
Systolic 140 (21.7) 137 (19.7) -3 (17.8) 0.505 147 (20.7) 150 (24.8) 2 (20.0) 0.625 
Diastolic 81 (13.5) 79 (10.8) -2 (12.1) 0.449 80 (12.7) 83 (13.7) 3 (11.7) 0.288 
Total cholesterol 4.7 (1.2) 4.2 (1.1) -0.5 (0.8) 0.017* 4.7 (1.1) 4.5 (1.2) -0.2 (1.1) 0.543 
(mmolll) 
HDL cholesterol 1.13 (0.29) 1.20 (0.30) 0.07 (0.18) 0.096 1.22 (0.42) 1.29 (0.47) 0.07 (0.19) 0.191 
(mmolll) 
Trigl ycerides 1.9 (1.1) 1.9 (1.1) 0.0 (1.0) 0.887 1.6 (0.7) 1.7 (0.8) 0.1 (0.5) 0.633 
(mmolll) 
LDL cholesterol 2.7 (1.1) 2.1 (0.8) -0.5 (0.9) 0.018* 2.8 (0.9) 3.1 (2.1) 0.3 (2.0) 0.530 
(mmolll) 
Pedometer reading 5140 (2727) 6401 (3343) 1266 (2526) 0.043* 5566 (4240) 4844 (4039) -721 (3383) 0.439 
(steps/day) 
* p<0.05 
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Table 5.8. Absolute changes from baseline at six months: video intervention v 
control group 
Variable Video intervention Control group p-value 
(n=21) (0=18) 
Ale (%) -0.7 -0.6 0.843 
Weight (kg) -1.4 0.2 0.223 
BMI (kg/m2) -0.4 0.0 0.347 
Waistlhip ratio 0.0 -0.01 0.416 
% body fat -0.8 -0.5 0.825 
Blood pressure: 
Systolic -3 2 0.416 
Diastolic -2 3 0.194 
Total cholesterol -0.5 -0.2 0.347 
(mmol/l) 
HDL cholesterol 0.07 0.07 0.939 
(mmol/l) 
LDL cholesterol -0.5 0.3 0.100 
(mmol/I) 
Triglycerides 0.0 0.1 0.737 
(mmol/I) 
Pedometer reading 1266 -721 0.063 
(steps/day) 
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Fig 5.2. % change from baseline at six months, video intervention v control 
group 
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Table 5.9. Mean changes in dietary intake from baseline at six months: video intervention v control 
Video intervention group (n=21) Control group (n=18) 
Variable Mean (SD) Mean(SD) 
Baseline 6 months Change p-value Baseline 6 months Change p-value 
Energy (kcal) 1854 (431) 1813 (299) -40 (532) 0.744 1970 (429) 1871 (390) -98 (294) 0.187 
Protein (g) 81.6 (12.4) 82.9 (14.3) 1.3 (19.6) 0.378 84.3 (25.8) 79.7 (19.0) -4.6 (19.5) 0.349 
Fat (g) 71.7 (22.4) 66.3 (20.9) -5.4 (30.8) 0.456 79.4 (28.3) 70.5 (16.6) -8.9 (25.8) 0.173 
Carbohydrate (g) 215.9 (59.8) 211.4 (52.7) -4.5 (61.8) 0.753 231.9 (61.9) 228.1 (62.1) -3.9 (50.5) 0.756 
Sugar (g) 71.9 (30.1) 73.9 (24.3) 2.1 (20.8) 0.669 92.4 (34.0) 91.5 (29.5) -0.9 (24.0) 0.879 
Saturated fat (g) 24.1 (10.7) 22.8 (11.0) -1.3 (13.2) 0.664 26.0 (9.6) 23.8 (7.0) -2.2 (10.0) 0.376 
Monounsaturated fat 22.6 (6.7) 21.7 (7.0) -0.9 (8.6) 0.639 26.7 (11.2) 22.2 (6.2) -4.4 (9.4) 0.070 
(g) 
Polyunsaturated fat 15.4 (6.1) 12.7 (5.0) -2.7 (8.5) 0.179 18.0 (8.1) 14.8 (4.8) -3.2 (6.9) 0.073 
(g) 
Dietary fibre (g) 15.6 (3.3) 15.2 (5.3) -0.4 (4.6) 0.716 17.9 (8.0) 16.1 (7.6) -1.8 (5.2) 0.160 
% energy from: 
Protein 18.0 (2.7) 18.4 (3.0) 0.4 (3.9) 0.635 17.1 (3.9) 17.2 (3.1) 0.1 (3.7) 0.913 
Fat 34.5 (6.8) 32.7 (7.4) -1.8 (8.2) 0.341 35.8 (6.4) 33.6 (5.1) -2.2 (7.3) 0.235 
Carbohydrate 43.6 (7.8) 43.5 (7.4) -0.1 (5.6) 0.967 44.2 (8.9) 45.6 (8.1) 1.4 (7.2) 0.437 
Alcohol 3.9 (5.1) 5.4 (8.5) 1.5 (5.5) 0.262 2.9 (4.7) 3.2 (4.5) 0.3 (2.8) 0.616 
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Table 5.10. Absolute changes in dietary intake from baseline at six months: video 
intervention v control group 
Variable Video intervention Control group p-value 
(n=21) (n=18) 
Energy (kcal) -40 -98 0.693 
Protein (g) 1.3 -4.6 0.378 
Fat (g) -5.4 -8.9 0.714 
Carbohydrate (g) -4.5 -3.9 0.972 
Sugars (g) 2.1 -0.9 0.879 
Saturated fat (g) -1.3 -2.2 0.828 
Monounsaturated fat (g) -0.9 -4.4 0.254 
Polyunsaturated fat (g) -2.7 -3.2 1.861 
Dietary fibre (g) -0.4 -1.8 0.382 
% energy from: 
Protein 0.4 0.1 0.795 
Fat -1.8 -2.2 0.897 
Carbohydrate -0.1 1.4 0.501 
Alcohol 1.5 0.3 0.458 
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Table 5.11. Mean changes in quality oflife from baseline at six months: video intervention v control 
Video intervention group (n=21) Control group (n=18) 
Variable Mean (SD) Mean (SD) 
Baseline 6 months Change p-value Baseline 6 months Change p-value 
WHO SWell-Being 64.0 (18.8) 63.8 (19.4) -0.2 (13.2) 0.947 64.7 (19.S) 68.0 (19.2) 3.3 (1S.0) 0.378 
(%) 
EQ-SD thennometer 77.1 (l1.S) 76.7 (lS.8) -0.4 (10.4) 0.876 I 7S.5 (16.1 ) 77.2 (16.6) 1.7 (17.4) 0.706 
(%) 
% reporting some problems 
EQ-SD 1 3S.0 2S.0 -10.0 0.602 26.7 26.7 0.0 1.000 
Mobility 
EQ-SD2 0.0 0.0 0.0 1.000 6.7 6.7 0.0 1.000 
Self-care 
EQ-SD3 10.0 IS.0 S.O 0.799 28.6 21.4 4.S 0.768 
Usual activity 
EQ-SD4 36.8 47.4 10.6 0.S82 33.3 33.3 0.0 1.000 
Pain/discomfort 
EQ-SD S 2S.0 2S.0 0.0 1.000 38.8 21.4 -17.4 0.264 
Anxiety/depression 
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Table 5.12. Absolute changes in quality of life from baseline at six months: video 
intervention v control group 
Variable Video intervention Control group p-value 
(n=21) (n=18) 
WHO 5 Well-Being (%) -0.2 3.3 0.456 
EQ-5D Thermometer (%) -0.4 1.7 0.668 
EQ-5D 1 -10.0 0.0 0.633 
Mobility 
EQ-5D 2 0.0 0.0 1.000 
Self-care 
EQ-5D 3 5.0 -4.5 0.569 
Usual activity 
EQ-5D 4 10.6 0.0 0.836 
Pain/discomfort 
EQ-5D 5 0.0 -17.4 0.323 
Anxiety/depression 
Table 5.13. Mean changes in total diabetes knowledge from baseline at six months: video 
intervention v control 
Variable 
All items 
(1-7) 
Video intervention group (n-21) 
% reporting correct answers 
Baseline 6 months p-value 
66.8 74.3 0.121 
Control group (n=18) 
% reporting correct answers 
Baseline 6 months p-value 
60.7 56.4 0.439 
Table 5.14. Absolute change in total diabetes knowledge from baseline at six months: 
video intervention v control group 
Variable 
All items (1-7, inclusive) 
* p=<O.OOOl 
Video intervention 
(n=21) 
7.5 
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Control group 
(n=18) 
-4.3 
p-value 
Table 5.15. Mean changes in diabetes knowledge by item from baseline at six months: video intervention v control 
Video intervention group (n=21) Control group (n=18) 
Variable % reporting correct answer 010 reporting correct answer 
Baseline 6 months Change p-value Baseline 6 months Change p-value 
Item 1 75.0 79.0 4.0 0.690 65.8 61.0 -4.8 0.841 
General diabetes 
Item 2 55.0 57.5 2.5 0.886 47.3 36.8 -10.5 0.685 
Physical activity 
Item 3 44.3 52.1 7.9 0.620 39.4 37.0 -2.4 0.949 
Food and blood 
glucose levels 
Item 4 71.7 80.6 8.9 0.386 65.2 58.8 -6.4 0.604 
Food 
Item 5 58.3 66.7 8.3 0.827 45.0 50.7 5.7 0.827 
Alcohol 
Item 6 81.7 93.3 11.7 0.400 86.0 78.0 -8.0 0.400 
Tissue damage 
Item 7 87.0 96.0 9.0 0.055 82.0 80.8 -1.2 0.841 
Regular examinations 
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Table 5.16. Absolute changes in diabetes knowledge by item from baseline at six 
months: video intervention v control group 
Variable 
Item 1 
General diabetes 
Item 2 
Physical activity 
Item 3 
Food and blood glucose 
Item 4 
Food 
Item 5 
Alcohol 
Item 6 
Tissue damage 
Item 7 
Regular examinations 
* p=<0.05 ** p=<O.OI 
5.3.2. Subjective analysis 
Video intervention 
(n=21) 
4.0 
2.5 
7.9 
8.9 
8.3 
11.7 
9.0 
Control group 
(n=18) 
-4.8 
-10.5 
-2.4 
-6.4 
5.7 
-8.0 
-1.2 
p-value 
0.309 
0.343 
0.165 
0.005** 
0.827 
0.100 
0.031 * 
Feedback about the videos was obtained by using an evaluation form designed and adapted 
from the pilot study. 17 of the 21 subjects (80%) allocated to the video intervention group 
completed and returned the evaluation form. Evaluation was by means of a Lickert linear 
scale and the responses were coded from 0% (negative) to 100% (positive). The general 
evaluations of the innovative approach utilising videos are given in Table 4.17. 
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Table 5.17. Overall evaluation of the videos 
Question 0 .......................................... 100 Mean 
score (%) 
How useful were these videos? Completely Very 77.1 
useless useful 
What do think of the idea of using Poor Excellent 89.9 
videos to give this type of information? 
What do you think of the presentation Poor Excellent 78.1 
of the videos? 
What do you think of the ease of use of Poor Excellent 83.2 
the videos? 
What do you think of the amount of Too little Too much 59.0 
information in the videos? 
These results show positive response to this approach to delivering information. A box asking 
for any general remarks about using videos for diabetes education was completed by 12 
subjects and included the following statements: 
1. I think the three videos provide useful information for early diabetes. 
2. It was good to have 'live' patients talking about their experience of being diabetic. I 
thought them very believable. The presentation was very easy to follow. I liked the 
idea of headings followed by an explanation. The length and amount of information 
did not overwhelm you. I would find these videos good to watch about 1 month after 
being diagnosed - giving enough time to adjust but at a time I might need good advice 
and reassurance. 
3. The tapes were very informative, short and to the point. I found them easy to 
understand and short enough to keep my attention. Well done! 
4. They seem to me to be well done. 
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5. Well presented and professional looking program. All the information would be better 
and easier to access if all on just one video or DVD. 
6. Would have thought all the information could have been put on one video. Would like 
to see more emphasis on water intake and its beneficial effects. 
7. The information is not detailed enough, giving no real guidance as to how to proceed 
with any actual positive actions. 
8. I found these DVDs very useful and interesting to watch. 
9. Good idea but content extremely basic. 
10. Very informative and well presented and confirms the information provided in the 
diabetes information provided by the practice nurse 
11. A very good idea but they could have contained more info for each category. They 
seemed to just repeat the same message. 
12. All had a very natural and pleasant way of delivering an important series of guidelines 
within an aid of living with diabetes. 
The majority of responses were positive and confirmed the scores from the Lickert scale 
showing that this approach to health education is acceptable to most patients. The highest 
score was given for the idea of using videos to deliver this information, and this suggests that 
using this innovative format was very acceptable to all the subjects. Then lowest score from 
the overall evaluation was given for the amount of information contained in the videos and 
the free-text feedback suggests that more information on each topic could have been included 
with 3 subjects stating that they thought the content was very basic and that more details 
could have been included. 
The second part of the evaluation form was designed to collect information about each 
separate video and subjects were encouraged to select and provide feedback about a topic of 
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their choice. 10 (59%) chose to evaluate the video entitled 'Food Choices', 4 (23%) chose 
'Physical Activity', none chose 'Weight Management', 1 (6%) chose to evaluate all 3 videos 
and 2 (12%) did not complete this section of the evaluation form. 
Results of the evaluation of the videos covering food and physical activity are given. The 
format was similar to that of the overall evaluation and asked similar questions with 
additional free-text boxes encouraging subjects to give their answers to the following 
questions: 
1. Are there any changes you could suggest to improve this video? 
2. Is there anything you would leave out? 
3. Are there any topics you would like to see included n another video? 
5.3.2.1. Evaluation of 'Food Choices' video 
The results for the videos about food are shown in Table 4.18. 
Table 5.18. Evaluation of the video entitled 'Food Choices' 
Question 0 ........................................... 100 Mean 
What do think of the idea of using Poor 
videos to give this type of infonnation? 
What do you think of the presentation Poor 
of the videos? 
What do you think of the ease of use of Poor 
the videos? 
What do you think of the amount of Too little 
infonnation in the videos? 
score (%) 
Excellent 95.3 
Excellent 86.1 
Excellent 90.1 
Too much 60.1 
This table shows that the video approach was well received by all subjects, but that there was 
not sufficient detailed information given. This is supported by the free-text comments to the 
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questions about improvements to the video. 5 of the 10 subjects selecting the food video for 
evaluation completed the free-text box and their answers to each question are shown below: 
Are there any changes you could suggest to improve the food video? 
1. There is no idea of quantity - lots of small amount can be quite meaningless. What is a 
portion of fruit 1 grape or 100 grapes? Detail is needed. 
2. More info about food management as the video only gives a general idea for eg 
amount of calories, portion etc. 
3. This format could be used to give more detailed information. This could be menu 
driven so that users can choose content. 
4. Expand more on meal tips and the idea for someone trying to make recipes for 
diabetics was good. Show more meals to show portion size and variety it stays better 
in your mind. 
5. Slightly longer and therefore more of the useful content available. 
Is there anything you would leave out of the food video? 
All of the subjects stated that nothing included in the food video should be omitted and one 
added that if anything, more details could have been given. Another subject suggested using a 
more positive case study, where the person seemed happier. 
Are there any topics you would like to see included in another video? 
1. How to control diet on special occasions - eg Xmas, celebrations which include a set 
meal; travel and holidays. Also the effect other illnesses have on diabetes- eg 
vomiting and diarrhoea, coughs, colds. 
2. More information about the beneficial effects of particular food like individual 
vegetables or herbs and seeds. The difference between type 1 and type 2 diabetes. 
3. No- just more content on diet. 
4. One more CD just on diabetes itself. 
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5. As a salutary measure - I think maybe a further educational message into the 
consequences of not heeding the advice proffered in these three videos. 
5.3.2.2. Evaluation of 'Physical activity' video 
Evaluation for the physical activity video is shown in Table 4.19. As only 4 subjects reported 
feedback on this topic it is difficult to draw conclusions from the results given. All 4 of these 
subjects provided feedback in the free-text boxes on the evaluation sheet and their responses 
are given below. 
Table 5.19. Evaluation ofthe video entitled 'Physical Activity' 
Question 0................. . ................... 100 Mean 
score (%) 
What do think of the idea of using Poor Excellent 86.4 
videos to give this type of information? 
What do you think ofthe presentation Poor Excellent 65.0 
of the videos? 
What do you think of the ease of use of Poor Excellent 55.7 
the videos? 
What do you think of the amount of 00 little Too much 52.0 
information in the videos? 
Are there any changes you could suggest to improve the physical activity video? 
1. There will be patients watching this who do not use insulin (eg controlling diabetes by 
diet alone) and may not have the means to check their blood glucose levels before and 
after exercise, as suggested. 
2. No, I thought it was pitched about right. 
3. I would put all the information on just one DVD. All the information is relevant and 
interesting so would be useful. 
4. More advice to people on alternative exercise, if patients have difficulty walking e.g. 
hip problems. More emphasis on the benefits of swimming as an alternative. 
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Is there anything you would leave out of the physical activity video? 
All four subjects stated that there was nothing they would leave out of this video and one 
subject added; 'As it's presented to Oxfordshire patients it would be better filmed and 
presented in England. I had difficulty in understanding the accent of the people. They were 
however also very inspiring.' This comment related to the fact that the case study was French 
and spoke in French with an English voice-over translation added at the editing stage. The 
case-study was filmed in Paris. 
Are there any topics you would like to see included in another video? 
1. I think it would be good to explain a bit more ofthe underlying science in another 
video. 
2. Warning signs of side effects. 
3. May be a bit more on exercises for not so fit (elderly). 
4. Could all three discs be incorporated onto a single disc? 
5.4. Discussion 
This intervention was designed to increase knowledge and improve outcomes for people with 
newly diagnosed Type 2 diabetes and included assessment of glycaemic control, body weight 
and cardiovascular risk factors. The results show that a short video intervention delivering 
lifestyle education significantly increased overall knowledge of diabetes compared to the 
control group, but that it had no significant effect on changes in biomedical outcomes or 
quality of life when compared to the control group. However, it is of interest that there were 
some significant positive changes from baseline in the intervention group compared to no 
change in any of the outcomes measured in the control group over the six months of the study. 
The completion rate of subjects recruited into this study was high (93%) and compares well 
with many other dietary and lifestyle studies where the attrition rate is typically much higher 
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(Dansinger, Gleason et a1. 2005). This suggests that lifestyle education delivered by means of 
video is acceptable to the majority of people with diabetes. This is further supported by 
subjective evaluation of the videos. Subjects receiving videos were asked to complete an 
evaluation form including visual analogue scales and free-text comments and all patients 
completed and returned this form suggesting that they had watched the videos. Reactions to 
this innovative approach to providing diabetes education were overwhelmingly positive with 
the subjects giving a mean score of over 90% for the idea of delivering lifestyle advice by 
means of video. 
The apparent lack of difference between the control and the intervention group in terms of 
biomedical indices and quality of life may be due to a variety of reasons. Firstly, the sample 
size was small and this may well have resulted in a type 2 statistical error, producing a false 
negative result. The small sample size was due to problems associated with recruitment to the 
study. The power calculations had indicated that 80 subjects were necessary to show a 
statistically significant difference between the intervention and the control group, but it 
proved difficult to recruit this number to the study. The main reason for this was the 
introduction of the Quality and Outcome Framework (Department of Health 2005) in the UK 
during the period of recruitment. QOFs were designed to provide financial incentives for GPs 
to improve outcomes and meet targets, including glycaemic control and cardiovascular risk 
factors, in people with diabetes and health professionals in primary care proved reluctant to 
refer people with diabetes out of their care into this study. 
Secondly, it has been demonstrated that the introduction of QOFs has improved treatment for 
people with diabetes. It is likely that both the control group and the intervention group 
received more intensive treatment than they otherwise might have obtained before 
introduction of QOFs, and this may have obscured any differences between the groups. 
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Fourteen (33%) subjects reported that they had been prescribed Metformin at diagnosis 
without a trial of lifestyle interventions as recommended by the then current NICE guidelines 
(NICE 2005). At six months follow-up, of the 39 completers, 12 (32%) were taking 
Metformin as single therapy, 10 (27%) taking a combination of Metformin and sulphonylurea 
and 1 taking triple therapy, leaving 16 (41%) subjects taking no glucose lowering agents. 
This intensification of treatment improved glycaemic control in this study and mean A I c 
values decreased significantly from 7.4% to 6.7% (p=0.009) over the study period, regardless 
of allocation to video education. The QOF also includes cardiovascular risk assessment and 
this is reflected by a significant reduction in total cholesterol from 4.7mmolJl to 4.3 mmolll 
(p=0.04) and an increase in HDL cholesterol from 1.17 mmolll to 1.24 mmolJl (p=0.03) in all 
subjects. Other parameters such as body weight, quality of life and diabetes knowledge are 
not assessed as part of the QOF and it is interesting to note that these indices showed no 
significant change for all subjects in this study. 
Thirdly, most studies have shown that any intervention at diagnosis of Type 2 diabetes 
appears to be effective (UKPDS 1990; Davies, Heller et al. 2008) and that it may be that six 
months is too soon for any benefit of the education to show. There may be additional benefit 
of education in the long-term for people with Type 2 diabetes, but at present there are no 
studies to support this supposition. 
5.4.1. Glycaemic control 
Over the six month of the study, glycaemic control measured by A I c decreased in both the 
intervention and the control group (-0.7 vs -0.6%, ns) although only the intervention group 
showed a significant difference from baseline to six months. Most studies of people with 
newly diagnosed Type 2 diabetes show that glycaemic control improves after diagnosis. The 
UKPDS reported a reduction in Alc of 2% (from 9.1 % to 7.0%) in three months following 
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diagnosis with all 5102 subjects receiving dietary advice alone (UKPDS 1990) and a more 
recent large-scale intervention trial, DESMOND (Diabetes Education and Self-Management 
in Newly diagnosed and On-going Diabetes), that was designed to deliver intensive education 
in primary care compared to standard care failed to show a difference in 842 subjects 
allocated to either the educational intervention or control group, although both groups showed 
significant reductions in Ale over the 12 months of the study (Davies, Heller et at. 2008). 
This may well suggest that, at diagnosis, people with Type 2 diabetes will improve glycaemic 
control by means of combination of standard lifestyle education and medication. However, 
Type 2 diabetes is characterised by progressive loss of beta cell function accompanied by a 
rise in Ale and it could be postulated that the benefits of intensive education may not be seen 
for many years. Most education programmes have short-term follow-up (6-12 months) and 
this may not be sufficient time for the benefits of education to be observed. In addition, at the 
time of recruitment for this study, the Quality and Outcomes Framework (QOF) was 
introduced in to General Practice and this provides incentives for reducing Al c in people with 
diabetes and this may account for the lack of difference in Ale between the two groups in this 
study. 
5.4.2. Body weight 
At entry to the study the majority of subjects were either overweight or obese (mean weight 
89.5 kg, BMI 31.3 kg/m2). Only 6 of the 42 participants (14%) were within the normal weight 
range (BMI 18-24.9 kglm2). There were no significant differences either within the groups or 
between the groups at six months follow-up. It has been established that weight loss is 
beneficial to people with Type 2 diabetes who are overweight or obese (Aucott, Poobalan et 
al. 2004) and for this reason, one of the lifestyle videos was entitled 'Weight management'. 
Weight loss is notoriously challenging for people with diabetes and there is evidence that 
people with diabetes find weight loss more difficult to achieve than those without diabetes 
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(Wing, Marcus et a1. 1987). In addition, the majority of medication prescribed for Type 2 
diabetes, with the exception of Metformin (which is weight-neutral), is associated with 
significant weight gain (UKPDS 1998). Despite this, the video intervention group reduced 
body weight by l.4kg, compared with a weight gain of 0.2kg in the control group. The more 
intensive education delivered by the DESMOND programme (Davies, Heller et a1. 2008) was 
associated with significant weight loss over 12 months (-2.98kg vs -1.8kg, p=0.027) and this 
may represent the importance of formal, structured education programmes for weight loss in 
people with newly diagnosed Type 2 diabetes. 
5.4.3. Cardiovascular risk 
There were no significant changes between the groups from baseline to six months in 
cardiovascular risk factors including lipid profiles, blood pressure and physical activity 
measured by pedometer, although total and LDL cholesterol was significantly reduced in the 
video intervention group, and they also showed an increase in number of steps recorded by 
the pedometer. Type 2 diabetes is associated with increased cardiovascular risk (Selvin, 
Marinopoulos et a1. 2004) and this is reflected in abnormal lipid profiles. This group of newly 
diagnosed Type 2 subjects showed lipid levels and blood pressure within the normal range, 
suggesting that there was not much scope for improvement. These levels of cardiovascular 
risk may be a result of the QOFs, which specifically target lipid levels and blood pressure in 
people with diabetes, and this is reflected in the treatment of the subjects in the study as 62% 
were taking lipid-lowering medication and 69% anti-hypertensive agents at entry to the study. 
5.4.4. Dietary intake 
There were no significant changes in dietary intake either within or between the two groups. 
This may be reflected by the fact that all subjects had received dietary advice at diagnosis 
from their practice nurse before referral to the study and most had adopted a reduced fat diet. 
175 
However, the majority of the subjects reported a relatively low energy intake, and this may 
reflect the previously-reported phenomenon of a strong inverse association between reported 
food intake and BMI (Heitmann and Lissner 1995). However, although absolute food intake 
may not have been fully reported, it is likely that any change in intake may have been 
identified and this is supported by the fact that there was no significant change in either body 
weight or reported energy intake. One of the three videos was entitled 'Food and diabetes' 
and was designed to educate the subjects about the effect of carbohydrate foods on blood 
glucose levels and to encourage a reduction in fat intake. There were no differences between 
baseline and six months in either group and no differences be~ween the two groups. This may 
be due to the relatively low fat intake in the subjects at baseline «35% total energy from fat) 
and the fact that they had already received healthy eating advice from a practice nurse at 
diagnosis. 
5.4.5. Quality of life 
There were no significant changes in quality of life measured by either WHO-5 Well-Being 
Index or the EQ-5D either within or between the groups. 
5.4.6. Diabetes knowledge 
There were no differences between the groups at baseline for diabetes knowledge assessed by 
the ADKnowl questionnaire. Comparisons between baseline and six months in both groups 
showed non-significant improvements in knowledge in the video intervention group for all 7 
items and non-significant deterioration in knowledge in the control group for 6 of the 7 items 
with the exception of alcohol. Comparisons of the changes between the two groups from 
baseline to six months showed a highly significant increase in overall diabetes knowledge in 
the video intervention group compared with the control group (p=<O.OOOI) and specifically in 
the areas of food (p=<O,OO 1) and the importance of regular examinations (p=<O.05). These 
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results indicate that delivering education by means of a video intervention have a positive 
effect on diabetes knowledge in people newly diagnosed with Type 2 diabetes. 
5.4.7. Subject evaluation 
The response of the subjects to this innovative approach to providing diabetes education was 
overwhelmingly positive with the subjects giving a mean score of over 90% for the idea of 
delivering lifestyle advice by means of video. This acceptance is supported by the fact that 
only 3 subjects failed to attend their follow-up visit at six months and all 3 were in the control 
group; none of the video intervention group failed to attend their follow-up visit. Evaluation 
for the video education process was high for all aspects except the content of the videos, with 
some subjects stating they would have like more detail on all three topics although there were 
others who felt that the information content was sufficient. 
This subjective evaluation suggests that innovative approaches to education are acceptable to 
people newly diagnosed with Type 2 diabetes, although people would welcome more detailed 
information, especially about how to relate theory to practice. 
5.5. Summary 
These results show that a short video intervention delivering lifestyle education to people 
newly diagnosed with Type 2 diabetes significantly increased overall knowledge of diabetes, 
especially about food and the need for regular examinations, but that it had no significant 
effect on biomedical outcomes, including glycaemic control, cardiovascular risk and body 
weight, or quality of life when compared to a control group. The lack of differences between 
the groups may have been caused by the fact that the sample size was too small, that the 
recently introduced Quality and Outcomes Framework had improved diabetes care in general 
practice and obscured any potential differences between the intervention and the control 
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group and that the positive effects of education may take more than six months to manifest 
themselves. 
At present, there are no diabetes education programmes delivered by video that have been 
subject to any assessment, one produced by Diabetes UK provides information to people with 
Type 2 diabetes but has not been formally evaluated. This study has demonstrated that video-
based interventions are highly rated by people with newly diagnosed Type 2 diabetes and that 
there may be a role for this type of education in the future. 
Study 1 has shown that a low carbohydrate diet is effective for weight loss in people with 
Type 2 diabetes, and this study (Study 2) that a novel approach to lifestyle education increases 
knowledge and may have some effect on weight loss and physical activity. This suggests that 
educational approaches other than the traditional individual appointment may benefit people 
with diabetes, and that more flexibility in the amount of carbohydrate included in the diet may 
improve weight loss. These two components of innovative approaches to education and 
manipulating carbohydrate intake were combined for Study 3, investigating the effect of 
carbohydrate counting and insulin adjustment delivered in a group setting for people with 
Type 1 diabetes. 
5.6. Publications 
An article based upon work from Chapter 5 has been published and is included in the 
Appendices at the back of this volume. This publication is entitled 'An assessment of lifestyle 
video education for people newly diagnosed with Type 2 diabetes' and was published in the 
Journal of Human Nutrition and Dietetics in 2010. It can be found in Appendix 3. 
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Chapter 6 
Carbohydrate counting, insulin adjustment and Type 1 diabetes 
6.0. Introduction 
Type 1 diabetes is associated with significantly increased mortality and morbidity 
(Diabetes UK 2004); a diagnosis of Type 1 diabetes is estimated to reduce life 
expectancy by more than 20 years (Department of Health 2001), although 
improvements in treatment have shown that life expectancy has improved over the 
past decade (Ioacara, Lichiardopol et al. 2009). Despite this, mortality rates remain up 
to five times higher for people with diabetes (Kanters, Banga et al. 1999). 
Morbidity in people with Type 1 diabetes includes macrovascular (cardiovascular) 
disease and microvascular disease including kidney disease (nephropathy), eye 
disease (retinopathy) and nerve damage (nephropathy). Although cardiovascular 
disease is rare in people with Type 1 diabetes in the 30 years following diagnosis, 
after 40 years of exposure to diabetes, cardiovascular disease accounts for 30% of 
deaths. Diabetes is now the leading cause of end stage renal failure in the UK, with 
approximately 20% of people with Type 1 diabetes reaching end stage kidney disease. 
The risk of kidney damage increases with the duration of diabetes, after twenty five 
years of exposure the risk is 40-50% for both types of diabetes. Blindness is more 
prevalent in people who have Type 1 diabetes, and twenty years after diagnosis nearly 
all people with Type 1 diabetes will have some form of retinopathy. Amputation is a 
complication caused by damage to the nerves and blood vessels that serve the limbs. 
In the UK, diabetes is the second most common cause of lower limb amputation, and 
the most common cause of non-traumatic amputation (Diabetes UK 2004). 
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Improvements in treatment leading to tighter glycaemic control have been shown to 
significantly reduce the morbidity associated with Type 1 diabetes (DCCT study 
group 1993). The Diabetes Complications and Control Trial (DCCT) showed that 
intensive management of blood glucose levels resulted in significant reductions in the 
risk of tissue damage. The results of the trial showed that a reduction in Al c from 9% 
to 7% was accompanied by a 34% reduction in incidence of microalbuminuria, a 
marker for kidney damage, and the development and progression of retinopathy was 
reduced by 27% and 34% respectively. Although the evidence for intensive 
management of Type 1 diabetes is compelling, the DCCT achieved this through close 
supervision by health professionals of the subjects' dietary intake, insulin adjustment 
and management of physical activity. In addition intensive insulin management had 
some deleterious effects; significantly more hypoglycaemia and weight gain were 
recorded in the intensively managed group during the course of the study. The 
resources needed to achieve the results seen in the DCCT, the increased rates of 
hypo glycaemia and weight gain have presented barriers to the adoption of this 
approach in routine clinical care. As a result, studies exploring alternative approaches 
to managing blood glucose levels in people with Type 1 diabetes have been carried 
out (DAFNE study group 2002). These studies have postulated that alternative 
methods of education which emphasise self-management skills may be a better use of 
resources, and may be accompanied by less hypoglycaemia and weight gain. The 
process of education for people with Type I diabetes has been identified as needing 
further exploration and in the UK this has led to the concept of structured education 
for people with diabetes (Diabetes UK 2005). A full description of the development of 
structured education for people with diabetes is given in Chapter 4. 
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6.1. Content of structured education programmes for Type 1 diabetes 
There is general agreement in the UK from the Diabetes Education Network that 
education programmes for people with Type 1 diabetes should include information 
about dietary intake, insulin dose adjustment, managing physical activity, 
hypoglycaemia and sick day rules. 
6.1.1 Dietary intake 
Traditionally, education for people with Type 1 diabetes aimed to match carbohydrate 
to a prescribed insulin dose at each meal or snack. Although there was recognition 
that people with Type 1 diabetes did not have to avoid carbohydrate entirely, there 
was also the recommendation that those using insulin to treat diabetes may need to 
consider amount and timing of carbohydrate foods (Nuttall 1980). People with 
diabetes were taught to identify carbohydrate-containing foods and were given 
various strategies to assess the amount of carbohydrate in different portions, including 
exchange lists which indicated the amount of food containing 10-ISg carbohydrate 
(Franz, Barr et a1. 1987). A prescription for the amount of carbohydrate to be 
consumed at each meal and snack was dispensed by the health professional and the 
person with diabetes was expected to adopt this. Different strategies were employed 
to facilitate the idea of carbohydrate control; the strategies used in the DCCT 
included healthy food choices, carbohydrate exchanges, carbohydrate counting and 
calculating total available carbohydrate (Anderson, Richardson et a1. 1993). In the 
UK, the recommended approach for people with Type 1 diabetes was that of 
carbohydrate prescription by means of 109 carbohydrate exchange lists (Nutrition 
sub-committee of the British Diabetic Association 1982). This approach was driven 
by the medical model of focussing on the metabolic outcomes of diabetes 
management and especially glycaemic control, which contrasts with the patient's 
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agenda where the emphasis is on daily management of diabetes and the challenge of 
integrating treatment into daily life (Wolpert and Anderson 2001). One of the most 
challenging aspects of diabetes management from the patient's perspective is that of· , 
dietary restriction (Bradley and Speight 2002), and it has been suggested that 
changing the emphasis of dietary restriction to dietary freedom accompanied by 
intensive insulin management may improve both biomedical outcomes and quality of 
life (DAFNE study group 2002). The basis of this approach is that the person with 
diabetes assesses the amount of carbohydrate eaten at each meal and snack and injects 
insulin to match the amount eaten. This approach was first introduced in Germany and 
was shown to be effective in improving glycaemic control (Muhlhauser, Bruckner et 
at. 1987), and is the general strategy for most structured education programmes. 
6.1.2. Insulin dose adjustment 
Insulin dose adjustment for people with Type 1 diabetes depends upon individual 
testing and titration. The main aim of insulin treatment is to mimic insulin secretion in 
people without diabetes. Typically, this is achieved by one injection of long-acting 
background or basal insulin and injections of short-acting insulin before each meal 
(Williams and Pickup 2004). As insulin requirements are subject to large individual 
variation, there are no current published recommendations for insulin doses for people 
with Type 1 diabetes, although some authorities have produced guidelines in the past 
(International Diabetes Federation 1998; American Diabetes Association 2009). 
Algorithms for insulin treatment of Type 1 diabetes are challenging in use due to this 
individual variation, and as a result very few centres publish these, although some 
centres employ this technique (Texas Department of State Health Services 2010). 
Traditionally, people with diabetes take set doses of insulin at each meal time, the 
amount of which is calculated by trial and error, and this can result in large 
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fluctuations in blood glucose levels if differing amounts of carbohydrate are eaten 
form day to day. The emphasis of the new approach is to provide flexibility in the 
amount of insulin taken at meal times and, by definition, this will change from day to 
day and meal to meal. 
6.1.3. Physical activity 
Management of physical activity in people with Type 1 diabetes is challenging owing 
to the increased risk of hypoglycaemia. Increased physical activity is recommended 
for general health for all people with diabetes (Weltman, Saliba et a1. 2009), although 
for people with Type 1 diabetes the recommendation is made in terms of reducing 
cardiovascular risk rather than improving glycaemic control (Kavookjian, Elswick et 
a1. 2007). Published reviews and recommendations state that the altered physiological 
response in diabetes means that more thought must go into preparation for exercise in 
people with Type 1 diabetes (Gallen 2006; Lumb and Gallen 2009). Before exercise, 
it is recommended that blood glucose levels should be between 7-12 mmoVl. If levels 
are <7 mmoVI, extra carbohydrate should be taken. In the absence of ketosis and with 
glucose levels> 12 mmoVI glucose replacement during exercise should be delayed. In 
the presence of ketosis, exercise should be avoided. It is recommended that blood 
glucose levels are monitored before, during and after exercise at thirty minute 
intervals to establish an individual's blood glucose response to exercise. 
To prevent hypoglycaemia during exercise, additional carbohydrate is advocated as 
needed. As a general guide, for moderate intensity endurance activities, high 
glycaemic index carbohydrate should be consumed after thirty minutes of exercise at 
a rate of up to approximately 19lkglhr. Lower intensity activities or intermittent high 
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intensity activities are likely to require smaller rates of carbohydrate supplementation. 
In addition, adequate hydration is essential. 
6.1.4. Hypoglycaemia 
Hypoglycaemia is generally accepted as a blood glucose level <3.5 mmolll (Amie1 
2009), although in clinical practice it is recommended that any blood glucose level 
<4.0 mmolll is treated as hypoglycaemia (American Diabetes Association (ADA) 
Workgroup on Hypoglycemia 2005). Many people with Type 1 diabetes find 
hypoglycaemia challenging to manage and struggle to establish the balance between 
improved glycaemic control and increased hypoglycaemia (Heller 2008). The DCCT 
showed that reducing Ale levels was accompanied by an increase in hypoglycaemia 
(DCCT study group 1993), but subsequent studies relating insulin to carbohydrate 
intake have shown no increase in hypoglycaemia with improved glycaemic control 
(Muhlhauser, Bruckner et al. 1987; DAFNE study group 2002). 
6.1.5. Sick day rules 
Illness and infection in people with Type 1 diabetes is frequently associated with 
raised blood glucose and ketone levels and if left untreated can lead to diabetic 
ketoacidosis (DKA). DKA is correlated with significant morbidity and mortality and 
requires close monitoring during episodes of illness (Weber, Kocher et al. 2009). To 
support the management of illness in people with Type 1 diabetes, general 
recommendations have been devised and these are commonly known as 'sick day 
rules' (Laffel 2000; Campbell and Alford 2006). 
6.2. Process of structured education 
A review of the education process is provided in Chapter 4 and the principles of 
structured education as recommended by both the Department of Health and Diabetes 
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UK have been adopted by many education programmes in the UK (DAFNE study 
group 2002; Deakin, Cade et al. 2006; Davies, Heller et al. 2008). All education 
programmes are required to comply with the four criteria for structured education 
programme including a structured, written curriculum with explicit philosophy and 
theoretical principles, utilising trained educators, a process of quality assurance and 
audit and evaluation of both biomedical and quality of life outcomes. 
6.3. Summary 
It appears that there are many barriers to improving glycaemic control in people with 
Type 1 diabetes, including lack of resources, increased hypoglycaemia and weight 
gain. Structured education programmes may improve outcomes by promoting self-
management skills. This chapter reviews published literature and evaluates the 
available data and then describes the application of a structured education programme 
for people with Type 1 diabetes in clinical practice. 
6.4. A review of structured education programmes for people with Type 1 
diabetes 
6.4.1. Background 
There is unequivocal evidence that improved glycaemic control in people with Type 1 
diabetes reduces both the risk and progression of tissue damage associated with 
hyperglycaemia (DCCT study group 1993). However, although targets of 6.5-7% for 
Alc levels are now routinely recommended (American Diabetes Association 2009), 
many people find this challenging to achieve in practice. For example, the DCCT 
reported that only 5% of the intervention group were able to maintain Ale at target 
levels throughout the study period of 6.5 years, despite the level of support and advice 
that was available (DCCT study group 1993). Unpublished data from Diabetes UK 
has reported that in 2000 the mean Ale of people with Type 1 diabetes was 8.6%. 
185 
There are a number of factors that may explain suboptimal diabetes control including 
inflexible insulin therapy with associated hyper and hypo glycaemia, lack of provision 
of appropriate healthcare by the diabetes team and the lack of education and 
associated self-management skills of people with diabetes (Davies 2004). 
6.4.2. Insulin therapy and hypoglycaemia 
Strong evidence for optimal insulin therapy for Type 1 diabetes is lacking, but most 
centres now recommend a basal prandial regimen with one injection of basal 
(background) analogue insulin, often taken at night, and three or more injections of 
rapid-acting analogue insulin (prandial) with meals and snacks. There is little 
evidence that this regimen is more effective that two injections daily of mixed insulin, 
but there is some evidence that using analogue insulins rather than human soluble 
insulin can significantly reduce both Ale and hypoglycaemia (Jacobsen, Henriksen et 
al. 2009). 
The main obstacle to reducing Alc for people with Type I diabetes is the fear of 
hypoglycaemia (Davis and Alonso 2004). Reducing Ale levels is associated with 
increasing insulin doses and the increased risk of hypoglycaemia, and patient's 
perceptions of this increased risk compromises glycaemic control (Gonder-Frederick, 
Clarke et al. 1997). 
6.4.3. Healthcare provision 
Healthcare professionals have a responsibility to provide optimal medical and 
educational advice to their patients. Healthcare professionals usually formulate advice 
based upon evidence from clinical trials and concentrate on biomedical outcomes and 
medical management, rather than the perspective of people with Type I diabetes, who 
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are more concerned with the day-to-day concerns of living with diabetes (Wolpert and 
Anderson 2001). 
6.4.4. Education and self-management 
Most authorities agree that self-management is fundamental for success for people 
living with Type 1 diabetes (DAFNE study group 2002). However, there is little 
evidence for the most effective method of delivering education to support and 
encourage self-management skills. It has been established that didactic teaching is 
effective in clinical trials, but is no longer effective once the trial ends. This has been 
demonstrated in the DCCT, where the intervention group, who received intensive 
insulin and education during the study, showed a rise in Ale once the study had 
finished and the education was no longer available (2002). Alternatives to didactic 
teaching include structured education incorporating dietary freedom, carbohydrate 
assessment and intensive insulin management. This approach was first adopted in 
Germany (Muhlhauser, Bruckner et al. 1987) and has since been trialled successfully 
in the UK (DAFNE study group 2002). 
6.4.5. Methods 
A literature search was undertaken to identify studies assessing structured education 
including carbohydrate counting and insulin adjustment in people with Type 1 
diabetes. An electronic search was performed using MEDLINE (1966 - March 2009), 
EMBASE (1988 - March 2009) and the Cochrane Central Register of Controlled 
Trials (1991 - March 2009) using the search terms structured education, Type 1 
diabetes, carbohydrate counting and insulin adjustment, see Fig 6.1. All studies 
relating to intervention trials of structured education in people with Type 1 diabetes 
were included. 
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Fig 6.1. Quorum flowchart of reviewing process for articles investigating video 
education and diabetes 
116 articles identified though 
database searching 
10 potentially appropriate 
articles to be included in review 
6 published articles identified 
106 articles excluded: 
104 did not include carbohydrate 
assessment 
2 non-English language articles 
4 articles excluded: 
all aimed specifically at children and 
adolescents 
Six studies were identified and are included in this review. Two of the studies were 
designed as randomised controlled trials, one as a delayed randomised controlled trial 
(DAFNE) and the other with block randomisation (BITES). Three other studies were 
designed as intervention trials and the remaining study was a retrospective audit. 
Results for the five studies are reported at intervals ranging from six weeks to one 
year. Table 6.1 summarises the characteristics of the six published studies. 
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Table 6.1 Details of structured education programmes for people with Type 1 diabetes 
Programme Subjects Age (years) Duration of MaleIFemale Type of study 
name (Number) Mean (SD) diabetes 
Mean (SD) 
DAFNE 141 40 (9) 16.6 (9.6) 69/72 Delayed randomised controlled 
trial 
REACCT 80 Data not reported Intervention 
NEP 137 47 (15) 15 (26.2) 61/76 Intervention 
BITES 114 41 (11) 195 (11.8) 51163 Block randomised 
controlled trial 
RECLAIM 298 44(14) Data not reported Retrospective audit 
FIT 45 41 (Range 18-79) 10 (Range 1-49) 21124 
DAFNE: Dose Adjustment for Normal Eating (DAFNE study group 2002) 
REACCT: Re-education and Carbohydrate Counting Training (Ulahannan, Ross et a1. 2007) 
NEP: Newcastle Empowerment Programme (Lowe, Linjawi et a1. 2008) 
Intervention 
BITES: Brief Intervention in Type 1 diabetes, Education for Self-efficacy (George, Valdovinos et a1. 2008) 
RECLAIM: Royal Infirmary of Edinburgh Carbohydrate Learning and Insulin Management (Teoh, Anderson et a1. 2010) 
FIT: Flexible Insulin Therapy (Falconnier Bendik, Keller et a1. 2009) 
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Duration of study 
6 months 
6 weeks 
4 and 12 months 
12 months 
12 months 
6 and 18 months 
6.4.6. Results 
Structured education programmes for people with Type 1 diabetes incorporating 
carbohydrate counting and insulin adjustment are postulated to have positive effects 
on glycaemic control, quality of life and rates of hypoglycaemia without increasing 
body weight. These factors are discussed more fully below. 
6.4.6.1. Glycaemic control and body weight 
Table 6.2 shows changes in Alc and body weight from baseline for the six studies 
investigating the effects of structured education in people with Type I diabetes. The 
results are somewhat contradictory, with three studies showing a significant 
improvement in glycaemic control and the remaining three studies indicating a small 
but non-significant improvement. The DAFNE study showed the greatest reduction in 
Al c (1 %), with other studies reporting reductions of 0.1-0.9%. There appears to be a 
trend towards greater improvement in those subjects with a higher Ale at baseline, 
and this is supported by data from one of the DAFNE centres showing that there was 
a greater mean fall in Ale (-0.7 v -0.3%, p=<O.OOl) for 102 individuals with a 
baseline Alc >8.5% (Lawrence, Hopkins et al. 2008). 
None of these studies indicate that structured education is associated with 
deterioration in glycaemic control in people with Type 1 diabetes, and this is 
particularly important within the context of relaxation of dietary prescription. All 
these studies promote a more flexible approach to food and eating than was 
previously the case, and this is particularly true of the DAFNE study where the study 
is promoted under the by-line 'Eat what you like, like what you eat.' Although none 
of the studies attempted to evaluate dietary intake in people with Type 1 diabetes, 
subjective feedback from the studies suggest that most subjects imposed no limits on 
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their carbohydrate intake and many began to include larger quantities of sugar-
containing foods into their diet. 
It has long been known that improvements in glycaemic control in people with Type 1 
diabetes are associated with significant weight gain (Zinman 1998). The DCCT trial, 
for example, reported significant weight gain in the intensively treated group and 
reported that during the first year of the study, mean weight gain in the intensively 
treated group was 5.lkg, compared with 2.4kg in the conventionally treated group 
(p<O.OOOI) (nCCT study group 1988). The studies reported here that investigated the 
effects of structured education have reported no significant change in weight, even 
when there is a reported significant improvement in glycaemic control. This suggests 
that structured education programmes enable people with Type 1 diabetes to improve 
glycaemic control and enjoy greater dietary freedom without a significant increase in 
weight. This may be important for future health, as follow-up data from the DCCT 
showed that those with the greatest weight gain exhibited significantly increased 
cardiovascular risk, namely raised blood pressure and changes in lipid levels (Purnell, 
Hokanson et al. 1998). 
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Table 6.2. Changes from baseline in body weight, BMI, and Alc in studies of structured education programmes for people with Type I 
diabetes 
Programme Ale (0/0) Weight (kg) BMI (kg/m2) 
name 
Baseline Change P value Baseline Change P value Baseline Change P value 
DAFNE 9.4 -1.0 <0.001 80.5 1.0 0.11 Data not reported 
REACCT 8.37 -0.09 NS Data not reported Data not reported 
NEP Data not reported Data not reported 
4 months 8.27 -0.17 0.04 
12 months 8.27 -0.19 0.04 
BITES 8.7 -0.3 0.94 Data not reported 26.3 0.07 0.77 
RECLAIM 8.91 -0.6 <0.001 79.3 0.45 NS Data not reported 
FIT 
6 months 7.2 -0.1 NS 68.1 1.3 NS 23.0 23.4 NS 
18 months 7.2 -0.1 NS 68.1 0.1 NS 23.0 23.0 NS 
NS, no significant difference 
DAFNE: Dose Adjustment for Normal Eating (DAFNE study group 2002) 
REACCT: Re-education and Carbohydrate Counting Training (Ulahannan, Ross et a1. 2007) 
NEP: Newcastle Empowerment Programme (Lowe, Linjawi et a1. 2008) 
BITES: Brief Intervention in Type 1 diabetes, Education for Self-efficacy (George, Valdovinos et a1. 2008) 
RECLAIM: Royal Infirmary of Edinburgh Carbohydrate Learning and Insulin Management (Teoh, Anderson et a1. 2010) 
FIT: Flexible Insulin Therapy {Falconnier Bendik, 2009) 
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6.4.6.2. Hypoglycaemia rates 
Improvements in glycaemic control in people with Type I diabetes are associated 
with an increase in the rate of hypo glycaemia. People with Type 1 diabetes report that 
hypoglycaemia is one of their greatest fears (Davies 2004), and avoidance of 
hypo glycaemia plays a large part in decision-making about treatment and targets for 
blood glucose levels (Davis and Alonso 2004). The DCCT reported that levels of 
severe hypo glycaemia in the intensively treated group were three times higher that 
those of the conventionally treated group, and that hypo glycaemia was more common 
in the intensively treated group at all comparable levels of Ale (DCCT study group 
1997). Structured education programmes aim to improve glycaemic control without 
increasing the risk and frequency of hypo glycaemia. 
Three of the published studies describing the effects of structured education in people 
with Type 1 diabetes reported effects on rates of hypoglycaemia. REACCT, NEP and 
RECLAIM did not assess or report hypoglycaemia rates and the three remaining 
studies used different measures to assess frequency and fear of hypoglycaemia. 
DAFNE assessed frequency of hypo glycaemia by means of the diabetes satisfaction 
questionnaire (DTSQ) (Bradley 2003) and showed that there was no increase in the 
frequency of hypo glycaemia in the intervention group despite a significant 
improvement in glycaemic control (DAFNE study group 2002). BITES measured 
both frequency and fear of hypoglycaemia using records of pre-defined 
hypo glycaemia and the hypoglycaemia fear scale (HFS) (Cox, Irvine et al. 1987). 
Hypoglycaemia was pre-defined as a recorded episode of blood glucose values <2.7 
mmo1l1 or the subject required assistance from a third party to treat clinical symptoms. 
There were no significant differences in rates of severe hypoglycaemia between the 
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intervention and the control groups. In addition, this study reported no change in fear 
of hypo glycaemia between the two groups (George, Valdovinos et al. 2008). The FIT 
study measured frequency of hypoglycaemia defined as any episode requiring 
assistance by a third party, and this was the only study to report a decrease in 
hypoglycaemia as a result of the education intervention. Severe hypoglycaemia 
decreased by ten-fold as a result of the intervention, decreasing from a mean of 0.66 
episodes per patient per year to <0.05 episodes per patient per year. The explanation 
offered for this was that patients were able to adjust their insulin doses more 
accurately by accounting for self-monitored blood glucose levels, amount of 
carbohydrate eaten and effects of physical activity (Falconnier Bendik, Keller et al. 
2009). 
These studies suggest that structured education programmes can improve glycaemic 
control in people with Type 1 diabetes without increasing the risk of hypoglycaemia, 
and may help prevent severe hypoglycaemia. 
6.4.6.3. Quality of life 
A large, global study of over 5000 people with diabetes has shown that psychological 
distress is common in people with diabetes. The Diabetes Attitudes Wishes and Needs 
(DAWN) study has shown that 41 % of people with diabetes report poor psychological 
well-being and experience emotional distress related to their diabetes (Peyrot, Rubin 
et al. 2005). Diabetes related distress is especially common at diagnosis, with 82.5% 
of this sample reporting high levels of distress (Funnell 2006). In addition, depression 
is more prevalent amongst those with diabetes, with twice as many people with 
diabetes reporting they are depressed and this has effects on self-management and 
diabetes care (Diabetes UK 2006). Structured education programmes aim to improve 
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quality of life and self-management skills in people with diabetes. Measurement of 
quality of life in people with diabetes presents methodological problems, typically 
different studies use different techniques to measure quality of life and this makes 
comparisons difficult (Speight, Reaney et al. 2009). Table 6.3 shows the effects of the 
different assessments of quality of life and diabetes distress in the studies under 
review. Five of the six studies assessed quality of life and although many different 
tools are available to measure quality of life and diabetes distress, all these reported 
studies show that structured education programmes significantly improved quality of 
life, independent of any change in either glycaemic control or hypoglycaemia. 
The DAFNE study used the ADDQoL questionnaire (Bradley and Speight 2002) to 
measure quality of life and the W-BQI2 (Bradley and Speight 2002) to measure 
psychological well-being. The ADDQoL produces a diabetes impact rating that 
includes 18 domains of life. Scores range from +9, representing the maximum 
positive effect of diabetes, to -9, representing the maximum negative effect. The W-
BQ12 is a series of 12 questions, each with a maximum score of3, and higher scores 
indicate better psychological welfare. DAFNE reported significant improvement in 
overall quality of life measured by ADDQoL, especially in the areas exploring the 
negative impact of diabetes and dietary freedom (DAFNE study group 2002). The 
REACCT study did not use a validated quality of life questionnaire, although 
subjective evaluation showed that 56% of subjects reported improved quality of life 
(Ulahannan, Ross et al. 2007). 
The NEP measured quality of life using the ADDQoL questionnaire and assessed self-
efficacy by means of a diabetes empowerment scale (DES) and which includes three 
sub-scales; managing psychological aspects, goal-setting and readiness to change 
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(Anderson, Funnell et al. 2000). DES is designed to assess self-efficacy and is rated 
by a score of 1-5 for each question. A higher score indicates greater self-efficacy. 
NEP showed that quality of life measured by ADDQoL improved significantly at 4 
months and this improvement was maintained at 12 month's follow-up. Self-efficacy 
measured by DES improved significantly at 4 months, but the effects were lost at 12 
months' follow-up (Lowe, Linjawi et al. 2008). BITES assessed self-efficacy using 
the DES and a diabetes health profile (DHP) which includes three sub-scales 
measuring psychological distress, barriers to activity and dis inhibited eating 
(Meadows, Steen et al. 1996). The DES showed significant improvement in two areas, 
but not in readiness to change and the DHP showed no differences between the groups 
except for reduced barriers to activity in the intervention group (George, Valdovinos 
et al. 2008). The FIT study used the same questionnaire as that used for DCCT, the 
diabetes quality of life questionnaire (DQOL) (DCCT study group 1988) and which 
includes 46 questions. Total scores range from 46-230, with higher scores indicating 
poorer quality of life. There was a significant reduction in total scores at the end of the 
study, indicating improved quality oflife (Falconnier Bendik, Keller et al. 2009). 
In summary, these studies under review show that structured education for people 
with Type 1 diabetes improves quality of life and diabetes related distress, although 
different studies have used different methods of assessment. 
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Table 6.3. Mean changes in quality of life in studies of structured education in 
people with Type 1 diabetes 
Programme Assessment tool Baseline Change 
name value 
DAFNE ADDQoL Not reported 0.4 
W-BQI2 20.94 3.4 
REACCT Subjective questionnaire Not reported Not 
reported 
NEP DES: 
4 months 0.19 
12 months 0.03 
ADDQoL: Not reported 
4 months 1.9 
12 months 3.9 
BITES DES: 
Managing psychological 4.6 
aspects: 
Setting and achieving 3.7 
goals: 
Readiness to change: Not reported 2.87 
DHP: 
Psychological distress -2.3 
Barriers to activity -3.5 
Disinhibited eating -3.6 
FIT DQOL: 
6 months 91.8 -6.1 
18 months 91.8 -6.2 
ADDQoL: diabetes dependent quality of life (Bradley and Speight 2002) 
W-BQ 12: 12-item well-being questionnaire (Bradley 2000) 
DES: diabetes empowerment scale (Anderson, Funnell et al. 2000) 
DHP: diabetes health profile (Meadows, Steen et al. 1996) 
DQOL: diabetes quality of life (DCCr study group 1988) 
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P value 
<0.01 
<0.01 
Not 
reported 
0.001 
0.19 
0.05 
0.005 
0.005 
0.02 
0.12 
0.93 
0.02 
0.12 
<0.001 
<0.001 
6.4.7. Conclusions 
In summary, the available evidence shows that in four intervention studies and two 
randomised controlled trials of structured education programmes in people with Type 
1 diabetes, the majority showed significant improvement in glycaemic control and 
quality of life. No study published to date has shown a deleterious effect on glycaemic 
control, body weight or risk of severe hypoglcaemia, but these findings should be 
interpreted with caution as there were no control groups in the majority of studies. In 
addition, the majority of studies report that their education programmes are designed 
to promote dietary freedom and flexibility, but this is not measured or reported in any 
of the studies to date. In an attempt to identify the role of structured education in 
people with Type 1 diabetes, we designed and evaluated an education programme for 
people with Type 1 diabetes and assessed its effects on glycaemic control, body 
weight, cardiovascular risk and quality of life. 
6.5. Structured education for people with Type 1 diabetes - the InSight 
programme 
6.5.1. Introduction 
The day to day responsibility for diabetes control lies with the individual with Type I 
diabetes, but without appropriate education and support from the healthcare team, self 
management can be challenging. Education is fundamental to enable the person with 
diabetes to acquire the relevant knowledge and skills to be successful in managing 
independently. 
The Diabetes Control and Complications Trial demonstrated the benefits of intensive 
glucose control in reducing long term complications (DCCT study group 1993), but 
was associated with significantly increased rates of hypo glycaemia and higher body 
weight, which in tum increased cardiovascular risk (DCCr study group 1988). To 
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facilitate improved glycaemic control in routine clinical practice without these 
undesirable side-effects, there is a need for self-management educational 
interventions. The aim is to improve self-management skills by providing knowledge 
and improving skills relating to carbohydrate assessment, insulin adjustment, and 
management of physical activity, illness and hypoglycaemia. 
Structured education has been recognised as a fundamental aspect of supporting 
people with diabetes. National policy in the UK now reflects this importance and 
education requirements are documented within the NSF for diabetes (Department of 
Health 2003) and specific NICE guidance (NICE 2003). There is an increasing core of 
evidence that structured education can improve both psychosocial and clinical 
outcomes, through developing self management skills. 
The development of structured education in the UK was initiated with the DAFNE 
trial (DAFNE study group 2002) based on the Dusseldorf model (Muhlhauser, 
Bruckner et al. 1987). Although DAFNE provided the template for skills training for 
people with Type 1 diabetes in the UK, initially there were significant resource issues 
and many routine diabetes clinics had financial restrictions preventing its application. 
The challenge was to develop a programme within existing resources that could be 
integrated into routine clinical service. Other clinical diabetes teams were also 
developing programmes and in order to share good practice, evaluate outcomes and 
ensure quality processes, the Type 1 education network, now known as the Diabetes 
Education Network (www.diabetes-education.net). was founded. 
The InSight programme was developed in Oxford and is a skills-based programme 
addressing carbohydrate assessment, insulin adjustment and self-care management of 
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hypo glycaemia, exercise and illness. Evaluation of the Insight programme IS 
presented as an observational study assessing education in routine clinical care. 
6.5.2. Aims and objectives 
The aims of the InSight programme are for participants to develop skills and 
techniques to enable them to understand the effects of lifestyle on their diabetes and 
vice versa, and how they can manipulate their treatment to enable them to lead the 
lifestyle of their choice and improve glycaemic control. 
6.5.3. Methods 
A full description of the methods is provided in Chapter 2. Briefly, this study received 
Chairman's approval from the local ethics committee and was designed to facilitate 
skills for matching insulin to carbohydrate intake based upon reflection from self-
monitoring diaries and to support self-management of hypoglycaemia, 
hyperglycaemia, illness and exercise. 
6.5.4. Results 
Baseline characteristics of the 51 InSight subjects who completed the education 
programme are shown in Table 6.4. One year data are presented for 48 (94%) of the 
subjects. Changes in A1c, weight and lipid levels at six and twelve months follow-up 
are shown in Table 6.5. PAID and hypoglycaemia questionnaires were fully 
completed by all 51 (100%) of the subjects at baseline, 46 (90.1 %) at six months and 
45 (88.2%) at one year. Changes in diabetes distress measured by PAID and changes 
in rates and severity of hypo glycaemia are shown in Table 6.6. 
Glycaemic control, assessed by Alc showed a significant improvement at six months 
(-0.4%, p=<0.006) and this was maintained at twelve months follow-up (-0.3%, 
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p=0.03). There were no changes in other biometric measurements including body 
weight, BMI and lipid levels. There was a highly significant reduction in diabetes 
related distress by six months measured by PAID (mean score 33% v 25%) and this 
positive effect was maintained at one year. This reduction in scores was significant at 
six months and one year compared to baseline (p=<0.01 and p=0.019 respectively). In 
addition, there was a significant reduction in the number of subjects reporting both 
moderate and severe hypoglycaemic events and an improvement in awareness of 
hypo glycaemia. 
Table 6.4 Baseline characteristics of 51 InSight subjects 
Variable 
Number 
% Male 
Age (years) 
Diabetes duration (years) 
Ale (%) 
Body weight (kg) 
BMI(kg/m2) 
Total cholesterol (mmol/I) 
HDL cholesterol (mmol/l) 
Triglycerides (mmoVI) 
LDL cholesterol (mmoVI) 
PAID score (%) 
Hypoglycaemia 
% reporting 1 or more episodes of severe 
hypogJyeaemia in the past year 
% reporting 1 or more episodes of moderate 
hypoglycaemia in the six months 
% reporting hypoglycaemic unawareness 
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Subjects 
Mean (SD) 
51 
34 
42.5 (11.3) 
21.0 (13.5) 
8.5 (1.4) 
76.4 (12.9) 
26.2 (3.8) 
4.6 (0.8) 
1.7 (0.5) 
0.9 (0.8) 
2.5 (0.6) 
33.7 (16.9) 
21.5 
41.2 
37.2 
Table 6.5. Changes in biomedical variables in InSight subjects at six and twelve 
months follow-up. 
Variable Change p-value Change p-value 
at6m at 12m 
Ale (%) -0.4 0.006 -0.3 0.028 
Body weight (kg) -0.3 0.292 0.2 0.708 
BMI (kglm2) -0.1 0.501 0.1 0.638 
Total cholesterol (mmolll) -0.03 0.679 0.04 0.757 
HDL cholesterol (mmolll) -0.04 0.126 -0.05 0.094 
Triglycerides (mmolll) 0.01 0.786 -0.12 0.136 
LDL cholesterol (mmolll) 0.0 0.926 0.11 0.196 
Table 6.6. Changes in PAID scores and rates of hypoglycaemia in InSight 
subjects at six and twelve months follow-up. 
Variable Change p-value Change p-value 
at6m at 12m 
PAID score (%) -8.2 <0.01 -7.3 0.019 
% reporting 1 or more episodes of -13.0 <0.01 -13.3 <0.01 
severe hypo glycaemia in the past 
year 
% reporting 1 or more episodes of -15.3 <0.01 -15.5 <0.01 
moderate hypoglycaemia in the six 
months 
% reporting hypoglycaemic -21.7 <0.001 -24.5 <0.001 
unawareness 
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6.5.5. Discussion 
6.5.5.1. Glycaemic control 
This study showed a significant improvement in glycaemic control in subjects who 
attended a structured education course incorporating carbohydrate counting and 
insulin adjustment. At twelve month's follow up Alc levels had decreased by 0.3% to 
8.2%, and although this may be statistically significant, there remain some questions 
about the clinical significance of this improvement in glycaemic control. Diabetes UK 
and the American Diabetes Association have both recommended target A I c levels of 
<7.0% for people with diabetes, with some authorities recommending lower levels of 
6.5% (Rodbard, Blonde et al. 2007). In this context, Alc levels of 8.2% may be 
considered unsatisfactory. In comparison DAFNE. the best-known randomised, 
controlled trial of this approach to structured education, showed a significant 
reduction in Alc of 1% over six months (DAFNE study group 2002). However, only 
subjects with an Alc >7.5% were included in the study and the mean Alc at entry 
was 9.4%. This is higher than that of the InSight participants whose mean Alc was 
8.5% at baseline. The Alc end-point of DAFNE was equivalent to the starting point 
of InSight. This may suggest that there is greater glycaemic benefit for those with a 
higher Ale at entry to the programme. A sub-analysis of the InSight data, using an 
arbitary cut-off of 7.5% showed that 12 individuals (24%) with Alc levels below 
7.5% at baseline showed an increase in Alc at one year (6.8 v 7.0%, p=0.2). 
Conversely, 36 subjects with Alc levels above 7.5% showed a larger reduction in Alc 
at one year compared to the full cohort (9.0 v 8.5%, p=0.003). In addition, DAFNE 
have reported one year follow-up data from use in routine clinical practice and these 
data show a reduction in Alc from 8.5% to 8.2% (Lawrence, Hopkins et al. 2008). 
Although this reduction was statistically significant, it does not match the magnitude 
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of reduction reported in the trial data and is comparable to the results from the InSight 
trial. 
6.5.5.2. Medication 
All InSight subjects had optimised prandial basal insulin regimens with analog 
insulins before entry to the study and continued with this during the study period. This 
is in contrast to both DAFNE and published data from Germany (Muhlhauser, 
Bruckner et al. 1987) where changes in insulin regimen, especially changes from 
twice daily biphasic insulin regimens to basal prandial regimens were common place. 
Any recorded effect of InSight was due solely to the education intervention. 
6.5.5.3. Diabetes related distress 
In common with other clinical programmes, the InSight programme showed 
significantly positive effects on well-being. PAID was used as a marker of diabetes 
distress and there were significant improvements at six months which were 
maintained at one year follow-up. 
6.5.5.4. Hypoglycaemia 
Improvements in glycaemic control in people with Type I diabetes and are associated 
with increased hypo glycaemia. The DCCT reported that hypoglycaemia was more 
common in the intensively treated group (DCCT study group 1997). People with Type 
1 diabetes report that hypoglycaemia is one of their greatest fears (Davies 2004), and 
avoidance of hypoglycaemia plays a large part in decision-making about treatment 
and targets for blood glucose levels (Davis and Alonso 2004). The InSight 
programme successfully reduced both Ale and hypoglycaemia. There were 
significant reductions in rates of both moderate and severe hypoglyeaemia and an 
increase in awareness of the symptoms of hypoglyeaemia. 
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6.5.6. Summary 
The introduction of the InSight programme has shown that it is feasible to integrate a 
local structured education programme, which meets the current Department of Health 
guidelines, into routine clinical practice. This programme has shown a significant 
improvement in glycaemic control, diabetes related distress and hypoglycaemia 
without compromising general health or increasing body weight, supporting the 
theory that more flexibility in both educational approaches and carbohydrate 
manipulation may improve outcomes in people with Type 1 diabetes. 
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Chapter 7 
Overall conclusions and recommendations for further work 
7.0 Conclusions 
Lifestyle education, especially dietary advice, has been shown to have a positive 
impact on the treatment of diabetes. There are two components to dietary education, 
the content of any education programme and the method of delivery of that 
programme. Both these aspects have been addressed in this thesis, with the aim of 
improving the provision and quality of education available for people with diabetes. 
The content of education programmes, and especially dietary education, has been 
traditionally dictated by a consensus of expert opinion, rather than relying upon 
evidence from randomised controlled trials. It is now generally agreed that evidence-
based recommendations for treatment of all diseases, including diabetes, should be 
adopted as the gold standard. However, the assessment of dietary interventions for 
people with diabetes has proved challenging as randomised trials that take place in 
free-living populations cannot be blinded, and may lead to issues with contamination 
between intervention and control groups and with concordance and compliance. In 
addition, many studies have involved small numbers of subjects, lacked a control 
group, have high attrition rates, short follow-up periods and shown relatively small 
changes in end-points. The impact this has for people with diabetes is that there is 
little hard evidence for most dietary components of education programmes, and in 
addition, adopting the recommendations to eat a low fat, high carbohydrate diet may 
not necessarily lead to the desired improvements in blood glucose levels or weight 
loss. 
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The emphasis of dietary advice for people with diabetes over the past twenty years 
has been aiming to reduce the risk of chronic disease, especially cardiovascular 
disease, by reducing total and saturated fat intake and obtaining the majority of energy 
from carbohydrate. This strategy may have an adverse affect upon glycaemic control 
as carbohydrate foods have been shown to increase blood glucose levels after eating, 
and large amounts of carbohydrate are associated with postprandial hyperglycaemia. 
There may be more effective dietary approaches which reduce the glycaemic load and 
this may be achieved by adopting a diet of low glycaemic index, reducing total 
carbohydrate intake or both. This thesis aimed to show that reducing the glycaemic 
load by adopting a low carbohydrate diet would be effective for the treatment of Type 
2 diabetes. A review of the available evidence showed that there was limited evidence 
for low carbohydrate diets in the treatment of Type 2 diabetes and Study 1 was 
designed as a randomised controlled trial to evaluate the effect of a low carbohydrate 
diet on glycaemic control and body weight. This study showed that weight loss was 
significantly greater in the low carbohydrate group and although there were no 
significant differences between the control group and the intervention group, 
glycaemic control improved with weight loss. The assumption that low carbohydrate 
diets are less healthy than conventional diets as they are higher in fat and protein was 
also disproved, as was the commonly held belief that low carbohydrate diets increase 
cardiovascular risk. This study showed for the first time that low carbohydrate diets 
are as effective in people with Type 2 diabetes as in people without diabetes, they 
induce significantly greater weight loss than conventional low fat diets and do not 
increase cardiovascular risk. These results suggest that low carbohydrate diets may be 
of benefit to people with Type 2 diabetes who are overweight or obese. The 
limitations of this study were that it included small numbers and was a short-term 
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study with three months, follow-up. There is no evidence that low carbohydrate diets 
are safe and effective over the longer term, and weight loss, glycaemic control, 
cardiovascular risk and adherence may be of issue in the longer term. Further studies 
in people with diabetes using low carbohydrate interventions over the longer term 
may show benefits in both glycaemic control and body weight, and elucidate the 
safety and efficacy of these diets. 
The process of delivery of education can also affect outcomes in people with diabetes. 
The traditional medical model is widely used to deliver lifestyle education to people 
with diabetes, with few studies investigating the efficacy and safety of education. 
Education is seen as a cornerstone to self-management for people with diabetes, yet 
there are few studies investigating and evaluating the effect of education for people 
with diabetes. Individual consultations, with the health professional seen as the expert, 
is the most widely adopted model of education delivery, especially in primary care, 
despite the fact that there is emerging evidence that structured education programmes 
delivered in groups can improve outcomes in people with diabetes. 
A review of education programmes for people with diabetes was performed and 
showed that, although education has been shown to be effective for the treatment of 
diabetes, there was little evidence to support alternative methods of education, largely 
because of lack of evaluation of different strategies. In practical terms, application of 
the structured education programmes delivered in research studies in routine clinical 
care requires resources well beyond that of the majority of health care systems. This 
suggests that there is a role for other methods of education delivery within clinical 
practice and this should be subject to evaluation. Innovative education programmes 
using alternative approaches, for example video education, have not been evaluated 
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in clinical practice and Study 2 was designed as a randomised controlled trial to assess 
a novel education programme delivered by video for people newly diagnosed with 
Type 2 diabetes in primary care. At six months follow-up, there was a significant 
increase in knowledge in the intervention group receiving the video and although 
there were significant improvements in glycaemic control, lipid levels and physical 
activity in the intervention group and no significant change in the control group, these 
failed to reach significance between groups. This study showed for the first time that 
education delivered by video improved knowledge in people with diabetes and had a 
positive impact upon health. The major limitations of this study are the small numbers 
recruited, the lack of effect compared to the control group and that follow-up lasted 
only six months. In terms of chronic conditions such as diabetes, it may be that the 
benefits of education are apparent over the longer term and that this type of education 
may be useful in primary care. However, it is worth noting that videos are fast 
becoming out-dated, and it may be of more benefit to explore the use of interactive, 
web-based education programmes and social networking sites to deliver diabetes 
education. 
The theme of investigating alternative methods of education and examining the role of 
carbohydrate in the diet of people with diabetes was continued in the third study, 
which examined group education with an emphasis on peer support and including 
carbohydrate counting and insulin adjustment in people with Type 1 diabetes. 
Traditionally, people with Type 1 diabetes have been advised to monitor and regulate 
their carbohydrate intake to a prescribed insulin dose, resulting in lack of flexibility 
with associated effects upon quality of life and issues with adherence. Previous 
studies applying this traditional but inflexible approach have shown significant 
improvements in glycaemic control, but accompanied by increased hypoglycaemia, 
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weight gain and increased cardiovascular risk. Study 3 applied carbohydrate counting 
and insulin adjustment in routine clinical practice and showed significant 
improvements in glycaemic control, diabetes related distress and hypoglycaemia rates 
in people with Type 1 diabetes without associated weight gain or any other adverse 
effects including any dietary restriction. These findings suggest that more flexibility 
in educational programmes, carbohydrate intake and insulin doses can improve 
outcomes for people with Type 1 diabetes. The limitations of this study were that 
follow-up was relatively short-term over one year, and that the lack of a control group 
prevented any firm conclusions being drawn from this intervention. 
Although there remams little firm evidence about the most effective lifestyle 
interventions to improve management of diabetes and its associated risk factors, this 
thesis has shown that flexibility in carbohydrate intake may improve glycaemic 
control and some risk factors in people with both Type 1 and Type 2 diabetes. In 
addition, more innovative methods of delivering education including video education 
and group-based education sessions can improve outcomes when compared to the 
traditional medical model. The results from the three studies making up this thesis 
suggest that there should be more flexibility in the dietary management of diabetes, 
both in terms of carbohydrate intake and educational strategies. Diabetes UK, the 
charity for people with diabetes, has published nutritional guidelines for diabetes and 
these recommend that people with diabetes should adopt a relatively high 
carbohydrate diet. This thesis challenges that view and would propose that overweight 
and obese people with Type 2 diabetes who are aiming to lose weight may benefit 
from reducing carbohydrate intake and that people with Type 1 diabetes can be more 
flexible in their carbohydrate intake if adjusting insulin to intake. In addition, the 
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traditional medical model of diabetes education can be improved by adopting more 
innovative approaches including delivering education by video and utilising peer 
support in group education. 
7.1. Further studies 
• Investigate the potential effects of reduced carbohydrate diets in people with 
Type I diabetes with special reference to glycaemic control, body weight, risk 
of complications, insulin dose and quality of life 
• Determine the effects of diets of low glycaemic load, whether low 
carbohydrate or of low glycaemic index, on glycaemic control and 
cardiovascular risk in people with both Type I and Type 2 diabetes 
• Assess the optimum amount of dietary carbohydrate for health in people with 
diabetes 
• Explore the application of web-based interactive education for people with 
Type I and Type 2 diabetes 
• Examine the application of video-based diabetes education for people of 
different ethnic origins 
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Ms Pamela Dyson 
Research Dietitian 
OCDEM 
Churchill Hospital 
Oxford OX3 7LJ 
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Dear Ms Dyson-
Oxford Clinical Research Ethics Committee 
Room 13, Manor House 
The John Radcliffe Hospital 
Headley Way 
Headington 
Oxford OX3 9DZ 
Tel: 01865 222548 
Fax: 01865 222699 
23 June 2004 
Re: OxREC 04/Q1606/39 - Low Carbohydrate Ketogenic Diet Study 
Thank you for your letter of June 1st 2004 enclosing copies of the 
documentation for the above study. The Committee met on Friday 18th June 
and after discussion at this meeting, the Committee agreed approval of this 
study. 
In accordance with the authority set out in the Terms of Reference, I am 
happy to confirm ethical approval and wish you every success with this study. 
Please note: 
• Ethical approval is valid for three years, subject to submission of a 
yearly progress report (a reminder letter will be sent when this is due). 
• No changes to the research protocol should be made' without 
appropriate research ethics approval. Any deviations from or changes 
to the protocol which increase the risk to subjects, or affect the conduct 
of the research, or are made to eliminate hazards to the research 
subjects should be made to OxREC. 
• OxREC should be made aware of any serious adverse events. 
Please ensure that a copy of any publication arising from this study is sent to 
OxREC. 
Yours sincerely 
---
Dr Brian Shine 
Chairman 
Oxfordshire Research Ethics Committee A 
BS/JW/C03.097 
Miss Susan Beatty 
Research Nurse 
OCDEM 
Churchill Hospital 
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OX37LJ 
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Dear .Miss- Beatty 
Oxfordshlre Clinical Research Ethics Committee 
Room 13, Manor House 
The John Radcliffe Hospital 
Headley Way 
Headington 
Oxford 
OX39DZ 
Tel: 01865 222548 
Fax: 01865 222699 
Email: joanne.westhead@orh.nhs.uk 
20 January 2004 
Re: C03.097 - Oxford Healthy Living for Type 2 Diabetes - A Media Based Learning 
Programme. Protocol Version 1.2 
Thank you for attending the meeting on Friday 9th January 2004 to discuss the above named study, 
addressing the concerns raised by the Committee at their meeting on 5th December 2003. After 
discussion at the meeting on 9th January and the Committee expressed the following views: 
1. The power of the trial was discussed and because of the nature of the study, large numbers of 
patients are required. The study might produce a negative conclusion if the trial numbers were too 
small. 
2. The video would enable patients to review information in their own home and in their own time. The 
videos captures the essence of what the Dietician would say in person. The aim Is that the patients 
can either meet with the Dietician or take a video home. 
3. It was decided that the upper age limit of 75 years was to be removed. 
4. The matter of telephoning patients was explained, highlighting that it was simply to keep track of 
the videos that have been distributed and the call would only last 30 seconds. It was confirmed that 
the patient would not be asked for any further information. 
S. The matter of creating the videos was discussed. The study needs funding to make the videos and 
they need ethical approval before they are able to get the funding. 
In accordance with the authority set out in the Terms of Reference, I am happy to confirm ethical 
approval and wish you every success with the study. 
Please note: 
• Ethical approval is valid for three years, subject to the submission of a yearly progress report (a 
reminder letter will be sent when this Is due). 
• No changes to the research protocol should be made without appropriate research ethics 
committee/chairman's approval. Any deviations from or changes to the protocol which increase the 
risk to subjects, or affect the conduct of the research, or are made to eliminate hazards to the 
research subjects, should be made known to OxA. 
• OxA should be made aware of any serious adverse events. 
An advisory committee to Thames VaHey Strategic Health Authority 
• Whilst the study has received approval on ethical grounds, it is necessary for you to obtain 
management approval from the relevant Clinical Directors and/or Chief Executive of the Trusts (or 
Health BoardslStHAs) in which the work will be done. 
I should be very grateful if you could send me a copy of any publication which may arise from this 
study. 
The committee would also need to see a copy of the video before It Is given to patients. Once 
the video has been made, a copy should be forwarded to the committee for review. 
Yours sincerely, 
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An advisory committee to Thames Valley Strategic Health Authority 
Oxford Radcliffe Hospitals r,'I:k1 
JM/JS/C03.097 
Professor David Matthews 
OCDEM 
Churchill Hospital 
Old Road 
Headington 
Oxford 0X3 7LJ 
Dear Professor Matthews 
-......----
NHS Trust 
From the Medical Director 
Dr James Morris, FRCPath 
clo R&D Office, Manor House 
The John Radcliffe Hospital 
Headley Way, Headington 
Oxford OX3 9DZ 
Tel: (01865) 222672 
Fax: (01865) 222699 
Email: julie.sha.nkland@orh.nhs.uk 
28 October 2003 
. --~ .. --.--'.- --_ .. -.",. 
Re: C03.097 Oxford Healthy Living for Type 2 Diabetes - A media based learning programme 
I can confirm that the Oxford Radcliffe Hospitals NHS Trust will provide indemnity for the 
above study, as described in your application to the Research Ethics Committee. This 
confirmation is dependent on the formal approval of the Research Ethics Committee and on 
the understanding that you have a contract of employment with this Trust. 
I wish you every success with the study . 
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CC Joanne Westhead, Ethics Administrator 
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The Oxford Centre 
for Diabetes, Endocrinology and Metabolism 
OxREC no: 04/Q1606/39 
Version 2. 
May 2004 
Low Carbohydrate Ketogenic Diet Study 
Patient Information Sheet 
Churchill Hospital 
Headington 
Oxford OX3 7LJ 
Tel: 01865857333 
Fax: 01865857311 
You are being invited to take part in a research study. Before you decide, it is important 
for you to understand why the research is being done and what it will involve. Please 
take time to read the following information carefully and ask us if there is anything that is 
not clear or if you would like more information. Take time to decide whether or not you 
wish to take part. Thank you for reading this. 
Q. What Is this study about? 
A. The aim of this 12-week study is to examine the effects of a very low carbohydrate 
diet in people who do and do not have diabetes. 
It is designed to measure the amount of weight lost and level of ketones in the blood 
while on this type of diet. In order to do this we will investigate ketone levels in two 
groups of people; one group maintaining a standard healthy eating weight reducing diet 
and one group following a low carbohydrate diet 
Q. What are ketones? 
A. When eating a normal diet the body digests the carbohydrate we eat and it turns into 
glucose that provides us with energy. When following a low carbohydrate diet the body 
uses our stores of fat instead of glucose and ketones are produced as a result of the 
breakdown of this fat. 
Q. What Is meant by a low carbohydrate diet? 
A. This type of diet is one where you would eat a very small amount of carbohydrate 
each day. This means that you would restrict the amount of starchy and sugary foods 
such as cake, sweets, biscuits bread, potatoes; but you are able to eat most other types 
of food. We will give you an opportunity to discuss the diet in full and give you a leaflet 
outlining the diet when you come for your first visit. 
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Q. What is a standard healthy weight reducing diet? 
A. This type of diet concentrates on reducing the amount of fatty and sugary foods eaten 
and increasing the amount of fruit and vegetables. You will be given specific advice 
about the quantity of food you need to eat. 
Q. Why have I been chosen? 
A. You may have said in the past that you are interested in helping with our research or 
you may have been approached by your doctor or dietician and have expressed a wish 
to take part. 
Q. Do I have to take part? 
A. It is up to you to decide whether or not to take part. If you do decide to take part you 
would be given this information sheet to keep and be asked to sign a consent form. If 
you do decide to take part, you are still free to withdraw at any time and without giving 
any reason. This would not affect the standard of medical care you receive. 
Q. What will happen to me If I take part? 
A. This is a short study over 12 weeks and would mean 5 visits in total to the Oxford 
Diabetes Centre at the Churchill Hospital 
• The first visit, which would last about 2 hours, would be to discuss the study, and 
if you agree to participate you would be asked to sign a consent form. We will do 
a short test called a glucose tolerance test. This involves giving you a glucose 
drink and measuring your blood glucose levels four times over the next two 
hours. We would also record some baseline measurements such as height and 
weight and take a blood sample. We will also ask you to complete 2 
questionnaires. 
• The next visit would be to allocate (randomise) you into one of two groups, one 
following a low carbohydrate diet and the other following a standard healthy 
eating weight reducing diet. The diet will be fully explained to you and you will 
have the opportunity to discuss this with the dietician. 
We randomise people into different groups because sometimes we do not know 
which way of treating patients is best and this allows us to make comparisons. 
The groups are selected by a computer, which has no information about the 
individual so it works by chance. Patients in each group then have a different 
diet and the effects of these are compared. 
• You will be contacted by telephone once a week by the research nurse to offer 
support and to monitor your blood glucose and ketone levels. 
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• The next two visits would take about % hour. During these visits we will record 
your weight, record your blood pressure and take a small blood sample. You will 
also have the opportunity to discuss any queries you have about the study at this 
time. 
• The final visit will take about 2 hours. We will again record your weight, record 
your blood pressure, take a small blood sample, repeat the glucose tolerance 
test and complete 2 questionnaires. If you have been allocated to the group that 
have maintained their normal diet, you will have the opportunity to discuss the 
low carbohydrate diet in more detail and be offered support if you wish to try the 
diet. 
Q. What do I have to do during the study? 
A. The study lasts for 12 weeks, during which we would expect you to maintain the diet 
you have been allocated. We would also ask that you complete a food diary for 3 days 
four times during the study and that you monitor your own blood glucose and ketone 
levels up to four times a day, in the early stages of the study although this will be 
reduced after the first week. 
Q. How do I measure my own blood ketone and glucose levels? 
A. We would also ask you to monitor your own blood ketone and glucose levels using a 
small meter. This would mean that you would use a finger-pricking device to get a small 
drop of blood that you place on a special strip that the meter can read. When you come 
for your first visit we will show you the meter and how to use it. 
Q. What would happen to the blood samples taken during the study? 
A. Some of the blood samples will be sent to the laboratory at the John Radcliffe 
Hospital for analysis. These samples will have your name on them and be destroyed 
immediately. A small part of the blood sample will be sent to the laboratories at the 
Diabetes Centre. These samples will only be identified by a number and will be stored 
for up to one year following completion of the study. These samples may be tested for 
two hormones (insulin and c-peptide) as part of other studies, however it is important to 
note that these samples will not have your name on them. 
Q. Are there any side effects of the diets used In the study? 
A. There have been some mild side effects reported when following a low carbohydrate 
diet, usually headaches, constipation and lethargy. If this happens to you, you will be 
given advice to reduce these side effects. 
Q. What are the advantages of taking part In the study? 
A. Both of these diets have been shown to be an effective way to lose weight. During 
the study you may have the opportunity to try the low carbohydrate diet under close 
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supervision and have weekly contact with a nurse or dietician to discuss any aspect of 
the diet. If you are asked to follow the healthy eating diet, you will be given the 
opportunity to try the low carbohydrate diet at the end of the study if you wish. 
Q. What are the disadvantages of taking part in the study? 
A. You will be asked to visit the Oxford Diabetes Centre five times and asked to give a 
small blood samples during the study. You will also be asked to use a finger-pricking 
device to enable you to monitor your own blood glucose and ketone levels on a regular 
basis. You may have some of the mild side effects we have described. 
Q. Is my GP informed that I am taking part in the study? 
A. Yes, if you agree, your GP will be informed by letter once you agree to take part in 
the study 
Q. What happens if I do not want to continue in the study? 
A. You can withdraw from the study at any time, without giving any reason and without 
your medical care or legal rights being affected in any way. 
Q. Would I be paid for taking part In the study? 
A. You will not be paid for taking part in the study, however all travelling expenses will 
be refunded. 
Q. What if new Information becomes available? 
A. Sometimes during the course of a research project, new information becomes 
available about the diets that are being studied. If this happens the research doctor will 
tell you about it and discuss with you whether you want to continue in the study. If you 
decide to withdraw your medical care will not be affected in any way, and if you decide to 
continue in the study you will be asked to sign an updated consent form. 
Q. What if something goes wrong? 
A. Indemnity for the study is provided by the Oxford Radcliffe Hospitals NHS Trust. 
There are also established procedures if you wish to make a complaint at any time and 
normal NHS complaints mechanisms are available to you. 
Q. Would my taking part In this study be kept confidential? 
A. All information that is collected about you during the course of the study would be 
kept strictly confidential. All information will be stored under the guidelines of the Data 
Protection Act 1999, and under University of Oxford Data Protection Policy. 
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Q. What will happen to the results of the research study? 
A. The results will be published in a professional journal and sent for display to 
professional meetings. You will not be identified in any way in any publication that arises 
as a result of this study. You will also be informed by letter of the results of the study. 
Q. Who is organising and funding the research? 
A. The research is organised by a team at the Oxford Centre for Diabetes, 
Endocrinology and Metabolism, Churchill Hospital, Oxford and is funded by a grant from 
Abbott Laboratories (Medisense) UK. 
Q. Who can I talk to about taking part in the study? 
A. You can contact Sue Beatty, Research Nurse at the Oxford Centre for Diabetes, 
Endocrinology and Metabolism. Telephone 01865 857333 
Thank you 
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The Oxford Centre 
for Diabetes, Endocrinology and Metabolism 
OxREC no: C03.097 
December 2004 
Version 1.5 
HEALTHY LIVING STUDY 
A MEDIA BASED LEARNING PROGRAMME 
PATIENT INFORMATION SHEET 
You are being Invited to take part In a research study. Before you decide It Is 
Important for you to understand why the research Is being done and what It will 
Involve. Please take the time to read the following Information carefully and ask 
us If there is anything that Is not clear or If you would like more Information. Take 
time to decide whether or not you wish to take part. Thank you for reading this 
Q. What Is this study about? 
A. We are developing a home-based education programme for people with type 2 
diabetes. We have produced 3 videos, each lasting 10 minutes, covering different 
aspects of diabetes that you could watch at home. This will address issues such as: 
What should I eat?' Physical activity and fitness', and 'Weight Management'. We are 
interested in what you think about this way of giving people information and whether it 
has any effect on the way you manage your diabetes. 
Q. How long Is the study? 
A. Your participation in the study will be for 6 months although the study itself will 
last for 2 years. 
Q. Do I have to take part? 
A. It is up to you to decide whether or not to take part. If you do decide to take part 
you would be given this information sheet to keep and be asked to sign a consent form. 
If you decide to take part, you are still free to withdraw at any time and without giving any 
reason. This would not affect the standard of care you receive. 
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Q. How often do I have to come to the hospital? 
A. Once you have agreed to take part in the study, we would ask that you visit the 
Oxford Diabetes Centre twice in a period of six months. We may be able to arrange to 
visit you at your local surgery. 
Q. What will I have to do during the study? 
A. The main part of the study involves you watching the videos mentioned above. 
We would also ask that you keep a food diary for 3 days and monitor your levels of 
physical activity using a pedometer (a small thing that you wear which counts the steps 
you take) at the beginning and end of the study. We would also ask you to complete 
questionnaires that will indicate your knowledge of diabetes, your quality of life and 
evaluation of the videos. 
Q. What will happen at each study visit? 
A. You will have the opportunity to discuss the study and we will record weight and 
blood pressure and take a small blood sample. This sample will allow us to measure 
and monitor any changes in your blood sugar and cholesterol levels. These samples will 
be destroyed at the end of the study and will not be used for any other purposes. 
Q. Would my medical notes need to be looked at? 
A. We would only access your medical notes if you give permission to do so and your 
notes will only be accessed by health professionals. We may need to look at your notes 
to clarify information and to document any relevant medical history. 
Q. Would my taking part In the study be kept confidential? 
A. All information that is collected about you during the course of the study would be 
kept strictly confidential. All information will be stored under the guidelines of the Data 
Protection Act 1999. 
Q. What happens if I do not want to continue In the study? 
A. You can withdraw from the study at any time, without giving any reason and without 
your medical care or legal rights being affected in any way. 
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Q. What are the advantages of the study? 
A. The videos will give you an opportunity to find out more about diabetes and give 
you some advice about managing life with diabetes. You will also have contact with a 
specialist research nurse. 
Q. What are the disadvantages of the study? 
A. You may need to come to the Oxford Diabetes Centre twice in 6 months and you will 
have to give a small blood sample at each visit. 
Q. Will I be paid for taking part? 
A. You will not be paid for taking part. However, all travel expenses will be refunded. 
Q. What if something goes wrong? 
A. Indemnity for the study is provided by the Oxford Radcliffe Hospitals NHS Trust. 
There are also established procedures if you wish to make a complaint at any time 
normal NHS complaints mechanisms are available to you. 
Q. Who can I speak to about taking part in the study? 
A. You can contact Sue Beatty, Research Nurse at the Oxford Centre for Diabetes, 
Endocrinology and Metabolism. Telephone 01865 857333 
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Pf1 The Oxford Centre 
'trI for Diabetes, Endocrinology and Metabolism 
OxREC no: 04/Q1606/39 
Version 2 
July2004 
CONSENT FORM 
Churchill Hospital 
Headington 
Oxford OX3 7LJ 
Tel: 01865 857333 
Fax: 01865 857311 
Title of Project: Low Carbohydrate Ketogenic Diet Study 
Name of Researcher: Professor D Matthews 
1. I confirm that I have read and understand the information sheet 
Dated July 2004,(version 3) for the above study and have 
had the opportunity to ask questions. 
2. I understand that my participation is voluntary and that I am free 
to withdraw at any time, without giving any reason, without my 
medical care or legal rights being affected. 
3. I understand that sections of any of my medical notes may be 
looked at by responsible individuals from the Oxford Diabetes 
Centre and I give permisSion for these individuals to have access 
to my records. 
4. I agree that part of the blood samples taken during the study will be 
stored, with full anonymity, for one year after the completion of the 
study. 
5. I agree that these blood samples may be used for further study 
after the samples are anonymised and it will not be possible to 
withdraw this consent in the future. 
Please Initial box 
D 
D 
D 
D 
6. I agree that my GP will be informed about my participation in the study. 
D 
D 
D 7. I agree to take part in the above study. 
Name of Patient 
Name of Person taking consent 
(if different from researcher) 
Researcher 
Signature 
Signature 
Signature 
1 for patient; 1 for researcher; 1 to be kept with hospital note 
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Date 
Date 
Date 
FrM The Oxford Centre 
\fI for Diabetes, Endocrinology and Metabolism 
Ox REC no: CO.097 
Version 1.4 
December 2004 
CONSENT FORM 
Title of Project: Oxford Healthy Living for Type 2 Diabetes 
A Media Based Learning Programme 
Name of Researcher: Professor 0 Matthews 
Churchill Hospital 
Headington 
Oxford OX3 7U 
Tel: 01865857333 
Fax: 01865857311 
Please Initial box 
7. I confirm that I have read and understand the information sheet 
dated December 2004,(version 1.5) for the above study and have 
had the opportunity to ask questions. 
8. I understand that my participation is voluntary and that I am free 
to withdraw at any time, without giving any reason, without my 
medical care or legal rights being affected. 
9. I understand that sections of any of my medical notes may be 
looked at by responsible individuals from the Oxford Diabetes 
Centre and I give permission for these individuals to have access 
to my records. 
4. I agree to take part in the above study. 
Name of Patient 
Name of Person taking consent 
(if different from researcher) 
Researcher 
Signature 
Signature 
Signature 
1 for patient; 1 for researcher; 1 to be kept with hospital notes 
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Date 
Date 
Date 
D 
D 
D 
D 
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GJ The Oxford Centre 
-.-,"- for Diabetes, Endocrinology and Metabolism 
LOW CARBOHYDRATE KETOGENIC DIET STUDY 
INFORMATION 
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Low Carbohydrate Diet 
Introduction 
This diet is high in protein (found in meat, fish, eggs, cheese) and very low in 
carbohydrate (starchy and sugary foods). This will make your body use its fat 
stores for energy and will help you to lose weight and to control your blood 
glucose levels. To make this diet work you will have to follow it very carefully. 
How will I know this diet is working? 
When you use your body's fat stores for energy your body produces 
substances known as ketones. You will learn how to measure the levels of 
ketones in your blood using a special meter. If you already measure your 
blood glucose levels, then you will be familiar with this process. 
What can I eat? 
You can include the following protein foods daily: 
Fresh, lean 
meat 
Processed 
meats 
Poultry 
Offal 
Game 
Fish 
Shellfish 
Eggs 
Cheese 
- beef, pork, lamb 
- lean bacon, gammon, ham, corned beef, brawn 
- chicken, turkey, duck, goose 
- liver, kidney, heart, oxtail, tongue, tripe 
- rabbit, hare, venison, wild boar, pheasant, partridge 
- white fish - cod, plaice, haddock, sole, coley 
oily fish - salmon, trout, tuna, sardines, mackerel 
- prawns, crab, shrimp, cockles, mussels 
- boiled, poached, scrambled, omelette 
- no more than 50g (20z) each day of hard cheese 
or 100g (4oz)cottage cheese 
Remember - some of these foods are very high in fat. To speed up weight 
loss and for general health you can reduce your fat intake by cutting all the 
visible fat off the meat that you eat, removing the skin from poultry and 
roasting, grilling, stewing or dry-frying rather than frying these foods. 
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Are there any foods I should avoid? 
This diet restricts carbohydrate foods to 40g each day. Carbohydrates are 
found in all starchy and sugary foods: 
Sugar, sweets, chocolate 
Jam, marmalade, honey, syrup 
Puddings, desserts, ice-cream 
Bread, biscuits (sweet and savoury), cakes, pastries 
Breakfast cereals, porridge 
Potatoes, pasta, noodles, rice 
Savoury snacks - crisps, twiglets, corn snacks, Bombay mix 
There are other foods that contain carbohydrate: 
Milk and yogurt 
Fruit and vegetables 
Try to avoid all starchy and sugary foods and take your daily portion of 
carbohydrate in the form of milk, fruit and vegetables. 
What about fat? 
Fat does not contain any carbohydrate but it is not good for your health to eat 
too much fat and it could slow down the rate of weight loss. Try to avoid too 
much of the following fatty foods: 
Butter and margarine 
Vegetable oils - blended oils, olive, sunflower, corn and rapeseed oil 
Cream 
Fried foods 
Is there a daily food plan I can use? 
Each day you should include the following foods and this will give you 40g of 
carbohydrate (CHO) daily. 
• 200ml (Y:Jpt) skimmed or semi-skimmed milk (enough for tea and coffee) 
or 150g (60z) natural or diet yogurt = 10g CHO 
• either 2 portions of fruit (20g CHO)and 2 portions vegetables (10g CHO) -
see lists below 
• or 1 portion of fruit (10g CHO)and 4 portions of vegetables (20g CHO)-
see lists below 
• At least 2 litres (4 pints) of fluid daily (see list) 
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Fruit 
1 portion of fruit will give 10g CHO. Choose your portion sizes from this list: 
100g (4oz) 
Apples 
150g (6oz) 200g (8oz) 400g (1Ib) 
Cherries 
Clementines 
Kiwi fruit 
Nectarines 
Oranges 
Paw-paw 
(papaya) 
Peaches 
Pears 
Pineapple 
Plums, damsons 
Satsumas 
Tangerines 
Apricots, fresh 
Blackcurrants 
Fruit cocktail -
canned in juice 
Grapefruit 
Passion fruit 
Strawberries 
Blackberries 
Guava 
Melon 
Raspberries 
Gooseberries 
Rhubarb 
The following fruit is high in carbohydrate and should be avoided: 
• bananas, grapes, Iychees, mangoes, 
• all dried fruit (currants, raisins, sultanas, prunes, figs, dates, apricots) 
• all fruit canned in syrup (check labels for fruit canned in juice) 
• glace cherries, mixed peel 
Vegetables 
1 portion of vegetables will give you 5g CHO. Choose your portion sizes from 
this list: 
100g (4oz) 200g (8oz) 400g (1Ib) 
Beansprouts 
Beetroot (pickled) 
Brussels Sprouts 
Cabbage (raw) 
Carrots (boiled) 
French beans 
Green beans 
Mangetout peas 
Onions(boiled, pickled) 
Runner beans 
Swede, turnip (raw) 
Tomatoes (raw, canned) 
Aubergine 
Baby corn 
Cabbage (boiled) 
Cauliflower (boiled) 
Chicory 
Courgette (boiled) 
Gherkin (pickled) 
Green pepper 
Leeks 
Marrow 
Okra 
Pumpkin 
Radish 
Spring onion 
Swede, turnip (boiled) 
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Asparagus 
Broccoli 
Celery 
Cucumber 
Curly kale (boiled) 
Fennel 
Gourd (karela) 
Lettuce 
Mushrooms 
Mustard and cress 
Spinach (boiled) 
Spring greens (boiled) 
Watercress 
The following vegetables are high in carbohydrate and should be avoided: 
• all starchy root vegetables - potatoes, parsnips, sweet potatoes, yams, 
beetroot (except pickled) 
• all types of peas and sweetcorn (except baby corn) 
• dried peas and beans - baked beans, lentils, kidney beans, butter beans, 
processed peas, chick peas 
• raw carrots, raw onion 
• mixed vegetables 
• red and yellow peppers 
Fluids 
Try to drink at least 2 litres (4 pints) fluid daily. Choose from these drinks 
• Water - tap water and bottled mineral water (still or sparkling) 
• Tea and coffee - use milk from allowance 
• Oxo, Bovril, Marmite, Vegemite 
• Diet fizzy drinks and squashes - check the label as some reduced sugar 
drinks still contain carbohydrate 
Meal suggestions 
Remember that you should eat no more than 40g CHO each day. 
Breakfast 
These meals all contain little or no carbohydrate (Og CHO): 
Eggs - boiled, poached or scrambled (cooked with milk from allowance) 
Bacon and egg 
Bacon, egg and mushrooms 
Grilled or poached kippers 
Smoked haddock and poached egg 
Grilled kidneys, bacon and mushrooms 
Cheese omelette 
Add 100g (40z) fresh or canned tomatoes to the above suggestions and the 
meals then contain 5g CHO 
Add a glass (125ml, 4fl oz) of unsweetened fruit juice and you add 10g CHO 
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Mid-day or evening meal 
Choose any lean meat, fish, game, offal or eggs - these provide Og CHO 
Each portion of vegetables you eat will add 5g CHO - see suggestions below: 
Cold meat eg ham, turkey, chicken, beef, pork with a large salad made from 
lettuce, cucumber, celery, watercress, mustard and cress (see vegetable lists 
list for portion sizes) 
Roast meat eg lamb, beef, pork, chicken, turkey or game with boiled or 
steamed vegetables - broccoli, cauliflower, courgettes, spinach, spring 
greens, cabbage or swede (see vegetables lists for portion sizes) 
Fish - any type steamed, grilled, fried, tinned (in either brine or oil, not tomato 
sauce) with salad or vegetables as above 
Omelette - cheese, ham or mushroom with salad and vegetables as above 
Each portion of fruit that you add provides 10g CHO 
To add some variety to your meals ask about the low carbohydrate recipe 
book. 
What about snacks between meals? 
You may take two or three weeks to get used to this diet. If you feel hungry 
between meals during this time then try the following as snacks: 
Cold meats - ham, beef, lamb, pork, chicken portions, hard boiled eggs, 
cheese, olives, handful of peanuts, celery sticks, cucumber sticks 
Can I drink alcohol? 
You do not need to avoid alcohol entirely but it is recommended that you 
avoid all alcohol containing carbohydrate and that you drink within healthy 
limits. Alcohol can be measured in units (1 unit = a small glass of dry wine or 
a pub measure of spirits), and it is recommended that men should have no 
more than 3 units a day and women no more than 2 units a day. You should 
also try to have at least 2 days each week without alcohol. 
These drinks contain carbohydrate and must be avoided - beer, lager, cider, 
sweet and medium wines, port, sherry, liqueurs and all types of alcopops. 
You may drink all types of spirits (gin, vodka, whisky, rum, brandy) with or 
without sugar-free mixers and dry red or white wines. 
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Can I eat manufactured or convenience foods? 
As long as you do not eat more than 40g of carbohydrate each day, you can 
include manufactured or convenience foods. Unfortunately. many of these 
foods contain large quantities of carbohydrate and you will not be able to 
include them in your diet. It is recommended that you always check the 
nutrition information on the label before you buy these foods. 
Some commonly asked questions about this low carbohydrate diet 
How quickly will I lose weight? 
During the first week you may find that you lose weight quite quickly and this 
is related to fluid loss, so you may notice that you pass more urine than 
normal. After this time you will find that you lose weight at the rate of about 
0.5 - 1.0kg (1-2Ib) per week. You may have times when weight loss is either 
faster or slower than this. 
Are there any side-effects? 
There are two main reported side-effects. First, you may feel light-headed or 
have headaches or palpitations for the first 7-10 days of this diet. Most people 
report that they feel better if they drink plenty of water during these first few 
days. If you have palpitations for the first time or if they get worse, you should 
see your doctor. 
Secondly. you may find that you have fewer bowel movements than before. 
On this diet, it is quite common to have only three bowel movements each 
week. You are not constipated unless you are straining to pass a motion. If 
you do think that you are constipated, you may find that drinking more fluid 
can help. Do not take laxatives unless they are recommended or prescribed 
by your doctor. 
What about my medication? 
You can continue with your usual medication. If you take insulin or tablets to 
treat diabetes. then you will be told how to change these to make sure your 
blood glucose stays at a safe level. 
Do I need to take any vitamin or mineral supplements? 
This diet may not give you all the vitamins or minerals that you need. You 
should take the supplements prescribed by the doctor to keep you healthy on 
this diet. 
My friend needs to lose weight - can I give her this diet? 
This diet has been prescribed for you by the doctor and should only be used 
under medical supervision. It is unsafe to give it to anyone else. 
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e The Oxford Centre 
\t1 for Diabetes, Endocrinology and Metabolism 
Churchill Hospital 
Headington 
Oxford OX3 7LJ 
Tel: 01865 857300 
Fax: 01865 857305 
Oxford Healthy Living Media-Based Learning Programme 
We are designing and evaluating videos to be used in education in people with type 2 
diabetes and would be very grateful if you could take a few minutes to complete this 
form. We are interested in what you think should be included in an education 
programme giving advice about lifestyle (food and physical activity). 
1. Please tick any of the following subjects that you think may be of importance 
and should be included in the education programme: 
Foods that affect blood glucose levels 
Foods that are related to heart disease 
Sugar 
Fruit and vegetables 
Fatty foods 
Saltyfoods 
Glycaemic index 
Alcohol 
Losing weight 
Physical activity (exercise) 
2. Please list below what you consider to be the 3 most important topics from 
the list above: 
3. Is there anything else that has not been mentioned that you think should be 
included in the video? 
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Food 
Title: So what can you eat? 
VO: Managing blood glucose levels effectively means getting the balance right with 
food, medication and physical activity. Food raises blood glucose level, but not all 
food has a similar effect. 
Title: Which foods have the most effect on blood glucose? 
VO: Foods which raise blood glucose are foods which contain carbohydrate. 
Carbohydrates are found in four groups of food. 
The first group is sugary foods, these food are rich in carbohydrate and will raise 
blood glucose quite quickly. They also often contain fat and calories, and large 
amounts can cause weight gain and high blood glucose levels. 
These foods do not need to be avoided entirely, and small amounts can be included. 
The second group is starchy foods. These foods contain vitamins and minerals and are 
a healthy source of carbohydrate. They should fonn the basis of the dietary 
carbohydrate and are found in all starchy foods; potatoes, bread, pasta rice and 
breakfast cereals. 
The third group is fruit and fruit juices. Fruit and vegetables are important for good 
health and at least five servings a day should be eaten, but large amounts of fruits will 
raise blood glucose levels. 
The fourth group is milk and yoghurt. 
Title: What about fat? 
VO: People with type 2 diabetes are at an increased risk of coronary heart disease and 
should be advised to reduce the amount of saturated or animal fat they eat, and use 
mono-saturated fat like olive oil, or rapeseed oil, or polyunsaturated fat like com or 
sunflower oil. 
Title: So what is a healthy diet for diabetes? 
A healthy diet should consist of, low fat foods, small amounts of saturated fat, like 
butter, cheese and fatty meat, and using more fish, poultry and lean meat. Substitute 
olive or com oil for lard or butter. 
Reduce sugar intake, use artificial sweeteners rather than sugar and include small 
amounts of sugary foods. 
Moderate amounts of starchy foods, remember they do have an effect on blood 
glucose levels, and large amounts will raise levels. 
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At least five servings of fruit and vegetables each day. Most green leafy vegetables 
and salads will have little effect on blood glucose, so these can be included freely. 
Physical Activity 
Title: Type 2 Diabetes I Physical Activity 
VO: Physical activity is important for general health and helps control blood glucose 
levels in people with diabetes 
Title: So how do you do it? 
VO: An easy way to start is to think of ways to increase your daily physical activity. 
You could try walking more, always use the stairs, or take up gardening. 
If you want to take up something more strenuous like jogging or aerobics then its best 
to start slowly and work up gradually. 
Title: Is it safe to start exercising? 
VO: If your going to increase your general daily physical activity then it is quite safe 
to do. If you want to do something more strenuous like going to the gym, jogging or 
aerobics, then it's best to check with your doctor first. You should always wear 
supportive footwear and never exercise if you feel unwell. 
If you're taking some medication for diabetes, and these drugs are called 
sulphonylureas, then you may find your blood glucose can go too low during exercise. 
If you think this is the case for you always keep some food or drink, like sports 
drinks, bananas or biscuits handy, so if your blood glucose levels go too low you can 
have something to eat or drink. 
Weight Management 
Title: What's the best way to lose weight? 
VO: The only way to lose weight successfully is to eat less but there is not just one 
way to achieve this. The best way to lose weight is the way that suits you and fits in 
with your lifestyle. Here are some strategies to think about. 
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First of all, you could try adopting a healthy diet. 
Another strategy is a calorie controlled diet. These diets do control the amount of food 
that you're eating, but they can be prescriptive, but they do suit people who like a set 
routine. 
Or you could try joining a slimming club. Some people find the support they get from 
members of slimming clubs like weight watchers or Rosemary Conley can help them 
lose weight. 
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~ The Oxford Centre 
'0' for Diabetes, Endocrinology and Metabolism 
Churchill Hospital 
Headington 
Oxford OX3 7 LJ 
Tel: 01865857399 
Fax: 01865 857368 
The Healthy living Programme - Evaluation form 
Thank you for taking the time to look at these videos and for completing this 
evaluation form. Please mark the line at the side of each question with a cross at 
the point that matches your personal opinion. 
Overall evaluation 
How useful were these videos? 
What do you think of the: 
idea of using videos to give this 
type of information? 
presentation? 
ease-of-use? 
amount of information? 
completely 
useless 
neither useful 
nor useless 
very 
useful 
1-------------------------1-------------------------1 
poor average excellent 
1-------------------------1-------------------------1 
1-------------------1-----------------------1 
1-------------------------1-------------------------1 
too little about right too much 
1-----------------------1-------------------1 
Do you have any general remarks about the three videos? 
Please choose one section - food, physical activity or weight management and 
complete the evaluation overleaf 
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Section ................................................ (please write food, activity or weight) 
What do you think of the: 
poor average excellent 
idea of using videos to give this 
type of information? 
presentation? 
ease-of-use? 
--, ------1----------------1 
1----------------1------------------------1 
1--------------1--------------------1 
too little about right too much 
amount of information? 1-----------------------1-------------------------1 
Are there any changes you could suggest to improve this video? 
Is there anything you would leave out? 
Are there any topics would you like to see included in another video? 
Please add any other comments below 
36 
Appendix 8 
3-day food diary 
37 
Low Carbohydrate Ketogenic Diet Study 
FOOD DIARY 
Name ............................................................... . 
Subject No I I I 
Date CD CD CD 
D D M M Y Y 
This diary is designed to obtain accurate 
information about the type and quantity of food you eat 
Please answer the General Question section and then go onto 
the Food Diary 
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Which type of bread do you usually eat? 
White D Brown / Hovis D 
Granary D Wholemeal D 
None D Other D 
Please specify ......................................................... . 
What size / type of bread do you buy? 
Large 
Small 
D 
D 
Sliced 
Unsliced 
D 
D 
If you eat any type of biscuit regularly, please specify which 
brands . 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 
Which type of milk do you usually use? 
Full cream milk D Semi-skimmed milk D 
Skimmed milk D Channel Islands D 
Evaporated D None D 
Other D 
How much milk do you usually drink? 
1-2 pints daily D 1/2-1 pint daily D 
1/4-1/2 pint daily D None D 
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How many tablespoons of milk do you take In tea and coffee? 
(please enter amount in box e .. g. 1/2, 1 tablespoon) 
D Tablespoons milk in tea None D 
D Tablespoons milk in coffee 
How much sugar do you take In your tea and coffee? 
D Teaspoon(s) in tea 
D Teaspoon(s) in coffee 
None D 
Which kind of spread do you use on bread, crispbread etc? 
Butter 
Low Fat Spread 
D 
D 
Margarine 
None 
Which brand do you normally use? 
.................................................... 
D 
D 
What do you do with visible fat on your meat? 
Eat most of it 
Eat some of it 
D 
D 
Eat as little as possible 
Don't eat meat 
How often do you eat food that is fried? 
Daily D 4-6 times a week 
1-3 times a week D Less than once a week 
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D 
D 
D 
D 
Filling in your Food Diary 
We would like to know what you eat and drink for THREE 
DAYS. 
One of these days should be either a Saturday or 
Sunday, so ideally, your diary should cover Thursday, 
Friday and Saturday or Sunday or Sunday, Monday, 
and Tuesday. This is because people tend to eat 
differently at weekends. 
Try to keep this diary with you and fill it in after each 
meal or snack while the information is fresh in your 
mind. 
Please do not change what you normally eat just 
because you are filling in this diary-be honest. 
Please write down everything you eat and everything 
you drink, including alcohol, snacks and nibbles 
between meals. 
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Please read these instructions carefully before you start 
Write down as accurately as you can, the type of food or drink 
• What type of cereal was it? 
• Was it butter, margarine or low fat spread? 
• What type of cheese was it? 
• What was the name of the biscuits? 
• Did you cut the fat off your meat? 
• Was it a level, rounded or heaped tablespoon? 
• Was it a large thick sausage or a small chipolata? 
• Was it a half pint glass or a small glass? 
• Was it a medium sliced large loaf or a small slice from a 
round granary / 
How was the food prepared: casseroled, grilled, boiled or fried? 
You do no need to weigh everything as long as you give a 
really good description 
• 
• 
• 
• 
• 
For many foods such as vegetable and cereals, state the 
number of tablespoons and whether level, rounded or 
heaped. 
For bread, fruit loaves etc. indicate the size of the loaf and 
the thickness of the slice. 
For meat, fish and cheese, describe as well as you can, 
e.g. 2/arge slices of ham or 2 small lamb chops (no fat 
eaten) or small fillet of cod grilled with 1 teaspoon of Flora 
or square of Cheshire cheese the size of a matchbox. 
State whether the drinks are in a glass / cup / mug. 
Remember to look at wrappers and labels and write down 
the brand name and weights ego 125g St Ivel Real Low Fat 
Yoghurt or 225g Heinz Baked Beans 
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Include everything you eat and drink, including 
nibbles 
Try to be as clear as you can 
Look at the example page. You might not eat 
any of the foods written down but it will show you 
how to fill in your diary 
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Example 
Day: Monday 
Date: 23.08.2004 
Before Breakfast 
Portion size / quantity 
1 cup 
1 tablespoon 
Breakfast 
Portion size / quantity 
~ heaped tablespoons 
1/4 pint 
1 medium slice 
1 teaspoon (level) 
2 mugs 
During the morning 
Portion size / quantity 
250 ml carton 
1 large 
1 teaspoon (level) 
1 small slice 
1 teaspoon (rounded) 
Midday Meal 
Portion size / quantity 
2 large serving spoons 
2 large serving spoons 
1 large 
1 large 
1 can 
Details of food and drink 
~ea with 
ISemi-skimmed milk 
Details of food and drink 
Branflakes (Kellogs) 
Semi-skimmed milk for cereals and drinks 
Wholemeal bread (large loaf) 
Flora extra light margarine 
Coffee 
Details of food and drink 
Low sugar Ribena Light 
Beefburger bun with 
Flora extra light margarine 
Corned beef 
Branston pickle 
Details of food and drink 
Canteen Meal 
Lamb curry 
Pilau rice 
~omato (sliced) 
Banana 
Diet Tango 
44 
During the afternoon 
Portion size / quantity Details of food and drink 
1 glass (1 tablespoon squash) Tescos's Low calorie orange squash 
make with concentrate 
1/2 a 26g packet KP plain crisps 
Evening Meal 
Portion size / quantity Details of food and drink 
3 heaped tablespoons painsbury's baked beans 
1 large Wacket potato 
Cereal bowl full ~hopped celery, carrot and tomato 
1 150g pot ~hape raspberry yoghurt 
1 275 ml can pkollager 
During the evening and night 
Portion size / quantity Details of food and drink 
1 mug Tea make with 
1 tablespoon Semi-skimmed milk 
2 Rich tea biscuits (McVities) 
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Day 
Date 
Before Breakfast 
Portion size / quantity 
Breakfast 
Portion size / quantity 
During the morning 
Portion size / quantity 
Midday Meal 
Portion size / quantity 
Details of food and drink 
Details of food and drink 
Details of food and drink 
Details of food and drink 
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During the afternoon 
Portion size / quantity Details of food and drink 
Evening Meal 
Portion size / quantity Details of food and drink 
During the evening and night 
Portion size / quantity Details of food and drink 
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Psychiatric Research Unit 
WHO Collaborating Centre in Mental Health 
WHO (Five) Well-Being Index (1998 version) 
Please indicate for each of the five statements which is closest to how you have been feeling over the 
last two weeks. Notice that higher numbers mean better wel1-being. 
Example: If you have felt cheerful and in good spirits more than half of the time during the past two 
weeks, put a tick in the box with the number 3 in the upper right comer. 
Over the last two weeks 
All of Most of More than Less lhan Some of At no 
the time the time halfoflhe halfofthe Ihe lime time 
time time 
1 I have felt cheerful and 0 5 0 4 0 3 0 2 01 00 in good spirits 
2 I have felt calm and 0 5 0 4 0 3 0 2 01 Do relaxed 
3 I have felt active and 0 5 0 4 0 3 0 2 01 Do vigorous 
4 I woke up feeling fresh and 0 5 04 0 3 0 2 01 00 rested 
5 My daily life has been filled 0 5 0 4 0 3 0 2 01 00 with things that interest me 
Scoring: 
The raw score is calculated by total1ing the figures of the five answers. The raw score range form 0 to 25, 0 representing worst possible and 25 representing best possible quality of life. 
To obtain a percentage score ranging from 0 to 100, the raw score is multiplied by 4. A percentage 
score of 0 represents the worst possible, whereas a score of 100 represents the best possible quality of 
life. 
C Psychiatric Research Unit, WHO Collaborating Center for Mental Health, Frcdcriksborg Geneml Hospital, OK-3400 lIi11enXI 
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IMAGING SERVICES NORTH 
Boston Spa, Wetherby 
West Yorkshire, LS23 7BQ 
www.bl.uk 
PAGE NUMBERING AS 
ORIGINAL 
© EuroQol Group 1990 
~ ... ~"" 
): "i ' ... r,:"'" 
\'::E~50 
Health Questionnaire 
English version for the UK 
(validated for Ireland) 
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By placing a tick in one box in each group below, please indicate 
which statements best describe your own health state today: 
Mobility 
I have no problems in walking about 
I have some problems in walking about 
I am confined to bed 
Self-care 
I have no problems with self-care 
I have some problems washing or dressing myself 
I am unable to wash or dress myself 
Usual activities (e.g. work, study, housework, family or 
leisure activities) 
o 
o 
o 
o 
o 
o 
I have no problems with performing my usual activities 0 
I have some problems with performing my usual activities 0 
I am unable to perform my usual activities 0 
Pain/Discomfort 
I have no pain or discomfort 
I have moderate pain or discomfort 
I have extreme pain or discomfort 
Anxiety/Depression 
I am not anxious or depressed 
I am moderately anxious or depressed 
I am extremely anxious or depressed 
© EuroQol Group 1990 
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o 
o 
o 
o 
o 
o 
To help people say how good or bad a 
health state is, we have drawn a scale 
(rather like a thermometer) on which the 
best state you can imagine is marked 100 
and the worst state you can imagine is 
marked O. 
We would like you to indicate on this scale 
how good or bad your own health is today, 
in your opinion. Please do this by drawing 
a line form the box below to whichever 
point on the scale indicates how good or 
bad your health state is today. 
© EuroQol Group 1990 
Your own 
health state 
today 
51 
Best 
imaginable 
health status 
100 
• a 
• a 
• a 
o 
Worst 
imaginable 
health status 
(0 EuroQol Group 1990 
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PAID and hypoglycaemia questionnaire 
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"" ." ., 
Which of the following diabetes issues are currently a problem for you? 
Circle the number that gives the best answer for you. 
Please provide an answer for each question. 
Nota Minor Moderate Somewhat Serious 
Problem Problem Problem Serious Problem 
Problem 
Not having clear and concrete goals for your diabetes care? 0 1 2 3 4 
Feeling discouraged with your diabetes treatment plan? 0 1 2 3 4 
Feeling scared when you think about living with diabetes? 0 1 2 3 4 
Uncomfortable social situations related to your diabetes care (eg. People telling you what to eat)? 0 1 2 3 4 
Feelings of deprivation regarding food and meals? 0 1 2 3 4 
Feeling depressed when you think about living with diabetes? 0 1 2 3 4 
Not knowing jf your mood or feelings are related to your diabetes? 0 1 2 3 4 
Feeling overwhelmed by your diabetes? 0 1 2 3 4 
Worrying about low blood sugar reactions? 0 1 2 3 4 
Feeling angry when you think about living with diabetes? 0 1 2 3 4 
Feeling constantly concerned about food and eating? 0 1 2 3 4 
Worrying about the future and the possibility of serious complications? 0 1 2 3 4 
Feelings of guilt and anxiety when you get off track with your diabetes management? 0 1 2 3 4 
Not -accepting- your diabetes? 0 1 2 3 4 
Feeling unsatisfied with your diabetes phYSician? 0 1 2 3 4 
Feeling that diabetes is taking up too much of your mental and physical energy every day? 0 1 2 3 4 
. 
Feeling alone with your diabetes? 0 1 2 3 4 
Feeling that your friends and family are not supportive of your diabetes management efforts? 0 1 2 3 4 
Coping with complications of diabetes? 0 1 2 3 4 I ! 
Feeling 'burned out' by the constant effort needed to manage your diabetes? 0 1 2 3 4 
------ ---- ---_._-
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Hypoglycaemia Questionnaire 
For each question, please tick the relevant box 
1. Which best describes you? 
I always have symptoms when my blood sugar is low D 
I sometimes have symptoms when my blood sugar is low D 
I no longer have symptoms when my blood sugar is low D 
2. Have you lost some of the symptoms that used to occur when your blood sugar was low? 
Yes D No D 
3. In the past six months, how often have you had a moderate hypoglycaemic episode? 
(where you have felt confused, disorientated or lethargic and you were unable to treat 
yourself) 
Never D Once or twice D More D 
4. In the past year, have you had a severe hypoglycaemic episode? 
(where you were unconscious and needed paramedic assistance) 
Never D Once or twice D More D 
5. How often in the last month have you had readings less than 4.0mmolll with symptoms? 
Never D 1-3 times D Once a week D 2-3 times a week D Daily D 
6. How often during the last month have you had a reading less than 4.0mmolll 
without symptoms? 
Never D 1-3 times D Once a week D 2-3 times a week D Daily D 
7. How low does your blood sugar need to go before you feel symptoms? 
3.5-4.0mmol/l D 3.0-3.5mmolll D less than 3.0mmolll D 
8. To what extent can you tell by your symptoms that your blood sugar is low? 
Rarely D Sometimes D Often D Always D 
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Appendix 12 
ADKnowl questionnaire 
The Oxford Centre 
for Diabetes, Endocrinology and Metabolism 
PATIENT NUMBER _,_,_ 
PATIENT INITIALS _,_,_ 
DATE OF CONTACT __ , __ , __ 
OxREC no: C03.097 
Version 1.1 
October 2003 
OXFORD HEALTHY LIVING 
DIABETES KNOWLEDGE QUESTIONNAIRE 
Below are some statements about diabetes. 
Churchill Hospital 
Headington 
Oxford OX3 7LJ 
Tel: 01865857333 
Fax: 01865857368 
For each statement, please tick the box to indicate whether you believe it to be 
true or false. 
There may be any number of true statements in each set. 
1 
True False Don't 
Please consider each of the following Know 
statements about diabetes 
a. Diabetes can be controlled with treatment 
b. A little glucose in the urine is a good thing 
c. Diabetes is likely to go away after a while 
d. Stressful experiences can affect blood glucose levels 
e. Blood glucose levels do not affect your chances 
of developing complications 
58 
2 
True False Don't 
The usual effect of physical exercise is to ••• Know 
a. Lower blood glucose levels 
b. Raise blood glucose level 
c. Increase blood glucose levels in urine 
d. Leave blood glucose levels unchanged 
3 
True False Don't 
Please consider each of the following statements Know 
about the effects of food on blood glucose levels 
a. Sugary foods affect blood glucose levels 
b. Starch foods (e.g. potato, bread etc.) affect blood glucose 
levels 
c. Protein foods (e.g. meat, cheese etc.) affect blood glucose 
levels 
d. Alcohol- free wines and lagers will have no effect on blood 
glucose levels 
e. Full-fat foods will affect blood glucose levels more than low-
fat foods 
f. Sugary foods require more insulin than starch foods, even if 
they contain the same amount of carbohydrate 
g. Any amount of fresh fruit can be eaten with little effect on 
blood glucose levels 
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4 
True False Don't 
Please consider the following statements about food Know 
a. People with diabetes need to avoid foods containing any 
sugar 
b. It is not possible to eat too much protein 
c. Fried foods are usually low in fat 
d. Pastry and cakes are high in fat 
e. Cheese and biscuits are usually less fattening than puddings 
f. All margarines and spreads have fewer calories than butter 
g. Restricting the use of salt can help to reduce high blood 
pressure 
h. High fat foods can increase the risk of complications 
I. Special diabetic products can be eaten freely without leading 
to weight gain 
5 
True False Don't 
Alcoholic drinks (particularly beer, ciders and IIquers) Know 
generally ... 
a. Lower blood glucose levels after a few hours 
b. Raise blood glucose levels initially 
c. Have no calories 
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6 
True False Don't 
Keeping diabetes well controlled over the years can Know 
lower your risk of damage to •.. 
a. Nerves in your feet 
b. Your kidneys 
c. Your eyes 
7. 
True False Don't 
Regular examinations are recommended to check Know 
a. For nerve damage to your feet 
b. Your blood pressure 
c. Your eyes 
d. Your cholesterol level 
e. Only things you have been having a problem with 
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Appendix 13 
Curriculum for InSight 
Week 1 
Process: 
• The InSight facilitator will make introductions and attempt to put all participants at their ease. The facilitator will encourage 
participants to set ground rules for the group and these will be written on a flip-chart and displayed during the course. The 
facilitator will describe the Insight programme and will provide a copy of the timetable to all participants. 
• Participants will be asked specific questions about their personal aims and objectives for the course, write these down on thought 
bubbles and discuss their expectations. They will share experiences of diabetes, their thought and beliefs about self-care 
management and the role of other people using pre-prepared statements. Information and answers will be written down on a f1ip-
chart. 
• The physiology of the fed and fasting state in individuals with and without diabetes and the role of carbohydrates will be explored 
using the Bodylink tool. The facilitator will encourage every individual to participate and contribute and all comments will be 
actively listened to. 
• The facilitator will engage the participants in discussion about self-monitoring and will introduce the diary log and discuss the 
importance of sharing information and recording usual practice. 
• All participants will be actively engaged throughout the session by being encouraged to reflect, share their experiences and to ask 
questions. Any questions not addressed immediately will be recorded on a flip-chart for the future. All questions will be answered 
in an honest, respectful, open and non-judgemental way. 
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Week 1: Session 1 
Introduction, aims and objectives, setting ground rules and clarifying the programme 
Time allocation: 45 minutes 
Specific aspects of Learning outcomes Facilitator activity Participant activity 
theory 
Introduction and Providing welcoming 
welcome atmosphere and refreshments 
Providing course materials 
Emotion management, To learn peoples' Asking for names and length of Giving name and 
elicitation of personal names and shared diagnosis recalling length of 
experience experiences of diagnosis 
diabetes 
To establish ground Discussing ground rules and Identifying and agreeing 
rules for course recording on flip-chart ground rules 
Emotion management, To identify personal Providing thought bubbles and Writing main aims on 
identification and aims and objectives for ask participants to identify main thought bubbles 
elicitation of expectations the programme aims 
Reviewing each comment and Describing and 
discuss realistic expectations discussing the aims of 
the group 
Delivering information To learn about the Providing slide of programme Clarifying programme 
content and duration of content 
the programme 
Elucidating philosophy To understand the Promoting discussion about the Discussing and sharing 
principles of non- roles of people with diabetes experience of the 
judgemental, shared and their relationships with other 'Diabetes Police' 
experience people 
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Resources ! 
OHP/computer 
Refreshments 
Pens 
Timetable of course 
Workbook 
Flip-chart and pens 
Thought bubbles 
Felt pens 
Blue-tack 
3 slides of programme 
content (slides 1-3) 
Policeman's hat 
Week 1: Session 2 
Diabetes myths 
Time allocation: 45 minutes 
Specific aspects of Learning outcomes 
theory 
Emotion management, To recognise that 
elicitation of beliefs and personal beliefs 
knowledge influence self-
management 
------ ~-
Week 1: Session 3 
Learning to think like a pancreas 
Time allocation: 45 minutes 
Specific aspects of Learning outcomes 
theory 
Elicitation of knowledge, To understand: 
role modelling, delivering • Normal 
information by utilising physiology in 
different learning styles the fed and 
fasting state 
• Diabetes 
physiology in 
the fed and 
fasting state 
• Physiology of 
insulin action 
To determine each 
individual's basal and 
prandial insulin 
Facilitator activity Participant activity Resources 
Providing myth cards and Reading statements Top hat and 6 myth cards 
encouraging each participant to and sharing their beliefs 
read a statement and knowledge 
Promoting discussion about Listening to other 
personal beliefs individuals point of view 
FaCilitating responses from all 
individuals 
-- -- ~- ~-~-- ~-- --------- ~-~ --
Facilitator activity Participant activity Resources 
Utilising Bodylink tool to Physically and verbally Slide 4 
encourage participants to engaging in using Bodylink tool and 
demonstrate normal physiology Bodylink to explore accessories 
and diabetes physiology physiology in diabetic Hand-out of bodylink 
Encouraging participants to and non-diabetic state diagram 
demonstrate active involvement Slides of insulin action 
(slides 5-7) 
Demonstrating insulin action Reflecting on insulin Template of record of 
using slide action and physiology insulin for flip-chart 
Recording each individual's Providing details of Flip-chart and pens 
insulin regimen on flip chart and personal insulin use Workbook pages 6 - 9 
evaluating proportion of basal Discussing and and appendix 1 (p 46) 
insulin formulating any 
changes to basal insulin 
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Week 1: Session 4 
Self-monitoring - introducing the diary log 
Time allocation: 35 minutes 
Specific aspects of Learning outcomes 
theory 
Elicitation of knowledge, To identify and record 
delivering information by carbohydrate 
utilising different learning containing foods and 
styles differing effects on 
blood glucose 
Experiential learning, To appreciate the 
discussing concrete principles of accurate 
experience and information gathering 
encouraging reflection and self-monitoring 
-
Facilitator activity 
Utilising Bodylink tool and food 
models to explore the different 
effects of different foods 
Discussing identification of 
individual's carbohydrate foods 
Explaining usefulness of 
recording weights of 
carbot}ydrate foods 
Introducing diary log and 
explaining com!)letion using an 
example 
Discussing use of scales for 
weighing portions of 
carbohydrate foods 
Reviewing principles of 
information gathering including 
food, exercise stress in relation 
to blood glucose monitoring 
Discussing importance of 
sharing information and 
maintaining usual lifestyle 
~ ~ ~ ~-- ---_ .. -
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Participant activity Resources 
Identifying carbohydrate Bodylink tool and 
containing foods accessories 
Recognising usefulness Food models: apple, slice 
of weighing and of bread, chocolate bar 
recording personal Slides 8-10 
portion size of foods 
eaten 
Understanding Testing slide (slide 11) 
principles of log as a Demonstration scales 
tool for self- Scales and batteries 
management Diary logs - 28 paper and 
Agreeing to diary 2 acetate logs 
completion and Acetate pens 
monitoring for the Slides of diary log and 
coming week example (slides 12-13) 
Practising using scales Form for weights of 
with food models commonly eaten 
carbohydrates 
--- -------
Week 1: Session 5 
Any other questions and evaluation 
Time allocation: 10 minutes 
Specific aspects of Learning outcomes 
theory 
Facilitator activity 
Asking for any questions or 
clarification of issues 
Recording any future topics on 
the flip-chart for discussion in 
week 4 
Providing and collecting PAID 
and hypo questionnaires (unless 
completed before course) 
Weighing patients and 
organising blood sample for A 1 c 
and lipid levels (unless 
completed before course) 
Providing evaluation forms for 
the session (at least once 
annually) 
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Participant activity Resources I 
Asking questions Flip chart and pens 
Completing forms PAl D and hypo 
questionnaires 
Agreeing to biomedical Scales 
assessment Process for blood 
collection 
Providing completed Evaluation form 
evaluation form 
Week 2 
Process: 
• The InSight facilitator will welcome back all participants. The facilitator will encourage individual participants to share and discuss 
their 2 day diary logs and will display them to the group using the overhead projector. The facilitator will promote group support, 
ask relevant questions and enable all individuals to offer advice and support based upon their own experiences 
• The facilitator will promote discussion about various means of calculating carbohydrates and will use food models, scales, food 
tables, nutritional labels and DAFNE plate models to encourage every individual to participate and contribute in the session 
• The facilitator will explain the formulae used to calculate both insulin:carbohydrate ratios and correction doses and encourage the 
participants to calculate their own ratios and practice this approach by referring to diary logs 
• Facilitators and participants will eat lunch together and practice carbohydrate counting and applying the new ratios. More practice 
will take place by completion of a carbohydrate quiz 
• Injections technique will be explored and addressed 
• All participants will be actively engaged throughout the session by being encouraged to reflect, share their experiences and to ask 
questions. Any questions not addressed immediately will be recorded on a flip-chart for the future. All questions will be answered 
in an honest, respectful, open and non-judgmental way 
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Week 2: Session 1: Introduction to carbohydrate counting 
Time allocation: 60 minutes 
Learning outcomes Facilitator activity Participant activity 
To accurately assess Asking participants to divide Physically and verbally 
carbohydrate-containing food models into 2 groups - engaging with food models 
foods those containing carbohydrates to identify carbohydrate 
and those not containing foods 
Summarising that fat and 
protein have little or no effect 
on blood glucose levels 
To identify different Asking partiCipants to rank food Physically and verbally 
methods of assessing models by carbohydrate engaging with food models 
carbohydrate content of content to rank carbohydrate 
foods containing foods 
Discussing methods of Identifying different 
accurately assessing methods of asseSSing 
carbohydrate content of foods carbohydrate 
and listing on flip-chart 
To establish weighing Discussing and demonstrating Using personal information 
foods and using food using weights of food and food to calculate carbohydrate 
tables to calculate tables to assess carbohydrate content of foods eaten 
carbohydrate content content 
To investigate us of Providing and explaining Practising carbohydrate 
nutritional labels to nutritional labels counting using nutritional 
count carbohydrates labels 
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Resources Key questions/statements 
Food models Do all foods raise blood glucose 
levels after eating? 
Can you identify those which have 
little or no effect on glucose levels? 
Only food containing carbohydrate 
have an effect on blood glucose 
levels after eating 
Food models Do all foods contain the same 
amount of carbohydrate? 
Different foods contain different 
amounts of carbohydrate. 
How could you estimate the 
carbohydrate content of the food 
you eat? 
Scales How do you calculate the 
Food tables (books) carbohydrate content of food from 
Calculators the weight? 
Which foods would this method be 
most useful for? 
Nutritional labels How is the information presented? 
How useful is information per 
100g? 
What are the issues with 
information per portion? 
Week 2: Session 1: Introduction to carbohydrate counting contd 
Learning outcomes Facilitator activity Participant activity 
To identify and use Providing DAFNE plates Observing and estimating 
visual calculation of Asking for estimation of carbohydrate content of 
carbohydrate carbohydrate content meals 
-- ~ - -- - ~--
Week 2: Session 2: Calculation of individual insulin:carbohydrate ratios 
Time allocation: 15 minutes 
Learning outcomes Facilitator activity Participant activity 
To calculate personal Discussing general guidelines 
insulin:carbohydrate of I unit of insulin for every 10-
ratio 15g carbohydrate 
Writing formula on flip chart Calculating total daily dose 
(total daily dose/50) 
Explaining that this figure gives 
the amount of units of insulin 
for each 10g carbohydrate 
Inviting participants to calculate Calculating personal doses 
individual ratio 
To assess the safety of Encouraging participants to Calculating and comparing 
this new approach compare new approach with new approach 
---- ~-- -~ 
LtJsual dose at meals 
~~--
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Resources Key questions/statements 
DAFNE plates Which foods on each plate would 
you need to count? 
How much carbohydrate do you 
think each food contains? 
What is the total carbohydrate of 
the meal? 
I 
--- ._-
Resources Key questions/statements 
Calculators Most people need I unit of insulin 
for every 10-15g carbohydrate, but 
there is individual variation. 
We can use a formula to calculate 
this more accurately 
We can practice this to see if it 
works by comparing what you 
usuall;t do 
Week 2: Session 3 
Safety rules, correction doses and summarising individual ratios 
Time allocation: 45 minutes 
Specific aspects of Learning outcomes Facilitator activity 
theory 
Delivering information by To identify amount of Discussing causes of high or low 
utilisation of different insulin needed to blood glucose levels 
learning styles, exploring correct out of target Encouraging participants to 
personal beliefs, goal blood glucose levels identify personal targets for 
setting blood glucose levels and 
recording on flip-chart 
Discussing formula for 
calculating correction doses and 
recording on flip-chart 
Inviting participant to calculate 
personal correction dose 
To identify and adopt Summarising and reviewing 
individual ratios for the each participants ratios 
coming week Dispensing personal calculator 
cards if required 
To identify situations Promoting discussion about 
when insulin is not situations when eating 
given with carbohydrate should not be 
carbohydrates accompanied by insulin 
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Participant activity Resources 
Identifying causes of Slide offormula (slide 15) 
high or low glucose Flip-chart 
Identifying personal Pens 
targets Workbook page 18 
Calculating personal 
ratio 
Documenting personal Flip-chart with completed 
ratios in workbook ratios 
Correction dose and carb 
counting personal 
calculator card 
Plan for week (slide 16) 
Sharing experiences Safety rules (slide 17) 
and discussing 
Week 2: Session 4 
Carbohydrate quiz 
Time allocation: 45 minutes 
Specific aspects of 
theory 
Experiential learning, 
utilisation of different 
learning styles 
Week 2: Session 5 
Injection technique 
Learning outcomes 
To calculate 
carbohydrate of foods 
using different 
strategies 
Time allocation: 20 minutes 
Specific aspects of Learning outcomes 
theory 
Elicitation of personal To identify and use 
experience, delivering correct needle size, 
information technique and site for 
insulin injections 
Facilitator activity Participant activity Resources 
Explaining and distributing Engaging and Carbohydrate quiz forms 
carbohydrate quiz forms calculating Food models 
Discuss correct answers carbohydrate content of DAFNE plates 
different foods in Take-away handouts 
different scenarios 
Encourage further practice at Agreeing to further 
home practice at home 
Facilitator activity Participant activity Resources 
Discussing factors affecting Engaging and Needles 
insulin absorption discussing personal Injection technique slides 
Eliciting discussion on current injection procedure (slides 18-21) 
practice Workbook Appendix 3 
(p 51) 
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Week 2: Session 6 
Any other questions and evaluation 
Time allocation: 20 minutes 
Specific aspects of Learning outcomes 
theory 
-
Week 3 
Facilitator activity 
Asking for any questions or 
clarification of issues 
Recording any future questions 
on the flip-chart 
Providing acetate diary logs 
Providing evaluation forms for 
the sessiol}{if applicable) 
Participant activity Resources 
Asking questions Flip chart and pens 
2 acetate diary logs 
Providing completed Evaluation form 
evaluation form 
--_._--- --_.-
Process: The InSight facilitator will welcome back all participants. The facilitator will encourage individual participants to share and 
discuss their 2 day diary logs and will display them to the group using the overhead projector. The facilitator will promote group support, 
ask relevant questions and enable all individuals to offer advice and support based upon their own experiences. The facilitator will 
promote discussion about hypoglycaemia by encouraging participants to share and reflect on their own experiences. A practical session 
will take place to categorise warning signs and symptoms. The Bodylink tool will be utilised to demonstrate physiology of hypoglycaemia 
and suitable treatments will be discussed. The tool will then be used to explore the effects of exercise and alcohol. More carbohydrate 
counting practice will take place if time allows by introducing a take-away game. All participants will be actively engaged throughout the 
session by being encouraged to reflect, share their experiences and to ask questions. Any questions not addressed immediately will be 
recorded on a flip-chart for the future. All questions will be answered in an honest, respectful, open and non-judgmental way. 
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vweeK .); i:>eSSIOn 1 
Welcome and reflection of individual diary logs 
Time allocation: 60 minutes 
Specific aspects of 
theory 
Reflection from concrete 
experience, utilisation of 
different learning styles, 
emotion management, 
vicarious learning 
Week 3: Session 2 
Hypoglycaemia 
Learning outcomes 
Welcome 
To learn about 
personal and other 
group member's blood 
glucose pattern 
To relate patterns to 
insulin, food, stress 
and activity 
To appreciate 
relevance of accurate 
written records to 
establish baseline 
information for future 
management 
Time allocation: 45 - 60 minutes 
Specific aspects of Learning outcomes 
theory 
Elicitation of personal 
experience, elicitation of 
knowledge and beliefs, To identify symptoms 
of hypoglycaemia 
Facilitator activity Participant activity Resources 
Providing welcoming Refreshments 
atmosphere and refreshments 
Displaying individual overheads Providing 2 completed OHP/computer 
of diary logs diary logs on acetate Completed acetate diary 
overheads logs 
Sharing and explaining 
Asking relevant questions to their 2 day record 
elicit further details 
Promoting group support and Offering advice and 
sharing of information support to other group 
Enabling all group participants to members 
i offer non-judgemental advice 
and support based on personal 
experience 
-- ------ ------- - _ .. _ ... _. __ __ I 
Facilitator activity Participant activity Resources , 
I 
I 
Asking relevant questions to Sharing experiences 
I 
elicit individual experiences and discussing 
Distributing hypo card game Engaging in Hypo cards I 
Reviewing symptoms using categorising symptoms Hypo symptom slides 
slides into sub-headings (slides 22-24) 
Workbook pages 21 - 24) 
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Specific aspects of 
theory 
Delivering information by 
utilisation of different 
learning styles, vicarious 
learning 
Week 3: Session 3 
Exercise 
Learning outcomes 
To understand 
physiology in relation 
to low blood glucose 
To identify blood 
glucose levels which 
equate to hypo 
To understand 
treatment in relation to 
low blood glucose 
Time allocation: 20 - 30 minutes 
Specific aspects of Learning outcomes 
theory 
Elicitation of personal 
experience, elicitation of 
knowledge and beliefs, 
delivering information by To understand the 
utilisation of different physiology of exercise 
learning styles, vicarious 
learning 
To formulate strategies 
for personal exercise 
Facilitator activity 
Encouraging discussion and 
engagement using Bodylink tool 
Eliciting viewpoints 
Clarifying safety levels 
Asking relevant questions to 
elicit individual treatment 
Advising most effective 
treatment 
Discussing effects of speCific 
amounts of carbohydrate 
Facilitator activity 
Asking relevant questions to 
elicit individual experiences 
Utilising Bodylink tool to explore 
and review effects of exercise 
Discussing and explaining 
individual response to planned 
or unplanned exercise 
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Participant activity Resources 
Physically and verbally Bodylink (used for hypos, 
engaged with exercise and alcohol) 
discussion and tool 
Volunteering personal Slide (25) 
views 
Sharing and discussing Samples of hypo 
suitable treatment treatment 
2 handouts - treatment 
and overview 
Rule of 15 and effect of 
--------
10g CHO slides (26 - 27) 
Participant activity Resources 
Sharing experiences 
and discussing 
Physically and verbally Bodylink 
engaging with tool to Workbook pages 36 - 37 
explore effects of and Appendix 4 (p 52) 
exercise 
Exploring and Slides (28 - 32) 
discussing individual 
responses 
Formulating strategies 
Week 3: Session 4 
Alcohol 
Time allocation: 10 - 20 minutes 
Specific aspects of Learning outcomes 
theory 
Elicitation of personal 
experience, elicitation of 
knowledge and beliefs, 
delivering information by To understand the 
utilisation of different physiological effects of 
learning styles, vicarious alcohol 
learning 
To calculate 
carbohydrate content 
of alcoholic drinks 
To identify safety 
factors 
Week 3: Session 5 
Any other questions and evaluation 
Time allocation: 10 minutes 
Specific aspects of Learning outcomes 
theory 
Facilitator activity Participant activity Resources 
Asking relevant questions to Sharing experiences 
elicit individual experiences and discussing 
Utilising Bodylink tool to explore Physically and verbally Bodylink 
and review effects of alcohol engaging with tool to Workbook pages 33 - 35 
explore effects of Bottle of alcohol 
alcohol 
Encouraging use of workbook to Reviewing section in 
calculate carbohydrate content workbook 
of drinks 
Asking relevant questions Sharing experiences Slide 33 
Explaining government safe and discussing 
levels of alcohol 
Discussing insulin adjustment 
Facilitator activity Participant activity Resources 
Asking for any questions or Asking questions Flip chart and pens 
clarification of issues 
Recording any future questions 
on the f1ip-chart 
Distributing acetate diary logs for 2 acetate diary logs 
week 4 
76 
Week 3: Supplementary sessions 
Practising carbohydrate counting 
Time allocation: 10 - 20 minutes 
Specific aspects of Learning outcomes 
theory 
Experiential learning, To calculate 
utilisation of different carbohydrate content 
learning styles of take-away meals 
To investigate the 
effect of carbohydrate 
on blood glucose 
Week 4 
Facilitator activity Participant activity Resources 
Distributing take-away game Practising calculating Take-away game 
Facilitating calculations and carbohydrate content of DAFNE plates 
stimulating discussion different meals Menu cards 
Advising the effect of 1 Og Exploring the effect of a Food containing 10g 
carbohydrate on blood glucose known amount of carbohydrate eg 1 Jaffa 
levels carbohydrate cake 
Encourag ing experimentation 
during the week with known 
amount of 10g carbohydrate 
Process: The InSight facilitator will welcome back all participants. The facilitator will encourage individual participants to share and 
discuss their 2 day diary logs and will display them to the group using the overhead projector. The facilitator will promote group 
support, ask relevant questions and enable all individuals to offer advice and support based upon their own experiences. 
The facilitator will promote discussion about hyperglycaemia by encouraging participants to share and reflect on their own 
experiences. A practical session will take place to categorise warning signs and symptoms. The Bodylink tool will be utilised to 
demonstrate physiology of hyperglycaemia and appropriate management will be discussed. A general review of participants aims 
amd objective from the first session will take place. All group agenda items not previously explored will be addressed. All 
participants will be actively engaged throughout the session by being encouraged to reflect, share their experiences and to ask 
questions. Any questions not addressed immediately will be recorded on a flip-chart for the future. All questions will be answered in 
an honest, respectful, open and non-judgmental way. 
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! 
Week 4: Session 1 
Welcome and reflection of individual diary logs 
Time allocation: 60 minutes 
Specific aspects of Learning outcomes 
theory 
Welcome 
Reflection from concrete To learn about 
experience, utilisation of personal and other 
different learning styles, group member's blood 
emotion management, glucose pattern 
vicarious learning To relate patterns to 
insulin, food, stress 
and activity 
To appreciate 
relevance of accurate 
written records to 
establish baseline 
information for future 
management 
-
Facilitator activity Participant activity Resources 
Providing welcoming Refreshments I 
atmosphere and refreshments Handout of description of , 
diabetes physiology using 
bodylink 
Displaying individual overheads Providing 2 completed OHP/computer 
of diary logs diary logs on acetate Completed acetate diary 
overheads logs 
Sharing and explaining 
Asking relevant questions to their 2 day record 
elicit further details 
Promoting group support and Offering advice and 
sharing of information support to other group 
Enabling all group participants to members 
offer non-judgemental advice 
and support based on personal 
experience 
_. __ .. -
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Week 4: Session 2 
Hyperglycaemia 
Time allocation: 30 minutes 
Specific aspects of Learning outcomes 
theory 
Elicitation of personal To identify symptoms 
experience, elicitation of of hyperglycaemia 
knowledge and beliefs, 
delivering information by To understand 
utilisation of different physiology in relation 
learning styles, vicarious to high blood glucose 
learning 
To identify blood 
glucose levels and 
ketone levels which 
equate to 
hyperglycaemia 
To understand 
carbohydrate content 
of foods and drinks to 
use when ill 
Facilitator activity Participant activity Resources 
Reviewing symptoms using Engaging in discussion Slides of symptoms 
slides and sharing experience (34 - 36) 
Encouraging discussion and Physically and verbally Bodylink 
engagement using Bodylink tool engaged with Workbook pages 25 - 29 
discussion and tool 
Eliciting viewpoints Volunteering personal Slide 37 - 39 
Clarifying safety levels views Ketone meter -
Identifying glucose and demonstration meter and 
ketone levels meters for partiCipants 
Urine ketone sticks 
Handout of ketone 
guidelines 
Asking relevant questions to Sharing and discussing Handout of common CHO 
elicit individual use suitable foods foods (given week 2) 
Advising use of altemative foods 
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Week 4: Session 3 
Review of programme 
Time allocation: 60 minutes 
Specific aspects of 
theory 
Elicitation of personal 
experience, elicitation of 
knowledge and beliefs, 
delivering information by 
utilisation of different 
learning styles, vicarious 
learning, goal setting 
Week 4: Session 4 
Evaluation 
Learning outcomes 
To gain information 
about agenda items 
To identify further 
support 
Time allocation: 20 minutes 
Specific aspects of Learning outcomes 
theory 
Facilitator activity 
Providing information about 
individual topiCS not covered in 
core curriculum and identified by 
participants 
Identifying and providing other 
options to provide further 
knowledge/support 
Facilitating discussion of thought 
bubbles and aims and objectives 
identified in week 1 
Eliciting information about future 
peer and professional support 
Facilitator activity 
Providing evaluation forms for 
the session 
--- -- -
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Participant activity Resources 
Gaining necessary Flip-chart from previous 
information to support weeks 
individual needs 
Engaging in discussion Completed thought 
bubbles 
Identifying future needs 
Participant activity Resources 
Providing completed Evaluation form 
evaluation form 
- _ .. _------------ ---
Low carbohydrate diet study· Demographics of all subjects at baseline 
Subject Gender Age Diabetic 
no (M/F) (years) status Randomisation 
01 F 47 diabetes healthy eating 
02 F 60 control low carbohydrate 
03 M 51 diabetes low carbohydrate 
04 M 58 diabetes low carbohydrate 
05 F 57 diabetes low carbohydrate 
06 F 35 diabetes healthy eating 
07 M 51 diabetes healthy eating 
08 M 64 diabetes healthy eating 
09 F 41 control healthy eating 
10 F 54 control low carbohydrate 
11 F 60 diabetes low carbohydrate 
12 M 44 control healthy eating 
13 F 40 control healthy eating 
14 F 60 diabetes low carbohydrate 
15 F 70 diabetes healthy eating 
17 F 42 control healthy eating 
18 F 60 control low carbohydrate 
19 F 52 control low carbohydrate 
20 M 58 diabetes healthy eating 
21 F 41 control healthy eating 
22 F 46 diabetes low carbohydrate 
23 M 48 diabetes healthy eating 
24 F 53 control low carbohydrate 
25 F 48 control healthy eating 
26 F 51 control low carbohydrate 
27 F 72 control healthy eating 
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Low carbohydrate diet study. Biomedical results for aU subjects at baseline 
Systolic Diastolic Total HDL LDL 
Subject Weight BMI Waist/hip %body BP BP A1c cholesterol cholesterol cholesterol Triglycerides Ketones 
no (kg) (kg/m~ ratio fat (mmHg) (mmHg) (%) (mmol/I) (mmol/I) (mmolll) (mmolll) Immolll) 
01 79.8 29.7 0.93 43.0 116 80 7.6 5.0 1.10 3.1 1.7 0.0 
02 81.0 30.1 0.79 44.1 112 73 6.1 6.8 1.66 4.5 1.3 0.0 
03 104.8 32.7 1.03 32.4 148 93 8.1 2.9 0.69 1.3 1.9 0.1 
04 89.2 29.5 0.96 34.0 116 72 5.8 6.0 1.37 3.6 2.2 0.1 
05 93.5 33.1 0.84 46.8 142 66 6.0 7.3 2.36 4.5 0.9 0.0 
06 101.3 37.7 0.84 48.8 115 83 8.4 4.8 1.30 2.9 1.3 0.0 
07 112.9 36.0 1.02 38.5 142 84 8.6 4.1 0.98 2.5 1.3 0.1 
08 85.4 29.6 1.02 31.7 184 92 7.4 5.0 2.30 2.4 0.6 0.1 
09 67.6 25.4 0.88 37.7 111 72 5.5 4.7 1.56 2.4 1.7 0.1 
10 82.4 30.6 0.82 47.2 118 65 5.9 5.0 1.04 3.5 1.1 0.1 
11 96.7 40.8 0.88 56.3 138 72 6.4 4.5 1.07 2.0 3.1 0.0 
12 93.2 30.8 0.86 31.9 139 80 6.0 5.1 1.08 3.2 1.7 0.0 
13 136.5 56.8 UTM 57.7 126 98 6.0 5.4 1.24 3.7 1.0 0.0 
14 87.4 36.4 0.89 52.3 166 64 6.9 4.4 0.96 3.0 0.9 0.0 
15 93.9 34.1 0.85 53.1 138 87 6.1 4.1 1.62 2.3 0.5 0.1 
17 104.6 38.4 0.78 51.1 145 84 5.8 6.2 1.08 4.2 2.0 0.0 
18 81.3 33.0 0.88 49.0 120 83 5.7 6.6 1.21 4.0 3.0 0.0 
19 126.7 48.9 0.85 58.8 174 108 6.1 4.7 1.31 2.8 1.2 0.0 
20 107.2 34.2 1.02 35.5 152 94 6.7 6.1 1.18 3.8 2.4 0.0 
21 81.2 30.2 0.88 45.1 116 73 5.7 4.8 1.34 3.1 0.7 0.0 
22 126.8 46.6 0.93 58.9 161 87 10.2 3.4 0.96 1.6 1.8 0.1 
23 108.1 32.6 0.92 36.0 133 92 6.7 4.9 1.53 2.9 1.1 0.0 
24 97.7 31.9 0.89 45.0 130 90 6.3 5.2 1.11 3.5 1.4 0.0 
25 100.6 38.8 0.90 51.2 154 71 5.7 3.9 1.43 1.8 1.4 0.0 
26 77.5 27.8 0.98 43.1 138 78 6.3 4.6 1.56 2.4 1.4 0.2 
27 85.6 36.1 0.90 53.6 157 87 6.4 6.9 1.39 5.0 '---- 1.2 0.1 ---- -- - _ .. _-------------
UTM = unable to measure 
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Low carbohydrate diet study - Biomedical results for all subjects at 3 months. 
Systolic Diastolic Total HDL LDL I 
I 
Subject Weight BMI Waist/hip %body BP BP A1c cholesterol cholesterol cholesterol Triglycerides Ketones 
no (kg) (kg/m2) ratio fat (mmHg) (mmHg) 1%) (mmollll Jmmolll) (mmolll) (mmollil Jmmolll) 
01 79.4 29.5 0.90 44.6 120 79 7.6 4.5 0.98 2.9 1.3 0.0 
02 71.7 26.6 0.79 43.2 124 84 5.8 6.3 1.47 4.4 0.9 0.0 
03 91.0 28.4 0.96 29.5 135 78 6.4 3.3 0.84 1.5 2.1 0.3 
04 85.8 27.4 0.94 32.4 127 78 5.8 5.7 1.38 3.7 1.4 0.1 
05 86.8 30.7 0.82 45.9 128 80 6.1 7.0 2.43 4.3 0.6 0.1 
06 101.2 37.7 0.83 NR 106 59 8.2 4.8 1.30 2.9 1.3 NR 
07 111.6 35.6 0.98 38.8 128 88 7.9 4.7 1.06 2.8 1.8 0.1 
08 82.6 28.6 0.96 32.1 176 96 7.2 4.6 1.74 2.4 1.1 0.1 
09 65.5 24.7 0.80 38.2 124 80 5.0 4.8 1.46 2.4 2.1 0.1 
10 74.3 27.6 0.81 45.1 122 66 5.4 5.7 1.26 4.0 0.9 1.0 
11 94.2 39.7 0.91 56.9 140 80 6.5 4.5 1.26 2.8 0.9 0.0 
12 88.0 29.1 0.85 30.1 125 76 6.0 4.7 1.22 2.9 1.2 0.1 
13 133.1 55.4 UTM 60.1 115 81 5.9 5.1 1.09 3.7 0.7 0.0 
14 78.6 32.3 0.92 48.7 165 72 6.3 4.6 1.09 3.0 1.1 0.1 
15 91.1 33.0 0.97 53.2 132 81 5.8 4.4 1.78 2.4 0.5 0.0 
17 LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU I 
18 77.5 31.4 0.95 50.6 128 76 5.9 7.7 1.38 4.7 3.6 0.0 
19 118.8 45.8 0.83 57.8 168 103 5.9 4.8 1.38 3.1 0.8 0.0 
20 LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU 
21 81.2 30.2 0.78 NR 116 73 5.7 4.8 1.34 3.1 0.7 0.0 
22 113.7 41.8 0.88 52.8 141 81 9.7 3.7 0.9 2.3 1.1 0.7 
23 110.4 33.3 0.93 35.7 137 96 7.0 4.7 1.16 3.1 1.0 0.0 
24 LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU 
25 LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU 
26 73.1 26.2 0.97 42.5 144 89 6.2 4.3 1.82 2.0 1.1 0.0 
27 80.2 33.8 0.95 53.0 152 85 6.2 6.9 1.73 4.6 1.3_ .. _ 0.2 
UTM = unable to measure, NR = not recorded, LFU = lost to follow-up 
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Low carbohydrate diet study· Dietary intake for all subjects at baseline 
% Energy from: 
Subject Energy Protein Carbohydrate 
no (kcal) (g) Fat (g) (g) Protein Fat Carbohydrate Alcohol 
01 1903 107.8 88.2 181.6 22.6 41.6 35.7 0.0 
02 1792 93.4 69.0 175.1 21.7 36.1 38.2 3.9 
03 2637 104.4 126.0 228.6 15.8 42.9 32.5 8.8 
04 2762 99.3 135.1 250.8 14.4 44.0 34.1 7.5 
05 1295 95.5 38.8 152.2 29.3 26.8 43.8 0.0 
06 2909 108.7 145.0 309.6 15.0 45.0 40.0 0.0 
07 1958 101.7 88.9 171.0 20.8 40.9 32.7 5.6 
08 1537 85.1 33.3 167.9 22.1 19.5 40.9 17.6 
09 1858 54.5 87.6 226.3 11.8 42.5 45.7 0.0 
10 1858 74.8 76.8 226.2 16.1 37.3 45.7 0.8 
11 2738 117.4 136.9 274.2 17.2 45.1 37.7 0.0 
12 2664 139.4 114.6 269.6 20.8 38.6 37.8 2.8 
13 1951 100.6 92.5 186.9 20.8 43.0 36.2 0.0 
14 2782 98.2 90.3 420.7 14.1 29.2 56.7 0.0 
15 1900 72.1 56.5 238.4 15.1 26.7 47.0 11.2 
17 2034 114.4 84.4 218.3 22.5 37.3 40.2 0.0 
18 2413 98.4 121.4 248.0 16.3 45.2 38.5 0.0 
19 1966 101.1 78.4 229.1 20.5 35.8 43.6 0.0 
20 2015 109.4 108.1 114.9 21.5 47.8 21.1 9.6 
21 1396 71.1 60.2 145.4 20.3 38.8 39.0 1.9 
22 2701 110.4 147.0 227.3 16.9 50.6 32.6 0.0 
23 2599 105.8 89.8 293.7 16.2 30.9 42.1 10.7 
24 1997 72.8 95.1 226.4 14.6 42.9 42.5 0.0 
25 1976 77.5 77.4 251.6 15.8 35.4 48.0 0.8 
26 1946 81.7 86.4 168.8 16.8 39.9 32.5 10.8 
27 1798 79.6 76.9 199.5 18.1 39.4 42.5 0.0 -------_ .. _---
84 
Low carbohydrate diet study. Dietary intake for all subjects at 3 months 
% Energy from: 
Subject Energy Protein Carbohydrate 
no (kcal) (g) Fat (g) (g) Protein Fat Carbohydrate Alcohol 
01 1701 82.8 65.0 209.3 19.5 34.4 46.1 0.0 
02 967 75.4 36.9 81.6 31.2 34.4 31.7 0.0 
03 1318 100.6 61.5 21.6 30.6 42.1 6.2 21.2 
04 1284 86.0 72.0 53.7 36.9 50.7 15.8 6.6 
05 1146 100.4 43.6 92.4 34.8 34.0 30.0 1.2 
06 FDNC FDNC FDNC FDNC FDNC FDNC FDNC FDNC 
07 1926 109.1 102.0 95.7 22.7 47.8 18.7 10.8 
08 1334 72.3 35.3 137.3 21.4 23.5 38.1 17.0 
09 1609 65.4 46.3 249.0 16.2 25.9 57.9 0.0 
10 1646 98.4 120.3 33.2 24.0 65.9 7.6 2.6 
11 1498 107.4 103.2 36.7 28.7 62.1 9.2 0.0 
12 1970 77.4 86.0 200.4 16.1 40.3 39.2 4.4 
13 1239 78.5 53.8 95.3 25.3 39.1 28.8 6.8 
14 1334 141.1 63.5 52.9 42.3 42.8 14.9 0.0 
15 1354 64.5 39.3 152.4 19.1 26.2 42.3 12.4 
17 LFU LFU LFU LFU LFU LFU LFU LFU 
18 1104 98.3 55.0 58.9 35.5 44.6 19.9 0.0 
19 1184 104.8 46.0 93.8 35.4 34.9 29.7 0.0 
20 LFU LFU LFU LFU LFU LFU LFU LFU i 
21 FDNC FDNC FDNC FDNC FDNC FDNC FDNC FDNC 
22 1422 69.5 75.8 23.2 19.6 48.1 6.2 26.1 i 
23 1872 105.3 86.3 109.9 22.4 41.3 22.0 14.3 
24 LFU LFU LFU LFU LFU LFU LFU LFU I 
25 LFU LFU LFU LFU LFU LFU LFU LFU ! 
26 1545 87.7 84.2 76.7 22.6 48.9 18.6 9.8 I 
27 1286 ~_58.3. 48.5 164.1 18·1_ L __ 34.0 47.9 0.0 I --_. -- ---- --
FDNC = food diary not completed, LFU - lost to follow-up 
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Low carbohydrate diet study - quality of life and hunger score for all subjects at baseline 
Subject Hunger 
no WHO·5 (%) score 
01 44 4 
02 76 3 
03 88 5 
04 92 4 
05 92 4 
06 24 4 
07 60 3 
08 88 4 
09 72 5 
10 52 4 
11 56 3 
12 68 5 
13 36 4 
14 44 5 
15 44 5 
17 24 4 
18 24 3 
19 60 3 
20 80 5 
21 32 3 
22 48 3 
23 48 4 
24 48 5 
25 52 5 
26 48 3 
27 20 8 
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Low carbohydrate diet study - quality of life and hunger score for all subjects at 3 months 
Subject Hunger 
no WHO-51%1 score 
01 32 3 
02 100 3 
03 80 3 
04 60 4 
05 80 5 
06 24 4 
07 68 4 
08 100 3 
09 68 3 
10 64 3 
11 36 4 
12 88 5 
13 56 3 
14 76 3 
15 68 4 
17 LFU LFU 
18 72 6 
19 80 6 
20 LFU LFU 
21 32 3 
22 72 6 
23 44 6 
24 LFU LFU 
25 LFU LFU 
26 32 4 
27 48 5 
LFU = lost to follow-up 
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Low carbohydrate study - Self-monitored ketone levels for all subjects during Week 1 
I 
Subject no Ketone readings (mmol/I) 
01 0.0 0.0 0.0 0.0 0.0 0.0 NR NR NR NR NR NR NR 
02 0.0 0.1 0.2 0.0 0.3 0.3 0.3 0.3 NR NR NR NR NR 
03 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.3 0.4 0.3 0.6 0.3 0.7 
04 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 
05 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 
06 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
07 0.0 0.0 0.1 0.2 0.2 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 
08 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 
09 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.1 
10 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.4 0.3 0.8 0.7 0.2 0.2 
11 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
12 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
13 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
14 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 
15 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
17 LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU 
18 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 
19 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 
20 LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU 
21 NR NR NR NR NR NR NR NR NR NR NR NR NR 
22 0.3 0.2 0.4 0.5 0.2 0.8 0.4 0.4 0.4 0.5 0.1 0.2 0.8 
23 NR NR NR NR NR NR NR NR NR NR NR NR NR 
24 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 NR NR NR NR 
25 LFU LFU LFU LFU LFU lFU LFU LFU lFU LFU LFU LFU LFU 
26 0.1 0.0 0.1 0.1 0.0 0.1 NR NR NR NR NR NR NR 
27 0.1 .0.0_ ~. 0.1 0.1 0.0 0.1 0.1 0.0 NR _ NR NR NR NR _. 
LFU = lost to follow-up, NR = no recordings 
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Low carbohydrate study - Self-monitored ketone levels for all subjects during Week 1 (contd) 
Subject no Ketone readings (mmolll) 
01 NR NR NR NR NR NR NR NR NR NR NR NR NR 
02 NR NR NR NR NR NR NR NR NR NR NR NR NR 
03 0.4 0.3 0.2 0.6 0.6 0.6 0.5 1.0 0.5 1.2 0.5 0.9 0.4 
04 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 
05 0.3 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.4 
06 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 
07 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.0 NR NR 
08 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 
09 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 NR NR 
10 0.4 0.1 0.0 0.3 0.6 0.6 0.7 0.6 0.9 1.2 0.2 0.3 0.2 
11 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
12 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 
13 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
14 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
15 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
17 LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU 
18 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 
19 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 
20 LFU LFU LFU LFU LFU LFU LFU LFU lFU lFU LFU LFU LFU 
21 NR NR NR NR NR NR NR NR NR NR NR NR NR 
22 0.6 0.4 0.9 0.3 0.2 0.4 0.5 0.4 0.4 0.2 1.2 0.7 0.7 
23 NR NR NR NR NR NR NR NR NR NR NR NR NR 
24 NR NR NR NR NR NR NR NR NR NR NR NR NR 
25 LFU LFU LFU LFU LFU LFU LFU LFU LFU lFU LFU LFU LFU 
26 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.1 NR NR NR NR NR 
27 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 
LFU = lost to follow-up, NR = no recordings 
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Low carbohydrate study· Self-monitored ketone levels for all subjects during Week 2 
Subject no Ketone readings (mmol/l) 
01 NR NR NR NR 
02 0.0 0.0 0.1 0.1 
03 0.8 0.4 0.2 0.9 
04 0.1 0.1 0.0 0.1 
05 0.1 0.3 0.2 0.0 
06 0.0 0.0 0.0 0.0 
07 0.0 0.0 0.0 0.1 
08 0.0 0.0 0.0 0.1 
09 0.0 0.0 0.1 0.0 
10 0.2 0.1 0.6 0.2 
11 0.0 0.0 0.0 0.0 
12 0.0 0.3 0.0 0.0 
13 0.0 0.0 0.0 0.0 
14 0.0 0.0 0.0 0.0 
15 0.0 0.0 0.1 0.1 
17 LFU LFU LFU LFU 
18 0.0 0.2 0.1 0.0 
19 0.0 0.1 0.1 0.1 
20 LFU LFU LFU LFU 
21 NR NR NR NR 
22 1.7 0.8 0.8 0.7 
23 NR NR NR NR 
24 NR NR NR NR 
25 LFU LFU LFU LFU 
26 0.1 0.2 NR NR 
27 NR NR NR NR 
LFU = lost to follow-up, NR = no recordings 
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Low carbohydrate study - Self-monitored ketone levels for all subjects during Week 3 
Subject no Ketone readings (mmol/l) 
01 0.0 0.0 0.0 0.0 
02 0.1 0.0 0.0 0.2 
03 0.8 0.8 0.8 0.4 
04 0.0 0.0 0.0 0.0 
05 0.0 0.1 0.3 0.1 
06 0.1 0.0 0.0 0.0 
07 0.0 0.0 0.0 0.0 
08 0.0 0.0 0.0 0.0 
09 0.0 0.0 0.0 NR 
10 0.4 0.2 0.4 0.3 
11 0.1 0.1 0.0 0.0 
12 0.0 0.1 0.0 0.0 
13 0.0 0.0 0.1 0.0 
14 0.0 0.0 0.0 0.0 
15 0.0 0.0 0.0 0.0 
17 LFU LFU LFU LFU 
18 0.0 0.0 0.0 0.0 
19 0.1 0.0 0.1 0.1 
20 LFU LFU LFU LFU 
21 NR NR NR NR 
22 NR NR NR NR 
23 NR NR NR NR 
24 NR NR NR NR 
25 LFU LFU LFU LFU 
26 0.0 0.0 0.1 
27 NR NR NR NR 
LFU = lost to follow-up, NR = no recordings 
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Low carbohydrate study - Self-monitored ketone levels for all subjects during Week 4 
Subject no Ketone readings (mmolll) 
01 0.0 0.0 0.0 0.0 
02 0.1 0.2 0.3 0.3 
03 1.1 0.6 0.6 0.4 
04 0.0 0.0 0.0 0.1 
05 0.0 0.0 0.1 0.0 
06 0.0 0.0 0.0 0.0 
07 0.0 0.0 0.0 0.0 
08 0.0 0.2 0.3 0.1 
09 0.0 0.2 0.1 NR 
10 0.1 0.2 0.7 0.7 
11 0.0 0.0 0.0 NR 
12 0.0 0.1 0.0 0.0 
13 0.0 0.1 0.1 0.0 
14 0.0 0.0 0.1 0.1 
15 0.0 0.0 0.0 0.0 
17 LFU LFU LFU LFU 
18 0.0 0.0 0.0 0.0 
19 0.1 0.1 0.0 0.0 
20 LFU LFU LFU LFU 
21 NR NR NR NR 
22 NR NR NR NR 
23 NR NR NR NR 
24 NR NR NR NR 
25 LFU LFU LFU LFU 
26 0.0 0.0 NR NR 
27 0.0 0.0 0.0 0.0 
LFU = lost to follow-up, NR = no recordings, DNA = did not attend this visit 
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Low carbohydrate study· Self-monitored ketone levels for all subjects during Week 5 
Subject no Ketone readings (mmol/l) 
01 0.0 0.0 0.0 0.0 
02 0.0 0.0 0.1 0.2 
03 0.8 0.5 0.5 0.2 
04 0.0 0.0 0.0 0.1 
05 0.0 0.0 0.0 0.0 
06 NR NR NR NR 
07 0.0 0.0 0.2 0.2 
08 0.2 0.0 0.0 0.4 
09 NR NR NR NR 
10 0.3 0.2 0.7 0.1 
11 0.0 0.0 0.1 0.1 
12 0.0 0.0 0.0 0.0 
13 0.0 0.0 0.1 0.0 
14 0.0 0.0 0.0 NR 
15 0.0 0.0 0.0 0.0 
17 LFU LFU LFU LFU 
18 0.0 0.0 0.0 0.0 
19 0.0 0.1 0.1 0.0 
20 LFU LFU LFU LFU 
21 NR NR NR NR 
22 NR NR NR NR 
23 DNA DNA DNA DNA 
24 LFU LFU LFU LFU 
25 LFU LFU LFU lFU 
26 0.0 0.0 0.0 NR 
27 0.0 0.0 0.0 0.0 
LFU = lost to follow-up, NR = no recordings, DNA = did not attend this visit 
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Low carbohydrate study· Self-monitored ketone levels for all subjects during Week 6 
Subject no Ketone readings (mmolll) 
01 0.0 0.0 0.0 0.0 
02 0.0 0.2 0.0 0.1 
03 0.5 0.4 0.4 0.3 
04 0.0 0.0 0.0 0.1 
05 0.0 0.0 0.0 0.0 
06 NR NR NR NR 
07 0.1 0.1 0.1 0.1 
08 0.1 0.1 0.1 0.1 
09 0.0 0.0 0.0 NR 
10 0.2 0.1 0.4 0.2 
11 0.0 0.0 0.0 0.1 
12 0.0 0.0 0.0 0.0 
13 0.0 0.0 0.1 0.0 
14 0.0 0.0 0.0 0.1 
15 0.0 0.0 0.0 0.0 
17 LFU LFU LFU LFU 
18 0.0 0.0 0.0 0.0 
19 0.0 0.0 0.0 0.0 
20 LFU LFU LFU LFU 
21 NR NR NR NR 
22 NR NR NR NR 
23 NR NR NR NR 
24 LFU LFU LFU LFU 
25 LFU LFU LFU LFU 
26 0.0 0.2 0.0 NR 
27 0.0 0.0 0.0 0.0 
LFU = lost to follow-up, NR = no recordings 
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Low carbohydrate study - Self-monitored ketone levels for all subjects during Week 7 
Subject no Ketone readings (mmolll) 
01 0.0 0.0 0.0 0.0 
02 0.0 0.0 0.0 0.0 
03 0.2 0.2 0.3 0.2 
04 0.0 0.1 0.1 0.0 
05 0.0 0.0 0.1 0.0 
06 NR NR NR NR 
07 0.1 0.1 0.1 0.0 
08 0.0 0.0 0.1 0.0 
09 0.0 0.2 0.0 NR 
10 0.4 0.5 0.5 0.2 
11 0.1 0.0 0.0 0.0 
12 0.0 0.1 0.0 0.0 
13 0.0 0.0 0.1 0.0 
14 0.0 0.0 0.0 0.0 
15 0.0 0.0 0.0 0.0 
17 LFU LFU LFU LFU 
18 NR NR NR NR 
19 0.0 0.0 0.1 0.1 
20 LFU LFU LFU LFU 
21 NR NR NR NR 
22 NR NR NR NR 
23 NR NR NR NR 
24 LFU LFU LFU LFU 
25 LFU LFU LFU LFU 
26 0.0 NR NR NR 
27 0.0 0.1 0.0 0.0 
LFU = lost to follow-up, NR = no recordings 
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Low carbohydrate study - Self-monitored ketone levels for all subjects during Week 8 
Subject no Ketone readings (mmolll) 
01 0.0 0.0 0.0 0.0 
02 0.0 0.0 0.2 0.0 
03 0.3 1.0 0.4 NR 
04 0.0 0.0 0.0 0.1 
05 0.0 0.0 0.0 0.1 
06 NR NR NR NR 
07 0.0 0.1 0.1 0.1 
08 0.0 0.3 0.0 0.0 
09 0.0 0.0 0.0 NR 
10 0.5 0.4 0.7 0.5 
11 0.0 0.0 0.0 0.1 
12 0.0 0.0 0.0 0.0 
13 0.1 0.1 0.0 0.1 
14 0.0 0.0 0.0 0.0 
15 0.0 0.0 0.0 0.5 
17 LFU LFU LFU LFU 
18 0.0 0.0 0.0 0.0 
19 0.0 0.1 0.1 0.0 
20 LFU LFU LFU LFU 
21 NR NR NR NR 
22 1.0 0.8 0.7 0.8 
23 NR NR NR NR 
24 LFU LFU LFU LFU 
25 LFU LFU LFU lFU 
26 0.0 0.1 0.3 0.0 
27 0.0 0.2 0.0 0.2 
LFU = lost to follow-up, NR = no recordings 
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Low carbohydrate study - Self-monitored ketone levels for all subjects during Week 9 
Subject no Ketone readings (mmolll) 
01 0.0 0.0 0.0 0.0 
02 0.0 0.0 0.1 0.0 
03 0.3 1.0 0.4 NR 
04 0.0 NR NR NR 
05 0.0 0.2 0.1 0.0 
06 NR NR NR NR 
07 0.0 0.0 0.0 0.0 
08 0.1 0.0 0.1 0.0 
09 0.0 0.0 0.0 0.0 
10 0.3 0.3 0.4 0.6 
11 0.0 0.0 0.0 0.0 
12 0.0 0.0 0.0 0.0 
13 0.0 0.0 0.0 0.0 
14 0.0 0.0 0.0 0.0 
15 0.0 0.0 0.0 0.0 
17 LFU LFU LFU LFU 
18 0.0 0.0 0.2 0.1 
19 0.1 0.0 0.0 0.1 
20 LFU LFU LFU LFU 
21 NR NR NR NR 
22 1.2 0.7 0.4 0.7 
23 NR NR NR NR 
24 LFU LFU LFU LFU 
25 LFU LFU LFU LFU 
26 0.0 0.0 0.0 NR 
27 0.0 0.0 0.1 0.1 
LFU = lost to follow-up, NR = no recordings 
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Low carbohydrate study· Self-monitored ketone levels for all subjects during Week 10 
Subject no Ketone readings (mmolll) 
01 0.0 0.0 0.0 0.0 
02 0.0 0.0 0.0 0.0 
03 0.4 0.3 0.3 0.2 
04 0.0 0.0 0.0 0.0 
05 0.0 0.0 0.0 0.1 
06 NR NR NR NR 
07 0.0 0.0 0.0 0.0 
08 0.0 0.0 0.1 0.1 
09 0.0 0.1 0.1 NR 
10 0.4 0.8 0.5 0.1 
11 0.0 0.0 0.0 0.1 
12 0.0 0.0 0.1 0.0 
13 0.0 0.0 0.0 0.0 
14 0.0 0.0 0.2 0.1 
15 0.0 0.0 0.0 0.0 
17 LFU LFU LFU LFU 
18 0.0 0.0 0.0 0.0 
19 0.0 0.0 NR NR 
20 LFU LFU LFU lFU 
21 NR NR NR NR 
22 0.9 0.7 0.5 0.5 
23 NR NR NR NR 
24 LFU LFU LFU LFU 
25 LFU LFU LFU lFU 
26 0.0 0.0 0.0 NR 
27 0.1 0.1 0.1 NR 
lFU = lost to follow-up, NR = no recordings 
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Low carbohydrate study - Self-monitored ketone levels for all subjects during Week 11 
Subject no Ketone readings (mmol/l) 
01 0.0 0.0 0.0 0.0 
02 0.0 0.0 0.0 0.0 
03 0.2 0.0 0.4 0.3 
04 0.0 0.0 0.0 0.1 
05 0.0 0.1 0.1 0.1 
06 NR NR NR NR 
07 0.0 0.0 0.1 0.2 
08 0.0 0.1 0.1 0.1 
09 0.0 0.0 0.0 NR 
10 0.0 0.2 0.2 0.1 
11 0.0 0.0 0.0 0.0 
12 0.0 0.2 0.0 0.0 
13 0.0 0.0 0.1 0.0 
14 0.0 0.0 0.2 0.1 
15 0.0 0.0 0.0 0.0 
17 LFU LFU LFU LFU 
18 0.0 0.0 0.0 0.1 
19 0.0 0.0 0.1 0.0 
20 LFU LFU LFU LFU 
21 NR NR NR NR 
22 1.2 0.7 0.8 0.5 
23 NR NR NR NR 
24 LFU LFU LFU LFU 
25 LFU LFU LFU LFU 
26 0.0 0.0 0.2 NR 
27 0.1 0.1 0.0 0.1 
LFU = lost to follow-up, NR = no recorrdings 
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Low carbohydrate study· Self-monitored ketone levels for all subjects during Week 12 
Subject no Ketone readings (mmol/I) 
01 0.0 0.0 0.0 0.0 
02 0.1 0.0 0.2 0.0 
03 0.1 0.1 0.1 0.1 
04 0.0 0.0 0.0 0.1 
05 0.0 0.1 0.1 0.0 
06 NR NR NR NR 
07 0.0 0.0 0.0 0.0 
08 0.0 0.1 0.0 0.2 
09 0.0 0.0 0.0 0.0 
10 0.1 0.4 0.4 0.7 
11 0.0 0.0 0.0 0.0 
12 0.0 0.0 0.0 0.0 
13 0.0 0.0 0.0 0.0 
14 0.0 0.0 0.0 0.0 
15 0.0 0.0 0.0 0.0 
17 LFU LFU LFU LFU 
18 0.0 0.0 0.0 NR 
19 0.0 0.0 0.0 0.0 
20 LFU LFU LFU LFU 
21 NR NR NR NR 
22 0.8 0.7 0.4 0.5 
23 NR NR NR NR 
24 LFU LFU LFU LFU 
25 LFU LFU LFU LFU 
26 0.0 0.0 0.0 0.1 
27 NR NR NR NR 
LFU = lost to follow-up, NR = no recordings 
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Video-based education study· Demographics of all subjects at 
baseline 
Duration of 
Subject Gender Age DM 
no (M/F) (years) (months) Randomisation 
001 F 67.9 2 video 
002 F 57.7 1 delay 
003 F 55.2 1 delay 
004 M 54.2 4 video 
005 M 60.6 2 video 
006 F 75.4 1 video 
007 M 49.9 4 delay 
008 M 64.5 4 delay 
009 F 64.2 3 delay 
010 M 70.9 6 video 
011 M 48.1 2 video 
012 F 63.0 7 delay 
013 M 72.1 2 delay 
015 F 56.5 7 video 
016 F 43.9 6 video 
017 F 47.6 7 video 
018 F 71.7 2 delay 
019 F 71.6 2 delay 
020 F 59.2 2 video 
021 F 66.6 2 video 
022 F 64.7 1 delay 
023 F 49.2 4 video 
024 F 60.5 1 video 
025 M 65.8 9 delay 
026 M 75.5 1 delay 
027 M 45.1 3 video 
028 M 68.2 1 delay 
029 M 65.8 1 video 
030 M 73.9 1 delay 
031 F 67.6 4 delay 
032 F 67.3 5 video 
034 M 45.7 2 delay 
035 M 63.3 1 video 
037 F 59.8 10 video 
038 M 70.5 6 delay 
039 M 67.3 3 video 
040 F 63.9 2 delay 
041 F 62.5 6 delay 
042 F 53.2 8 video 
043 M 53.5 4 delay 
045 F 47.8 4 video 
046 F 39.8 6 delay 
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Video-based education study - Biomedical results for all subjects at baseline 
Systolic Diastolic Total HDL LDL 
Subject Weight BMI Waist/hip %body BP BP A1c cholesterol cholesterol cholesterol Triglycerides 
no (kg) (kg/m2) ratio fat (mmHgl (mmHg) (%) (mmolll) (mmolll) (mmolll) (mmolll) 
001 116.5 39.4 0.89 56.7 136 84 9.0 4.9 1.05 2.71 2.5 
002 82.3 29.5 0.95 47.3 133 78 8.3 7.3 1.13 4.35 4.0 
003 88.5 33.3 0.88 50.3 134 79 6.6 6.0 1.47 3.62 2.0 
004 96.4 32.2 0.97 34.2 126 92 8.2 5.5 0.75 4.02 1.6 
005 87.1 27.4 0.99 28.7 180 84 8.8 6.0 1.39 2.29 5.1 
006 74.6 27.1 0.96 49.1 133 76 7.3 4.8 1.64 2.57 1.3 
007 113.0 30.3 0.95 31.4 167 99 6.3 5.7 1.25 3.95 1.1 
008 90.7 30.3 1.02 34.0 124 72 6.3 3.4 0.71 1.83 1.9 
009 93.2 35.0 0.89 51.6 123 82 6.5 3.8 0.94 2.00 1.9 
010 79.1 26.7 0.95 28.2 161 80 6.6 2.4 0.66 1.33 0.9 
011 88.4 31.7 0.94 35.6 136 94 8.0 6.1 1.54 3.29 2.8 
012 106.4 37.7 1.00 56.1 132 84 7.4 no result no result no result no result 
013 84.7 28.2 1.00 32.2 179 81 7.3 4.1 1.01 2.73 0.8 
015 99.0 35.1 1.00 49.9 158 68 7.2 5.3 1.09 3.21 2.2 
016 90.4 31.7 0.91 46.9 108 79 7.1 5.2 1.01 3.51 1.5 
017 92.8 31.7 1.02 46.6 125 70 8.4 5.1 1.18 3.33 1.3 
018 108.0 40.6 0.91 58.4 160 84 7.0 3.8 0.85 2.13 1.8 
019 83.0 31.6 0.95 51.0 156 78 6.7 4.3 0.96 2.39 2.1 
020 73.0 28.2 0.85 44.9 147 90 6.7 6.3 1.22 4.63 1.0 
021 82.6 27.9 0.89 45.6 143 64 6.1 4.9 1.1 3.00 1.8 , 
022 75.6 26.5 0.83 42.2 142 76 14.0 6.0 2.4 3.26 0.8 , 
023 85.5 34.7 0.83 49.6 147 98 7.1 6.1 1.3 3.92 1.9 
024 111.5 42.5 0.95 no result 130 89 8.4 4.3 1.6 2.20 1.1 
025 71.0 24.9 0.97 32.3 144 60 5.8 2.7 1 1.37 0.7 
026 110 29.8 1.03 36.3 174 95 7.2 4.2 1.5 2.08 1.4 
027 78.3 24.7 0.89 26.3 123 76 6.1 2.5 0.8 0.62 2.4 
028 83.5 30.3 0.98 37.8 162 86 6.4 5.4 0.9 3.05 3.2 
029 92.1 30.8 0.94 31.6 140 74 11.6 3.6 0.8 1.65 2.5 
030 86.7 27.1 0.95 31.0 158 87 6.1 4.7 1.1 no result_ no result 
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Video-based education study - Biomedical results for all subjects at baseline (contd) 
Systolic Diastolic Total HDL LDL 
: Subject Weight BMI Waist/hi %body BP BP A1c cholesterol cholesterol cholesterol Triglycerides 
no (kg) (kg/m2) p ratio fat (mmHg) (mmHg) (%) (mmolll) (mmolll) (mmolll) . (mmolll) 
031 66.5 24.4 0.83 40.3 108 68 6.3 5.5 1.3 3.20 2.2 
032 58.1 22.1 0.87 42.9 134 68 6.5 3.3 1 1.69 1.3 
034 110.1 36.8 1.04 39.1 140 100 11.7 6.7 1.1 4.31 2.8 
035 127.0 39.2 1.02 39.6 182 117 6.4 5.8 1.3 4.10 0.8 
037 108.2 36.0 0.91 50.6 130 80 5.8 5.1 1.1 3.50 1.1 
038 85.0 31.2 1.02 30.7 130 68 6.7 4.3 0.8 2.60 1.9 
039 96.1 29.7 0.91 30.0 116 67 7.3 3.1 0.8 1.60 1.5 
040 59.4 23.2 0.91 39.1 176 60 5.9 3.8 1.8 1.60 0.9 
041 100.5 38.3 0.98 51.0 164 77 6.4 5.5 1.3 3.70 1.0 
042 73.9 32.0 0.95 47.8 169 83 8.4 4.1 1.0 1.30 3.9 
043 75.5 23.6 0.95 23.8 116 62 6.9 3.9 1.0 2.50 0.9 
045 94.4 39.8 0.96 45.7 103 62 7.6 3.9 1.3 2.30 0.6 
046 80.2 30.2 0.95 43.5 159 91 6.3 4.3 0.9 2.70 1.5 -
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Video-based education study· Biomedical results for all subjects at 6 months follow-up 
Systolic Diastolic Total HDL LDL 
Subject Weight BMI Waist/hip %body BP BP A1c cholesterol cholesterol cholesterol Triglycerides 
no (kg) (kg/m2) ratio fat (mmHg) (mmHg) (%) (mmol/l) (mmol/l) (mmolll) (mmol/l) 
001 106.7 36.1 0.90 53.4 130 88 7.6 3.7 0.97 3.46 1.7 
002 LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU 
003 84.3 31.7 0.82 48.6 137 73 6.5 6.8 1.7 4.2 2.0 i 
004 99.6 33.3 0.97 35.3 145 84 6.6 4.2 0.9 2.6 1.6 
005 87.4 29.9 1.00 31.1 158 80 9.7 5.6 1.8 3 1.8 
006 74.9 27.1 0.92 48.1 146 84 7.2 5.0 1.6 2.8 1.4 
007 116.6 31.6 0.98 34.8 171 100 6.8 4.6 1.3 2.9 0.8 
008 92.9 31.0 0.98 34 137 82 6.6 3.7 0.6 1.5 3.6 
009 92.7 34.9 0.90 52.5 136 83 6.1 4.1 no result 2.1 
010 81.2 27.4 0.95 34.2 173 88 6.6 2.1 0.7 0.8 1.3 
011 88.2 31.6 0.92 31.3 156 94 6.6 5.5 1.2 2.34 4.3 
012 LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU 
013 LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU LFU 
015 99.2 35.1 1.00 51.1 168 86 7.5 5.1 1.1 2.5 3.2 
016 92.5 32.4 0.88 43.1 125 73 6.6 5.6 no result no result 1.6 
017 91.3 31.2 1.00 40.6 102 63 5.1 4.3 1.5 2.5 0.7 
018 107.8 40.6 0.92 56.8 147 74 7.1 3.5 0.9 1.8 1.7 
019 81.4 31.0 0.98 50.5 183 100 5.8 4.5 1.5 2.2 1.8 
020 62.4 24.1 0.93 39.9 121 81 6.2 4.2 1.5 2.3 0.9 
021 78.8 26.6 0.89 44 127 75 6.1 4.4 1.2 2.5 1.5 
022 71.6 25.1 0.81 36 101 57 7.6 3.9 2.4 1.2 0.6 
023 84 34.1 0.82 47.3 157 102 6.4 5.9 1.3 3.6 2.2 
024 105.5 40.2 0.88 no result 125 74 6.7 4.3 1.6 2.0 1.6 
025 70.4 24.6 0.98 32.5 136 64 5.8 2.7 0.9 1.4 0.9 
026 109.4 29.7 1.01 36.2 163 100 7.5 4.8 1.5 1.95 2.0 
027 77.4 24.4 0.88 19.9 111 76 6 2.5 0.9 1.0 1.4 
028 85.1 30.9 0.98 38.2 166 94 6.7 7.9 1.0 5.5 3.0 
029 87.7 29.3 0.96 28.8 140 80 6.3 3.1 1.1 1.2 1.7 
030 90.8 28.3 0.97 32.4 ,------204 __ 104 6.4 4.2 1.0 2.6 '----- _ _ 1_.3 ______ - --- --- - -------- ---_._---
LFU lost to follow up 
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Video-based education study - Biomedica\ resu\ts for a" subjects at 6 months fonow-up (contd) 
Systolic Diastolic Total HDL LDL I 
Subject Weight BMI Waist/hip %body BP BP A1c cholesterol cholesterol cholesterol Triglycerides I 
no (kg) (kg/m2) ratio fat (mmHgl JmmHgl (%) (mmolll) (mmolll) (mmolll) (mmolll) 
031 65.4 24.0 0.82 40.8 135 80 6 4.9 1.2 2.9 1.8 
032 57.3 21.8 0.91 40.1 133 58 6.6 3.2 0.9 1.5 1.8 
034 120.1 40.1 1.06 38.1 132 79 7.3 4 0.9 2 2.36 
035 133.2 41.0 1.08 43.6 136 77 6.5 3.3 1.4 1.6 0.66 
no no no 
037 no result result no result result result no result 5.7 4.4 no result no result no result 
no no 
038 81 29.8 no result result result no result 6.3 3.7 no result no result 1.74 
039 95.2 29.3 0.91 31.3 124 73 7.7 2.8 0.9 1.2 1.42 
040 57.3 22.4 0.89 41.4 173 72 5.9 4.6 2.1 2.2 0.75 
041 104.7 39.7 0.95 55.6 159 85 7 4.9 1.3 3.2 0.82 
042 78.2 33.8 0.94 54.1 155 77 7.5 4.1 1.1 no result 5.14 
043 76.7 23.9 0.90 27.2 126 71 5.9 4.2 1.1 2.7 0.95 
045 87.8 37.0 0.94 47.7 111 60 7.7 5.2 1.2 3.2 1.68 
046 76.2 28.6 0.90 39.6 142 91 6.2 4 1.2 2.1 1.54 
LFU lost to follow up 
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Video-based education study - Absolute dietary intake for an subjects at baseline 
Total Dietary 
Subject Energy Protein Carbohydrate sugars Saturated Monounsaturated Polyunsaturated fibre 
no (kcal) (g) Fat (g) (g) (g) fat (g) fat (g) fat (g) (g) 
001 1563 65.8 62.5 197.1 79.2 22.6 23.3 11.1 14.5 
002 1401 60.8 60.0 165.5 55.2 24.4 17.6 10.1 9.6 
003 1307 83.3 48.7 142.9 69.3 16.4 15.4 10.7 11.3 
004 1871 95.7 68.4 234.5 89.1 21.7 23.4 14.5 17.0 
005 1442 85.6 51.4 98.1 29.4 18.5 13.2 17.2 12.9 
006 1701 71.3 76.2 195.1 99.6 33.8 23.1 11.7 16.2 
007 2046 101.9 76.1 154.7 69.4 17.7 22.5 17.9 11.7 
008 2046 70.7 75.0 294.0 94.6 18.0 25.0 19.0 18.5 
009 1646 69.3 67.4 202.0 73.1 21.3 25.6 16.4 11.8 
010 2300 89.0 76.5 304.2 87.6 17.9 25.7 25.5 21.9 
011 2135 101.6 66.5 235.6 30.8 14.4 21.9 18.9 12.9 
012 1266 64.9 43.7 162.7 48.8 13.9 14.1 12.2 14.0 
013 1333 76.7 44.6 163.6 62.2 17.0 17.1 6.4 14.3 
015 1647 70.0 50.6 258.3 95.0 13.4 14.7 12.0 16.2 
016 2051 78.6 79.3 251.3 101.4 32.1 24.8 14.9 16.9 
017 3142 99.6 128.7 353.8 103.6 51.9 31.0 11.9 17.8 
018 1484 52.1 58.3 182.9 69.4 25.4 19.7 7.9 10.6 
019 1553 54.2 58.3 213.0 119.2 16.1 21.4 15.6 24.4 
020 1189 67.3 32.3 154.5 60.2 11.4 12.3 6.0 13.0 
021 1688 79.6 55.7 225.3 78.5 16.0 12.7 13.5 18.7 
022 2169 87.1 98.5 242.9 114 32.9 36.3 21.3 21.1 
023 1795 73.4 70.4 181.4 75.0 24.6 23.8 15.7 15.2 
024 1406 66.1 75.7 122.6 32.9 32.2 26.7 11.5 8.0 
025 1819 83.3 54.7 261.2 113.5 15.8 17.1 14.5 28.2 
026 1698 98.1 82.6 125.6 39.1 22.5 36.9 15.5 11.1 
027 1546 81.1 44.0 210.3 90.5 7.2 14.7 11.6 19.9 
028 2257 128.2 77.1 284.7 65.1 29.4 20.8 17.9 26.8 
029 2312 108.1 99.9 235.7 36.9 27.4 29.2 27.5 14.9 
030 1886 61.8 68.1 271.2 141.3 23.8 20.2 17.9 18.9 
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Video-based education study - Absolute dietary intake for all subjects at baseline (contd) 
Total Dietary 
Subject Energy Protein Carbohydrate sugars Saturated Monounsaturated Polyunsaturated fibre 
no (kcal) (g) Fat (g) (g) (g) fat (g) fat (g) fat (g) (g) 
031 1589 58.9 67.5 197.4 76.5 32.4 19.2 7.1 13.5 
032 2031 80.2 95.4 227.3 47.4 29.9 33.8 19.9 19.1 
034 2414 99 110.9 240.1 72.1 38.2 36.1 28.5 17.4 
035 1794 82.3 89.3 151.0 36.9 38.0 32.3 12.2 10.5 
037 1280 66.8 36.8 181.6 101.6 9.7 11.2 3.5 9.7 
038 2326 107 96.1 273 138.8 41.5 34.7 12.8 14.1 
039 1917 77.0 84.5 226.9 58.5 24.1 23.6 28.1 15.1 
040 1826 59.7 65.2 263.9 96.8 23.2 19.1 14.3 19.0 
041 2466 131.4 70.4 374.6 183.1 20.3 21.2 16.0 17.0 
042 1829 84.0 69.3 206.0 99.4 17.1 23.1 21.1 20.0 
043 2995 122.4 167.2 256.3 86.1 49.8 59.5 42.3 25.0 
045 1691 77.9 54.4 239 133.2 20.7 19.4 9.6 15.0 
046 2287 70.9 103.8 234.2 88.0 38.0 37.4 22.7 18.0 
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Video-based education study· Absolute dietary intake for all subjects at six months 
Total Dietary I 
Subject Energy Protein Carbohydrate sugars Saturated Monounsatured Polyunsaturated fibre 
no (kcal) (g) Fat (g) (g) (g) fat (g) fat (g) fat (g) (g) 
001 1492 74.1 50.1 200.2 83.1 12.3 20.2 12.7 8.2 
002 LFU LFU LFU LFU LFU LFU LFU LFU LFU 
003 1576 71.7 64.3 190.3 75.4 22.5 22 13 7.3 
004 2306 95.3 89.3 298.5 116.1 34.3 30 16.9 17.1 
005 1851 87 38 126.9 48.7 17.7 11.7 4.2 11.8 
006 1907 87.3 80.2 214.6 109.7 34.9 22.7 7.4 19.1 
007 2199 101.2 79.8 201.4 86.6 37.5 25.3 10.3 13.5 
008 2209 80.8 80.7 315.5 102 15.1 20.1 19.3 25.3 
009 1283 71.7 54.9 132.6 48 22.1 19.2 8.4 12 
010 1814 79.3 59.9 232.7 67 21.7 21.1 8.1 23.8 
011 2036 90.8 60.1 272.3 35.6 13.8 17.9 17.1 9.5 
012 LFU LFU LFU LFU LFU LFU LFU LFU LFU 
013 LFU LFU LFU LFU LFU LFU LFU LFU LFU 
015 1927 92.7 62 276.9 86.7 18 16.2 13 13 
016 2016 75.1 120.1 174 91.1 52.2 37.9 17.7 11.9 
017 1675 99.4 43.9 200.6 75.7 12.4 15.9 6.3 20.4 
018 1232 63 47.5 142.2 55.9 19.2 14.9 8.7 4.4 
019 1565 61.6 47.6 233.6 119.9 13 15.6 13.8 23.6 
020 1793 101.9 66.3 196.9 99.8 19.7 20.1 21.4 20.3 
021 1435 68.5 47.1 179.3 74.1 12.2 17.7 12.7 14.6 
022 1838 80.6 70.8 233.4 73.2 24.4 23.8 17 23 
023 2393 88.6 106.5 247 67.8 41.1 35 17 13.7 
024 1387 76.5 51.2 165 42 18.5 16.5 11.3 11.3 
025 1972 78.2 65.9 277.7 110.5 12.9 27.9 20.2 22 
026 1447 75.7 75.5 95.8 23.8 28.5 28.7 11.3 6.4 
027 1903 77.1 58.4 259.5 93.6 9.6 15.5 20.2 27 
028 1901 69.1 82 237.1 93.9 25.3 28 23 16.4 
029 1409 57.2 53.2 139.2 49.1 20.3 17.8 7.2 12.8 
030 2453 ~ ,-----91.2 109.4 277 107.5 36.1 26 20.1 12.2 - _ .. -
LFU lost to follow up FDNC food diary not completed 
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Video-based healthy living study - Absolute dietary intake for all subjects at six months. LFU = lost to follow up 
Total Dietary 
Subject Energy Protein Carbohydrate sugars Saturated Monounsatured Polyunsaturated fibre 
no (kcal). .(g) FatJg) (g) (g) fat (g) fat (g) fat (g) (g) 
031 1620 69.9 50 237.1 113.5 20.8 10.7 8.5 10.2 I 
032 1430 53 64.4 168.1 65 25.6 18 14.1 8 
034 2144 92.8 74.7 216.8 83.1 24.3 21.1 19.4 13.1 
035 1607 95.3 63.1 136.4 31.4 21.8 22.8 7.9 12.2 
037 FDNC FDNC FDNC FDNC FDNC FDNC FDNC FDNC FDNC 
038 FDNC FDNC FDNC FDNC FDNC FDNC FDNC FDNC FDNC 
039 2098 103.4 75.7 268.2 84.0 21.3 28.3 16.4 19.6 
040 1830 49.1 74.3 231.9 100.4 23.4 18.4 13.6 14.1 
041 1922 103.4 63.5 249.1 143.3 24.1 20.6 12.0 24.4 
042 FDNC FDNC FDNC FDNC FDNC FDNC FDNC FDNC FDNC 
043 2644 128.2 95.8 327.4 114.7 31.8 36.5 20.0 31.1 
045 1974 71.8 70.0 259.7 84.5 25.0 26.4 9.6 13.9 
046 1980 66.4 61.8 276.9 103.6 22.8 19.4 12.5 14 
LFU lost to follow up FDNC food diary not completed 
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Video-based education study· % energy from macronutrients for all subjects at baseline 
%Energy from %Energy from %Energy from O/OEnergy from 
Subject no Protein Fat Carbohydrate Alcohol 
001 16.8 35.9 47.2 0.0 
002 17.3 38.5 44.2 0.0 
003 25.0 32.8 40.2 2.0 
004 20.4 32.8 46.8 0.0 
005 23.9 32.2 25.6 18.2 
006 16.8 40.3 43.0 0.0 
007 19.9 33.4 28.3 18.3 
008 13.7 32.8 53.5 0.0 
009 16.9 37.0 46.2 0.0 
010 15.5 30.0 49.7 4.9 
011 19.0 28.0 41.3 11.8 
012 20.6 31.2 48.3 0.0 
013 23.2 30.4 46.4 0.0 
015 16.4 26.7 56.8 0.0 
016 15.4 35.0 46.3 3.3 
017 12.7 36.9 42.3 8.0 
018 14.0 35.2 46.0 4.8 
019 13.8 33.5 51.0 1.7 
020 22.6 24.4 48.6 4.7 
021 18.8 29.6 49.9 1.7 
022 16.1 41.0 42.1 0.8 
023 16.2 35.1 37.6 11.0 
024 18.8 48.5 32.7 0.0 
025 18.2 26.9 53.5 1.4 
026 23.1 43.7 27.7 5.5 
027 21.0 25.6 50.9 2.5 
028 22.6 30.5 47.0 0.0 
029 18.8 39.0 38.4 3.9 
030 13.0 32.2 53.4 1.5 
031 14.9 38.4 46.8 0.0 
032 15.8 42.3 42.0 0.0 
034 16.4 41.4 37.4 4.8 
035 18.5 45.3 31.9 4.3 
037 20.9 25.9 53.2 0.0 
038 18.5 37.3 44.1 0.1 
039 16.0 39.6 44.3 0.0 
040 13.2 32.3 54.5 0.0 
041 21.3 25.7 52.7 0.0 
042 18.4 34.1 42.3 5.2 
043 16.6 50.9 32.5 0.0 
045 18.4 28.9 52.8 0.0 
046 12.5 41.0 38.6 8.0 
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Video-based education study· % energy from macronutrients for all subjects at 6 months 
%Energy from %Energy from %Energy from %Energy from 
Subject no Protein Fat Carbohydrate Alcohol 
001 19.8 30.1 50.1 0.0 
002 LFU LFU LFU LFU 
003 18.2 36.6 45.2 0.0 
004 16.5 34.9 48.6 0.0 
005 18.8 18.5 25.7 36.9 
006 18.4 37.9 42.3 1.4 
007 18.5 32.8 34.5 14.3 
008 14.5 32.5 53.0 0.0 
009 22.4 38.7 38.9 0.0 
010 17.5 29.8 48.3 4.3 
011 17.8 26.5 50 5.7 
012 LFU LFU LFU LFU 
013 LFU LFU LFU LFU 
015 18.9 28.9 52.8 0.0 
016 14.8 53.2 32.1 0.0 
017 23.7 23.5 44.8 8.0 
018 20.3 34.5 43.0 2.1 
019 15.6 27.2 55.5 1.7 
020 22.7 33.3 41.2 2.8 
021 19.1 29.5 46.8 4.7 
022 17.6 34.7 47.7 0.0 
023 14.9 40.3 39.0 5.8 
024 22.0 33.1 44.5 0 
025 15.8 30.0 52.7 1.4 
026 20.9 47.0 24.8 7.2 
027 16.4 27.7 51.3 4.6 
028 14.5 30.8 46.7 0.0 
029 16.1 33.8 36.9 13.2 
030 14.8 39.9 42.1 3.3 
031 17.3 27.8 54.9 0.0 
032 14.9 40.8 44.3 0.0 
034 17.3 31.4 38.0 13.3 
035 23.7 35.3 31.8 9.2 
037 FDNC FDNC FDNC FDNC 
038 FDNC FDNC FDNC FDNC 
039 19.7 32.4 47.9 0.0 
040 10.9 37.2 48.8 3.5 
041 21.6 29.8 48.6 0.0 
042 FDNC FDNC FDNC FDNC 
043 19.3 32.5 48.2 2.0 
045 14.4 31.5 48.7 5.4 
046 13.4 28.1 52.6 5.9 
LFU = lost to follow-up FDNC = food diary not completed 
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Video-based education study - number of steps per day measured by pedometer 
Baseline 6 months 
Subject Steps Subject Steps 
no per day no per day 
001 2819 001 3530 
002 9120 002 LFU 
003 5871 003 ONe 
004 3046 004 4669 
005 12785 005 9364 
006 6082 006 3499 
007 11944 007 9276 
008 3952 008 8136 
009 1865 009 703 
010 6214 010 11948 
011 4452 011 6500 
012 2194 012 LFU 
013 3922 013 LFU 
015 3500 015 1857 
016 9418 016 6793 
017 7189 017 7020 
018 358 018 586 
019 1546 019 3000 
020 8081 020 6947 
021 1208 021 7367 
022 9904 022 7867 
023 3321 023 3369 
024 7671 024 4576 
025 3614 025 423 
026 4580 026 1543 
027 9524 027 7694 
028 ONe 028 2146 
029 3289 029 3728 
030 6239 030 5779 
031 6825 031 7987 
032 7788 032 4686 
034 11895 034 13441 
035 643 035 2430 
037 DNC 037 ONe 
038 6383 038 DNC 
039 3609 039 2091 
040 945 040 2526 
041 5454 041 3015 
042 9493 042 ONe 
043 8014 043 2870 
045 11810 045 8756 
046 2292 046 8698 
LFU lost to follow up ONe diary not completed 
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Video-based education study· Quality of life for all subjects at baseline 
EQ-SO Dimensions· reported problems 
Subject WHO·S EQ-SD 1 2 3 4 S 
no (%) VAS Mobility Self-care Usual activity Pain/discomfort Anxiety/depfession 
001 24 60 some none some moderate moderate 
002 80 NR none none none none none 
003 48 70 NR NR NR NR none J 
004 80 80 some none none some none ! 
005 48 80 none none none none none 
006 80 90 none none none none none 
007 72 85 none none none none moderate 
008 68 79 none none none moderate none 
009 56 NR none none none none none 
010 80 75 none none none none none 
011 52 80 none none none none none 
012 72 75 none none none none none 
013 68 65 none none none moderate none 
015 76 80 none none none none moderate 
016 28 45 some none none moderate moderate 
017 36 50 some none none none moderate 
018 48 80 some none some moderate moderate 
019 72 60 none none none none moderate 
020 84 NR none none none none none 
021 72 85 some none none moderate none 
022 96 95 none none none none none 
023 80 90 none none none none none 
024 68 71 none none none none none 
025 60 60 some none some moderate moderate 
026 80 90 none none none none none 
027 76 80 none none none not done none 
028 96 80 NR NR NR NR NR 
029 60 67 some none none moderate moderate 
030 60 60 some none some moderate moderate 
NR = not recorded 
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Video-based education study· Quality of life for all subjects at baseline (contd) 
EQ-SD Dimensions· reported problems 
Subject WHO-S EQ-SD 1 2 3 4 5 
no (%) VAS Mobility Self-care Usual activity Pain/discomfort Anxiety/depression 
031 24 50 some some some extreme extreme 
032 56 85 none none none none none 
034 72 85 none none none none none 
035 84 69 none none none none none 
037 76 95 none none none moderate none 
038 88 85 some none some moderate none 
039 80 85 some none some moderate none 
040 72 88 none none none none none 
041 80 90 none none none none NR 
C42 60 90 none none none none none 
043 64 80 none none none none none 
045 56 75 none none none moderate none 
046 32 40 none none none none moderate ! -----
NR = not recorded 
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Video-based education study. Quality of life for all subjects at 6 months. 
EQ-5D Dimensions - reported problems 
Subject WHO-5 EQ-5D 1 2 3 4 5 
no (%) VAS Mobility Self-care Usual activity Pain/discomfort Anxiety/depression 
001 20 59 some none some moderate moderate 
002 LFU LFU LFU LFU LFU LFU LFU 
003 36 50 none none some moderate moderate 
004 92 90 none none none none none 
005 32 60 none none none none none 
006 84 89 none none none none none 
007 76 85 none none none none moderate 
008 76 85 none none none moderate none 
009 72 75 none none none none none 
010 80 85 none none none none none 
011 68 75 none none none none none 
012 LFU LFU LFU LFU LFU LFU LFU 
013 LFU LFU LFU LFU LFU LFU LFU 
015 48 70 none none none none moderate 
016 32 30 some none some moderate moderate 
017 48 NR none none none none moderate 
018 40 50 some none some moderate moderate 
019 76 NR none none none none none 
020 88 90 none none none none none : 
021 60 65 none none none moderate moderate 
022 100 100 none none none none none 
023 72 90 none none none none none 
024 72 81 none none none moderate none 
025 72 85 some none none moderate none 
026 80 98 none none NR none none 
027 76 80 none none none moderate none 
028 80 80 none none none moderate none 
029 80 70 some none none moderate none 
030 80 65 some none some moderate none --
LFU = lost to follow up, NR = not recorded 
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Video-based education study - Qua\ity ot \ife for an subjects at 6 months (contd) 
EQ-5D Dimensions - reported problems 
Subject WHO-5 EQ-5D 1 2 3 4 5 
no (%l VAS Mobility Self-care Usual activity Pain/discomfort Anxietv/depression 
031 80 50 some some some extreme extreme 
032 76 85 none none none moderate none 
034 68 85 none none none none none 
035 72 80 none none none none none 
037 NR NR NR NR NR NR NR 
038 NR NR NR NR NR NR NR 
039 56 90 some none some some none 
040 64 90 none none none none none 
041 84 80 none none none none none 
042 60 91 some none none moderate none 
043 64 70 none none none none none 
045 84 90 none none none moderate none 
046 84 85 none none none none none 
LFU = lost to follow up, NR = not recorded 
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InSight study· Demographics of all subjects at baseline 
Duration of Gender 
Subject No Age (years) OM (years) (M/F) 
001 48 17 F 
002 47 33 F 
003 44 41 M 
004 44 26 M 
005 58 45 F 
006 41 1 F 
007 33 26 F 
008 37 6 F 
009 26 16 F 
010 36 10 M 
011 40 1 F 
012 63 33 F 
013 37 31 F 
014 27 18 F 
015 59 46 F 
016 31 3 M 
017 31 19 M 
018 42 21 F 
019 43 31 M 
020 59 43 F 
021 39 37 F 
022 55 29 F 
023 63 29 F 
024 39 6 M 
025 38 10 M 
026 60 16 F 
027 32 10 M 
028 72 37 M 
029 51 42 M 
030 46 12 F 
031 43 37 M 
032 23 18 F 
033 54 10 M 
034 46 29 M 
035 31 10 F 
036 46 19 F 
037 42 7 F 
038 36 13 M 
039 56 52 M 
040 33 8 F 
041 29 14 M 
042 42 31 F 
043 35 24 F 
044 33 2 F 
045 46 12 F 
046 51 24 F 
047 46 5 F 
048 51 unknown M 
049 31 3 F 
050 28 22 F 
051 25 17 F 
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InSight stu Iy • lome Ica resu s 0 a su IJec sat ase me d B' d' I It f II b' t b r 
Total HDL LDL 
Weight BMI HbA1c cholesterol cholesterol Triglycerides cholesterol 
(kg) (kg/m2) (%) (mmol/l) (mmolJl) Jmmol/l) (mmolll) 
001 103.1 31.5 10.6 4.5 0.9 1.3 3.01 
002 83.1 27.8 7.1 4.0 2.2 0.7 1.48 
003 92.0 31.5 8.8 4.0 1.07 2.0 2.02 
004 87.3 26.1 7.9 4.8 1.4 1.4 2.76 
005 85.1 30.2 8.3 5.2 2.1 1.1 2.60 
006 64.4 22.5 6.7 4.5 1.84 0.6 2.39 
007 83.5 25.5 6.9 4.4 2.2 0.6 1.93 
008 73.6 31.0 5.9 5.6 0.9 5.0 2.43 
009 76.5 29.5 7.1 4.4 1.6 1.1 2.30 
010 79.9 23.6 7.0 4.5 1.1 1.0 2.95 
011 61.4 22.3 8.4 4.5 2.2 0.7 1.98 
012 65.6 25.3 8.7 4.6 3.1 0.5 1.27 
013 60.7 22.6 7.9 4.2 2 0.3 2.06 
014 63.5 25.8 7.4 5.0 2.4 0.8 2.24 
015 67.3 25.0 8.8 3.5 1.1 0.5 2.17 
016 75.8 23.1 7.4 5.5 2.2 0.4 3.12 
017 77.9 23.0 6.1 no data no data no data no data 
018 74.4 24.0 8.6 4.3 no data 0.3 no data 
019 85.6 30.0 7.6 2.8 no data 0.6 no data 
020 64.7 21.9 9.6 no data no data no data no data 
021 74.5 26.4 7.4 4.9 1.9 0.8 2.64 
022 85.9 32.7 7.0 5.4 1.8 1.2 3.05 
023 64.2 23.6 7.7 4.0 1.9 0.7 1.78 
024 86.8 29.0 10.6 6.7 1.0 3 4.34 
025 61.2 21.7 8.8 3.7 1.2 1.1 2.00 
026 52.9 22.9 10.3 4.7 2.6 0.6 1.83 
027 83.1 23.0 10.6 3.3 1.2 0.8 1.74 
028 112.6 35.5 8.1 4 1.4 1.1 2.10 
029 77.6 23.4 8.3 5.5 1.9 0.7 3.28 
030 86.8 30.8 9.0 4.8 1.7 0.7 2.78 
031 81.4 26.3 7.7 5.6 2.3 0.6 3.03 
032 62.8 21.5 10.8 4.9 2.1 1.2 2.25 
033 85.9 25.7 8.7 4.7 1.6 0.9 2.69 
034 73.1 22.3 8.8 4.4 1.1 0.6 3.03 
035 58.4 23.1 8.5 5.4 2.0 0.8 3.04 
036 76.5 27.8 8.1 5.2 2.2 0.4 2.82 
037 65.2 23.7 9.7 5.3 1.9 0.7 3.08 
038 104.0 30.7 10.0 3.4 1.5 0.4 1.72 
039 79.9 25.5 no data no data no data no data no data 
040 68.7 23.0 9.3 4.1 1.6 0.9 2.09 
041 71.3 21.3 8.9 3.7 1.8 0.5 1.67 
042 75.1 29.3 7.6 3.8 1.7 0.5 1.87 
043 77.6 27.5 8.2 5.0 1.8 0.6 2.93 
044 52.2 18.9 8.9 3.9 1.8 0.5 1.87 
045 79.2 29.8 5.6 4.3 1.9 0.4 2.22 
046 82.8 30.4 8.4 5.3 1.9 0.8 3.04 
047 67.3 23.8 10.0 5.7 1.5 1.4 3.56 
048 77.7 27.9 9.8 no data no data no data no data 
049 60.0 22.3 10.5 4.8 1.7 0.6 2.83 
050 91.1 31.5 9.2 3.6 1.2 0.7 2.08 
051 95.7 32.3 12.8 5.4 1.6 1.4 3.16 
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InSight study - Biomedical results of all subjects at 6 months 
Total HDL LDL 
Weight BMI HbA1c cholesterol cholesterol Triglycerides cholesterol 
(kg) (kg/m2) (%) (mmol/I) (mmol/I) {mmol/l) immol/I) 
001 no data no data 9.4 4.5 0.9 1.3 2.95 
002 84.4 28.2 8.0 4.1 2.5 0.7 1.25 
003 no data no data 7.5 3.9 1.2 1.5 1.95 
004 no data no data 8 no data no data no data no data 
005 no data no data 8.4 no data no data no data no data 
006 no data no data 6.3 4.2 1.8 0.5 2.17 
007 no data no data 8.3 no data no data no data no data 
008 71.4 30.1 no data 4.9 0.8 3.7 2.42 
009 74.6 28.8 6.3 4.4 1.6 1.1 2.30 
010 82.3 24.3 no data no data no data no data no data 
011 63.7 23.1 7.5 4.9 2.0 0.4 2.72 
012 no data no data 8.5 no data no data no data no data 
013 59.3 22.0 8.0 3.5 1.5 0.4 1.82 
014 63.8 25.9 7.9 no data no data no data no data 
015 no data no data 8.8 5.4 1.5 0.8 3.54 
016 no data no data no data 5.3 1.9 0.5 3.17 
017 no data no data 6.2 4.3 1.4 0.8 2.54 
018 no data no data no data 4.4 2.2 0.5 1.97 
019 no data no data 7.4 2.8 1.4 0.5 1.17 
020 no data no data 8.4 no data no data no data no data 
021 no data no data 7.3 4.7 1.8 0.6 2.63 
022 85.6 32.6 6.7 4.4 1.5 1.9 2.04 
023 65.4 25.5 6.7 4.3 2.1 0.6 1.93 
024 83.7 28 9.2 6.2 1.0 4.1 3.34 
025 61.2 21.7 8.1 3.7 1.2 1.1 2.00 
026 51.5 22.3 9.1 4.7 2.6 0.6 1.83 
027 83.0 23.0 9.5 3.3 1.2 0.8 1.74 
028 110.6 34.9 7.9 4.0 1.4 1.1 2.10 
029 75.1 22.7 8.1 5.2 1.9 1 2.85 
030 87.2 30.9 9.3 4.8 1.7 0.7 2.78 
031 80.0 25.8 8.1 5.6 2.3 0.6 3.03 
032 60.4 20.7 9.3 4.9 2.1 1.2 2.25 
033 90.4 27 8.5 4.5 1.43 1 2.62 
034 no data no data 8.8 4.6 1.1 0.5 3.27 
035 58.7 23.3 8.2 5.5 2.1 0.7 3.08 
036 77.3 28.1 9.3 4.5 2.1 0.6 2.13 
037 65.5 23.8 10.3 5.1 1.9 0.7 2.88 
038 104.6 30.9 9.3 2.9 1.3 0.4 1.42 
039 80 25.8 no data no data no data no data no data 
040 67 22.4 8.7 3.7 1.5 0.6 1.93 
041 72.5 21.6 9.4 4.1 1.6 0.8 2.14 
042 73.6 28.7 8.1 5.1 1.6 0.6 3.23 
043 77.4 27.4 7.7 4.8 1.9 0.7 2.58 
044 52.2 18.9 7.8 3.7 1.6 0.5 1.87 
045 79.2 29.8 no data no data no data no data no data 
046 79.5 29.2 8.8 5.4 1.87 0.8 3.17 
047 no data no data 9.1 5.7 1.5 0.9 3.79 
048 79.5 28.5 9.5 no data no data no data no data 
049 58.5 21.8 8.6 4.2 1.4 0.7 2.48 
050 92.2 31.9 9 4.4 1.2 0.9 2.79 
051 92.9 31.4 10.2 5.3 1.7 1.7 2.83 
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. I f InSi! ht study· Biomedlca resu ts 0 all subjects at 1 year 
Total HDL LDL 
Weight BMI HbA1c cholesterol cholesterol Triglycerides cholesterol 
(kg) (kg/m2) (%) (mmolll) (mmolll) lmmolll) (mmolll) 
001 no data no data 9.8 6.7 1.1 1.5 4.85 
002 81 27.1 7.9 3.7 1.9 0.6 1.50 
003 94.9 32.5 7.5 4.2 1.3 1.2 2.30 
004 no data no data 8 4.3 1.3 0.9 2.55 
005 85 30.1 8.4 4.1 1.4 0.9 2.25 
006 85 30.1 7.9 4.3 1.9 0.4 2.20 
007 no data no data 7.9 no data no data no data no data 
008 70.3 29.6 7.1 4.3 0.9 2.5 2.26 
009 75.2 29 6.2 4.7 1.5 0.7 2.88 
010 82.3 24.3 6.4 5.6 1.3 1.1 3.80 
011 67.4 24.5 8.7 4.8 2.2 1.0 2.15 
012 62.8 24.2 8.0 4.5 2.7 0.5 1.57 
013 58.4 21.7 8.5 4.0 1.6 0.4 2.22 
014 66.7 27.1 7.4 4.5 2.1 1.2 1.85 
015 67.7 25.2 8.7 3.9 1.4 0.7 2.18 
016 74.6 22.8 7.2 4.3 2 0.7 1.98 
017 no data no data 6.3 no data no data no data no data 
018 no data no data 7.5 no data no data no data no data 
019 79.7 27.6 7.5 no data no data no data no data 
020 no data no data 7 no data no data no data no data 
021 71.2 25.2 7.8 5.0 1.9 0.8 2.74 
022 85.6 32.6 7.2 6 1.9 1.3 3.51 
023 65.4 25.5 7.2 4.3 2.1 0.6 1.93 
024 83.7 28 9.6 4.3 1 1.5 2.62 
025 63.5 22.5 9 4 1.2 0.9 2.39 
026 53.3 23.1 8 5.2 2.7 0.6 2.23 
027 83.2 23 8.9 4.2 1.2 1 2.55 
028 112.1 35.4 7.8 4.4 1.4 1.2 2.45 
029 75.8 22.9 8.6 5.9 2 0.8 3.54 
030 82.3 29.2 10.2 5.4 1.8 0.8 3.24 
031 79.5 25.7 7.8 5.5 2.1 0.8 3.04 
032 60.4 20.7 9.3 4.9 2.1 1.2 2.25 
033 no data no data 8.4 5 1.57 1 2.98 
034 no data no data 8.9 4.6 1.1 0.5 3.27 
035 57.9 22.9 no data no data no data no data no data 
036 77.2 28 9.5 4.6 1.9 0.2 2.61 
037 no data no data no data no data no data no data no data 
038 103.9 30.7 9.5 3.4 1.3 0.6 1.83 
039 80.5 26 9.8 4.2 2 1.1 1.70 
040 69.2 23.1 8.6 4.7 1.6 0.9 2.69 
041 75.5 22.5 8.9 3.4 1.3 0.7 1.78 
042 73.6 28.7 8.1 5.1 1.6 no data no data 
043 76.9 27.2 7.9 4.7 1.8 0.6 2.63 
044 54.8 19.9 8.5 3.9 1.7 0.5 1.97 
045 79.2 29.7 5.5 4.1 1.9 0.6 1.93 
046 82.2 30.2 7.9 4.7 1.9 0.6 2.53 
047 66.3 23.4 9.5 5.6 1.5 1.2 3.55 
048 80.4 28.8 9 no data no data no data no data 
049 62.5 23.2 9.2 5.1 1.7 0.6 3.13 
050 90.8 31.1 8.7 3.8 1.2 0.6 2.33 
051 93.7 31.7 10 5.4 1.5 0.6 3.63 
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InSight study· PAID results of all subjects at baseline 
Question number (PAID questionnaire) 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
i 001 2 2 3 3 2 3 4 2 3 2 1 2 3 3 2 2 3 1 3 2 
002 0 0 1 0 0 2 3 2 1 2 1 3 2 0 0 1 2 1 1 2 I 
003 1 1 2 0 0 2 1 1 2 3 1 3 0 1 4 1 3 0 2 1 
004 1 1 0 0 1 0 1 0 1 0 1 2 2 0 0 1 0 0 1 1 
005 2 4 0 0 0 1 0 0 3 0 4 2 0 1 2 3 0 0 2 3 
006 1 1 1 0 0 1 1 0 1 0 1 3 3 0 1 0 2 0 1 0 
007 1 1 1 3 1 1 4 0 4 0 0 2 2 1 1 2 1 3 3 1 
008 2 1 0 0 1 0 2 0 0 0 2 1 2 0 0 0 0 0 0 0 
009 0 2 0 0 0 0 0 0 0 0 2 2 2 0 3 0 0 0 0 0 
010 3 0 2 1 1 1 4 1 3 1 0 2 3 1 2 1 1 0 0 0 
011 3 2 3 0 0 4 2 2 4 3 0 4 0 0 2 2 1 0 0 0 
012 0 1 1 0 1 1 1 0 1 0 2 3 3 0 0 3 1 0 2 3 
013 2 2 0 1 0 2 1 0 1 0 3 3 1 0 0 1 3 1 0 2 
014 1 2 0 1 0 1 1 0 2 0 0 2 1 0 0 1 0 0 1 1 
015 0 0 3 0 3 2 0 3 2 3 3 3 3 3 0 0 3 3 3 3 
016 0 1 2 2 1 1 2 1 3 2 1 2 3 0 0 2 1 0 2 1 
017 2 0 2 2 0 2 2 0 1 2 1 2 0 1 0 2 2 0 0 2 
018 2 3 3 0 0 0 2 2 0 0 1 2 2 2 4 1 3 3 0 1 
019 1 1 0 0 0 1 2 0 2 0 2 3 2 0 0 1 0 0 3 2 
020 0 4 4 4 4 4 4 0 0 4 2 4 4 4 0 3 0 0 4 4 
021 0 4 4 0 0 0 2 4 4 0 0 2 0 0 3 4 0 0 4 4 
022 2 2 2 0 0 2 2 0 1 1 3 3 3 0 1 0 2 0 1 0 
023 1 1 0 0 0 0 1 0 1 0 2 2 3 0 0 0 0 0 1 0 I 
024 1 0 1 0 3 3 0 2 3 3 3 4 4 0 0 3 0 0 3 3 , 
025 2 2 2 0 2 3 1 2 1 3 2 4 3 2 2 3 2 0 1 3 I 
026 0 1 0 0 0 2 1 1 3 1 2 1 0 0 0 1 1 0 0 1 
027 1 1 0 2 1 2 3 1 1 1 1 3 2 0 1 1 1 2 3 1 
028 1 1 0 1 0 1 2 0 1 0 1 3 2 2 0 3 1 0 3 1 , 
029 2 0 0 0 0 0 2 0 0 0 0 0 0 0 1 0 0 1 0 0 
030 2 1 2 2 1 3 2 2 1 2 2_ -?- 2 1 0 2 2 2 1 1 ---
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InSight study· PAID results of all subjects at baseline contd 
Question number (PAID questionnaire) 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
032 4 3 4 2 2 4 4 4 2 3 2 4 4 4 0 4 4 4 2 3 
033 0 0 1 1 0 1 1 1 2 2 1 2 2 0 0 0 1 0 0 1 
034 2 3 1 2 3 2 2 2 1 2 3 2 2 1 2 2 2 1 2 2 
035 3 2 1 3 1 2 1 1 4 1 3 1 3 1 2 2 2 1 1 1 
036 1 1 0 0 1 1 1 0 1 0 0 1 1 0 1 1 1 1 1 1 
037 3 4 4 2 2 3 3 4 1 4 4 4 3 4 3 3 4 2 3 3 
038 3 4 0 1 3 1 2 0 1 2 2 1 2 0 2 1 1 0 1 2 
039 0 0 1 0 0 0 0 0 3 0 0 1 0 0 0 0 0 0 0 0 
040 1 1 0 1 0 0 0 0 2 0 1 2 2 0 2 1 1 0 2 0 
041 2 1 2 1 1 1 3 1 2 0 2 3 2 0 1 1 1 1 1 2 
042 1 1 1 2 1 1 1 1 2 1 0 2 1 0 0 2 2 0 1 1 
043 1 2 3 0 0 3 2 3 1 0 3 4 3 1 1 1 2 0 2 1 
044 0 1 1 1 1 0 0 1 2 0 1 1 1 1 1 1 0 0 1 1 
045 1 0 0 1 0 1 1 0 1 0 1 2 1 0 2 1 1 0 0 1 
046 4 3 1 2 0 1 0 0 0 0 0 2 0 0 2 4 2 2 4 4 
047 3 2 4 2 1 3 3 3 4 2 3 3 3 4 1 1 3 3 3 3 
048 3 4 2 0 0 1 1 0 2 0 1 4 3 0 4 1 0 0 3 1 
049 1 2 0 0 0 1 1 1 2 0 2 0 1 0 2 0 1 1 1 0 
050 0 0 3 0 0 3 3 2 1 3 1 3 2 3 0 2 2 0 0 3 
051 0 0 1 1 2 0 0 0 1 0 1 1 0 0 0 0 0 0 0 0 
- _ .. _--
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Insight study· PAID results of all subjects at 6 months 
Question number (PAID Questionnaire) 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
001 1 1 2 1 1 2 2 2 1 1 2 1 1 1 1 2 1 1 2 1 
002 0 0 0 0 1 0 1 0 0 2 2 1 0 1 0 0 0 1 1 0 
003 0 0 1 0 0 1 1 1 1 0 0 0 0 1 2 0 0 1 0 1 
004 0 1 0 0 1 0 0 0 0 0 0 1 2 0 0 1 0 0 1 1 
005 1 2 0 0 0 1 0 0 0 0 3 0 0 1 0 1 0 0 2 2 
006 0 0 0 0 0 0 0 0 1 0 0 1 1 0 0 0 0 0 1 0 
007 1 0 1 4 1 3 4 2 4 0 0 3 4 3 0 1 1 0 3 4 
008 1 1 0 0 1 0 2 0 0 0 1 1 1 0 0 0 0 0 0 0 
009 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 
010 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
011 0 0 2 0 2 3 3 2 2 1 3 3 3 0 0 1 0 1 0 1 
012 0 0 0 0 0 0 2 0 1 0 1 2 3 0 0 2 0 0 2 2 
013 2 2 1 0 0 1 2 1 0 0 3 2 3 0 0 1 2 1 0 1 
014 1 2 0 1 0 1 1 0 2 0 0 2 1 0 0 1 0 0 1 1 
015 1 1 3 2 2 4 4 4 0 2 3 4 4 3 2 3 3 0 4 3 
016 1 1 2 2 0 2 0 1 3 0 1 2 2 0 0 1 2 1 1 1 
017 1 1 1 2 1 2 2 1 2 2 1 3 3 2 0 1 2 1 1 1 
018 2 1 2 0 0 0 2 1 0 0 1 2 2 2 4 1 3 3 0 1 
019 1 0 1 0 0 0 2 0 2 0 1 2 1 0 0 1 0 0 2 1 
020 0 2 4 0 2 4 1 2 0 4 1 4 2 3 0 2 0 0 2 3 
021 1 1 1 1 0 1 1 1 2 1 0 2 2 0 0 1 0 0 4 2 
022 1 1 2 1 0 1 0 1 3 0 3 4 4 1 0 0 2 2 1 0 
023 0 0 1 0 0 0 2 0 1 0 0 1 1 0 1 1 0 0 1 0 
024 1 0 1 0 2 3 0 2 2 3 3 2 3 0 0 3 0 0 3 3 
025 0 1 2 0 1 2 1 0 1 2 1 4 2 0 2 1 1 0 2 1 
026 0 0 2 0 2 0 2 1 2 0 2 3 2 0 0 1 0 1 1 1 
027 ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe 
028 1 2 0 0 1 1 2 0 2 0 1 3 2 0 0 1 0 0 1 1 
029 2 0 0 0 0 0 2 0 0 0 0 0 0 0 1 0 0 1 0 0 
030 2 1 2 2 1 3 2 2 1 2 2 2 2 1 0 2 2 2 1 1 
ONe = questionnaire not completed 
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Insight study - P AlD results of aU subjects at 6 months contd 
Question number (PAID questionnaire) l 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
031 2 2 2 0 0 3 2 1 1 3 1 4 0 1 3 3 3 0 3 3 
032 3 3 4 2 2 3 4 3 2 2 2 3 4 3 1 2 3 3 2 3 
033 0 0 1 0 0 1 1 0 0 0 0 1 1 0 0 0 0 0 0 0 
034 0 2 1 2 0 2 1 2 0 2 2 1 1 0 1 2 0 1 0 1 
035 0 0 1 0 0 1 0 0 1 1 2 2 0 0 0 1 0 0 0 1 
036 ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe 
037 ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe 
038 3 2 3 1 1 1 2 0 1 2 3 4 4 1 2 1 2 1 1 2 
039 1 1 0 0 0 1 0 0 3 0 2 1 0 0 0 0 0 0 1 0 
040 0 0 0 1 0 0 0 0 1 0 0 1 2 0 0 0 0 1 0 0 
041 1 1 1 0 1 2 3 0 2 1 1 3 2 0 0 1 1 1 0 0 
042 0 0 0 2 2 2 1 0 2 1 1 1 1 0 0 2 1 0 1 1 
043 1 0 2 0 0 2 1 1 0 0 1 2 2 0 2 1 0 0 0 1 
044 0 1 1 1 1 0 0 1 2 0 1 1 1 1 1 1 0 0 1 1 
045 0 0 1 0 0 1 0 0 1 0 0 2 1 0 1 1 1 1 0 1 
046 2 3 1 2 0 1 0 0 0 0 0 2 0 0 2 3 2 2 3 2 
047 2 0 2 2 2 2 2 2 2 2 2 2 3 2 1 1 1 2 2 2 
048 0 0 0 0 1 0 1 0 1 0 1 2 1 0 2 0 0 0 1 0 
049 0 0 0 1 0 1 0 0 1 0 0 1 0 0 0 0 0 1 0 o I 
050 ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe ONe l 
051 0 0 1 0 1 1 1 0 1 1 0 1 0 0 0 0 0 0 _ 0 ol 
ONe = questionnaire not completed 
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Insight study· PAID results of all subjects at 1 
year 
1 2 3 4 5 6 
001 1 1 2 1 1 2 
002 0 a a a 1 0 
003 0 a 1 a a 1 
004 1 2 a 0 a 1 
005 1 2 a a a 1 
006 0 0 0 a 0 0 
007 2 0 2 4 1 3 
008 1 0 a a 1 1 
009 0 a 0 a 0 0 
010 a a 0 a 0 a 
011 0 0 2 a 2 3 
012 ONe ONe ONe ONe ONe ONe 
013 2 2 1 a 0 1 
014 1 a 1 1 a 1 
015 1 1 3 2 2 4 
016 1 1 2 2 a 2 
017 1 1 1 2 1 2 
018 ONe ONe ONe ONe ONe ONe 
019 1 0 1 0 0 0 
020 0 2 4 0 2 4 
021 1 1 1 1 a 1 
022 1 1 2 1 0 1 
023 0 0 1 a a 0 
024 1 0 1 0 2 2 
025 0 1 2 a 1 2 
026 0 0 2 0 2 0 
027 ONe ONe ONe ONe ONe ONe 
028 1 2 0 0 1 1 
029 2 0 0 a 0 0 
030 2 1 2 2 1 2 
ONe = questionnaire not completed 
7 
2 
1 
1 
0 
a 
a 
4 
1 
0 
a 
3 
ONe 
2 
1 
4 
a 
2 
ONe 
2 
1 
1 
a 
2 
0 
1 
2 
ONe 
2 
2 
2 
----
Question number1PAIDquestionnaire) 
8 9 10 11 12 13 
2 1 1 2 1 1 
a a 2 2 1 a 
1 1 a a a a 
a a a 3 a a 
a 0 a 3 a a 
a 1 a 0 1 1 
2 4 a a 3 4 
a a 1 1 1 1 
0 0 a 0 1 1 
a 0 a a a 0 
2 2 1 3 3 3 
ONe ONe ONe ONe ONe ONe 
1 a a 3 2 3 
0 1 a 0 1 1 
4 0 2 3 4 4 
1 3 a 1 2 2 
1 2 2 1 3 3 
ONe ONe ONe ONe ONe ONe 
0 2 a 1 2 1 
2 a 4 1 4 2 
1 2 1 0 2 2 
1 3 0 3 4 4 
a 1 a 0 1 1 
2 3 2 2 3 3 
a 1 2 1 4 2 
1 2 0 2 3 2 
ONe ONe ONe ONe ONe ONe 
0 2 0 1 3 2 
0 0 0 0 0 0 
2 1 2 2 2 2 
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14 15 16 17 18 19 20 
1 1 2 1 1 2 1 
1 a a a 1 1 0 
1 2 a a 1 a 1 
1 a 1 a a 2 2 
1 a 1 a a 2 2 
a a a a a 1 0 
3 a 1 1 a 3 4 
0 a 0 0 a a 0 
0 a a 0 a 0 0 
a a a a a 0 a 
0 a 1 a 1 a 1 
ONe ONe ONe ONe ONe ONe ONe 
a 0 1 2 1 2 1 
a a 1 a a 1 1 
3 2 3 3 0 4 3 
a a 1 2 1 1 1 
2 a 1 2 1 1 1 
ONe ONe ONe ONe ONe ONe ONe 
a 0 1 a 0 2 1 
3 a 2 0 0 2 3 
a a 1 a 0 4 2 
1 0 a 2 2 1 0 
a 1 1 a a 1 0 
a a 2 a a 3 3 
a 2 1 1 a 2 1 
a 0 1 a 1 1 1 
ONe ONe ONe ONe ONe ONe ONe 
0 a 1 0 0 1 1 
0 1 0 0 1 a 0 
1 a 2 2 2 1 1 
lnsight study· PAlO results of an subjects at 1 year 
contd 
1 2 3 4 5 6 
031 2 2 2 0 0 1 
032 4 3 4 2 2 2 
033 0 0 1 0 0 1 
034 0 2 1 2 0 2 
035 0 0 1 0 0 1 
036 ONC QNC ONC QNC ONC QNC 
037 ONC QNC QNC QNC ONC QNC 
038 3 2 3 1 1 1 
039 1 1 0 0 0 1 
040 0 0 0 1 0 0 
041 1 1 1 0 1 2 
042 0 0 0 2 2 2 
043 0 0 1 0 1 1 
044 0 1 2 2 1 0 
045 0 1 0 0 0 1 
046 2 3 1 2 1 1 
047 3 2 2 2 1 3 
048 2 3 2 1 0 1 
049 1 2 0 0 0 1 
050 0 0 3 0 1 2 
051 0 0 1 1 0 0 
ONC = questionnaire not completed 
Question number (PAID questionnaire) 
7 8 9 10 11 12 13 
2 1 1 3 1 4 0 
3 2 2 3 2 2 3 
1 0 0 0 0 1 1 
1 2 0 2 2 1 1 
0 0 1 1 2 2 0 
QNC ONC QNC ONC ONC QNC QNC 
QNC ONC QNC QNC QNC QNC ONC 
2 0 1 2 3 4 4 
0 0 3 0 2 1 0 
0 0 1 0 0 1 2 
3 0 2 1 1 3 2 
1 0 2 1 1 1 1 
0 0 0 0 2 1 2 
0 1 2 0 1 1 1 
0 0 1 0 1 1 2 
1 0 0 0 0 2 0 
3 3 2 2 3 3 3 
1 0 2 0 1 2 3 
1 1 2 0 2 0 1 
3 2 1 2 1 1 2 
0 0 1 0 1 0 0 
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14 15 16 17 18 19 20 
1 3 3 3 0 3 3 
3 1 3 2 3 2 3 i 
0 0 0 0 0 0 0 , 
0 1 2 0 1 0 1 
0 0 1 0 0 0 1 
QNC QNC QNC QNC QNC QNC QNC 
ONC QNC QNC QNC QNC QNC QNC 
1 2 1 2 1 1 2 
0 0 0 0 0 1 0 
0 0 0 0 1 0 0 
0 0 1 1 1 0 0 , 
0 0 2 1 0 1 1 
0 0 0 0 0 1 0 I 
1 0 1 0 0 1 0 
1 1 2 1 0 1 2 
0 2 1 1 1 2 2 
3 1 1 3 2 3 3 
0 3 1 0 0 3 1 
0 2 0 1 1 1 0 
2 0 2 2 0 0 3 
0 0 1 0 o~ ~--- 0 
InSight study - hypoglycaemia questionnaire results of all subjects at baseline 
Question number 
1 2 3 4 5 6 7 8 
001 alwa:is no once twice once twice once a week never 3.5-4.0 often 
002 sometimes xes more more once a week never 3.0-3.5 sometimes 
003 always no never never 2-3 times never 3.5-4.0 often 
004 always yes once twice never once a week never 3.0-3.5 often 
005 sometimes yes more once twice 2-3 times 2-3 times less than 3.0 sometimes 
006 always yes never never 2-3 times never 3.0-3.5 often 
007 no longer yes more more once a week 2-3 times less than 3.0 rarely 
008 sometimes no never never never never 3.5-4.0 sometimes 
009 always yes never never 2-3 times never 3.5-4.0 often 
010 always yes never never once a week never 3.5-4.0 always 
011 always no never never 1-3 times never 3.5-4.0 often 
012 sometimes yes never never daily 1-3 times less than 3.0 often 
013 sometimes yes more never once a week 1-3 times less than 3.0 sometimes 
014 sometimes ~es never never daily_ 1-3 times 3.0-3.5 often 
015 always no once twice more 1-3 times never 3.5-4.0 always 
016 sometimes yes never never 2-3 times 1-3 times 3.0-3.5 often 
017 alwaYJi no once twice once twice dailv never less than 3.0 often 
018 always no never never once a week never 3.5-4.0 always 
019 sometimes yes once twice once twice 2-3 times 1-3 times 3.5-4.0 often 
020 always yes more never once a week never less than 3.0 always 
021 no longer yes more once twice once a week 2-3 times less than 3.0 sometimes 
022 sometimes yes never never 1-3 times once a week less than 3.0 often 
023 always no once twice never 1-3 times never 3.5-4.0 often 
024 always yes never never 2-3 times never less than 3.0 always 
025 always no never never 2-3 times never 3.5-4.0 always 
026 always no never never 1-3 times never 3.5-4.0 often 
027 sometimes no once twice never once a week never 3.5-3.5 always 
028 sometimes yes more never once a week 1-3 times 3.5-3.5 sometimes 
029 always no never never 2-3 times never 3.5-4.0 often 
030 __ ~waYL_. no - - never never 1-3 times never 3.5-4.0 always 
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InSight study - hypoglycaemia questionnaire results of all subjects at baseline contd 
Question number 
031 1 2 3 4 5 6 7 8 
032 always no never never 1-3 times never 3.5-4.0 often 
033 always yes never never 1-3 times never 3.5-4.0 often 
034 always no never never 2-3 times never 3.0-3.5 often 
035 sometimes yes once twice never 2-3 times never 3.0-3.5 often 
036 always no never never 2-3 times 1-3 times 3.0-3.5 always 
037 always no never never never 1-3 times 3.0-3.5 always 
038 always no never never 1-3 times never 3.5-4.0 often 
039 no longer yes more once twice never 1-3 times less than 3.0 rarely 
040 alwa~s no more never once a week once a week 3.0-3.5 always 
041 sometimes yes never never once a week 1-3 times 3.5-4.0 often 
042 sometimes yes once twice never never never 3.5-4.0 often 
043 always no never never 2-3 times never 3.5-3.5 always 
044 always no never never daily once a week 3.5-4.0 always 
045 always no once twice never 1-3 times never 3.5-4.0 always 
046 sometimes yes more once twice daily 2-3 times 3.5-4.0 rarely 
047 alway_s no never never once a week never 3.5-4.0 always 
048 sometimes no once twice once twice 2-3 times never less than 3.0 often 
049 sometimes yes never never 2-3 times 1-3 times less than 3.0 often 
050 always yes never never once a week never 3.5-4.0 often 
051 _ alwaYli_ no -_.- never - never once a week never 3.5-4.0 ~alw~ _ 
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InSight study· hypoglycaemia questionnaire results of all subjects at 6 months 
Question number 
1 2 3 4 5 6 7 8 
001 always no once or twice never never never 3.5-4.0 always 
002 always no once or twice never 1-3 times never 3.5-4.0 often 
~03 always no never never once never 3.5-4.0 always 
004 always yes never never 1-3 times never 3.0-3.5 always 
005 always yes once or twice never 1-3 times 1-3 times 3.0-3.5 often 
006 always yes never never once once week 3.0-3.5 often 
007 no longer yes more more 1-3 times 2-3 times less than 3.0 rarely 
008 always no never never never never 3.5-4.0 sometimes 
009 always no once or twice never 1-3 times never 3.5-4.0 often 
010 always no never never once once week 3.5-4.0 often 
011 always no never never 2-3 times once week 3.5-4.0 always 
012 always yes never never 2-3 times never 3.0-3.5 always 
013 always yes never never 1-3 times never 3.5-4.0 often 
014 sometimes yes never never daily 1-3 times 3.0-3.5 often 
015 always no never never 1-3 times never 3.5-4.0 always 
016 always yes never never 2-3 times once week 3.0-3.5 always 
017 always yes once or twice never 2-3 times never 3.0-3.5 often 
018 always no never never once a week never 3.5-4.0 always 
019 sometimes yes once or twice never 1-3 times never 3.0-3.5 often 
020 always no more never once never 3.5-4.0 always 
021 sometimes yes never never 1-3 times 1-3 times less than 3.0 often 
022 sometimes yes never never 2-3 times once week 3.0-3.5 often 
023 always no never never 1-3 times never 3.5-4.0 always 
024 always yes never never 2-3 times never less than 3.0 always 
025 always no never never 2-3 times never 3.5-4.0 always 
026 always no never never once never 3.5-4.0 often 
027 ONe ONC ONe ONe ONe ONC ONe ONe 
028 sometimes yes more once twice 2-3 times once week 3.0-3.5 often 
029 always no never never 2-3 times never 4.0-4.5 often 
030 always no never never 1-3 times never 3.5-4.0 always 
ONe = questionnaire not completed 
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InSight study - hypoglycaemia questionnaire results of all subjects at 6 months contd 
Question number 
1 2 3 4 5 6 7 8 
031 always no never never 1-3 times never 3.5-4.0 often 
032 always no never never 1-3 times never 3.5-4.0 often 
033 alway_s yes never never 1-3 times never 3.5-4.0 always 
034 always no never never 1-3 times never 3.5-4.0 always 
035 always yes never never 1-3 times never 3.0-3.5 often 
036 ONe ONe ONe ONe ONe ONe ONe ONe 
037 ONe ONe ONe ONe ONe ONe ONe ONe 
038 always no never never 1-3 times never 3.5-4.0 often 
039 no 101'l~er yes more more 2-3 times 2-3 times less than 3.0 rarely 
040 always no never never once never 3.0-3.5 often 
041 always yes never never once never 3.5-4.0 often 
042 always yes once or twice never never never 3.5-4.0 always 
043 always no never never 2-3 times never 3.0-3.5 often 
044 always no never never daily once a week 3.5-4.0 always 
045 always no never never 2-3 times once week 3.5-4.0 always 
046 sometimes yes more once twice daily 2-3 times 3.5-4.0 rarely 
047 always no never never 1-3 times never 3.5-4.0 always 
048 always yes once or twice once twice 1-3 times 1-3 times less than 3.0 often 
049 no longer yes never never once 2-3 times 3.5-4.0 sometimes 
050 ONe ONe ONe ONe ONe ONe ONe ONe 
051 always no never never once never 3.5-4.0 always 
ONe = questionnaire not completed 
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InSight study· hypoglycaemia questionnaire results of all subjects at 1 year 
Question number I 
1 2 3 4 5 6 7 8 
001 always no once or twice never never never 3.5-4.0 always 
002 always no once or twice never 1-3 times never 3.5-4.0 often 
003 always no never never once never 3.5-4.0 always 
004 alwa~s yes once or twice never 1-3 times 1-3 times 3.0-3.5 often 
005 always yes once or twice never 1-3 times 1-3 times 3.0-3.5 often 
006 always yes never never once once-week 3.0-3.5 often 
007 no longer yes more more 1-3 times 2-3 times less than 3.0 rarely 
008 always no never never never never 3.5-4.0 always 
009 always no once or twice never 1-3 times never 3.5-4.0 often 
010 always no never never once once week 3.5-4.0 often 
011 always no never never 2-3 times once week 3.5-4.0 always 
012 ONC ONC ONC ONC ONC ONC ONC ONC 
013 always yes never never 1-3 times never 3.5-4.0 often 
014 always yes never never daily 1-3 times 3.0-3.5 always 
015 always no never never 1-3 times never 3.5-4.0 always 
016 always xes never never 2-3 times once week 3.0-3.5 always 
017 always yes once or twice never 2-3 times never 3.0-3.5 often 
018 ONC ONC QNC ONC ONC ONC ONC ONC 
019 sometimes yes once or twice never 1-3 times never 3.0-3.5 often 
020 always no more never once never 3.5-4.0 always 
021 sometimes ~es never never 1-3 times 1-3 times less than 3.0 often 
022 sometimes yes never never 2-3 times once week 3.0-3.5 often 
023 always no never never 1-3 times never 3.5-4.0 always 
024 always yes never never 2-3 times never less than 3.0 always 
025 always no never never 2-3 times never 3.5-4.0 always 
026 always no never never once never 3.5-4.0 often 
027 ONC ONC QNC ONC ONC ONC QNC ONC 
028 sometimes yes more once or twice 2-3 times once week 3.0-3.5 often 
029 always no never never 2-3 times never 4.0-4.5 often 
~30_ _.always no never never ~3times never __ _ 3.~.0 always 
-- --
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InSight study - hypoglycaemia questionnaire results of all subjects at 1 year contd 
Question number 
1 2 3 4 5 6 7 8 
031 always no never never 1-3 times never 3.5-4.0 always 
1032 always no never never 1-3 times never 3.5-4.0 always 
033 alwa~s yes never never 1-3 times never 3.5-4.0 always 
034 always no never never 1-3 times never 3.5-4.0 always 
035 always yes never never 1-3 times never 3.0-3.5 often 
036 ONe ONe ONe ONC ONC ONe ONe ONe 
037 ONe ONe ONe ONe ONe ONe ONe ONe 
P38 always no never never 1-3 times never 3.5-4.0 often 
039 no longer yes more more 2-3 times 2-3 times less than 3.0 rarely 
040 always no never never once never 3.0-3.5 often 
041 always yes never never once never 3.5-4.0 often 
042 always yes once or twice never never never 3.5-4.0 always 
043 always no never never once never 3.5-4.0 often 
044 always no never never 2-3 times once week 3.5-4.0 often 
045 always no never never 2-3 times 1-3 times 3.5-4.0 often 
046 always yes more once twice daily 2-3 times 3.5-4.0 always 
047 always no never never once a week never 3.5-4.0 always 
048 always no once twice never 2-3 times never less than 3.0 always 
049 sometimes xes never never 2-3 times 1-3 times less than 3.0 often 
050 always yes never never once a week never 3.5-4.0 often 
051 always_ no never never once a week never 3.5-4.0 always -- -- --- - ---------
ONe questionnaire not completed 
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